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Abstract 
 
The enzyme 3-deoxy D-arabino-heptulosonate 7-phosphate (DAH7P) synthase 
catalyses the first step of the shikimate pathway. This pathway lies at the heart of 
bacterial metabolism, and is responsible for the synthesis of a variety of compounds 
essential to the chemistry of life; from the aromatic amino acids phenylalanine, 
tyrosine and tryptophan, to a number of aromatic and non-aromatic natural products. 
 
 
This thesis describes the design, synthesis and evaluation of inhibitors of DAH7P 
synthase. These inhibitors exploit a variety of strategies to interrupt the activity of 
DAH7P synthase, ranging from simple substrate mimicry to inhibitors that mimic 
unstable reaction intermediates; inhibitors that exploit metal coordination and entropic 
effects, and inhibitors that gain improved potency by interacting with multiple sites. 
 
In Chapter Two, the synthesis of a mimic for a proposed unstable reaction 
intermediate is described, and its interaction with DAH7P synthase characterised. The 
compound was prepared in twelve steps from D-arabinose, and was found to be a 
slow-tight binding inhibitor of Escherichia coli DAH7P synthase. 
 
 
 
In Chapter Three, a number of compounds are prepared that were designed to bind to 
the phosphoenolpyruvate subsite of the DAH7P synthase active site. The binding of 
these compounds to the enzyme is investigated in order to gain an understanding of 
iv 
the factors involved in DAH7P synthase inhibition. The enantiomeric phospholactates 
were prepared, and the extent of inhibition of E. coli DAH7P synthase was shown to 
be dependent on compound chirality. Several other phosphoenolpyruvate-like 
molecules were prepared, and were also shown to be effective DAH7P synthase 
inhibitors. 
 
 
 
In Chapter Four extended compounds are designed that will bind the enzyme by 
multiple interactions at both substrate binding sites. Four compounds were prepared, 
and an increase in inhibitory potency was observed.  
 
 
 
In Chapter Five computational techniques are explored to aid the interpretation of the 
inhibition of DAH7P synthase by the compounds prepared in these studies. Several 
approaches for more potent inhibition of this enzyme are outlined and discussed. 
v 
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Chapter One: Introduction 
 
1.1 The shikimate pathway 
 
The shikimate pathway is a biosynthetic pathway responsible for producing a variety 
of organic compounds necessary for life. The pathway converts D-erythrose 4-
phosphate (E4P), a product of the pentose phosphate pathway, and two molecules of 
phosphoenolpyruvate (PEP) to chorismate (Figure 1.1).1 
 
2-O3PO
O
OH
OH
PEP Pi
O
OH
HO
OH
CO2
-
2-O3PO
DAH7P
synthase
O
CO2
-
OH
OH
HO
DHQ
synthase
CO2
-
OH
OHO
CO2
-
OH
OHHO
CO2
-
OH
OH2-O3PO
CO2
-
OH
O2-O3PO
PEP Pi
EPSP
synthase
ATPADP
shikimate
kinase
dehydroquinase
shikimate
dehydrogenase
chorismate
synthase
shikimic acid
CO2
-
CO2
-
OH
O
chorismate
CO2
-
E4P
 
Figure 1.1 The shikimate pathway, and a selection of downstream products 
 
Chorismate is at a metabolic branch point, and is converted into a variety of 
compounds of utility in the cell (Figure 1.2). 
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Figure 1.2: The diverse fates of chorismate 
 
In a series of enzymatic steps, chorismate is converted into the three aromatic amino 
acids tyrosine, phenylalanine and tryptophan. These compounds are required not only 
for the synthesis of proteins, but a variety of other aromatic compounds. In addition to 
serving as a feedstock for amino acid biosynthesis, chorismate is converted directly 
into other compounds performing diverse roles in life, such as the antibiotic natural 
product echinosporin2, a defensive antibiotic produced by some Streptomyces species; 
the electron transfer agent menaquinone3; a necessity for bacterial aerobic 
metabolism, and enterobactin4, a siderophore which allows bacteria to scavenge 
iron(III) from the low iron environments found inside other organisms. 
 
The shikimate pathway is present in plants, bacteria, fungi and apicomplexan 
parasites5; such as Toxoplasma gondii, Cryptosporidium parvum and Plasmodium 
falciparum; responsible for the human diseases toxoplasmosis, cryptosporidiosis and 
malaria, respectively. The pathway is absent in animals, and consequently the 
pathway has attracted interest as a target for medicines and herbicides.6, 7 This 
Chapter One: Introduction   3 
 
pathway has been shown to be essential in some disease causing organisms; for 
example gene disruption studies have shown that the pathway is essential for the 
viability of Mycobacterium tuberculosis.8 The pathway has also recently attracted 
interest as a target for bioengineering for the industrial scale synthesis of chiral pool 
compounds such as (-)-shikimic acid9; the starting material for the Roche industrial 
synthesis of the anti-viral neuraminidase inhibitor oseltamivir phosphate (Tamiflu®) 
(Figure 1.3). The availability of shikimic acid from natural sources is low, and Roche 
already consumes 95% of the annual harvest of Chinese star anise (the most cost 
effective natural source) at current oseltamivir production levels.10 
 
 
Figure 1.3: The utility of shikimate pathway compounds as chiral pool materials: shikimic acid 
and oseltamivir phosphate (Tamiflu®) 
 
The herbicide glyphosate, a molecule of enormous commercial and agricultural value, 
is an inhibitor of the sixth step of the pathway, 5-enolpyruvyl-shikimate 3-phosphate 
(EPSP) synthase11 (Figure 1.4). In addition to its success as a herbicide, glyphosate 
shows limited antimicrobial activity12; and inhibits the growth of apicomplexan 
parasites in vivo.5 The success of this compound demonstrates the potential of 
shikimate pathway inhibitors as herbicidal and antimicrobial agents. 
 
 
Figure 1.4: Glyphosate, and the target of its action. Inhibition data is shown for the EPSP 
synthase from the weed goosegrass (Eleusine indica).13 
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1.2 DAH7P synthase 
 
1.2.1 Enzyme mechanism 
 
The first step of the shikimate pathway is catalysed by the enzyme 3-deoxy-D-
arabino-heptulosonate 7-phosphate (DAH7P) synthase, which catalyses an aldol-like 
reaction between E4P and PEP to form the seven carbon sugar DAH7P (Figure 1.5)1. 
 
 
Figure 1.5: The reaction catalysed by DAH7P synthase 
 
An analogous reaction with the five carbon sugar D-arabinose 5-phosphate is 
catalysed by 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P) synthase. This 
enzyme is discussed in detail in Section 1.3. DAH7P synthase is known to exist as 
three isozymes in Escherichia coli, which are each subject to feedback inhibition by 
phenylalanine, tyrosine or tryptophan.1 This feedback inhibition mechanism has been 
shown to be the major regulatory mechanism for the entire shikimate pathway.14 In 
addition, the shikimate pathway is responsible for up to 30% of the total carbon flux 
within the cell, so this makes DAH7P synthase a vital part of the overall control of 
cellular carbon flux.1 Consequently, being able to interrupt the activity of this enzyme 
could have widespread cellular effects, making inhibitors of DAH7P synthase of 
particular interest for development as antibiotics or herbicides. 
 
DAH7P synthase(phe), the phenylalanine inhibited isozyme of DAH7P synthase, is 
responsible for approximately 80% of the DAH7P synthase activity in E. coli, and 
remainder is made up by DAH7P synthase(tyr) (~20%) with very little contribution 
from DAH7P synthase(trp) (<1% total activity).1 
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The mechanism of DAH7P synthase has been investigated by a number of groups, 
and a number of key observations have been made. Unusually, DAH7P synthase 
catalyses the cleavage of the C-O bond of PEP15 (Figure 1.5); typically enzymes 
utilising PEP make use of the high energy contained in the phosphate ester bond (∆G° 
= -62 kJ mol-1) by cleavage of the oxygen-phosphorus bond of PEP. 
 
All DAH7P synthases require a divalent metal ion for activity, and reactivation 
studies of the three E. coli apoenzymes has shown activity is dependent on the metal 
present, with the order of activity Mn2+ > Cd2+, Fe2+ > Co2+ > Ni2+, Cu2+, Zn2+ >> 
Ca2+.16 The nature of the metal ion bound in vivo is a matter of dispute, since the 
highly active Mn2+ complex is also rather labile, and prone to displacement by other 
ions, particularly Fe2+, Co2+ and Zn2+, which form more stable metal-enzyme 
complexes. The metal dependencies of DAH7P synthases from other organisms have 
been studied; while the metal ions that provide activity are generally the same, the 
relative order of activity varies from species to species.17-21 
 
Analysis of the product of the reaction utilising stereospecifically deuterated PEP 
shows that the addition proceeds in a stereospecific manner, with the si face of PEP 
attacking the re face of E4P22 (Figure 1.6). 
 
OPO3
2-
CO2
-
O
H OH
HO OPO3
2-
re
si
 
Figure 1.6: Stereospecificity of the DAH7P synthase reaction 
 
Detailed kinetic studies have shown that the reaction proceeds through an ordered 
sequential mechanism, where PEP binds to the enzyme first, followed by E4P, 
followed by phosphate release, followed by DAH7P release.23 The reaction is also 
irreversible under physiological conditions, based on the failure of DAH7P synthase 
to exchange 32P-labelled phosphate into PEP, and the failure of DAH7P synthase to 
exchange 14C into DAH7P from [U-14C]-PEP.23  
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The mechanism of DAH7P synthase has been the subject of some debate, and the 
most chemically plausible mechanism is shown in Figure 1.7. 
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Figure 1.7: Key points of the favoured mechanism for DAH7P synthase 
 
In the mechanism (Figure 1.7), the electron rich enol alkene of PEP attacks the 
carbonyl group of E4P, which has been activated by coordination of the carbonyl to 
the metal ion. The resulting oxocarbenium ion is attacked by water, giving rise to a 
labile phosphate hemiketal intermediate. This intermediate can undergo loss of 
phosphate, forming the C2 carbonyl of DAH7P and giving the required C-O 
phosphate bond cleavage. Product release, followed by spontaneous cyclisation in 
solution gives rise to cyclic DAH7P. 
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Other variants of this mechanism have been proposed at various times. One possibility 
has been instead of the oxocarbenium ion being intercepted by water, it is intercepted 
intramolecularly by the C3 hydroxyl of E4P, giving a cyclic phosphate hemiketal. 
Explusion of phosphate and interception of the oxonium ion by water would then give 
the cyclic form of DAH7P, which would be released into solution. This mechanism 
has been discredited by a number of observations. The compound 3-deoxyE4P is a 
substrate for the reaction, so if this mechanism does operate, it is not the exclusive 
mechanism of DAH7P formation.24 In addition, the study of the structures of DAH7P 
synthase from a number of species by X-ray crystallography has shown that in every 
case the DAH7P synthase active site forms a long linear pocket, in which there is 
insufficient space for such an intramolecular cyclisation.17, 25-29 
 
The exact role of the metal ion in DAH7P synthase and related enzymes has been the 
subject of some debate, and two competing views are held (Figure 1.8). In one view 
(the Lewis acid mechanism), the metal encourages attack of PEP on E4P by 
withdrawing electron density from the E4P carbonyl as presented earlier. In the other 
view (the carbanion mechanism), the coordination of a water molecule by the metal 
creates a metal-generated hydroxide ion, which can attack PEP at the C2 position. The 
electrons of the PEP alkene then attack the aldehyde of E4P, either through the 
intermediacy of a free carbanion30 (path b) or through a concerted mechanism 31 (path 
a). 
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Figure 1.8: The two competing roles for the metal ion in DAH7P synthase 
 
There are a number of problems with the proposed carbanion mechanism. It requires 
PEP to have an otherwise unprecedented electrophilic character at C2, in order for the 
attack of hydroxide to occur. In addition, in the free carbanion variant it requires the 
existence of a resonance unstabilised carbanion, with a likely pKa of >30, inside an 
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enzyme active site populated by carbon-hydrogen bonds of greater acidity; in addition 
to water molecules, carboxylic acids and ammonium ions. Thus it is likely that 
anything other than the most transient of carbanions would immediately be quenched 
by hydrogen abstraction from another active site species. The need to propose such an 
unprecedented mechanism becomes even further lessened when one considers the 
number of known abiotic Lewis acid promoted alkene-carbonyl reactions; such as the 
Mukaiyama aldol reaction32 and Evans asymmetric copper-catalysed ene reaction 
(Figure 1.9).33 
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Figure 1.9: Examples of abiotic alkene-carbonyl reactivity promoted by Lewis acids 
 
Furthermore, studies of model compounds has shown the necessary Lewis acid 
promoted reaction can occur, provided the reaction is intramolecular34 (Figure 1.10). 
The reaction occurs rapidly under anhydrous conditions (tin tetrachloride in cold 
dichloromethane), with an excess of Lewis acid, and gives a single configuration at 
the former aldehyde centre (C4). The initially formed strained 
dioxabicyclo[2.2.1]heptane is unstable to the reaction conditions, and undergoes 
Lewis acid catalysed ring opening. Subsequent reaction of the mixture with acidic 
methanol returned the monocylic compound in excellent yield. 
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Figure 1.10: A model system for the Lewis acid mechanism 
 
The reaction also occurs under aqueous conditions with a related substrate, utilising 
mildly acidic conditions (pH 5) and zinc(II) chloride as a promoter, leading directly to 
the product as a single epimer at C4 (Figure 1.11). Omitting the Lewis acid but 
reacting at the same pH gives slowed consumption of the enol ether (t1/2 ~ 22 hr). In 
addition, rather than exclusive formation of a single product with D-manno 
stereochemistry, the 4-epi D-gluco diastereomer is also formed in a 55:45 D-manno: 
D-gluco ratio (68% yield based on consumed enol ether), along with breakdown 
products (32% yield from consumed enol ether). These precedents demonstrate that 
the reaction can occur under Lewis acid promoted conditions, and in the presence and 
absence of water. This casts additional doubt on the proposed carbanionic mechanism. 
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Figure 1.11: An aqueous model system Lewis acid promoted reaction 
 
1.2.2 Enzyme structure  
 
The family of DAH7P synthases have been broadly divided into two groups based on 
sequence similarities; type I and type II DAH7P synthases35 (Figure 1.12). Sequence 
similarities between the two families is ~10%, below the level of significance for such 
a measurement. Type II DAH7P synthases are distinct in sequence and size (typically 
~50 kDa) from type I DAH7P synthases. While originally identified in plants, a large 
number of bacterial DAH7P synthases (such as those from M. tuberculosis, 
Helicobacter pylori and Campylobacter jejuni) have recently been identified as 
belonging to this group. 
 
 
Figure 1.12: The families of DAH7P synthases based on sequence similarity 
 
Type I DAH7P synthases have masses of less than 40 kDa; and represent the most 
well characterised family of DAH7P synthases. The family is further subdivided on 
sequence into two subfamilies, Iα and Iβ. The Iβ family is considered ancestral to all 
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DAH7P and KDO8P synthases; and contains species of comparatively ancient 
lineages such as Pyrococcus furiosus and Thermotoga maritima.36 
 
The most well characterised examples of DAH7P synthase activity are those from 
Escherichia coli. The three enzymes from E. coli are Type Iα, all approximately 38 
kDa in size, and are closely related in sequence. The structures of these enzymes have 
been investigated by X-ray crystallography. The tertiary structures of the E. coli 
enzymes are (β/α)8 TIM barrel folds27, with the active site located near the C-terminal 
end of the barrel, as is typical with enzymes of this fold.37 
 
 
 
Figure 1.13: Top (left) and side (right) views of a monomeric enzyme unit from E.coli DAH7P 
synthase(phe), with helical (red), sheet (yellow) and loop (green) regions indicated. PEP (C/O/P 
blue/red/orange respectively), manganese (grey sphere) and a sulfate ion (S/O gold/red 
respectively) are indicated; the sulfate ion can be taken as an estimate of the position of the 
phosphate group of E4P in the ternary enzyme-PEP-E4P complex. The side view is taken from 
the twelve-o-clock position relative to the top view. Drawn from 1n8f, chain A.38 
 
Amazingly, despite the large variations in sequence and size across the DAH7P 
synthase family, Type Iα27, Iβ29, and Type II17 DAH7P synthases all share the general 
(β/α)8 TIM barrel fold; additions of various domains such as regulatory modules 
comprising the major structural differences between species and classes. Furthermore, 
despite the low overall sequence similarity; the identity and positions of several key 
active site residues are absolutely conserved over all classes of DAH7P synthases 
(Figure 1.15). 
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These conserved residues are crucial to the operation of the enzyme, and are 
presumably so important that evolutionary change has not been permitted. The roles 
of these residues will be illustrated with examples from the structure of the E. coli 
Phe-repressible enzyme. 
 
The metal coordination site is strongly conserved with no natural variations in the four 
residues responsible for metal coordination across all classes of DAH7P synthase. In 
E. coli DAH7P synthase the metal atom is held in a distorted trigonal bipyrimidal 
geometry (Figure 1.14), coordinated to the enzyme via histidine, cysteine, asparate 
and glutamate residues (E. coli numbering: H268, C61, D326 and E302 respectively).  
 
 
Figure 1.14: Metal coordination environment in E. coli DAH7P synthase. The metal (in this case 
manganese(II)) is held to the enzyme via interactions with absolutely conserved cysteine, 
histidine, aspartate and glutamate residues. The fifth ligand is a water molecule, located in the 
E4P site. Bond distances are in angstroms, figure drawn from 1n8f.27 
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Sce             rttesq-lhrelasglsfpvgfkngtdgtlnvavdacqaaahshhfmgvtkhgvaaittt 
Pfu             rnsqnf-ellkevgkvenpvllkrgmgntiqellysaeyima------------------ 
Tma             rnaqnf-rllskagsynkpvllkrgfmntieefllsaeyian------------------ 
                *. :        .     ** .* *   * :  :   :                       
 
Eco             sgngdchiilrggke--------pnysakhvaevkeglnkaglpaqvmidfshanss--- 
Mtu             nkpgrltlvsrxgnh--------kv--rdllppivekvqatghqviwqcdpxhgnthess 
Sce             kgnehcfvilrggkk-------gtnydaksvaeakaql--pagsnglmidyshgnsn--- 
Pfu             qgnenvilcergirtfetatrftldi--savpvvkel-----shlpiivdpshpa----- 
Tma             sgntkiilcergirtfekatrntldi--savpiirke-----shlpilvdpshsg----- 
                .      :  *  .              . :.                 *  *        
 
Eco             -----kqfkkqmdvcadvcqqiaggekaiigvmveshlvegn------qsle--sgepla 
Mtu             tgfktrhfdrivdevqgffevhralgthpggihveitgenvteclggaqdis--etdlag 
Sce             -----kdfrnqpkvndvvceqiangenaitgvmiesninegn------qgipaegkaglk 
Pfu             -----grrslviplakaayai------gadgimvevhpepe------------------- 
Tma             -----grrdlviplsraaiav------gahgiivevhpepe------------------- 
                                              *: :*                          
 
Eco             ygksitd--acigwedtdallrqlanavkarrg----  key 
Mtu             ryetacd--prlntqqslelaflvaexlrd-------  metal 
Sce             ygvsitd—acigwettedvlrklaaavrqrrevnkk  PEP   
Pfu             --kalsdsqqqltfddflqllkelealgwkg------  re-water 
Tma             --kalsdgkqsldfelfkelvqemkkladalgvkvn-  E4P 
                   :  *    :  :    :   :              
 
 
Figure 1.15: Structure-based sequence alignment of DAH7P synthases from a variety of classes. 
Shown are enzymes from E. coli (Eco, Iα), M. tuberculosis (Mtu, II), Saccharomyces cerevisiae 
(Sce, Iα), P. furiosus (Pfu, IβD) and T. maritima (Tma, IβD). Roles of key residues discussed in the 
text are indicated. Alignment generated with Expresso, www.tcoffee.org. 
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In addition to these interactions, a water molecule is typically found as the fifth 
ligand, located in the E4P binding site. A comparatively long range (3.13 Å) 
interaction also exists with one carboxylate oxygen of PEP (not shown). 
 
Interestingly, despite a common metal binding site scaffold, relative metal preferences 
differ across species. For example, while the Type Iα E. coli DAH7P synthase has the 
relative activities16 of Mn2+ > Cd2+, Fe2+ > Co2+, for Type II M. tuberculosis DAH7P 
synthase the same metals have a different order of activity; namely Co2+ > Mn2+, Cd2+ 
>> Fe2+; with iron(II) being reportedly inactive.17 The reasons for differing metal 
activities across species remain to be determined. 
 
The water ligand of the metal centre could be replaced by the carbonyl oxygen of E4P 
in the enzyme-PEP-E4P ternary complex, activating the carbonyl group to attack. This 
interaction is yet to be observed by any experimental technique, however has been 
modelled into P. furiosus DAH7P synthase39; based on the structure a P. furiosus 
DAH7P synthase-PEP complex29, and of an inert S. cerevisiae DAH7P synthase-PEP-
glycerol 3-phosphate complex40 (Figure 1.16). 
 
Figure 1.16: E4P (pale blue/red/gold) modelled into P. furiosus DAH7P synthase-PEP complex, 
showing the metal coordination environment postulated to exist in the enzyme-PEP-E4P 
complex. The carbonyl oxygen-metal distance is indicated in angstroms. Residues interacting 
with PEP and E4P have been removed for clarity. Generated from the previously published 
model.39 
Chapter One: Introduction   15 
 
By simply adding an additional carbon to glycerol 3-phosphate (giving E4P), it can be 
seen that without any distortion of the conformation of the enzyme or the glycerol 3-
phosphate the carbonyl group passes within 2.9 Å of the metal ion, giving a distorted 
trigonal bipyrimidal geometry as observed before. This conformation presents the 
correct (re) face of the aldehyde to the si face of PEP, in accordance with the known 
stereochemical outcome of the DAH7P synthase reaction. PEP C3 sits close to E4P 
C1 (2.1 Å), and approaches at an angle compressed (74.4°) from the ideal Bürgi-
Dunitz trajectory for attack on a carbonyl (105±5°).41 This compression may reflect 
the increased polarisation of the carbonyl bond in the metal-carbonyl complex, or the 
likely differences between the model and the actual transition state geometry of the 
complex.  
 
In addition to conservation of the metal binding site, many other residues are 
conserved in the PEP binding site. 
 
Figure 1.17: The PEP site in E. coli DAH7P synthase. Shown is the si face of PEP (pale 
blue/red/orange), surrounding residues (grey/ blue/ red) and close water molecules (green). The 
metal and metal binding histidine have been deleted for clarity; the metal would positioned in the 
foreground, between the 8 and 9-o’clock position in this diagram. Distances to neighbouring 
polar atoms are indicated in angstroms. Drawn from 1n8f.pdb.27 
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As can be seen in Figure 1.17, PEP is recognised by a finely tuned network of non-
covalent interactions, mostly with the side chains of amino acids such as lysine and 
arginine, although a close approach (2.9 Å) with a main chain amide between glycine 
and alanine exists (E. coli numbering: G163, A164). In addition, some contact of the 
PEP phosphate group with the enzyme is mediated through water molecules. The 
positively charged residues mediating these interactions are conserved absolutely 
across all classes of DAH7P synthases (R165, K196, K97, R92 and R234; all marked 
in Figure 1.17). In addition G163 is absolutely conserved, for presumably steric 
reasons, while A164 is conserved across the Type I family of DAH7P synthases; in 
the Type II M. tuberculosis and H. pylori DAH7P synthases, the corresponding 
residue is glutamate.17, 18 
 
An interesting mechanistic point is illustrated by Figure 1.17. The combination of a 
R92 and K97 (and potentially the metal ion) interacting with the PEP carboxylate 
group, pulls the carboxyl group out of the plane of the PEP alkene, increasing the 
carboxylate-alkene dihedral angle. This phenomenon has been observed in a number 
of high resolution X-ray crystal structures of DAH7P synthase27, 28, 40, and the related 
enzyme KDO8P synthase42 (Section 1.3). It has been calculated that introducing this 
twist into the C1-C2 bond of PEP lowers the delocalisation across the α,β-unsaturated 
carboxylate system; localising the alkene electrons to the C2-C3 bond and increasing 
the nucleophilicity of the PEP C3.43 
 
In addition to these metal and PEP binding residues, several other residues are also 
conserved. On the re face of PEP, between PEP and the wall of the active site lies a 
hydrogen-bonded network of three water molecules, held in place by interactions 
amongst themselves, and with both PEP and the enzyme (Figure 1.18). 
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Figure 1.18: The hydrogen-bond network on the re face of PEP in E. coli DAH7P synthase. 
Shown are the water molecules (green, O1-O3), PEP (light blue/orange/red), and key residues. 
Visible in the background are H268, E302 and the manganese(II) atom, in the midground are the 
PEP-recognising residues R92 and R234. 
 
The glutamate residue holding in place the water O2, E143, is absolutely conserved in 
all classes of DAH7P synthase. Since the side chain of E143 does not make direct 
contact with either of the substrates, the metal cofactor or any enzyme residue, it 
follows that it has been preserved during evolution due to the necessity of having the 
water O2 on the re face of PEP during the reaction. This is supported by X-ray 
crystallography; the water at position O2 has been observed in a number of high 
resolution structures. 
 
This suggests that O2 may be one of the substrates of the reaction, and O2 could be 
conceivably used to quench the oxocarbenium ion intermediate of the reaction, and 
generate the hemiketal phosphate intermediate. The phosphate group of PEP could be 
used as a base to sequentially remove hydrogen atoms from O2, resulting in the 
protonation of phosphate during the final elimination, and the resulting elimination of 
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dianionic phosphate, which can be reasonably assumed to be more favourable than the 
elimination of trianionic phosphate (Figure 1.19). 
 
The water on the re face is well placed to attack the oxocarbenium ion, although 
admittedly the angle of attack toward the oxocarbenium ion is compressed relative to 
the ideal Bürgi-Dunitz trajectory for attack on a carbonyl (84.1° across the O2-PEP 
C2- enol O unit, compared to the Burgi-Dunitz angle of 105±5°).41 Although this may 
reflect the obvious electronic differences between a carbonyl group and the 
oxocarbenium ion. It is also of note that the re face water and the aldehyde of E4P are 
arranged in an anti manner across the PEP double bond. 
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Figure 1.19: A possible role for the conserved water-E143 system on the re face of PEP. The 
relative order of phosphate elimination and alkoxide protonation is not intended to be implied by 
this diagram. 
 
It is possible that O3 plays a role in the mechanism too, although it should be noted 
that tyrosine Y94 is not conserved in all DAH7P synthases, whereas it is conserved 
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across Iα DAH7P synthases in some Type Iβ and Type II DAH7P synthases (such as  
P. furiosus and M. tuberculosis DAH7P synthases) Y94 is replaced by a 
phenylalanine residue. 
 
The final group of absolutely conserved residues lie sequentially in the primary 
structure of the protein, forming an absolutely conserved KPRT(S) motif (E. coli 
numbering K97, P98, R99, T100) across all DAH7P synthases. From analysis of the 
X-ray crystal structure it is clear that this motif forms a binding pocket for the 
enzyme’s second substrate E4P (Figure 1.20). 
 
 
Figure 1.20: The conserved KPRT(S) motif as seen in E. coli DAH7P synthase structure 
1n8f.pdb27. Shown are PEP (pale blue/red/orange) the E. coli KPRT motif and an adventitious 
sulfate ion from the crystallisation conditions (gold/red). This sulfate can be considered a model 
for the terminal phosphate of E4P. Distances are given in angstroms. 
 
The lysine residue K97 interacts with PEP, as previously mentioned. The proline 
residue P98 folds the protein backbone toward a new direction. In addition, the ring 
carbons of P98 have a hydrophobic interaction with C3 of PEP, which may help 
orientate PEP in the binding site. This could explain why substitution of proline for 
another residue with flexible backbone torsion angles such as glycine is not seen in 
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DAH7P synthase sequences. The remaining arginine R99 and threonine T100 (or 
serine in other sequences) form a binding pocket for the phosphate group of E4P. This 
interaction can be seen from the adventitious sulfate ion present in Figure 1.20. The 
guanidinium group of R99 forms a salt bridge with two oxygen atoms of the 
phosphate, while the backbone amide nitrogen and hydroxyl group of threonine T100 
also each form a hydrogen bond. It is of note that unlike the PEP phosphate binding 
pocket, the E4P phosphate pocket only has an overall charge of +1 (from the arginine 
guanidinium group), which may suggest the phosphate group of E4P binds in its 
monoanionic form. 
 
In addition to the phosphate group, E4P possesses two secondary hydroxyl groups 
which could be used to bind E4P to the enzyme, and orientate it in the active site. 
These interactions are of considerable importance to the enzyme, as alternative 
substrate studies have shown removal of both hydroxyl groups of E4P leads to no 
activity (Figure 1.21).44 
 
O
OH
OH
2-O3PO
D-E4P
Km (E. coli): 39 4 M
kcat (E. coli): 26 3 s
-1
kcat / Km: 0.7 0.1 s
-1 M-1
O
2-O3PO
dideoxyE4P
not a substrate
 
Figure 1.21: A comparison of native substrate E4P39 and dideoxyE4P44, illustrating the 
importance of the secondary hydroxyl groups in catalysis 
 
While no structures exist of ternary enzyme-PEP-E4P complexes, the structure of a S. 
cerevisiae DAH7P synthase has been determined to high resolution containing bound 
cobalt(II), PEP and D-glycerol 3-phosphate (GO3P).40 The position of GO3P in this 
structure can be used to infer information about the binding of E4P. 
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Figure 1.22: The binding of the secondary hydroxyl groups of GO3P in the S. cerevisiae DAH7P 
synthase Co-PEP-GO3P co-complex (PDB: 1of8). Shown in the diagram are PEP and GO3P in 
pale blue/orange/red (C/O/P respectively), the absolutely conserved KPRT motif and the strongly 
conserved aspartate D342. Key water molecules mediating interactions with GO3P are in green; 
the metal coordinated water molecule (equivalent to the E4P carbonyl oxygen) is in yellow. 
Residues are numbered with the corresponding E. coli residue numbers for continuity. Distances 
are indicated in angstroms. 
 
In addition to the R99-T100 E4P phosphate binding pocket seen earlier (Figure 1.20), 
the hydroxyl groups of GO3P form contacts both with the enzyme and with several 
water molecules (Figure 1.22). The C1 hydroxyl group of GO3P (equivalent to the C2 
hydroxyl group of E4P) forms a hydrogen bond to the backbone amide oxygen of the 
conserved proline P100. While this solitary interaction does help E4P bind, it is 
dispensable; as demonstrated by alternative substrate studies utilising 2-deoxyE4P and 
D-threose 4-phosphate (T4P).39, 45 These substrates lack the C2 hydroxyl group or 
have it in an inverted configuration so it points away from proline P98. In each case, 
the compounds are still processed as substrates (Figure 1.23). 
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Figure 1.23: Kinetic parameters for E4P39, 2-deoxyE4P45 and threose 4-phosphate39 with E. coli 
DAH7P synthase . 
 
Both 2-deoxyE4P and T4P bind to the E. coli enzyme with about 10% the affinity of 
E4P, as indicated by the Michaelis constant Km, confirming the 2-hydroxyl group does 
have a role in the E4P-enzyme interaction. Both E4P and 2-deoxyE4P are processed 
at similar rates as shown by the catalytic constant kcat, indicating that E4P can adopt 
the conformation required for reaction without the guidance of the C2-hydroxyl 
group. The reduced kcat for T4P reflects the deleterious effect of the 2-hydroxy-P98 
interaction altering the aldehyde orientation. However, both 2-deoxyE4P and T4P are 
comparitively good substrates for P. furiosus DAH7P synthase, indicating that the 
precise mechanisms of substrate recognition vary across the classes of DAH7P 
synthase.39 
 
The C2-hydroxyl group of GO3P (equivalent to the C3-hydroxyl group of E4P) is 
positioned to form a number of interactions. It interacts directly with the enzyme 
through hydrogen bonding with the absolutely conserved metal coordinating aspartate 
residue D342 (S. cerevisiae numbering; equivalent to E. coli D326). In addition to 
interacting with D342, the C2-hydroxyl group of GO3P interacts with a number of 
water molecules. One water molecule bridges between the hydroxyl group and the 
phosphate group of PEP, held in place by hydrogen bonds with both groups. It is 
tempting to speculate that this interaction, and its corresponding effects on the 
conformations of E4P and PEP, may form part of a signal that initiates the reaction 
upon E4P binding, by orientating the PEP phosphate group into position that it 
deprotonates the water O2. A similar interaction between an arabinose 5-phosphate 
(A5P) hydroxyl and the PEP phosphate group exists in KDO8P synthase, a related 
enzyme (Section 1.3). 42 
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Additionally, the C2-hydroxyl group of GO3P interacts with another water molecule, 
which in turn interacts with the GO3P phosphate group. The phosphate ester oxygen 
also hydrogen-bonds to a water molecule held in place by the absolutely conserved 
metal binding aspartate residue D342. Alternative substrate studies have shown that 3-
deoxyE4P is a substrate of Type Iα, Type Iβ and Type II DAH7P synthases, although 
it binds the E. coli enzyme comparatively poorly (Km 2.7 mM) and is processed 
slowly (kcat 4.5 ± 0.1 s-1) (Figure 1.24).24 This suggests that while the 3-hydroxyl is 
clearly important to high levels of DAH7P synthase activity, it is ultimately 
disposable if the 2-hydroxyl is present. 
 
 
Figure 1.24: A comparison of E4P39 and 3-deoxyE4P24 as DAH7P synthase substrates. 
 
1.3 Related Enzymes 
 
Only a few enzymes share the unusual C-O cleavage of the PEP phosphate bond 
catalysed by DAH7P synthase: EPSP synthase46, MurA47, N-acetyl neuraminic acid 9-
(phosphate) (NeuNAc(P)) synthases and 3-deoxy-D-manno-octulosonate 8-phosphate 
(KDO8P) synthase.48 These enzymes can be broadly divided into two categories, 
enolpyruvyl transferases and PEP aldolases. The enolpyruvyl transferases catalyse the 
transfer of an enolpyruvyl moiety from PEP to an acceptor alcohol via an addition-
elimination mechanism, whereas the PEP aldolases catalyse an aldol-like addition of 
PEP to an aldehyde (Figure 1.25). 
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Figure 1.25: Enzymes sharing the unusual C-O cleaving behaviour of DAH7P synthase 
 
While originally thought to be unrelated due to low overall sequence similarity, the 
aldolases are now thought to be closely related, and it is believed they share a similar 
mechanism.36, 49 KDO8P synthases catalyse the addition of PEP to D-arabinose 5-
phosphate, to form 3-deoxy-D-manno-octulosonate 8-phosphate, an 8-carbon 
analogue of DAH7P, while NeuNAc synthases catalyse the formation of N-acetyl 
neuraminic acid or N-acetyl neuraminic acid 9-phosphate from PEP and N-acetyl 
mannosamine or N-acetyl mannosamine 6-phosphate.  
 
The relationship between these enzymes is summarised in the phylogenetic tree in 
Figure 1.26. This tree summarises the degree of difference between DNA sequences 
of KDO8P, NeuNAc(P) and two classes of DAH7P synthases in a variety of 
organisms.50 In this tree, the line junctions indicate a common ancestor sequence, and 
the length of the line indicates the degree of relation between the sequences, with 
shorter lines being more similar to the branch point sequence than longer lines. This 
tree predicts that all the PEP aldolases are derived from a common ancestor sequence, 
which is more similar to Type Iβ DAH7P synthases than to any of the other PEP 
aldolase enzymes. 
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Figure 1.26: Phylogenetic tree of PEP aldolase enzymes. Taken from Bravo et al.50  
 
The detailed characterisation of NeuNAc(P) synthases is comparatively incomplete, 
and little work has been published. However, it appears that at least Campylobacter 
jejuni NeuNAc synthase shares the same stereochemical preference as DAH7P 
synthase (si face attack of PEP on the re face of an aldehyde).49 However, the 
structure of Neisseria meningitidis NeuNAc synthase has recently been published, and 
it is clear despite the level of homology predicted from DNA sequences the structure 
of the NeuNAc active site is very different to that of DAH7P synthase.51 
 
In comparison, KDO8P synthase has been well characterised, and the extensive 
studies of this enzyme can be used to infer information about DAH7P synthase. The 
major variation between DAH7P synthases and KDO8P synthases is their difference 
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in metal dependency. All known DAH7P synthases require a metal ion for activity, 
and while some KDO8P synthases are metal dependent, others are not52. The metal 
dependent KDO8P synthases are very similar in sequence and structure to metal-
independent KDO8P synthases, and several recent studies53-55 have shown that metal-
dependent KDO8P synthases from a variety of species can be converted into metal-
independent KDO8P synthases by simply mutating one residue, from a metal-binding 
cysteine to asparagine.53-55 This asparagine residue is present and absolutely 
conserved in metal-independent KDO8P synthases; likewise the cysteine residue is 
similarly conserved in all metal-dependent KDO8P synthases and all DAH7P 
synthases. The reverse mutation in metal-independent KDO8P synthases likewise 
restores metal dependency to metal independent E. coli KDO8P synthase.54, 55 
However, the corresponding mutation in the metal-binding site of P. furiosus DAH7P 
synthase (C31N) gives inactive enzyme.39 
 
The metal-dependent KDO8P synthases differ from DAH7P synthases in conserved 
sequences; they all have an absolutely conserved phenylalanine residue in the PEP 
phosphate-binding pocket, which replaces a correspondingly conserved arginine 
residue in DAH7P synthases.39 This phenylalanine is also present in metal-
independent KDO8P synthases, and at least one (N. meningitidis) NeuNAc synthase.51 
All KDO8P synthases have an additional asparagine-alanine mutation in the active 
site, which is absent in DAH7P synthases, changing the absolutely conserved 
KPRT(S) motif in DAH7P synthases (Section 1.2); to a KANRS motif in KDO8P 
synthases.39 It is notable that both the hydrophobic recognition of PEP C3 and 
hydrogen binding to the monosaccharide hydroxyl groups by the KPRT(S) proline is 
preserved in the KANRS motif. 
 
While these differences may be small, they provide evidence that the underlying 
mechanisms of KDO8P synthases and DAH7P synthases may be more different than 
has been previously assumed. A mechanism has been proposed that accounts for these 
conserved changes in KDO8P synthases (Figure 1.28).39  
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Figure 1.27: Overlay of the active site of E. coli DAH7P synthase (salmon) and A. aeolicus 
KDO8P synthase (green), as defined by residues within 4Å of PEP. Structures are from 
1n8f.pdb27 and 1fws.pdb56 respectively; the three carbon atoms enol oxygen and phosphorus 
atom of PEP have been overlaid by 3-dimensional least-squares superposition; the RMS-
difference between the five atoms is 0.049. The manganese atom in the DAH7P synthase structure 
is shown in grey, the cadmium atom in KDO8P synthase structure in yellow. 
 
 
Figure 1.28: The reaction catalysed by KDO8P synthases; and a proposed partial mechanism to 
account for the conserved sequence differences between KDO8P synthases and DAH7P 
synthases.39 
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The conserved phenylalanine may ensure that PEP binds as its dianion form, and the 
weaker phosphate second ionisation may be used to protonate the carbonyl oxygen of 
A5P, as a protic acid substitute for the metal-based Lewis acid catalysis. The 
dianionic phosphate can then deprotonate a water molecule to produce a hydroxide 
ion to intercept the carbocation intermediate, analogous to DAH7P synthase (vide 
supra; Section 1.2, Figure 1.19). Note in this mechanism the metal (in metal 
dependent enzymes) or the asparagine (replacing cysteine in metal independent 
enzymes) is in the same location as the metal in DAH7P synthase, and consequently 
binds the C2-hydroxyl of A5P, rather than A5Ps C1 carbonyl.39 This proposal 
explains the observed substrate specificity of KDO8P synthases, where substrates 
such as ribose 5-phosphate (R5P) and 2-deoxyA5P (which either have the incorrect 
C2 hydroxyl configuration, or lack the C2 hydroxyl altogether) are not substrates for 
either metal dependent30 or independent57 KDO8P synthases, whereas the 
corresponding 2-deoxyE4P and T4P are still substrates for DAH7P synthase39 (vide 
supra). This highlights the role of the C2 hydroxyl-enzyme interaction in orientating 
the carbonyl group for reaction in KDO8P synthases, whereas in DAH7P synthases 
the carbonyl is orientated by its interaction with the metal atom.  
 
Despite this proposed difference in carbonyl activation, there are still important 
similarities in the enzymes. Both enzymes catalyse the addition of the si face of PEP 
to the re face of the carbonyl of a sugar phosphate, both bind their substrates in an 
ordered sequential manner57, with PEP first and the sugar phosphate second. Both 
have similar active site architecture, and appear to bind both the PEP and sugar 
phosphates in similar locations, despite the differing length of their substrates. 
 
The KDO8P synthase reaction has been studied by time-resolved ESI-TOF mass 
spectrometry, an emerging technique which can be thought of as the mass-
spectrometry equivalent of stopped-flow spectrophotometry.58 This technique allows 
the detection of enzyme-intermediate complexes with lifetimes of less than 10 ms, and 
was able to demonstrate the existence of the hemiketal phosphate KDO8P synthase 
enzyme intermediate (Figure 1.29), providing the first direct support for the proposed 
mechanism for KDO8P synthase, and consequently supporting the proposed 
mechanism for DAHP synthase. Both acidic and basic rapid chemical quench 
techniques had previously failed to detect this intermediate, presumably due to its 
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lability.59 The detection of this intermediate is remarkable, given the KDO8P synthase 
reaction has a half-life of around 7 ms, and clearly demonstrates the promise of this 
emerging technique. 
 
 
 
 
Figure 1.29: Time resolved ESI-TOF mass spectra for the KDO8P synthase reaction, and 
mechanistic analysis of the mass peaks. Taken from Anderson et al.58 
 
Utilising the same mass spectroscopy technique, detailed rate data was able to be 
collected for the KDO8P synthase reaction (Figure 1.30).60 The formation of the 
hemiketal phosphate intermediate was found to be rate-limiting (k = 95 s-1), with the 
rate of intermediate breakdown considerably faster (k = 500 s-1). This agrees well with 
the overall kinetic constant, determined by more traditional pre-steady state burst 
kinetics (k = 100 s-1). Whether this data is holds true for the reaction of DAH7P 
synthase remains to be determined. 
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Figure 1.30: Rate constants for the KDO8P synthase reaction 
 
A recent paper containing several high resolution structures of mutant A. aeolicus 
KDO8P synthases claims to have observed directly the hemiketal phosphate 
intermediate of the reaction (Figure 1.31) in two structures.42 The authors claim the 
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intermediate bears the (R)-configuration at the ketal carbon, which implicates the PEP 
si-face water as the nucleophile, either by the carbanion mechanism or by quenching 
the oxocarbenium ion formed in the protic acid activation mechanism. 
 
 
Figure 1.31: The crystallographically observed intermediate as reported by Gatti et al; in 
crystallographic and skeletal representations.42 
 
However, this finding should not be taken as certain. The observed intermediate has 
been previously determined to be highly unstable, and the rate constants for the 
formation and breakdown of the intermediate have been measured to be 95 s-1 and 500 
s-1 respectively for the E. coli enzyme (vide supra). The proposed intermediate in one 
structure is observed in a large unit cell, containing twelve crystallographically 
independent triple-mutant (C11N/S235P/Q237A) enzyme monomers. In eleven of the 
twelve active sites; a ternary enzyme-PEP-A5P complex is observed, and the trigonal 
planar geometry of PEP is evident in most of the active sites. The remaining PEP 
molecules have some bent character at C2, which is also observed in crystal structures 
of this enzyme lacking A5P, and in some DAH7P synthases. This bent character has 
been assigned as degradation of PEP due to Michael addition of water at C3. 
 
In their paper, the authors show a |Fo-Fc| σA map of the modelled enzyme without the 
intermediate included; overlaid with the proposed model of the intermediate (Figure 
1.32). In this map, the amplitudes of the experimentally observed structure factors 
(Fo) are compared after subtraction of the structure factors that would be observed for 
the proposed model (Fc); the mean structure factor amplitude is denoted σ. Ideally, in 
such a diagram one would expect to see a large unexplained area of electron density, 
arising from the difference between the observed data (which contains the ligand) and 
the calculated data (which does not contain the ligand). The heavy atoms of the ligand 
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(atomic weights of 12 and above) should all appear inside this area, showing they are 
correctly placed. This should occur at a significant level of signal; such that the 
amplitudes shown are much greater than the average amplitude. In practice, this level 
is typically near 3σ (ie. three times the average density). This map (also known as an 
omit map) constitutes a simple method for assessing whether a ligand in an enzyme 
structure is a real ligand, rather than an artifact of the cycles of observation and model 
refinement utilised in macromolecular crystallography. The diagram presented in the 
paper, contoured at 3σ, clearly shows that the new oxygen atom (the only heavy atom 
distingushing the intermediate structure from that of the substrates) lies outside the 
density, giving some doubt to the claimed observation of the intermediate. 
 
 
Figure 1.32: Stereo diagram of the |Fo-Fc| σA (omit) map contoured at 3σ; with the modelled 
intermediate overlaid. A and B show different representations of the same electron density; the 
protrusion of the modelled oxygen atom from density has been marked. Deformations of the 
“intermediate” C4, C5 hydroxyls from areas of peak density are shown on the right (green 
arrows). Diagram is taken from Gatti et al42, the green elements have been added. 
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In addition, the C4 and C5 atoms of the intermediate (corresponding to C1 and C2 of 
A5P) appear to be deformed away from the peak electron density. This could occur if 
the intermediate had been modelled incorrectly over density derived from two 
separate molecules, since the observed density is from molecules separated by a larger 
distance than that across than the covalent C3-C4 bond in the model.  
 
Based on these arguments, the possibility remains that the proposed intermediate is 
simply an artifact, and partial tetrahedral character introduced by the breakdown of 
PEP by Michael addition has been misinterpreted during model building. Further 
work will be required to substantiate the existence of the proposed intermediate and 
its configuration. 
 
1.4 The project 
 
The intention of this project was to design and synthesise inhibitors for the DAH7P 
synthase reaction. These inhibitors could help provide information about the enzyme 
mechanism, and help provide a basis for future drug design work. 
 
There has been little previous published work in this area, and prior to this work only 
three inhibitors were known (Figure 1.33), and a distinct lack of any designed 
inhibitors. 
 
 
Figure 1.33: Previously reported DAH7P synthase inhibitor 
 
3-Bromopyruvate is an irreversible inhibitor of E. coli DAH7P synthase, causing 
inactivation by covalent modification.61 The inactivation is competitive with respect 
to PEP, and the presence of metal ions protects the enzyme from inactivation, 
suggesting a nucleophilic metal binding ligand such as cysteine is being modified. 
 
Glyphosate (Figure 1.33, centre) has been reported to inhibit plant DAH7P synthases 
during the search for mechanism of the herbicidal activity of glyphosate.62 Plant cells 
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treated with glyphosate have a deficiency of aromatic amino acids, which suggested 
inhibition of the shikimate pathway. DAH7P synthase was found to be inhibited by 
glyphosate, but it is now known EPSP synthase is the target of glyphosate.11 Later 
work found that there are two plant isozymes of DAH7P synthase, and only one 
isozyme of DAH7P synthase is inhibited by glyphosate, and only when cobalt(II) is 
the metal co-factor.63 
 
A family of compounds known as methylene bisphosphonates display herbicidal 
properties when injected into whole plants, in particular the pyridyl bisphosphonate 
shown on the right in Figure 1.33. Some early work had identified DAH7P synthase 
as the target of this inhibition, however the reported inhibition constants are modest 
(0.62 mM against E4P, 0.43 mM against PEP).64 A more recent paper disputes the 
author’s conclusions, and shows that the target of the methylene bisphosphonates is 
likely to be farnesyl pyrophosphate synthase, based on potent inhibition by the same 
pyridyl methylene bisphosphonate (IC50: 23 nM).65  
 
In the course of this work a paper was published which claimed to describe a 
mechanism-based inhibitor of a DAH7P synthase (Figure 1.34).66 However, the 
authors have not conducted any enzyme assays to prove this assumption, and their 
only characterisation consisted of testing growth retardation of whole cells, for which 
they provide no data, and only state the retardation was “comparatively poor”. While 
the molecule does bear similarity to a proposed enzyme intermediate, it remains to be 
demonstrated whether it is a DAH7P synthase inhibitor. 
 
 
Figure 1.34: The proposed inhibitor of Grison et al 
 
While there has been little work on DAH7P synthase inhibition, because of the close 
relationship between DAH7P synthase and KDO8P synthase the pool of work on 
KDO8P synthase can be used to provide a basis for the design of DAH7P synthase 
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inhibitors. There have been four designed inhibitors of KDO8P synthase synthesised 
and characterised kinetically (Figure 1.35). 
 
+ +
 
Figure 1.35: Previously designed KDO8P synthase inhibitors 
 
The first pyran molecule (Figure 1.35, left) was designed as an inhibitor of a proposed 
cyclic intermediate of the KDO8P synthase reaction.67 The Ki (4.9 µM) against E. coli 
KDO8P synthase is remarkable, given that it is now accepted that KDO8P synthase 
has a linear mechanism.  
 
It has recently been shown that under some conditions ribose 5-phosphate, which is 
not a substrate for KDO8P synthase, can bind to the enzyme A5P site in its furanose 
form.42 This may explain the ability of the pyran to inhibit KDO8P synthase. 
 
The enol phosphate inhibitor (Figure 1.35, centre left) was designed to mimic the 
planar nature of the PEP enol phosphate. Despite being the D-gluco configuration, and 
lacking a terminal phosphate group, this compound inhibited H. pylori KDO8P 
synthase in a complex manner, but the molecule did not become incorporated into the 
active site of A. aeolicus KDO8P synthase (as detected by X-ray crystallography) at 
concentrations up to 4.4 mM.68 The tertiary amine (Figure 1.35, centre right) was 
designed to mimic the oxocarbenium ion proposed in the KDO8P synthase 
mechanism, and has been shown to inhibit KDO8P synthases from a variety of 
species, with a Ki of 0.37 µM against E. coli KDO8P synthase.69 The analogous 
phosphonate tertiary amine (Figure 1.35, right) was created in an attempt to improve 
the antibacterial properties of the earlier amine inhibitor by interfering with a 
Chapter One: Introduction   35 
 
proposed dephosphorylation, it was found to be a less effective inhibitor, with a Ki of 
50 µM against E. coli KDO8P synthase.70 
 
The structures of the most potent inhibitor in complex with a variety of KDO8P 
synthase enzymes have been determined by X-ray crystallography.30, 68, 71 These 
structures have shown that the inhibitor binds to the enzyme, mimicking the position 
of PEP and A5P, utilising the same phosphate and carboxylate binding pockets 
(Figure 1.36). 
 
Figure 1.36: A comparison of an inhibitor and substrates bound to A aeolicus KDO8P synthase, a 
metal-dependent KDO8P synthase, and an enzyme•PEP•R5P ternary complex. (A) shows R5P 
and PEP modelled into the active site,. (B) is a SigmaA weighted omit map, contoured at 0.9σ,  of 
the enzyme•PEP•R5P ternary complex. (C) and (D) show the analogous diagrams for the 
enzyme•inhibitor complex. Taken from Gatti et al.30 
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By comparison of (b) and (d) in Figure 1.36, it can be seen that the inhibitor 
phosphonate and phosphate groups occupy the PEP and R5P phosphonate binding 
pockets respectively. It is also of note that the R5P C2 hydroxyl in (A) is not a metal 
ligand, leading to considerable conformational flexibility in C1 and C2 of R5P, as 
revealed by the low electron density in these regions. The fact that the equivalent 
hydroxyl group is a metal ligand in the inhibitor (which has the opposite 
stereochemistry at the equivalent hydroxyl), leading to the corresponding carbon 
chain being well defined in the omit map lends weight to the earlier argument 
(Section 1.3) that the metal is vital for orientating the A5P carbonyl via a metal-C2 
hydroxyl interaction.39 This would also suggest that the inhibitor binding strength is 
dependent on the hydroxyl orientation at this position, something that is being 
investigated in our laboratory. The inhibitor carboxylate group is poorly defined in the 
omit map (d), indicating that it is not strongly bound. This has been tested 
experimentally68, with a second-generation inhibitor lacking the carboxymethyl 
substituent on the amine (Figure 1.37).68 This compound inhibits E. coli KDO8P 
synthase with a comparable inhibition constant to the original inhibitor, highlighting 
the low contribution of this group to the enzyme-inhibitor interaction. The finding that 
removal of the phosphonomethyl moiety leads to no inhibition reinforces the 
importance of the phosphonate-enzyme interaction.68 
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Figure 1.37: Limited SAR of amine KDO8P synthase inhibitors.68 
 
Given the success of these compounds against KDO8P synthase, and the similarity in 
active site architecture between KDO8P synthase and DAH7P synthase, we decided 
to start our investigations of the inhibition of DAH7P synthase with the analogous 
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inhibitor reconfigured to mimic the DAH7P synthase oxocarbenium ion. This work is 
described in Chapter Two. Following this work, studies to design and synthesise other 
inhibitors of DAH7P synthase are described in Chapters Three and Four. 
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Chapter Two: Early Approaches to Designed Inhibition 
of DAH7P synthase  
 
2.1 Inhibitor Design 
 
When this work was commenced there was little known about inhibition of DAH7P 
synthase. However, work had been carried by other groups on the related enzyme 
KDO8P synthase; which had resulted in the potent inhibitor 2.1.69 This molecule was 
designed as a mimic of the putative oxocarbenium intermediate 2.2 (Figure 2.1), and 
strongly inhibits E. coli KDO8P synthase. 
 
 
Figure 2.1: KDO8P synthase mechanism and known inhibitor 2.1 
 
Since there are strong mechanistic similarities between the reactions of KDO8P 
synthase and DAH7P synthase, we proposed that it should also be possible to inhibit 
DAH7P synthase by mimicking the oxocarbenium ion intermediate involved in the 
DAH7P synthase reaction.  
 
Designing inhibitors to mimic transition states or intermediates, rather than substrates, 
can lead to very high potencies.72 Enzymes achieve catalysis through locating 
functional groups in such a way as to stabilise a given transition state or intermediate, 
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in turn lowering the activation energy for the process concerned relative to the 
spontaneous reaction. Consequently, the best ligand for an enzyme is in fact the 
transition state for a reaction, rather than the substrate or products. Molecules which 
mimic this transition states or intermediates can achieve much higher potencies than 
those which mimic substrates. With this in mind, initial efforts were set toward 
synthesising proposed inhibitor 2.3. 
 
 
Figure 2. 2: Proposed DAH7P synthase intermediate, and the proposed DAH7P synthase 
inhibitor 2.3 
 
In earlier work, the synthesis of 2.3 was attempted by directly coupling glyphosate 
onto a sugar phosphate backbone by reductive amination (Figure 2.3). Due to the high 
cost of preparative quantities of D-arabinose 5-phosphate, the reaction was modelled 
by substituting ribose 5-phosphate. 
 
 
Figure 2.3: Attempted direct approach similar compounds to the desired inhibitor 
 
This approach was unsuccessful, despite the analogous reaction with D-mannose 6-
phosphate being successful in both our hands and others. After several attempts at this 
coupling had failed, a new approach was sought. 
 
Another possible method to construct 2.3 is to build the amino moiety in a stepwise 
fashion onto a suitable aldehyde bearing the required D-arabino stereochemistry 
(Figure 2.4). 
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Figure 2.4: Retrosynthesis of proposed inhibitor 2.3 
 
While many methods are available in modern synthesis to construct chiral alcohol and 
polyol systems, we decided to harvest the chirality in aldehyde 2.4 from the chiral 
pool, in the form of the relatively cheap and abundant carbohydrate D-arabinose.  
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Figure 2. 5: The ultimate source of chirality for 2.4; the carbohydrate D-arabinose 
 
2.2: Synthesis of proposed inhibitor  
 
In order to access all of the chiral hydroxyl groups in D-arabinose, a suitable group 
has to be introduced to stop the intramolecular cyclisation to the furanose and 
pyranose forms of the carbohydrate. Due to their success in our earlier work involving 
D-arabinose, we chose the dithioacetal group to achieve this. Treatment of D-
arabinose with aqueous ethanethiol by a modifed literature procedure gave excellent 
yields of crystalline dithioacetal 2.5 (Figure 2.6).73 
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Figure 2.6: Dithioacetal formation reaction 
 
With the hydroxyl groups liberated, suitable protecting groups need to be introduced 
to the hydroxyl groups to allow regeneration of aldehyde at C1 without problems from 
competing cyclisation. For reasons of simplicity, we chose to use isopropylidene 
acetal groups to block the hydroxyl groups. They are cheap and relatively atom 
economic protecting groups, and are stable to a wide variety of powerful bases, 
nucleophiles and reducing agents, yet are readily removed by dilute acid. Several 
possible acetals are possible in a tetraol such as 2.5; but by drawing on the results of a 
systematic study by Koelln et al74 into the factors affecting product distributions in 
such systems, an excellent yield of the desired 2,3:4,5 diacetal 2.6 was produced 
utilising kinetic conditions (Figure 2. 7). 
 
 
Figure 2. 7: Production of the kinetic 2,3:4,5 diacetonide 2.6 
 
With the hydroxyl groups of 2.5 protected, the C1 aldehyde could be unmasked. 
Many conditions have been reported to cleave dithioacetals75; a possible corollary of 
this is that no conditions are sufficiently general for widespread adoption. 
 
A wide set of conditions were screened for the deprotection of 2.6; and the removal of 
this group proved difficult (Figure 2.8). Treatment of 2.6 and related compounds 
under a variety of conditions76 failed to produce the required aldehyde, generally 
giving a lack of reaction. Although in the case of iodine in methanol, decomposition 
of the starting material was also observed. 
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Figure 2.8: Attempted dithioacetal cleavages 
 
In classical synthesis thioacetals have been known to be cleaved readily by exploiting 
the relatively specific interaction between mercury(II) and sulfur. Due to modern 
concerns about the toxicity of mercury compounds this method is no longer the 
technique of first resort;75 however in our case treatment of 2.6 with mercuric chloride 
and mercuric oxide in acetone gave an excellent yield of aldehyde 2.7 (Figure 2.9). 
An attempt to limit the amount of mercury compounds used by substituting calcium 
carbonate for mercuric oxide was unsuccessful. 
 
 
Figure 2.9: Mercury(II) induced deprotection of thioacetal 2.6 
 
With the aldehyde liberated, introduction of the amino group could begin. Initial 
attempts to introduce the amino group by the method used in the synthesis of the 
KDO8P synthase inhibitor 2.169 (namely direct reductive amination with ethyl glycine 
hydrochloride and sodium cyanoborohydride) meet with little success, and only small 
amounts of product were observed. However, by including sodium acetate to allow 
generation of equilibrium levels of the otherwise unstable ethyl glycine free base, and 
molecular sieves to drive the imine formation equilibrium by selective absorption of 
water, good yields of amine 2.8 could be obtained from unpurified aldehyde 2.7 
(Figure 2.10).  
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Figure 2.10: Deprotection and reductive amination to give amine 2.8 
 
Further optimisation of the reactions of thioacetal 2.6 with iodine led to conditions 
where the thioacetal group could be removed in the presence of the sensitive 
acetonide groups, without resort to mercury compounds. The crude product from this 
reaction could also be used to generate amine 2.8, albeit in lower overall yield (Figure 
2.11). 
 
 
Figure 2.11: Iodine mediated cleavage of thioacetal 2.6; and subsequent reductive amination 
 
With the required amine in hand, a method was required to introduce the 
phosphonomethyl substitutent. The use of phosphonomethyl sulfonates seemed to be 
an attractive approach; they can be generated from the corresponding hydroxymethyl 
phosphonates, which are themselves available from dialkyl phosphites and aldehydes. 
We elected to use the ethyl protected phosphonates, they are stable as protecting 
groups, and their use in the synthesis of KDO8P synthase inhibitor 2.1 showed that 
they could be removed under conditions compatible with our other functionality. 
 
The required hydroxymethyl phosphonate 2.9 could be generated by the reaction 
between diethyl phosphite and monomeric formaldehyde, produced by thermally 
cracking paraformaldehyde in situ. The reaction performed similarly using either 
alumina77 or triethylamine78 as a basic catalyst (Figure 2.12), but the triethylamine 
method was operationally simpler, and could be readily run on large scale (28 g of 
phosphite). 
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Figure 2.12: Synthesis of diethyl hydroxymethyl phosphonate 2.9 
 
The hydroxymethyl phosphonate 2.9 underwent some decomposition during 
attempted vacuum distillation; and in practice it was easier to purify the product by 
solvent extraction; the material produced was of sufficient quality to be used in the 
following steps. 
 
Treatment of the phosphonate at low temperature with triflic anhydride79 produced 
crude triflate 2.10 (Figure 2.13) of approximately 80% purity; due to concerns about 
the stability of this reagent it was not purified or stored further, but immediately used 
in the phosphonomethylation reaction after isolation. 
 
 
Figure 2.13: Triflation of alcohol 2.9 to give phosphonomethylating reagent 2.10 
 
With a phosphonomethylating reagent in hand, work could begin on installing the 
phosphonomethyl moiety onto amine 2.8. 
 
In their synthesis of the KDO8P synthase inhibitor 2.1, Du et al used a phase transfer 
method to introduce the phosphonomethyl group (Figure 2.14). However this method 
required an excess of triflate 2.10, delivered in portions to counter the hydrolysis of 
the reagent under the aqueous conditions.  
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Figure 2.14: The aqueous phase transfer method of Du et al for introduction of the 
phosphonomethyl group69 
 
In order to ease acess to proposed inhibitor 2.3, attempts were made to devise an 
improved method for the phosphonomethylation reaction. The treatment of the 
potassium amides of secondary amines in dimethoxyethane with alkyl halides has 
been reported to give good yields of the tertiary amine.80 However in our case this 
produced a complex mixture of products that was not further investigated.  
 
With this failure we decided to trial simpler conditions for this reaction. It was 
reasoned that by utilising a more polar solvent than dichloromethane the rate of the 
reaction should be increased, and by using an insoluble base as an acid absorbent the 
reaction should proceed without excessive hydrolysis of triflate 2.10. 
 
Gratifyingly, treatment of amine 2.8 with fresh triflate 2.10 in a heterogenous mixture 
of acetonitrile and anhydrous potassium carbonate gave good yields of the required 
aminophosphonate 2.11. This reaction was even effective in cases where triflate 2.11 
was the limiting reagent (Figure 2.15), highlighting the low rate of non-productive 
triflate hydrolysis under these conditions. 
 
 
Figure 2.15: Phosphonomethylation of amine 2.8 to aminophosphonate 2.11 
 
With the aminophosphonate portion of the molecule assembled, the distal phosphate 
needed to be introduced. In order for this to occur, the terminal 4,5-isopropylidene 
acetal needed to be removed in the presence of both the 2,3-isopropylidene acetal and 
the aminophosphonate. A comment in the paper describing the synthesis of KDO8P 
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synthase inhibitor 2.1 suggested that this transformation may not be straightforward,69 
and with this in mind conditions were trialled which were known to show selectivity 
in deprotection of one isopropylidene acetal over another. 
 
Treatment of aminophosphonate 2.11 with iron(III) chloride hexahydrate adsorbed on 
silica gel81 failed, leading only to recovery of starting material. Presumably the traces 
of acid produced in this system are rapidly neutralised by the basic nitrogen atom in 
2.11. Likewise treatment of aminophosphonate 2.11 with zinc(II) nitrate hexahydrate 
in refluxing acetonitrile failed to give the desired product.82 
 
One condition which has been reported to selectively cleave a 4,5-isopropylidene 
acetal in a 2,3:4,5 di(isopropylidene acetal) is cerium(III) chloride heptahydrate in 
acetonitrile, containing a trace of oxalic acid.83 These conditions appeared successful 
in producing diol 2.12 (Figure 2.16), although the reaction time was considerably 
longer than the reported time (52 hours for our substrate, versus 0.5 – 2 hours for the 
substrates in the original paper).  
 
 
Figure 2.16: Selective cleavage of the terminal acetonide of 2.11 with cerium(III) chloride 
 
The crude product produced by this route was difficult to characterise by NMR 
spectroscopy, presumably due to traces of paramagnetic cerium(III) in the crude 
product. It was also too polar for purification by silica flash chromatography. Crude 
diol 2.12 was directly treated with diethyl chlorophosphate to introduce the terminal 
phosphate group. Disappointingly, phosphorylation appeared to be only partly 
selective for the 5-position, and the corresponding polar mixture of compounds were 
unable to be separated by flash chromatography. 
 
Preliminary investigations showed the mixture was able to separated by costly and 
time consuming preparative HPLC, however it was felt that a better use of time might 
be to rework the initial steps of the synthesis to incorporate orthogonal protecting 
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groups on C5 and the other hydroxyl groups. This would allow selective liberation of 
the 5-hydroxyl group, and thus sidestep the chemo- and regioselectivity problems 
encountered in the 4,5-acetonide deprotection and the 5-phosphorylation. 
 
A tert-butyldiphenylsilyl (TBDPS) group should fulfill this requirement; it is known 
to be stable to a variety of conditions yet can be readily cleaved utilising fluoride ions, 
conditions which leave many other groups unaffected. Furthermore, from earlier work 
with dithioacetal 2.5, we knew that the group could be regioselectivity introduced at 
the 5-position in dichloromethane, without problems with further reaction. 
Accordingly, treatment of thioacetal 2.5 with tert-butyldiphenylsilyl chloride gave 
triol 2.13, bearing the silyl group at the 5-position (Figure 2.17). 
 
 
Figure 2.17: Silylation of thioacetal 2.5 to triol 2.13 
 
Attempts to introduce benzyl groups to the 2,- 3- and 4-hydroxyls of triol 2.13 under 
standard conditions76 (BnBr, NaH, TBAI) gave a complex mixture of partially 
benzylated prodcuts, and no improvement was noted using benzyl 
trichloroacetimidate and catalytic triflic acid (Figure 2.18).84  
 
 
Figure 2.18: Attempted benzylation of triol 2.13 
 
The difficulty in perbenzylating 2.13 is probably due to increasing steric hindrance to 
reaction as each successive hydroxyl group is benzylated. With this in mind, we 
attempted to introduce the smaller acetyl group onto triol 2.13, and complete reaction 
could be achieved under forcing conditions (Figure 2.19). The conditions required to 
completely acetylate 2.13 are consistent with protection of the triol unit being 
sterically disfavoured. 
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Figure 2.19: Acetylation of triol 2.13 to triacetate 2.14 
 
Deprotection of triacetate 2.14 under our previously developed mercury(II) chloride/ 
mercury(II) oxide conditions cleanly afforded the corresponding aldehyde 2.15 
(Figure 2.20). 
 
Figure 2.20: Deprotection of the thioacetal of triacetate 2.14 to aldehyde 2.15 
 
Attempts to introduce the amine unit onto aldehyde 2.15 under our previously 
developed reductive amination conditions returned a complex mixture of products, for 
reasons which remain unclear. It is possible the electron withdrawing nature of the 
acetate protecting groups was interfering, or that the acetate groups were sensitive to 
the reaction conditions. 
 
Based on this, it was decided to utilise a hybrid protecting group scheme, where the 2, 
3-hydroxyls are masked as an isopropylidene acetal, the 4-hydroxyl as an acetate, and 
the 5-hydroxyl as a TBDPS group. Acetal 2.6 was treated with dilute hydrochloric 
acid in warm aqueous methanol to selectively remove the 4,5-isopropylidene acetal 
and give diol 2.16 in good yield (Figure 2.21).  
 
 
Figure 2.21: Selective removal of the 4,5-acetonide from 2.6 to give diol 2.16 
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Treatment of diol 2.16 with TBDPSCl, followed by treatment with acetic anhydride 
and pyridine and catalytic DMAP gave the required protecting group regime in good 
yield in a convenient one-pot operation (Figure 2.22). 
 
 
Figure 2.22: One-pot silylation/acetylation to give fully protected thioacetal 2.17 
 
Deprotection of thioacetal 2.17 under our mercury-mediated conditions gave the 
required aldehyde cleanly, and subsequent reductive amination gave the required 
amine 2.18 (Figure 2.23). 
 
Figure 2.23: Deprotection and reductive amination to give amine 2.18 
 
While the yield of the reductive amination was not as high as that achieved as that 
with the isopropylidene acetal 2.6, it was adequate for our purposes, and had the 
advantage of giving an orthogonally protected amine.  
 
Treatment of the amine 2.18 with fresh phosphonomethyl triflate 2.10 under the 
previously developed heterogeneous conditions gave aminophosphonate 2.19 in fair 
yield. 
 
 
Figure 2.24: Phosphonomethylation of amine 2.18 to aminophosphonate 2.19 
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With the aminophosphonate 2.19 constructed, the 5-hydroxyl could now be released 
and phosphorylated. Treatment of aminophosphonate 2.19 with tetrabutylammonium 
fluoride (TBAF) gave the required alcohol 2.20 cleanly (Figure 2.25). Unlike the diol 
produced from diactonide 2.8, alcohol 2.20 was readily purified and characterised. 
 
 
Figure 2.25: Desilylation of 2.19 with TBAF to give alcohol 2.20 
 
Treatment of alcohol 2.20 with freshly prepared diethyl iodophosphate gave a fair 
yield of terminal phosphate 2.21 (Figure 2.26). The yield of 2.21 is perhaps indicative 
of the difficulties of working with small quantities of highly polar compounds such as 
2.21, rather than the formation of side products. 
 
 
Figure 2.26: Phosphorylation of alcohol 2.20 to give phosphate 2.21 
 
With the final protected compound 2.21 in hand, deprotection could begin. This was 
achieved by essentially the method used by Du et al in the synthesis of the KDO8P 
synthase inhibitor 2.1; but modified to include simultaneous deprotection of the ethyl 
phosphate and phosphonate groups in 2.21. 
 
Treatment of 2.21 with trimethylsilyl bromide, in the presence of excess triethylamine 
to protect the nitrogen atom of 2.21 from alkylation, removed the ethyl groups from 
the phosphate and phosphonate of 2.21. Treatment with water cleaved the resulting 
silyl esters, and heating the aqueous mixture to 75°C gave autocleavage of the 
isopropylidene acetal protecting group, catalysed by the acidic phosphate and 
phosphonate groups. Treatment with aqueous potassium hydroxide gave cleavage of 
carboxy ester groups (Figure 2.27).  
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The resulting mixture of products could be separated by preparative anion exchange 
chromatography on SourceQ® resin, eluting with a gradient of ammonium 
bicarbonate. The desired product eluted between at approximately 125 mM 
ammonium bicarbonate. Detection of the product provided an interesting challenge; 
detection by standard methods such as ultraviolet absorbance is complicated by the 
only useful chromophore in 2.3 having an absorbance at around 214 nm, which 
unfortunately is also a wavelength at which the bicarbonate ion absorbs.  
 
The problem was solved by utilising the Lanzetta assay85, a colourimetric assay for 
inorganic phosphate.85 Treatment of fractions suspected to contain product with calf 
alkaline phosphatase to cleave the terminal phosphate ester, followed by incubation 
with the Lanzetta reagent allowed detection of the product. 
 
 
Figure 2.27: Deprotection of precursor 2.21 to target 2.3 
 
Section 2.3: Characterisation of the enzymatic properties of proposed inhibitor 2.3 
 
With the synthesis of our desired target 2.3, investigation of its behaviour with E. coli 
DAH7P synthase could begin. Gratifyingly, qualitative investigations showed 2.3 was 
indeed an inhibitor of E. coli DAH7P synthase; as designed. However, it quickly 
became apparent that the measurement of a traditional inhibitory constant, Ki, for this 
compound was complicated by a number of factors. 
 
The binding of 2.3 to E. coli DAH7P synthase was complicated by severe time 
dependence, as 2.3 was incubated with DAH7P synthase for varying lengths of time 
the apparent inhibition became greater (Figure 2.28). This behaviour indicates that the 
rate of formation of the enzyme-inhibitor complex is comparatively slow. Close 
inspection of the progress curves in Figure 2.28 shows that after the initial dilution of 
the preincubated enzyme-inhibitor solution into the assay cuvette, the maximum rate 
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is not obtained initially, but only after a lag period. This indicates two things, that the 
binding of 2.3 to DAH7P synthase is in fact reversible (since irreversibly inactivated 
enzyme cannot be reactivated, and thus would have a maximum rate at the beginning 
of the assay); and furthermore that the dissociation rate of the enzyme-inhibitor 
complex is also slow. 
 
 
Figure 2.28: Progress curves for enzyme preincubated with inhibitor 2.3 for varying lengths of 
time. A solution of enzyme (120 µg) and inhibitor 2.3 (900 µM) in BTP buffer (20 µL) was 
incubated, and at the specified time period an aliquot (2 µL) was removed an used to initiate a 
substrate cuvette, and the loss of absorbance monitored at 232 nm. Substrate cuvettes contained 
PEP (25 µM), manganese(II) sulfate (200 µM), E4P (13 µM) in 50 mM pH 6.8 BTP buffer (1 mL).  
 
The slow association and dissociation rates are characteristic of a particular type of 
enzyme inhibition kinetics, known as slow-tight inhibition.86 Relevant equilibria for a 
simple hypothetical example are shown in Figure 2.29. 
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Figure 2.29: Equilibria for slow-tight inhibition 
 
In slow-tight inhibition, the formation of the normal enzyme-substrate complex E-S is 
hampered by the reversible formation an enzyme-inhibitor complex, E-I, as in simple 
competitive inhibition. However, in slow-tight inhibition the initial relatively weakly 
bound E-I complex can undergo a slow isomerisation to a tightly held complex, E-I*, 
where the equilibrium favours the tightly held complex. This results in a slow 
sequestering of enzyme as the tight complex E-I*, and a consequent time dependent 
drop in enzyme concentration (and hence reaction rate).86 
 
This behaviour is typically observed in transition state inhibition, and indeed it was 
observed with the related KDO8P synthase inhibitor 2.1.69 It arises as a consequence 
of enzyme mechanism; whereas enzymes achieve catalysis by binding to a transition 
state or intermediate, this form of the enzyme is not necessarily the optimum for 
binding the substrates. Consequently enzymes typically exist in several conformers 
(Figure 2.30); the ground state conformation is one which recognises the enzymes 
substrate (blue); upon substrate binding a conformational change occurs which 
rearranges the active site to a form which favours the transition state. The subsequent 
distortion of the substrate molecule leads to catalysis; the product (red) is released and 
the enzyme relaxes to its substrate binding state.  
 
If the inhibitor molecule resembles the transition state, it will likely have some 
affinity for the substrate binding form of the enzyme; and the subsequent 
isomerisation of the enzyme to the transition state binding form will the tight enzyme 
inhibitor complex E-I*.  
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Figure 2.30: Induced-fit enzyme catalysis 
 
Another problem that was present in assays with inhibitor 2.3 was its interaction with 
other assay components. The parent aminophosphonate of 2.3, glyphosate, is known 
to form 1:1 and 1:2 metal:ligand coordination complexes with a number of transition 
metal ions, including manganese(II) 87, 88. Based on the strong structural similarities 
between glyphosate and inhibitor 2.3, we were concerned that this might also be a 
factor in our assay mixtures. 
 
Mixing an aqueous solution of inhibitor 2.3 with aqueous manganese(II) results in a 
visible yellow colouration. This colouration also occurs with a mixture of glyphosate 
and manganese(II); and spectrophotometric analysis of the mixture shows the 
appearance of a broad absorption across the 200-400 nm region, which is much 
stronger than that expected from a simple additive effect. This absorption is consistent 
with a charge-transfer transition, which is known to occur in the UV-visible spectra of 
glyphosate-metal complexes.88 Furthermore, the presence of manganese(II) in 
mixtures of preincubated enzyme and inhibitor 2.3 gives a protective effect (Figure 
2.31), presumably by the formation of manganese-inhibitor complexes sequestering 
the inhibitor 2.3.  
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Figure 2.31: Protective effect of manganese(II) on preincubation of inhibitor 2.3 with E. coli 
DAH7P synthase. For the mangenese-free experiment, a series of cuvettes were prepared, 
containing 80 µM PEP, 200 µM manganese(II) sulfate, 440 µM E4P in a total volume of 940 µL 
50mM BTP, pH 6.8, containing 10 µM EDTA. A sample of enzyme (120 µg) and inhibitor 2.3 (3 
mM) in 110 µL 50mM BTP, pH 6.8 was incubated, and 20 µL samples added to the cuvettes at 
time intervals. The loss of PEP was followed spectrophotometrically at 232 nm; the initial rates 
were determined from linear least-squares regression. The experiment in the presence of 
mangenese was conducted in the same way, except with 860 µM manganese(II) sulfate present in 
the incubation solution. 
 
It is worth noting that the inhibition constants of KDO8P synthase inhibitor 2.1 have 
only been reported for non-metalloenzyme KDO8P synthases such as the enzyme 
from E. coli. Despite the fact that structures of inhibitor 2.1-metalloenzyme 
complexes (such as A. aeolicus KDO8P synthase30) have been determined and 
published; the corresponding inhibition data has not been reported. This may indicate 
others have encountered similar difficulties. 
 
Based on the dose-response data in Figure 2.32, we estimate that the concentration of 
inhibitor 2.3 required the reduce the enzyme activity by 50% (IC50) is approximately 6 
µM. However, it should be noted like all IC50 values, this value is strongly dependent 
on the assay conditions, and its utility is limited. 
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Figure 2.32: Concentration dependent inhibition of E. coli DAH7P synthase by increasing 
concentrations of 2.3. Assay cuvettes contained PEP (25 µM), E4P (15 µM), MnSO4 (45 µM) and 
were initiated with 2 µL of enzyme-inhibitor solution preincubated for 40 minutes at varying 
inhibitor concentrations (0 - 3.75 mM). The loss of PEP was followed spectrophotometrically at 
232 nm; the initial rates were determined from linear least-squares regression. Inhibitor 
concentrations shown are the final concentrations in the assay cuvette. 
 
The inhibition of DAH7P synthase by 2.3 was more complex than was hoped, and the 
availability of the final compound limited detailed analysis. However, our enzyme 
studies did show that our hypothesis was correct; that it is possible to adapt inhibitors 
for KDO8P synthase into potent DAH7P synthase inhibitors.  
 
2.4: Summary 
 
In summary, the first designed inhibitor of a DAH7P synthase was synthesised in 
twelve steps from D-arabinose. This molecular was a very slow onset inhibitor of E. 
coli DAH7P synthase, and detailed analysis was hampered by a number of factors 
including possible formation of metal-inhibitor complexes in situ. Despite these 
difficulties, the behaviour of the molecule validated the design approach, and 
demonstrated that the rational design of DAH7P synthase inhibitors was possible. 
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Chapter Three: Single-Site Inhibitors of DAH7P 
synthase 
 
3.1: Analysis of aminophosphonates 
 
With the successful synthesis of inhibitor 2.3, a new direction of investigation was 
required. Due to the lack of previous work on the inhibition of DAH7P synthase, little 
guidance was available from the literature on what types of molecules would bind to 
DAH7P synthase. Initial investigations centred around molecules similar to the PEP-
mimicking portion of 2.3. Accordingly, the commercially obtained 
aminophosphonates 3.1 and 3.2 (Figure 3.1) were screened for inhibitory activity. 
Surprisingly, both molecules failed to inhibit E. coli DAH7P synthase well. The rate 
of enzyme reaction in the presence and absence of each molecule was measured; 
racemic phosphonoalanine 3.2 failed to inhibit the reaction at concentrations up to 5.5 
mM; and only a slight effect of glyphosate 3.1 was observed at a concentration of 1 
mM. 
 
 
Figure 3.1: Commercially available aminophosphonates 3.1 and 3.2 screened for DAH7P 
synthase inhibition. The synthesis of 2.3 is described in Chapter Two. 
 
The failure of glyphosate 3.1 to strongly inhibit DAH7P synthase was especially 
surprising, especially given the inhibitory power of the inhibitor 2.3, where the 
glyphosate portion was designed to fit to the PEP site. However, this finding 
suggested a new design method to achieve potent DAH7P synthase inhibition. By 
discovering molecules that acted as inhibitors of DAH7P synthase by competing 
against PEP binding, this would give a series of structures known to bind to the 
enzyme’s PEP subsite. By elaborating these molecules to make further contacts with 
the enzyme, potent DAH7P synthase inhibitors should result.  
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Due to a paucity of molecules known to bind to the DAH7P synthase PEP-subsite, we 
decided to prepare and test a variety of potential mimics of PEP. This chapter focuses 
on the results in this area. The elaboration of these molecules into DAH7P synthase 
inhibitors designed to display increased potency is described in Chapter Four. 
 
3.2: PEP-mimicking molecules 
 
3.2.1: Changes in geometry at C2 
 
As seen in Chapter One, the enol phosphate moiety of PEP is a crucial part of the 
DAH7P synthase mechanism. Consequently altering this moiety should interrupt the 
enzyme’s activity, whilst retaining most of the contacts the enzyme uses to bind and 
recognise PEP. In addition to providing a basis for future inhibitor design, 
comparisons between these molecules may be able to provide information about the 
enzyme mechanism of DAH7P synthase. 
 
In order to achieve this three molecules were prepared with a change in geometry 
from trigonal to tetrahedral at the equivalent of PEP C2; (R)- and (S)-phospholactates 
3.3 and 3.4, and achiral cyclopropane 3.5 (Figure 3.2). 
 
 
Figure 3.2: PEP-mimicking molecules with changes at the equivalent to C2 
 
Phospholactates 3.3 and 3.4 have been previously prepared in the study of other PEP-
utilising enzymes;89 they have been found to be moderately effective inhibitors of 
PEP carboxykinase, pyruvate kinase and enolase but have no effect on PEP 
synthetase. However, their interaction with any C-O cleaving PEP aldolase has not 
been reported. 
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Accordingly phospholactates 3.3 and 3.4 were prepared by the phosphorylation of the 
corresponding methyl lactates with freshly prepared diethyl iodophosphate. 
Deprotection with trimethylsilyl bromide and aqueous potassium hydroxide, followed 
by acidification and neutralisation with cyclohexylamine gave the corresponding 
tris(cyclohexylammonium) phospholactates 3.3 and 3.4 (Figure 3.3). 
 
 
Figure 3.3: Synthesis of phospholactates (R)-3.3 and (S)-3.4 
 
(S)-Phospholactate 3.4 was evaluated as an inhibitor of E. coli DAH7P synthase by 
kinetic assay. Analysis of the initial rate data by a Lineweaver-Burk analysis90 showed 
that (S)-phospholactate 3.4 is a competitive inhibitor with respect to PEP; fitting of 
the Michaelis-Menten equation modified for competitive inhibition revealed that (S)-
phospholactate binds to E. coli DAH7P synthase with an inhibition constant Ki of 670 
± 120 µM (Figure 3.4). 
 
In a similar fashion, the interaction of (R)-phospholactate 3.3 with E. coli DAH7P 
synthase was measured (Figure 3.5). (R)-Phospholactate was a competitive inhibitor 
with respect to PEP, however the inhibition constant was greater than an order of 
magnitude stronger than the (S)-isomer, with a Ki  of 49 ± 8 µM. 
 
The vast difference in affinity between (R)- and (S)-phospholactate is intriguing, and 
the causes and implications of this finding for the mechanism of DAH7P synthase are 
discussed in Chapter Five. 
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Figure 3.4: Inhibition measurements for (S)-phospholactate 3.4 against E. coli DAH7P synthase; 
as Michaelis (top) and Lineweaver-Burk (bottom) plots. Solutions of PEP (20-120 µM), 
manganese(II) sulfate (100 µM), E4P (200 µM) and (S)-phospholactate (0-2207 µM) in 1 mL of 
BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), and 
the loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by linear 
least squares regression of the absorbance data, and converted to progress rates. 
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Figure 3.5: Michaelis (top) and Lineweaver Burk (bottom) plots for inhibition of E. coli DAH7P 
synthase by (R)-phospholactate 3.3. Solutions of PEP (50-250 µM), manganese(II) sulfate (100 
µM), E4P (200 µM) and (R)-phospholactate (0-2336 µM) in 1 mL of BTP buffer (50 mM, pH 6.8) 
were initiated by the addition of E. coli DAH7P synthase (2 µg), and the loss of PEP followed 
spectrophotometrically at 232 nm. Initial rates were obtained by linear least squares regression 
of the absorbance data, and converted to progress rates. 
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Cyclopropane 3.5 has previously been reported as an inhibitor of various PEP-
utilising enzymes.91 Cyclopropane 3.5 is generally a more potent inhibitor of these 
enzymes than either enantiomer of phospholactate, a fact which is attributed to the 
steric and electronic similarities between cyclopropyl rings and alkenes.91 However 
this compound has never been tested against any C-O bond cleaving PEP aldolase. 
 
Treatment of commercially available carboxylic acid 3.6 with freshly prepared 
diazomethane gave the methyl ester 3.7 which was immediately treated with diethyl 
chlorophosphate to give phosphoryl ester 3.8 (Figure 3.6). 
 
 
Figure 3.6: Esterification and phosphorylation to give phosphoryl ester 3.8 
 
Treatment of the precursor 3.8 with trimethylsilyl bromide followed by aqueous 
potassium hydroxide workup gave a white solid. Analysis of this solid by 1H NMR 
spectroscopy revealed that the major product was in fact α-ketobutyrate 3.9, with only 
a small quantity of the required cyclopropane 3.5 being present. The ring opened 
product is presumably produced by neighbouring group assisted hydrolysis of the 
phosphoryl group; accompanied by ring opening of cyclopropyl group. Hydrolysis of 
the acyl phosphate produced would then lead to α-ketobutyrate 3.9. The ring opening 
of cyclopropyl alcohols under basic conditions is a well precedented reaction, with 
considerable application in organic synthesis.92 
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Figure 3. 7: Ring opening reaction of cyclopropane 3.8 during deprotection 
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However, despite this difficulty, small amounts of crude cyclopropane 3.5 were able 
to be isolated. Recrystallisation of the crude cyclohexylamine salt from 
methanol/acetone removed the ring opened product 3.9, and separation of the 
resulting mixture was achieved by preparative anion exchange chromatography 
(Figure 3.8). 
 
 
Figure 3.8: Overall purified yield of deprotected cyclopropane 3.5 
 
Analysis of cyclopropane 3.5 as a competitive inhibitor of E. coli DAH7P synthase 
showed that it was a competitive inhibitor with respect to PEP, with a Ki of ≤ 190 ± 
20 µM (Figure 3.10). 
 
This inhibition constant is less than that determined for (S)-phospholactate, and more 
than that determined for (R)-phospholactate. Given that cyclopropane effectively 
shares the stereochemistry of both stereoisomers of phospholactate, it is also 
considerably less than the mean value for the phospholactates (360 µM). This may be 
due to the greater electronic similarities between the cyclopropyl ring system and the 
PEP alkene than the more strictly sp3 phospholactate motif.  
 
 
Figure 3.9: Comparison between the structure of phospholactate, cyclopropane 3.5 and PEP; and 
the linear combination of atomic orbitals (LCAO) contributing to the C2-C3 bond in each 
 
As can be seen in Figure 3.9, the combination of atomic orbitals leading to the C2-C3 
σ bond in phospholactate lies in the plane of the bond, whereas in PEP the equivalent 
bond is formed by overlap above and below the plane of the bond. The bonding in 
cyclopropanes has been described in a similar manner93, with the electron density in 
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the centre of the ring, rather than along the direction of the bonds. This model has 
been used to explain why cyclopropane rings undergo reactions more similar to 
alkenes than to other cycloalkanes.93 
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Figure 3.10: Inhibition of E. coli DAH7P synthase by cyclopropane 3.5. Solutions of PEP (10-100 
µM), manganese(II) sulfate (100 µM), E4P (200 µM) and cyclopropane 3.5 (0-1784 µM) in 1 mL 
of BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), 
and the loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by 
linear least squares regression of the absorbance data, and converted to progress rates. 
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3.2.2: Removal of the enol oxygen of PEP 
 
The enol oxygen of PEP is a crucial part of the DAH7P synthase mechanism; 
providing the electron-donating substituent required for nucleophilic attack by the 
alkene of PEP. The necessity of this oxygen was known at the outset of this work, and 
both phosphonate94 3.10 and difluorophosphonate95 3.11 (Figure 3.11) have been 
found by others to not be substrates for the enzyme reaction, but instead act as 
inhibitors. 
 
 
Figure 3.11: The role of the enol oxygen in the enzyme mechanism; and two previously 
discovered DAH7P synthase inhibitors 
 
With this in mind, a new inhibitor lacking the crucial enol oxygen was designed. In 
this compound, the alkene has been moved from between C2-C3 of PEP, and instead 
occupies a position equivalent to the C2-O2 bond of PEP. This compound was 
designed to mimic the enzyme bound conformation of PEP, which has been observed 
in a number of enzyme structures (determined by X-ray diffraction) to have a syn 
relationship between the phosphorus atom and C3 of PEP (Figure 3.12). By having a 
(E)-vinyl phosphonate, the syn relationship is preformed and locked in position. This 
would be expected to give the binding of vinyl phosphonate 3.12 an entropic 
advantage over the binding of allylic phosphonate 3.10, as the entropic cost of 
restricting the conformation of the phosphonate has been paid during the formation of 
the vinyl phosphonate alkene, rather than during the inhibitor-enzyme association. 
This lower loss of entropy should lead to a larger Gibbs free energy of association, 
and hence a lower inhibition constant. 
 
Chapter Three: Single-Site Inhibitors of DAH7P synthase  66 
 
 
 
     
  
Figure 3.12: Relationship between proposed inhibitor 3.12 and PEP active site geometry (PEP as 
found in the structure of S cerevisiae DAH7P synthase; PDB accession number: 1of8.pdb).40 
 
The Horner-Wadsworth-Emmons (HWE) reaction was chosen to construct the vinyl 
phosphonate, utilising tetraethyl methylene bisphosphonate. 
 
The presence of different alkali metal cations in Wittig and HWE reactions has been 
shown to influence the stereochemical outcome of these reactions96. However, there 
has been little work on HWE reactions with bisphosphonates or α-ketoesters as 
reaction partners. The stereoselectivity of the required HWE reaction was investigated 
utilising lithium diisopropylamide, lithium chloride/ 1,7-diazabicyclo-[5.4.0]-undec-7-
ene (DBU),97 sodium bis(trimethylsilylamide) and potassium tert-butoxide as bases. 
The reactions were carried out on a small scale, and after aqueous workup the 
stereoselectivity was determined on the crude mixtures by NMR spectroscopy (Figure 
3.13). 
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Figure 3.13: Investigation of the stereochemical outcome of the HWE reaction 
 
The stereoselectivity was dependent on the alkali metal ion used, with the reaction 
selective toward the (E)-isomer with the small lithium cation, but (Z)-selective with 
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the larger potassium anion. Lithium chloride and DBU, previously reported as a mild 
system for HWE reactions gave only low conversion, with mostly starting materials 
present after 48 hours at room temperature.97 However, preforming the lithium anion 
at -78°C with LDA gave improved conversion, and slightly improved 
stereoselectivity. A model to explain the stereochemical outcome of similar HWE 
reactions has not been reported in the literature; however a model has been proposed 
to explain the outcome of this and related reactions, which is presented in Chapter 
Four (Section 4.6). 
 
In order to access both the (E)- and (Z)-isomers for further study, the reaction was 
carried out utilising sodium (bistrimethylsilyl)amide, giving a moderate overall yield 
of vinyl phosphonates (Figure 3.14). 
 
 
Figure 3.14: Preparative scale HWE reaction 
 
The stereochemistry of the vinyl phosphonates was assigned by 1H NMR 
spectroscopy, utilising a 1D transient nuclear Overhauser enhancement spectroscopy 
(NOESY) experiment. In the NOESY experiment, a selected resonance is irradiated, 
and the through-bond magnetisation transfer is eliminated, leaving the much weaker 
through-space transfer of magnetisation between nuclei. This transfer decreases with 
the sixth root of the distance between the nuclei;98 so intramolecular distances can be 
readily judged by the strength of the resulting nuclear Overhauser enhancement 
(NOE). The NOESY spectra for the two isomeric vinyl phosphonates are shown in 
Figure 3.15. In the undesired (Z)-isomer 3.14, the allylic methyl protons are on the 
same face as the vinyl proton, and a typical NOE is observed between them (blue 
box). No such signal is present in the spectrum of the (E)-isomer 3.13, where the 
corresponding protons are on opposite faces.  
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Figure 3.15: 1H and 1D-NOESY spectra of (E)-vinyl phosphonate 3.13, and NOESY for (Z)-vinyl 
phosphonate 3.14, showing the diagnostic NOESY signal 
 
Interestingly, the (Z)-isomer 3.14 was unstable during purification, and despite clean 
separation of the two isomers during chromatography, the (Z)-isomer was obtained as 
a mixture containing ~10-15% (E)-product 3.13 on every occasion. A photochemical 
process involving the electron-deficient double bond may be responsible for this, 
namely a photochemical pi → pi* transition allowing momentary rotation of the former 
double bond, followed by relaxation pi* → pi giving some product with the (E)-
configuration.  
 
Treatment of the purified (E)-vinyl phosphonate 3.13 with trimethylsilyl bromide, 
followed by aqueous potassium hydroxide, gave the desired phosphonate 3.12 as its 
tris(cyclohexylammonium) salt. 
 
 
Figure 3.16: Deprotection of 3.13 to vinyl phosphonate 3.12 
 
Attempts to deprotect the isolated (Z)-isomer under the same conditions led to further 
decomposition. Enzyme assay of the mixture of compounds obtained showed vastly 
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decreased inhibition when compared the same concentration of (E)-isomer, and 
further pursuit of the (Z)-isomer was abandoned.  
 
The (E)-vinyl phosphonate 3.12 was assayed as an inhibitor against E. coli DAH7P 
synthase (Figure 3. 17). Gratifyingly, (E)-vinyl phosphonate 3.12 proved to be a 
potent inhibitor of DAH7P synthase, competitive with respect to PEP, with a Ki of 4.7 
± 0.7 µM. 
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Figure 3. 17: Inhibition of DAH7P synthase with vinyl phosphonate 3.12. Solutions of PEP (20-
120 µM), manganese(II) sulfate (100 µM), E4P (200 µM) and vinyl phosphonate 3.12 (0-88 µM) in 
1 mL of BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 
µg), and the loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained 
by linear least squares regression of the absorbance data, and converted to progress rates. 
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Although vinyl phosphonate 3.12 was a potent inhibitor, its affinity might be 
improved by increasing its ability to mimic PEP. Phosphonates have decreased acidity 
compared to phosphates, due to the decreased electron withdrawing properties of 
oxygen relative to carbon. The acidity of phosphonates can be increased by 
mimicking the electron-withdrawing properties of oxygen by adding one or two 
fluorine atoms to the phosphonate carbon (Figure 3.18).99  
 
 
Figure 3.18: Acidities of phosphates, phosphonates, monofluoro- and difluorophosphonates. 
Acidity data taken from Romanenko et al.99 
 
With this in mind, we designed fluorinated compound 3.15. While the fluorine atoms 
are not on the phosphonate carbon, they are vinylogous to it, and so may still have the 
desired effect. 
 
Treatment of methyl 2,2,2-trifluoropyruvate under the LDA HWE conditions 
described above, gave a moderate yield of trifluorinated vinyl phosphonate 3.16 
(Figure 3.19). A single isomer was obtained under these conditions.  
 
 
Figure 3.19: Synthesis of trifluorinated vinyl phosphonate 3.16 
 
Due to the lack of the necessary nuclei for a NOESY experiment, the configuration of 
this compound was provisionally assigned as (Z). This was based on the similar shift 
of the vinyl proton 1H signal between (E)- vinyl phosphonate 3.13 and 3.16, as well as 
Chapter Three: Single-Site Inhibitors of DAH7P synthase  71 
 
the single product observed under lithium HWE conditions. It should be noted that 
though (E)-3.12 and (Z)-3.16 share the same configuration, they differ in assignment 
due to the relative substituent priorities under the Cahn-Ingold-Prelog system of 
nomenclature.  
 
Treatment of ester 3.16 under our standard trimethylsilyl bromide deprotection 
conditions gave the desired phosphonate 3.15 as its tris(cyclohexylammonium) salt 
(Figure 3.20). 
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Figure 3.20: Deprotection of fluorinated phosphonate 3.16 
 
Fluorinated phosphonate 3.15 was tested as an inhibitor of E. coli DAH7P synthase 
(Figure 3.21). Phosphonate 3.15 proved to be an effective inhibitor of DAH7P 
synthase, competitive with respect to PEP, with a Ki of 8.8 ± 2.5 µM.  
 
Unfortunately fluorinated phosphonate 3.15 was not significantly more potent than its 
non-fluorinated equivalent 3.12. This could be due to a number of factors; one 
possible explanation is the size of the trifluoromethyl substituent is slightly greater 
than the methyl group it replaces.100 The methylene group of PEP sits in close 
proximity to a conserved active site proline residue (Figure 3.22), so any gain in 
binding from improving pKa2 in 3.15 may be balanced in steric clashes between the 
fluorine atoms and the proline residue, disfavouring binding. 
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Figure 3.21: Inhibition data for trifluorinated vinyl phosphonate 3.15. Solutions of PEP (50-250 
µM), manganese(II) sulfate (100 µM), E4P (200 µM) and trifluorinated vinyl phosphonate 3.15 
(0-272 µM) in 1 mL of BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli 
DAH7P synthase (2 µg), and the loss of PEP followed spectrophotometrically at 232 nm. Initial 
rates were obtained by linear least squares regression of the absorbance data, and converted to 
progress rates 
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Figure 3.22: Close contacts between PEP and the conserved active site proline (P133) in S. 
cerevisiae DAH7P synthase (PDB: 1of8).40 The dots are drawn at the Van der Waals contact radii 
for the carbon atoms in each structure; the centre to centre distances between the proline ring 
carbons Cγ and Cδ and PEP C3 are 3.8 and 4.0 Å, respectively. 
 
3.2.3: Compounds retaining the enol substructure 
 
The enol phosphate substructure of PEP is a crucial component of the enzyme 
mechanism. As was seen in Section 3.2.2, the enol oxygen also has an effect on 
substrate binding, by decreasing the pKa2 of the neighbouring phosphoryl group. 
These favourable effects could be incorporated into an inhibitor, if some way was 
found to stop the enzyme processing the enol phosphate as a substrate. 
 
Considering the Lewis-acid mechanism of DAH7P synthase activity, for the enol 
alkene to act as a nucleophile, activation of the aldehyde electrophile is required. In 
DAH7P synthase this is proposed to be achieved by coordination of the aldehyde 
carbonyl to the metal centre, so in principle disrupting this interaction should stop the 
enzyme reaction. 
 
One method to achieve this aim would be to incorporate a strong coordinating group 
into a PEP-like compound. Once the compound binds to the enzyme, the coordinating 
group should become a metal ligand, and block coordination of the aldehyde 
carbonyl, rendering the PEP-like compound inert to the enzyme reaction. 
 
Cyanophosphate 3.17 (Figure 3.23) has previously been reported as an inhibitor of the 
PEP-metalloenzymes pyruvate kinase and PEP carboxylase,101 and its inhibition 
Chapter Three: Single-Site Inhibitors of DAH7P synthase  74 
 
constant was found to be dependent on the metal cofactor used, with inhibition of the 
manganese(II)-enzyme complex more than 10-fold greater than that for the 
magnesium(II)-enzyme complex in each case. Interestingly, the compound is also a 
weak substrate of pyruvate kinase.101 
 
 
Figure 3.23: CyanoPEP 3.17 
 
This compound seemed ideal, so efforts were made to prepare it by the known 
preparation. Treatment of diethyl oxalate with the potassium anion of acetonitrile, 
generated in situ from acetonitrile and potassium ethoxide, gave a good yield of a pale 
yellow solid identified as potassium enolate 3.18 (Figure 3.24). 
 
 
Figure 3. 24: Generation of potassium enolate 3.18 
 
Attempts to phosphorylate this compound by a slight modification of the literature 
method, substituting commercially available and comparatively stable diethyl 
chlorophosphate for its dimethyl equivalent, led only to small quantities of the desired 
product. Attempts to create a more naked anion by adding 10 mol% 18-crown-6 also 
failed to give clean reaction.102 In each case the reaction mixture rapidly became deep 
brown-black upon addition of the phosphorylating reagent. In addition, it was 
suspected the enol phosphate was unstable toward chromatography, so we required a 
method to maximise the production of the desired compound and minimise the 
production of byproducts. To more closely investigate this reaction, a time course 31P 
NMR experiment was conducted (Figure 3.25). 
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Figure 3.25: 31P NMR spectroscopy of a timecourse experiment of the enolate phosphorylation 
reaction, time between each spectrum is 150 minutes 
 
Analysis of the spectrum shows the slow disappearance of a signal at around 4 ppm, 
which corresponds with a slow increase in another peak at -13 ppm. These signals 
correspond to diethyl chlorophosphate and tetraethyl pyrophosphate respectively. The 
small signal at -7 ppm is assigned as the desired product, based on a correlation 
between the vinylic proton and this phosphorus signal in a 31P-1H HMBC experiment.  
 
What is clear from the above spectra is that a steady population of the desired product 
is formed quickly, and no increase in this product is observed with increased reaction 
time. However, the diethyl chlorophosphate continues to be consumed for several 
more hours, being slowly converted to tetraethyl pyrophosphate. Based on this 
evidence it is proposed that the desired product is being destroyed in the reaction 
mixture at a similar rate to its formation; presumably by elimination of phosphate 
across the enolate ester system promoted by the remaining alkoxide ion.103 The 
potassium diethyl phosphate produced rapidly reacts with the remaining diethyl 
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chlorophosphate, forming tetraethyl pyrophosphate. Once the entire alkoxide ion is 
consumed the elimination ceases, and no more tetraethyl pyrophosphate is produced, 
nor diethyl chlorophosphate consumed. The dark colouration of the reaction mixture 
can be explained by formation of polymeric side products from the highly electron-
deficient alkyne side product produced. 
 
Based on this analysis, it should be possible to rapidly quench the reaction and still 
obtain a similar yield of the desired product, and minimise the production of 
difficultly separated tetraethyl pyrophosphate. Gratifyingly, conducting the reaction 
for only ten minutes returned a good yield of crude product (Figure 3.26), of greater 
purity than attained by previous methods. 
 
 
Figure 3.26: Rapid phosphorylation of enolate 3.18 
 
Deprotection of the product with trimethylsilyl bromide, isolation as its 
cyclohexylammonium salt and recrystallisation from methanol/ether gave a solid 
containing (E)-cyanophosphoenolpyruvate 3.17 (Figure 3.27), the (Z)-isomer 
presumably being unstable to the deprotection conditions as described in the original 
publication.101 
 
 
Figure 3.27: Deprotection and isolation of (E)-cyanophosphoenolpyruvate 3.17 
 
With the small quantity of impure 3.17 produced by this route it was possible to 
briefly study its interaction with E. coli DAH7P synthase. (E)-
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Cyanophosphoenolpyruvate 3.17 undergoes a slow hydrolysis under the assay 
conditions, as revealed by a slow decrease in absorbance at 232 nm. This hydrolysis is 
enzyme concentration dependent, but independent of E4P concentration. Based on 
this, it was presumed the enzyme was catalysing dephosphorylation of 3-cyanoPEP to 
3-cyanopyruvate. A spectrophotometric coupled assay utilising E. coli DAH7P 
synthase, rabbit lactate dehydrogenase and NADH showed oxidation of NADH was 
occurring, which supports this theory. Similar behaviour has been noted during 
studies of 3-halophosphoenolpyruvates95. Based on the consumption of NADH in the 
coupled assay system, this hydrolysis proceeds at a slow rate (~20 pmol min-1) under 
typical assay conditions. 
 
 
Figure 3.28: Enzymatic hydrolysis to cyanopyruvate, and in situ enzymatic reduction.  
 
Attempts to accurately quantify the amount of (E)-cyanophosphoenolpyruvate 3.17 
present by dephosphorylating the compound with pyruvate kinase, reducing the 3-
cyanopyruvate to 3-cyanolactate with lactate dehydrogenase, and quantitating the 
amount of NAD+ produced (Figure 3.28) spectrophotometrically was unsuccessful, 
with readings significantly higher than that plausible by weight per volume 
measurements. The concentration of (E)-cyanophosphoenolpyruvate in solution was 
estimated based on the weight of solid used, assuming it was pure (E)-
cyanophosphoenolpyruvate 3.17. (E)-Cyanophosphoenolpyruvate 3.17 proved to be 
an inhibitor of E. coli DAH7P synthase, competitive with respect to PEP, with an 
inhibition constant Ki ≤ 75 ± 25 µM. The results of these studies are shown in Figure 
3.29. 
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Figure 3.29: Inhibition properties of (E)-cyanophosphoenolpyruvate 3.17. Solutions of PEP (50-
100 µM), manganese(II) sulfate (100 µM), E4P (200 µM) and (E)-cyanophosphoenolpyruvate 3.17 
(0-924 µM) in 1 mL of BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli 
DAH7P synthase (2 µg), and the loss of PEP followed spectrophotometrically at 232 nm. Initial 
rates were obtained by linear least squares regression of the absorbance data, and converted to 
progress rates 
 
Another possible way to disrupt the enzyme would be to substitute the phosphoryl 
group for a similar group, whilst retaining the enol substructure. A compound with 
these features is the enol sulfate 3.20 (Figure 3.30).  
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Figure 3.30: Comparision between enol phosphate PEP and enol sulfate 3.20 
 
The effect of heteroatom enol esters other than the natural phosphate of PEP on the 
reactivity of DAH7P synthase has not been reported, so it was possible that the sulfate 
3.20 may even be a substrate for DAH7P synthase. Adventitous sulfate ions has been 
observed in DAH7P synthase crystal structures, occupying the E4P phosphate pocket 
when E4P or an analogue is not present.26 With this in mind, sulfate 3.20 was 
prepared by a modified literature route.104 Treatment of ethyl bromopyruvate with 
sodium cyanoborohydride under mildly acidic conditions gave bromolactate 3.21 in 
an acceptable yield (Figure 3.31), given the possibility of side reactions such as ester 
reduction and bromide displacement. 
 
 
Figure 3.31: Reduction of bromopyruvate to lactate 3.21 
 
Treatment of lactate 3.21 with pyridine-sulfur trioxide complex gave the pyridinium 
sulfate 3.22 in good yield as a viscous oil (Figure 3.32). 
 
 
Figure 3.32: Sulfation of lactate 3.21 with pyridine-sulfur trioxide complex to sulfate 3.22 
 
Treatment of unstable pyridinium sulfate 3.22 with an excess of aqueous potassium 
hydroxide, added slowly in portions, gave elimination and ester hydrolysis in the one 
pot, to give a solution of sulfoenolpyruvate (SEP) 3.20 (Figure 3. 33). 
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Figure 3. 33: One-pot elimination and saponification to give sulfoenolpyruvate 3.20 
 
After quenching the excess base, SEP was isolated as its barium salt, which was 
purified by selective precipation. Treatment of this salt with Dowex-50X8 K+-form 
returned the dipotassium salt of SEP in acceptable overall yield. 
 
Analysis of the behaviour of SEP toward E. coli DAH7P synthase was then carried 
out. Initial studies showed SEP was not an inhibitor of DAH7P synthase under normal 
conditions, with no significant inhibition observed up to a 10 mM level of SEP. Based 
on this lack of inhibition, it was thought SEP may be processed by the enzyme under 
the reaction conditions, however no loss of SEP was observed spectrophotometrically; 
with enzyme-manganese(II), enzyme-copper(II), enzyme-zinc(II) or enzyme-
cobalt(II) as catalysts. Since KDO8P synthase is thought to bind and utilise the 
dianionic form of PEP, rather than the trianionic form like DAH7P synthase, 
reactivity with KDO8P synthase was also investigated. Treatment with metal-
independent Neisseria meningitidis KDO8P synthase, or metal dependent 
Acidithiobacillus ferreoxidins KDO8P synthase also failed to show any consumption 
of SEP. This apparent lack of binding or reactivity with  either DAH7P synthase or 
KDO8P synthase was perplexing, and in order to ensure that the spectrophotometric 
results were accurate we carried out an NMR time-course experiment, where SEP was 
incubated overnight with E4P, manganese(II) sulfate and E. coli DAH7P synthase 
(Figure 3.34).  
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Figure 3.34: 1H NMR spectroscopy study of SEP with E4P in the presence of E. coli DAH7P 
synthase. A solution of SEP (41 mM), E4P (18 mM), and manganese(II) sulfate (42 µM) in 20% 
D2O/H2O (600 µL) was adjusted to pH 6.8 with a small quantity of 1 M sodium hydroxide. E. coli 
DAH7P synthase (400 µg) was added, and the mixture monitored overnight at room temperature 
by NMR spectroscopy, utilising a 1H presaturation pulse sequence. 
 
Analysis of the spectra showed that no DAH7P-like product had been formed, and 
that no SEP had been consumed through non-productive hydrolysis. This confirmed 
the stability of SEP toward DAH7P synthase.  
 
The intensity of one unknown peak at around δ 5 ppm had changed significantly. This 
peak was further analysed by a selective total correlation spectroscopy (selTOCSY) 
NMR experiment. In a selTOCSY experiment a resonance of choice is irradiated, and 
after a suitable delay, tmix, the spectrum is collected. The signals that appear are those 
belonging to protons that can be excited by magnetisation transfer during tmix; which 
are those protons within the same spin system as the irradiated proton. The selTOCSY 
experiment (Figure 3.35) showed that this peak was likely to be E4P hydrate, formed 
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by slow equilibration between the oligomeric and monomeric forms of E4P during the 
overnight run. 
ppm (f1)
3.504.004.505.00
Figure 3.35: selTOCSY analysis of the changed δ 5 ppm peak, tmix = 150 ms. 
 
Addition of an aliquot of the NMR reaction mixture after overnight incubation to a 
mixture of PEP, E4P and manganese(II) showed that enzyme was still catalytically 
competent, ruling out any irreversible covalent enzyme modification as the cause of 
the non-reactivity of SEP. 
 
The failure of SEP 3.20 to be processed by or inhibit DAH7P synthase was surprising. 
Since its stability to the reaction conditions has been verified, the failure of SEP to 
inhibit DAH7P synthase (even when present in a two hundred fold molar excess with 
relation to PEP) can be taken as indication that it is failing to bind to the enzyme PEP 
binding site. However, in the absence of PEP; E4P is known to rapidly covalently 
inactivate DAH7P synthase, by imine formation between the presumably Lewis acid 
activated aldehyde of E4P with an active site lysine in the PEP pocket.105 This 
inactivation quickly renders DAH7P synthase inactive under typical assay 
concentrations of E4P (~ 200 µM) in the absence of PEP. However, no such 
inactivation occurred in the NMR experiment despite a very high E4P concentration 
(18 000 µM), indicating a protective effect of SEP. This suggests that in the absence 
of PEP, a weak enzyme-SEP complex can form, and obscure the lysine from imine 
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formation. However it is clear that this complex is unable to be continue the normal 
reaction pathway to DAH7P, perhaps indicating a role of the PEP phosphate group in 
initiating the enzyme reaction.  
 
The vast difference in affinity between PEP and SEP is surprising, since the single 
atom change from PEP to SEP can be considered a conservative change. Semi-
empirical calculations (AM1 level) show little difference in overall minimised 
geometry and key bond lengths between the gas phase structures of PEP and SEP, and 
with the exception of the P-O bond length these calculations agree well with the PEP 
geometry found by X-ray crystallographic analysis of S. cerevisiae DAH7P synthase-
PEP-G3P complex.40 
 
The one obvious difference between SEP and PEP is the charge state. The phosphate 
of PEP is capable of being either mono- or dianionic; the sulfate of SEP is only 
capable of being a monoanion. The failure of SEP to inhibit DAH7P synthase might 
suggest that the enzyme exclusively binds the trianionic form of PEP, with 
exceptional selectivity. This finding is hard to reconcile with the fact that simple 
phosphonates, whose dominant form at the assay pH would be dianionic, are capable 
of competing with PEP for DAH7P synthase very effectively (vide supra). It may be 
possible that the enzyme PEP phosphate binding pocket has evolved a suitable 
method for discriminating between phosphate and sulfate groups, in order to avoid 
inhibition by free sulfate ions in the cell. The mechanism of this discrimination is 
unclear, and not obvious in nature. Efforts to understand this discrimination utilising 
computational methods are described in Chapter Five. 
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Figure 3.36: Crystallographically determined PEP geometry, from 10f8.pdb40 
 
Figure 3. 37: Calculated (AM1) PEP geometry 
 
Figure 3. 38: Calculated (AM1) SEP geometry 
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3.2.4: Compounds bearing other functional groups 
 
In addition to the designed molecules characterised above, the interaction of DAH7P 
synthase with small compounds containing more diverse functional groups was also 
measured. 
 
Fosfomycin 3.23 is produced by cultures of certain Streptomyces species, and is now a 
clinically important antibiotic. Its molecular target is MurA (UDP-N-
acetylglucosamine-enolpyruvate transferase), a member of the enolpyruvyl transferase 
family of enzymes. These enzymes catalyse the transformation of an alcohol and PEP 
to an enolpyruvyl ether and phosphate, via phosphate C-O bond cleavage. Fosfomycin 
inhibits MurA by covalent modification of a nucleophilic cysteine residue.106 
 
 
Figure 3.39: The reaction of UDP-N-acetylglucosamine-enolpyruvate transferase; and its 
inhibitor fosfomycin 3.23. 
 
Since DAH7P synthase also possesses an active site cysteine, fosfomycin was 
investigated both as a reversible competitive inhibitor and as a time-dependent 
irreversible inhibitor of E. coli DAH7P synthase. No inhibitory activity of either type 
was observed. This finding indicates the importance of both the carboxyl group and 
the phosphoryl group in targeting molecules to the PEP binding site. 
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With the discovery of routes to β-substituted β-halo-α-ketoesters, PEP mimicking 
compounds that could be prepared from these compounds became of interest. 
Heterocyclic compounds have many properties that make them favourable as enzyme 
inhibitors and medicines; they offer a readily functionalised scaffold for the 
attachment of functionality, and often have favourable metabolic stability.107 In 
addition, many families of heterocycles can be prepared from α-haloketones, making 
them potentially accessible as branches from the synthetic routes in Chapter 4, and 
thus of interest as DAH7P synthase inhibitors. 
 
In order to investigate the use of heterocyclic compounds in the inhibition of DAH7P 
synthase, aminothiazole 3.24 was prepared as a representative member. It bears a 
carboxyl group to orientate it in the enzyme active site; and the multiple heteroatoms 
allow the possibility of favourable hydrogen bonding contacts in the PEP phosphate 
binding pocket. Aminothiazole 3.24 was readily prepared by treatment of 
bromopyruvic acid with thiourea; followed by treatment with sodium acetate (Figure 
3.40). 
CO2H
Br
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H2N NH2
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3.24
 
Figure 3.40: Synthesis of thiazole 3.24 
 
The sodium salt of aminothiazole 3.24 was assayed as an inhibitor of E. coli DAH7P 
synthase, no inhibition was seen under standard conditions up to 0.4 mM, and its 
intense UV absorbance made assay at high concentrations impractical. The failure of 
this compound to inhibit DAH7P synthase again reinforced the necessity of both 
carboxyl and phosphoryl groups in potential inhibitors. 
 
The antibiotic fosmidomycin 3.25 was isolated as an antibacterial agent from cultures 
of Streptomyces lavendulae, further studies determined it is active against some 
Gram-positive and most Gram-negative bacteria108, 109. The biological target of 3.25 
remained a mystery for several years, until the discovery of the non-mevalonate 
pathway in the mid- 1990s.110, 111 The non-mevalonate pathway provides some 
organisms with an alternative method to synthesise the isoprenoid precursors 
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isopentenyl diphosphate (IPP) and dimethallyl diphosphate (DMAPP); themselves 
used to synthesise a number of primary and secondary metabolites. Further studies 
determined fosmidomycin was a potent inhibitor of 1-deoxy-D-xylulose 5-phosphate 
reductoisomerase (DXR), which catalyses the conversion of 1-deoxy-D-xylulose 5-
phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate (MEP); the second step of 
the non-mevalonate pathway (Figure 3.41).112 
 
 
Figure 3.41: Fosmidomycin 3.25 and DXR 
 
The mechanism of inhibition of DXR by fosmidomycin has been studied by detailed 
enzyme kinetics and X-ray crystallography; fosmidomycin binds as a slow-tight 
inhibitor of DXR, competitive with DXP with an initial inhibition constant Ki of 215 
nM, and a tight inhibition constant Ki* of 21 nM113 (Figure 3. 42).  
 
E E DXP
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Figure 3. 42: Relevant equilibria for slow-tight inhibition of DXR by fosmidomycin 
 
Crystallographically, fosmidomycin binds its phosphonate group at the DXR 
phosphate binding pocket, and the formylhydroxamate portion forms bidentate ligand 
for the metal cofactor, in this case magnesium(II).114 
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Figure 3. 43: Binding of fosmidomycin (salmon/red/blue/orange C/O/N/P respectively) to E. coli 
DXR-magnesium complex (PDB accession code: 2EGH).114 
 
Despite a lack of sequence, structural or mechanistic homology; the structure and 
behavior of DXR bears obvious parallels with the binding of E4P to DAH7P synthase. 
Both enzymes bind their substrates through a phosphate distant from the site of 
reactivity, and both enzymes exploit a divalent metal ion for catalysis. Both E. coli 
enzymes have maximum activity with manganese(II).16, 113 DXR catalyses a retro-
aldol reaction as part of its mechanism,115 a known side reaction of DAH7P synthase 
under some conditions.105. DAH7P synthase substrate E4P is a known poor alternative 
substrate of DXR,113 and compounds bearing the threo stereochemistry of DXP are 
alternative substrates of DAH7P synthase.39 Based on these parallels we postulated if 
fosmidomycin is capable of inhibiting DXR; then it should, by extension, be capable 
of inhibiting DAH7P synthase (Figure 3.44). 
Chapter Three: Single-Site Inhibitors of DAH7P synthase  89 
 
 
Figure 3.44: A comparison of DXR-DXP, DAH7P synthase-E4P and metalloenzyme-
fosmidomycin complexes 
 
Based on this a commercial sample of fosmidomycin was obtained, and a preliminary 
study showed gratifyingly it is an effective inhibitor of DAH7P synthase. However, 
detailed studies to determine the inhibition mechanism led to a surprising discovery. 
Fosmidomycin is not a competitive inhibitor with respect to E4P; it is uncompetitive, 
as signaled by the parallel lines on a Lineweaver-Burk plot (Figure 3.46). If 
fosmidomycin bound as we had postulated, competitive behaviour with respect to E4P 
would be expected (Figure 3.45). 
 
 
Figure 3.45: Relevant equilibria for competitive and uncompetitive behaviour with respect to 
E4P. In the competitive model, both E4P and fosmidomycin (I) compete for the same 
intermediate, in the uncompetitive model E4P and I are not in direct competition for the same 
species. For simplicity, the metal association equilibrium prior to substrate binding has been 
omitted, as have the product release equilibria. 
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Figure 3.46: Inhibition of DAH7P synthase with fosmidomycin with relation to E4P; in both 
Michaelis-Menten and Lineweaver-Burk representations. Solutions of PEP (100 µM), 
manganese(II) sulfate (100 µM), E4P (100-300 µM) and fosmidomycin (0-1112 µM) in 1 mL of 
BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), and 
the loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by linear 
least squares regression of the absorbance data, and converted to progress rates 
 
 
In the competitive model (Figure 3.45), both E4P and fosmidomycin compete for the 
same intermediate enzyme-PEP complex. Consequently, the rate of the reaction in the 
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presence of fosmidomycin is primarily a function of the concentrations and 
association equilibrium constants for both fosmidomycin and E4P.  
 
In the uncompetitive model, E4P and fosmidomycin bind at distinct sites, and are not 
in competition for the same position on the enzyme. Assuming fosmidomycin binds at 
the PEP site, the rate is then primarily a function of the concentrations and association 
equilibrium constants for fosfomycin and PEP. The concentration of E4P will still be 
expected to have a slight effect in this scenario, since it exerts an effect on the relative 
concentrations of the enzyme-PEP and enzyme-fosmidomycin complexes through the 
ratio of its association constant with each species. 
 
Assuming the uncompetitive model in Figure 3.45 is correct, it would be expected that 
fosmidomycin would be a competitive inhibitor with relation to PEP, since 
fosmidomycin and PEP compete for the same position on the enzyme. Further 
experiments showed that this is indeed the case; fosmidomycin competitively inhibits 
E. coli DAH7P synthase with respect to PEP (Figure 3.47), with a surprisingly potent 
inhibition constant of 35 ± 4 µM. 
 
This result was initially surprising; since we had already demonstrated with several 
diverse scaffolds (vide supra) that for a compound to inhibit DAH7P synthase 
competitively with respect to PEP it required both phosphoryl and carboxyl groups. 
Fosmidomycin only has a phosphonate group, so does not obey this finding. However, 
once the phosphonate has bound to the enzyme phosphate pocket, the carbon chain of 
fosmidomycin could then adopt a conformation that allowed the formylhydroxamate 
access to the metal ion. The corresponding chelate complex would then constitute an 
additional contact with the enzyme, which would strengthen the inhibitor-enzyme 
interaction. 
 
If this is the case, one might expect slow kinetics for the binding of fosmidomycin to 
the enzyme: an initial low affinity phosphonate-phosphate pocket interaction, 
followed by metal-hydroxamate complexation, giving a higher affinity enzyme-
inhibitor complex. This would manifest itself as a time dependency in the inhibition 
of DAH7P synthase with fosmidoycin, a behaviour which is in fact observed (Figure 
3.48). 
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In addition, one would expect the inhibition of DAH7P synthase by fosmidomycin 
might vary depending on the particular metalloenzyme complex used, since the 
stability of the resulting hydroxamate complex can be expected to be dependent on the 
characteristics of the d-orbitals at the metal centre, which themselves are dependent 
on both metal type and ligand environment. This behaviour is also observed, while 
both enzyme-manganese(II) and enzyme-iron(II) complexes are affected to the same 
extent by 280 µM fosmidomycin, the corresponding enzyme-cobalt(II) complex is 
affected to a much lesser extent (Figure 3.48). A detailed analysis of these results is 
confounded by a number of factors; however the difference does indicate a role for 
the metal ion in inhibition of DAH7P synthase with fosmidomycin. 
 
The behaviour of fosmidomycin towards DAH7P synthase raises interesting questions 
about the mechanism of fosmidomycin antibacterial activity. While it is clear that 
DXR is the primary target of fosmidomycin activity (with a Ki three orders of 
magnitude smaller than that against DAH7P synthase), the role of DAH7P synthase 
should not be overlooked. At least one of the outward signs of fosmidomycin action 
(reduced levels of vitamin K synthesis) can be also explained by DAH7P synthase 
inhibition, since while the isoprene side chain of vitamin K is non-mevolonate 
pathway derived, the quinone portion is shikimate pathway derived. In addition, 
fosmidomycin has recently been found to possess activity toward malarial parasites116 
such P. falciparum, which as well as possessing a non-mevalonate pathway is one of 
the few classes of eukaryotes to possess a shikimate pathway.117 At very least, given 
the potency of unelaborated fosmidomycin as a lead structure against DAH7P 
synthase, and the known whole organism properties of fosmidomycin, fosmidomycin 
should serve as a useful starting point for the design of antibiotics targeting DAH7P 
synthase. Possible future directions for this research, along with computational 
investigations of the fosmidomycin-enzyme complex are discussed in Chapter Five. 
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Figure 3.47: Inhibition of E. coli DAH7P synthase by fosmidomycin, with relation to PEP; in both 
Michaelis-Menten (top) and Lineweaver-Burk (bottom) representations. Solutions of PEP (20-
100 µM), manganese(II) sulfate (100 µM), E4P (200 µM) and fosmidomycin (0-1112 µM) in 1 mL 
of BTP buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), 
and the loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by 
linear least squares regression of the absorbance data, and converted to progress rates 
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Figure 3.48: A possible slow-tight binding mechanism of fosmidomycin inhibition, and time (left) 
and metal (right) dependency of fosfomycin inhibition.  
A. Time dependence: Fosmidomycin (280 µmol) and E. coli DAH7P synthase (20 µg) were 
incubated at 0°C in 50 mM BTP, pH 6.8 (30 µL) , and at the time indicated a portion (2 µL) was 
removed and used to initiate a cuvette of PEP (50 µM), E4P (200 µM) and manganese(II) sulfate 
(100 µM) in 1mL BTP buffer (50 mM, pH 6.8), and the initial rates taken. 
B. Metal dependence: Cuvettes of PEP (50 µM), E4P (200 µM) and the appropriate metal salt 
(FeSO4, MnSO4, CoCl2; 100 µM) in 50 mM BTP, pH 6.8 were initiated with E.  coli DAH7P 
synthase (2 µg), and the initial rates taken. The measurement was repeated in the presence of 280 
µM fosmidomycin. Reported values are means of duplicate experiments. 
 
3.3: Summary 
 
In summary, a number of small molecule inhibitors were designed and synthesised for 
DAH7P synthase. It was shown that DAH7P synthase can accept PEP-like molecules 
with tetrahedral geometries at the equivalent to PEP C2 (Figure 3.49). For chiral 
tetrahedral molecules such as phospholactate, it was shown the configuration of the 
C2 stereocentre has a strong influence on the affinity of binding. Even the most potent 
of the molecules tetrahedral at C2 bound to the enzyme approximately 25-fold weaker 
than PEP, indicating a preference of the enzyme for the trigonal planar geometry of 
PEP at C2. 
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Figure 3.49: C2 tetrahedral inhibitors of DAH7P synthase compared to PEP 
 
The importance of entropic effects in enzyme-inhibitor interactions were highlighted 
in the interactions of molecules with a trigonal planar geometry at the equivalent 
position to PEP C2. By simply restricting the conformation of a single rotatable bond; 
a greater than a 50-fold improvement in inhibitor potency was observed between 
previously reported allylic phosphonate 3.10 and conformationally restricted vinyl 
phosphonate 3.12.94, 95 The binding of the conformationally restricted vinyl 
phosphonate was unable to be improved by substituting the methyl hydrogen atoms 
for fluorine atoms, although the binding was not strongly weakened by this 
modification either (Figure 3.50). 
 
 
Figure 3.50: The behaviour of molecules with trigonal planar geometries at C2 
 
The necessity of a phosphate or phosphonate group in order to achieve DAH7P 
synthase inhibition was demonstrated by the failure of thiazole 3.24 and 
sulfoenolpyruvate 3.20 to inhibit E. coli DAH7P synthase. The remarkable failure of 
sulfoenolpyruvate 3.20 demonstrates a strong specificity of the enzyme for the PEP 
phosphate group. While necessary for inhibition (as shown by thiazole 3.24), the 
presence of a phosphate mimicking group is not sufficient for inhibition of DAH7P 
synthase, as shown by the failure of fosfomycin 3.23 (Figure 3.51). 
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Figure 3.51: PEP and compounds that fail to inhibit DAH7P synthase. 
 
The aminophosphonates 3.1 and 3.2 were also not strong inhibitors of the enzyme, 
perhaps at least partially due to the destabilising repulsion of the positively charged 
ammonium group from the highly positively charged PEP binding site (Figure 3.52). 
 
 
Figure 3.52: PEP and failed aminophosphonate molecules 
 
The utility of exploiting metal-inhibitor interactions in the inhibition of DAH7P 
synthase was demonstrated (Figure 3.53); by using a PEP analogue bearing a strong 
metal coordinating group, cyanoPEP 3.17. The interaction of an inhibitor with the 
DAH7P synthase metal site was also invoked in the inhibition of DAH7P synthase by 
fosmidomycin 3.25, a clinically important antibiotic. The strong interaction of 
fosmidomycin with DAH7P synthase highlighted the potential dispensability of 
groups mimicking the carboxylate group of PEP as long as other contacts with the 
enzyme are made. 
 
 
Figure 3.53: PEP compared to inhibitors exploiting inhibitor-metal interaction 
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Chapter Four: Novel, Dual-Site inhibitors of DAH7P 
synthase  
 
4.1: Inhibitor design 
 
With the better understanding of the DAH7P synthase PEP binding site gained by the 
studies in Chapter Three, work could now begin on designing new high affinity 
inhibitors for DAH7P synthase. 
 
In order to improve the binding of inhibitors to DAH7P synthase, we decided to 
utilise the principle of multivalency. Multivalency in inhibitor design involves 
elaborating an existing inhibitor so that it contains additional binding motifs, allowing 
the molecule to simultaneously interact with multiple sites on the target, and create a 
more stable enzyme-inhibitor complex by utilising the binding energy associated with 
both binding sites118 (Figure 4.1). 
 
 
Figure 4.1: Comparison between mono and multivalent binding to an enzyme with two 
independent sites 
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This approach also makes the second binding event effectively intramolecular; so 
while the first binding event is controlled by the dissocation constant Kd and the 
relative concentrations of enzyme and ligand, the binding at the second site is 
dependent not on the overall concentration of ligand, but on the effective 
concentration, Ceff.118 The effective concentration is a function of the probability of 
the two binding motifs being found at an appropriate distance to allow the second 
binding event to occur, and for long chains (greater than 15 linker atoms) Ceff can be 
estimated by assuming the linker behaves as a random coil, with suitable adjustments 
for linker flexibility and space occupied by the protein which cannot be occupied by 
the linker.118 The intramolecular binding interaction is stronger than the corresponding 
intermolecular interaction. This can be explained on entropic grounds, when the 
enzyme and ligand are free in solution, the each have an associated translational 
entropy along each axis of their movement. When the two molecules interact to form 
a complex, there is a corresponding loss in entropy, as the total of six translational 
degrees of freedom (along x, y and z for each molecule) is reduced to just three (x, y, 
and z for the whole complex). This decrease in entropy forms a component of the 
overall Gibbs energy of interaction. However, if the binding event is intramolecular, 
then the reactants and products each have three degrees of translational entropy, 
which results in a smaller entropy decrease, and thus a smaller Gibbs energy of 
interaction (and hence a stronger interaction).118 
 
In order to apply this principle to DAH7P synthase inhibitors, we decided to elaborate 
our known PEP-mimicking inhibitors by adding a distal phosphate, capable of 
interacting with the E4P phosphate binding pocket. In order to better understand the 
contribution of the distal phosphate, multivalent inhibitors were designed utilising 
strong, moderate and weak PEP-mimicking motifs (Figure 4. 2). For the linker we 
chose a simple tetramethylene carbon chain, it should be more readily constructed 
than the corresponding triol portion of DAH7P, while still providing the appropriate 
spacing between the PEP-mimicking end and the distal phosphate. While the absence 
of alcohol groups on the chain might be expected to provide a large decrease in 
binding affinity for enthalpic reasons, the interaction of the enzyme with the linker 
will reduce the conformational flexibility of the linker, resulting in a decreased 
entropy of interaction. The entropic cost of freezing the rotation of a carbon-carbon 
bond is approximately 2 kJ mol-1, the values for other single bonds range from 
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approximately 0.4 – 4 kJ mol-1.118 In order to form hydrogen bonds from a triol unit in 
the linker, the positions of multiple ligand atoms and additional receptor atoms must 
be restricted, and this loss of entropy works against the increased enthalpy of binding. 
 
 
Figure 4. 2: The interaction of substrates and cofactors with DAH7P synthase, and 
corresponding multivalent inhibitors. Inhibitor 3.10 has been previously reported by other 
workers94, 95, as outlined in Chapter Three. 
 
With the appropriate designs in place, focus shifted to constructing the required 
molecules. 
 
4.2: Synthesis of acrylate 4.2 
 
The proposed inhibitor 4.2 was designed in order to probe the influence of a PEP 
phosphate mimic on multivalent inhibitors. As shown in Chapter Three, occupying the 
PEP phosphate binding pocket was required for inhibition of DAH7P synthase for 
simple PEP mimicking compounds; thus whether the addition of a distal phosphate 
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could create inhibition from otherwise poor compounds was of interest. Preliminary 
investigations showed that the parent compound, acrylate 4.1, did not display 
detectable inhibition of DAH7P synthase. 
 
Synthesis of the weak multivalent inhibitor 4.2 was envisaged to be relatively 
straightforward; the PEP-mimicking portion could be directly coupled to the linker 
portion, already containing the distal phosphate in a protected form (Figure 4.3). This 
convergent approach was designed to minimise protecting group manipulations during 
the synthesis. In order to construct the C2-C3 bond, alkene cross metathesis was 
chosen. Whereas ring-closing alkene metathesis has rapidly become an established 
synthetic tool, alkene cross metathesis is an emerging technique for forming acyclic 
double bonds.119 The synthesis of 4.2 should provide an ideal example for this 
technique; the product double bond is disubstituted and electron-deficient, which 
should drive the reaction away from the statistical distribution of initially formed 
dimeric homocoupled alkenes, and toward a single product.119  
 
 
Figure 4.3: Disconnection of weak inhibitor 4.2 via cross-metathesis 
 
The required phosphoalkene was readily prepared from commercially available 5-
hexen-1-ol by phosphorylation with diethyl chlorophosphate (Figure 4.4). 
 
 
Figure 4.4 Production of phosphoalkene 4.5 
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Treatment of the phosphoalkene 4.5 with two equivalents of methyl acrylate and a 
catalytic quantity of the second generation Grubbs catalyst120 gave an excellent yield 
of acrylate 4.6 with excellent diastereoselectivity (Figure 4.5). The ruthenium-
containing catalyst degradation products tenaciously coordinated the product 
(presumably mediated by the phosphoryl group), however two rounds of ruthenium 
ligand exchange with DMSO121 followed by column chromatography gave near 
colourless material. 
 
 
Figure 4.5: Alkene cross metathesis leading to acrylate 4.6 
 
Deprotection of acrylate 4.6 with trimethylsilyl bromide, followed by treatment with 
aqueous potassium hydroxide, gave a mixture of products which could be separated 
by preparative anion-exchange chromatography to give the desired inhibitor 4.2 in 
low yield (Figure 4.6). 
 
 
Figure 4.6: Deprotection and purification to give target 4.2 
 
4.3 Inhibition properties of acrylate 4.2 
 
The ability of acrylate 4.2 to inhibit the DAH7P synthase reaction was measured by 
enzyme inhibition assay against E. coli DAH7P synthase. At typical assay 
concentrations no effect was seen on the rate of the enzyme reaction; and at 1 mM 
acrylate no significant inhibition was observed even at low PEP concentrations 
(Figure 4.7). Due to the weak inhibition shown by acrylate 4.2, a more detailed kinetic 
characterisation was not attempted. 
Chapter Four: Novel, Dual-Site Inhibitors of DAH7P synthase  102 
 
 
No inhibitor 1 mM  acrylate 4.2
ra
te
/ m
AU
 
s-
1
60
80
100
 
Figure 4.7: The effect of acrylate 4.2 on E. coli DAH7P synthase activity. A solution of PEP (50 
µM), manganese(II) sulfate (100 µM), E4P (200 µM) and acrylate 4.2 (0 or 1 mM) in 1 mL of BTP 
buffer (50 mM, pH 6.8) was initiated by the addition of E. coli DAH7P synthase (2 µg), and the 
loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by linear least 
squares regression of the absorbance data, and converted to progress rates. Values are averages 
of triplicate experiments, error bars are drawn at one standard deviation. 
 
The inability of extended acrylate 4.2 to strongly inhibit DAH7P synthase is not 
unexpected, and validates our design approach. Considering that acrylic acid does not 
inhibit DAH7P synthase, it suggests that simultaneous interaction of the inhibitor with 
both the PEP and E4P subsites are required in order to achieve inhibition, and as 
before a mimic of the PEP phosphate group is required for binding to the PEP 
phosphate site. Further analysis of the binding of 4.2 and other compounds to DAH7P 
synthase is presented in Chapter Five. 
 
4.4: Synthesis of allyl phosphonate 4.3  
 
4.4.1: Alkene metathesis approaches 
 
Our initial synthetic scheme for the allyl phosphonate 4.3 sought to apply alkene 
metathesis chemistry, which had performed well in the synthesis of acrylate 4.2. 
However, alkene cross metathesis chemistry is sensitive to both steric and electronic 
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effects in the olefin,119 and the necessary substrate olefin for cross metathesis 
possesses both steric (1,1-disubstitution) and electronic (electron deficiency) 
deactivating properties. It was feared that this combination would make the olefin 
unreactive toward cross-metathesis, and such properties have been previously 
observed.122  
 
Based on the prospect of this difficult coupling, it was decided to perform a ring 
closing metathesis to form the key bond; transesterification of the product medium-
ring lactone 4.8 would give the necessary acyclic alkene 4.7, and the phosphonate and 
phosphate groups could then be introduced (Figure 4.8). 
 
 
Figure 4.8: Retrosynthesis of allylic phosphonate 4.3 
 
In order to carry out this scheme, access to the bromoacrylate ester 4.9 was required. 
Reported esterifications of 2-(bromomethyl)acrylic acid are typically limited to simple 
alkyl esters,123, 124 formed by Fischer esterification. The yields are generally moderate, 
due to competing polymerisation processes. Attempted generation of 2-
(bromomethyl)acryloyl chloride is reported to lead to extensive exchange of the 
halide, leading to mainly 2-(chloromethyl)acryloyl chloride.125  
 
In order to access the required ester, we decided to explore alternative esterifications. 
However, the required ester was surprisingly difficult to access. Steglich esterification 
with dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino) pyridine (DMAP) led 
to no identifiable product. Steglich esterifications of acrylates are reported to be 
difficult due to side reactions involving nucleophilic addition to the acrylate alkene, 
presumably the presence of an allylic bromide makes this addition even more 
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facile.126 Attempted esterification with PyBOP/DMAP also gave no product,127 as did 
attempts to utilise the acryloyl-trifluoroacetyl mixed anhydride. 
 
Transesterification is a mild method for the formation of esters in sensitive substrates, 
and can be accomplished under both acid and base catalysis. The variety of conditions 
available made this method seem like a useful approach, and consequently we 
required access to methyl (bromomethyl)acrylate 4.10. However given the difficulty 
in synthesising esters of 2-(bromomethyl)acrylic acid (vide supra), we decided to start 
with the ester bond intact, and add the bromomethyl substituent. Treatment of methyl 
acrylate under Baylis-Hillman conditions gave a low yield of the required allylic 
alcohol 4.11 (Figure 4.9).128 
 
 
Figure 4.9: Baylis-Hillman reaction of methyl acrylate to give alcohol 4.11 
 
Though the yield of the alcohol was low, the reagents are commodity chemicals, 
readily available in litre quantities, and the reaction is readily performed on a large 
(50 g) scale. Treatment of the allyl alcohol 4.11 under conditions reported128 to give 
the desired bromide 4.10 instead gave the saturated dibromide 4.12 as the major 
product, with the desired bromide 4.10 present as a minor product in a 
chromatographically inseparable mixture. Bromination of the alcohol under other 
previously reported129 conditions gave rise to a good yield of crude product, but 
distillation returned a low yield of the desired bromide, although it was free of 
contamination by the dibromide (Figure 4.10). 
 
 
Figure 4.10: Bromination to give (bromomethyl)acryl ester 4.10 by two literature methods128, 129 
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Transesterification of the methyl ester was then attempted. Treatment of 4.10 with 1.5 
equivalents of alcohol 4.13 in refluxing toluene, in the presence of catalytic 
toluenesulfonic acid gave a slow conversion to hexenyl ester 4.9 by TLC. Attempts to 
improve conversion by sequestering the formed methanol in 4Å or 13X molecular 
sieves were unsuccessful (Figure 4.11). 
 
 
Figure 4.11: Attempted transesterification with toluenesulfonic acid 
 
Otera’s distannoxane catalysts have been recommended as transesterification catalysts 
for difficult cases, the reactions proceed under mild conditions, do not require a large 
excess of alcohol, and can be carried out with less than 1 mol% of catalyst.130-132 
Treatment of methyl ester 4.10 with alcohol 4.13 in the presence of 1 mol% 
distannoxane 4.14 gave some conversion to products by TLC, but the reaction was 
slow. Addition of further alcohol or catalyst did not seem to increase conversion 
(Figure 4.12). Conducting the reaction in 10% dichloroethane/hexanes under 
microwave irradiation gave a similar mixture of products after 160 minutes; however 
no improvement in conversion was seen. 
 
 
Figure 4.12: Attempted transesterification with Otera catalyst 4.14 
 
With the failure of these simple approaches to esterification, it was thought the 
Mitsunobu reaction might be a useful method to prepare the ester.133 The Mitsunobu 
reaction had been used successfully to form a related ester by Furstner et al134; and in 
our case treatment of hexenyl alcohol 4.13 with a slight excess of 
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(bromomethyl)acrylic acid under Mitsunobu conditions gave a good yield of the 
corresponding diene ester 4.9 (Figure 4.13). 
 
 
Figure 4.13: Diene ester 4.9 from the Mitsunobu reaction 
 
With the required diene 4.9 in hand, the pivotal ring closing metathesis step was 
investigated. The production of lactones by ring closing metathesis was an early 
application of this methodology, and both small ring lactones and macrolactones are 
now commonly generated via this route. The production of medium rings by this route 
is considered more challenging, in particular the preparation of eight-membered rings 
such as the desired lactone 4.8, but examples of eight-membered ring closure are 
known.135 
 
Treatment of a dilute solution of diene 4.9 under microwave irradiation, with two 2 
mol% portions of the Grubbs second generation catalyst120, gave after two ten minute 
irradiations complete conversion of the starting diene to a single permanganate 
reactive species by TLC. Isolation of this product showed that instead of the expected 
lactone 4.8, the linear dimer 4.15 had been formed, as a 9:1 E:Z mixture (Figure 4.14). 
 
 
Figure 4.14: Initial microwave metathesis reaction leading to linear dimer 4.15 
 
In order for the linear dimer 4.15 to form, the catalyst must react with the terminal 
monosubstituted alkene of 4.8, extruding ethylene to form the intermediate 
metallocarbene 4.16, which instead of undergoing the desired intramolecular ring 
closing reaction to give the lactone 4.8, undergoes a cross-metathesis reaction with 
another molecule of 4.9 giving the linear dimer 4.15 (Figure 4.15). 
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Figure 4.15: Possible fates of metallocarbene 4.16 
 
Given the rapidity of the microwave reaction, it was reasoned that the linear dimer 
4.15 obtained may simply be a kinetic product, and that on further reaction may be 
converted into the desired ring closed product. However, metathesis under 
conventional heating for longer reaction time showed no formation of the desired 
lactone, and resubjecting the isolated linear dimer 4.15 to further reaction with Grubbs 
second generation catalyst in toluene at 80°C showed no conversion of the linear 
dimer 4.15 to lactone 4.9. This implies that dimer 4.15 is a dead-end product of the 
metathesis process, and cannot be further processed by the catalyst into the desired 
lactone.  
 
With this fact in mind, a number of attempts were made to modify the conditions of 
the metathesis reaction to promote the intramolecular ring closure over the formation 
of the dead end dimer product 4.15. Reducing the concentration of the diene 4.9 
should reduce the likelihood of metallocarbene 4.16 encountering another molecule of 
diene before it has a chance to ring close to the desired 4.8. Accordingly, higher 
dilution conditions than those orginally chosen were screeened. Reducing the 
concentration of diene from 20 mM to 5 mM did not succeed in producing the desired 
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lactone 4.15, and using ultra-high dilution conditions (diene concentration: 111 µM) 
in toluene had no effect other than slowing the overall reaction.  
 
Since changing the diene concentration had little effect, other possibilities were 
explored. The Grubbs second generation catalyst has a broad substrate specificity, but 
an acknowledged weakness is its decreased reactivity toward sterically or 
electronically challenging alkenes.119 A variety of other commerically available 
catalysts were explored, including the Grubbs first generation catalyst136, the 
Hoveyda-Grubbs first generation catalyst,137 and the Hoveyda-Grubbs second 
generation catalyst.138 None of these catalysts succeeded in producing the desired 
lactone. The phosphine-free Grubbs second generation catalyst139 was prepared 
(Figure 4.16), in the hope its greater rate of initiation may prove beneficial, but it too 
was unsuccessful in producing the lactone 4.8.  
 
 
Figure 4.16: Preparation of the second generation phosphine-free Grubbs catalyst139 
 
It was possible that acrylate alkene may be forming a dead end complex with the 
catalyst, converting it into a catalytically inactive chelate complex such as 4.17 
(Figure 4.17), a problem that has been reported for other acrylates140. The addition of 
mild Lewis acids such as titanium(IV) isopropoxide has been reported to improve 
catalyst reactivity in these cases.140 It has been proposed these co-catalysts work by 
competing with the ruthenium atom for coordination with the carbonyl oxygen; 
forming bimetallic complexes such as 4.18 (Figure 4.17),140 however it has not been 
addressed whether these reagents simply increase the rate of precatalyst activation by 
scavenging the free phosphine produced during catalyst activation. 
 
 
Figure 4.17: Inactive chelate 4.17, and activated bimetallic complex 4.18 
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Attempts to overcome this supposed catalyst inactivation by slow addition of fresh 
catalyst to a refluxing dilute solution of diene over a period of eight hours, or 
simultaneous slow addition of a solution of diene and a solution of catalyst to 
refluxing solvent were unsuccessful. Likewise, the addition of catalytic quantities (10-
25 mol% with relation to diene 4.9) of titanium(IV) isopropoxide had no effect. 
 
Another method of potentially slowing the undesired dimerisation step would be to 
utilise the sensitivity of Grubbs second generation catalyst to steric effects, and use a 
more hindered repalcement for the terminal monosubsituted alkene. This alkene 
would lead to the same metallocarbene intermediate 4.16, while the additional bulk 
should slow the undesired intermolecular dimerisation step, and perhaps allow the 
desired intramolecular ring closure to occur. 
 
Cross metathesis of diene 4.9 with excess (Z)-diacetoxybutene in the presence of 
Grubbs second generation catalyst gave a good yield of hindered diene 4.19 after 
chromatography, as an inseperable 93:7 E/Z mixture. Also isolated was a small 
quantity of the symmetrical dimer 4.15 (Figure 4.18). 
 
 
Figure 4.18: Synthesis of the hindered diene 4.19 
 
However, treatment of the hindered diene 4.19 with Grubbs second generation 
catalyst in the presence of titanium(IV) isopropoxide also failed to give the desired 
lactone, instead returning unreacted starting material, symmetrical dimer and traces of 
catalyst-derived styrene products. Presumably the diacetoxybutene produced during 
the formation of the dimer 4.15 was lost in the aqueous workup used to quench the 
titanium(IV) isopropoxide. 
 
At this stage it was decided that the source of the problem was perhaps the formation 
of the medium ring lactone, since no analogous examples to our desired ring closure 
are known, and the formation of an eight membered ring is known to be a very 
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difficult ring size to close with ring closing metathesis.135 In order to test this 
hypothesis, allyl ester 4.20 was prepared under similar Mitsunobu conditions to those 
used for hexenyl ester 4.9 (Figure 4.19). 
 
 
Figure 4.19: Synthesis of allyl ester 4.20 
 
Treatment of allyl ester 4.20 under ring closing metathesis conditions should give rise 
to a five-membered ring lactone, a more favourable process than closing a medium 
ring lactone. The most similar example to this ring closure in the literature is one 
reported by Furstner et al in the total synthesis of the marine natural product (S,S)-(+)-
dehydrohomoancepsenolide;134 slow addition, high dilution and titanium(IV) 
isopropoxide cocatalysis was required to achieve the ring closure (Figure 4. 20). 
Notable in this reaction is the chemoselectivity for closure of the 5-membered ring 
over possible enyne metathesis products containing larger 8-13 membered rings. 
 
 
Figure 4. 20: Furstners ring closing metathesis en route to (S,S)-(+)-
dehydrohomoancepsenolide134  
 
Attempts to apply the conditions of Furstner to closing the ring of allyl diene 4.20 
were unsuccessful; the use of Grubbs second generation catalyst also failed to give the 
desired lactone product, instead linear dimer 4.21 was isolated (Figure 4.21). 
 
Figure 4.21: Attempted ring closing metathesis of allyl diene 4.20 
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In summary, despite a thorough investigation of possible metathesis reaction 
conditions, no conditions were found that gave any cyclised lactones from 2-
(bromomethyl)acrylates. Factors that are known to slow metathesis reactivity and 
exist in 2-(bromomethyl)acrylates include 1,1-disubstitution, large allylic substituents, 
and an electron withdrawing group directly attached to the alkene.119 No metathesis 
reactions of related 2(halomethyl)acrylates are known in the literature; an anomaly in 
an area of such active research. In addition, a recent systematic study of ring closing 
metathesis of 2-alkyl acrylates found that while six membered rings are formed in 
good yield, five and seven membered rings are formed in moderate yield, and 
attempts to produce eight and nine membered rings led solely to dimerisation of the 
more reactive terminal alkene as seen here with 2-(bromomethyl)acrylates.141 Based 
on the results obtained, and the indications in the literature, a new approach to our 
desired inhibitor 4.3 was sought. 
 
4.4.2: Allylic rearrangement approaches 
 
With the failure of our earlier metathesis approach, a new method to access to the 
phosphonate inhibitor 4.3 was required. The addition of a variety of carbon and 
heteroatom nucleophiles to β’-acetoxy-α,β-unsaturated esters is known to proceed not 
via a direct substitution at the β’ carbon, but via a sequence of initial Micheal addition 
followed by elimination from the resulting ester enolate to give an overall SN2’ 
substitution (Figure 4.22).142 
 
 
Figure 4.22: Tandem addition/ transposition reaction of β’-acetoxy-α,β-unsaturated esters142 
 
Furthermore, it has been reported that trialkylphosphites behave similarly, giving 
allylic phosphonium ions, which in turn dealkylate to allylic phosphonates in a 
manner analogous to the Arbusov reaction (Figure 4.23).143 
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Figure 4.23: Sequential addition/transposition/dealkylation reaction with trialkylphosphites143 
 
Based around this new method for creating an allylic phosphonate, a new 
retrosynthetic scheme was designed around gaining access to allylic alcohol 4.22 
(Figure 4.24). 
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Figure 4.24: Retrosynthesis of allylic phosphonate 4.3 via a Baylis-Hillman reaction 
 
In order to form the key allylic alcohol 4.22, the Baylis-Hillman reaction was 
explored. The Baylis-Hillman reaction144 is an organocatalytic carbon-carbon bond 
formation, in which a nucleophilic species (typically 1,4-diazabicyclo[2.2.2]octane, 
also known as DABCO) adds reversibly to an electron deficient olefin, and the 
intermediate zwitterionic enolate formed attacks a carbonyl group. Subsequent 
elimination of the catalyst reforms the original olefin, giving a net exchange of the 
vinylic carbon-hydrogen bond for a carbon-carbon bond (Figure 4.25).144 Virtually 
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ignored for a decade after its discovery, the reaction has undergone a renaissance in 
recent years with the rising interest in organocatalysis.144 
 
 
Figure 4.25: The generally accepted mechanism of the Baylis-Hillman reaction144 
 
Selective monoprotection of 1,5-pentanediol using a 3:1 ratio of diol to tert-
butyldimethylsilyl chloride gave the desymmetrised alcohol 4.23 in good yield 
(Figure 4.26). 
 
 
Figure 4.26: Monoprotection of pentanediol to give alcohol 4.23 
 
Oxidation of alcohol 4.23 with the periodinane 2-iodoxybenzoic acid (IBX) gave a 
good yield of the corresponding aldehyde 4.24 (Figure 4.27).145  
 
 
Figure 4.27: Production of aldehyde 4.24 by IBX oxidation 
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However, treatment of aldehyde with methyl acrylate and DABCO failed to give the 
required allylic alcohol 4.22. Similar Baylis-Hillman reactions to the desired 
transformation remain unreported with related aldehydes. Despite the renewed 
popularity of the Baylis-Hillman reaction, it is reported to work best with 
comparatively electron deficient aldehydes such as aromatic aldehydes, particularly 
those with electron withdrawing para substituents. Reaction times have been found to 
stretch into weeks for unfavourable aldehydes, and the product acrylates are prone to 
further side reactions, such as polymerisation promoted by the reaction conditions.144 
Mindful of the likely difficulty in having a key step with such a long reaction time 
early in the synthesis, we sought an alternative method for the construction of the C2-
C3 bond. 
 
The use of 2-lithio or 2-magnesioacrylates as nucleophiles is largely unreported, 
presumably due to ease of the metalloacrylate to undergo side reactions such as 
conjugate addition. This observation is supported by the literature, the only examples 
of lithio- or magnesio- acrylates involve halogen-metal exchange on 2-haloacrylates 
disubstituted at the 3-position, conducted at low temperature. 
 
The corresponding vinyl alanes 4.25 however, have been recommmended as a way to 
overcome the shortcomings of the Baylis-Hillman reaction.146 These alanes are 
reported to react readily with aldehydes at room temperature. The vinyl alanes system 
can be prepared by hydroalumination of propolic esters 4.26, with 
diisobutylaluminium hydride (DIBAL) in the presence of either highly carcinogenic 
hexamethylphosphoramaide (HMPA)147 or the safer N-methylmorpholine N-oxide 
(NMO)146, resulting in the overall transformation as shown in  
Figure 4.28. 
 
 
Figure 4.28: Hydroalumination of propiolic esters 4.26 to vinyl alanes 4.25 and subsequent 
nucleophilic attack on aldehydes to give allyl alcohols 4.27 
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This methodology seemed like a promising method to construct the allylic alcohol 
functionality in 4.22. In order to investigate the method, the known model reaction 
with benzaldehyde was undertaken according to the literature146, and the 
corresponding allylic alcohol was indeed formed, albeit in a low yield ( 
Figure 4.29). 
 
 
Figure 4.29: Hydroalumination/ nucleophilic attack of benzaldehyde 
 
Application of this reaction to our system was then undertaken. The tert-
butyldiphenylsilyl (TBDPS) protected aldehyde 4.30 was prepared in two steps from 
1,5-pentanediol (Figure 4.30). 
 
 
Figure 4.30: Preparation of aldehyde 4.30 
 
Ethyl propiolate was treated with preformed DIBAL-NMO complex at 0°C for thirty 
minutes, and then aldehyde 4.30 was introduced. After workup, analysis of the 
reaction mixture by 1H NMR spectroscopy showed only starting material was present, 
contaminated with traces of the desired product 4.31 (<0.5% based on integration) ( 
Figure 4.31). Allowing the alane to react with the aldehyde overnight failed to give 
the desired product, and heating the mixture to 50°C also failed to produce 4.31.  
 
 
Figure 4.31: Attempted synthesis of allylic alcohol 4.31 by analogy to Figure 4.29  
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The reason for the failure of these reactions was unclear, but it was thought that it may 
be due to the lower electrophilicity of the aliphatic aldehyde 4.30 compared with the 
aromatic aldehyde in benzaldehyde. It was reasoned that if this was the case, it may be 
possible to circumvent this problem by increasing either the electrophilicity of the 
aldehyde by Lewis acid activation; or increasing the nucleophilicity of the 
organometallic reagent by transmetallation. Treatment of a mixture of vinyl alane and 
aldehyde 4.30 with zinc(II) bromide in order to give transmetallation to the more 
reactive zinc species failed to give any product. Lewis acid activation of the aldehyde 
with boron trifluoride etherate managed to give a low yield of the desired allyic 
alcohol 4.31, however extensive polymerisation was also observed. Rerunning the 
reaction at -78°C suppressed visible signs of polymerisation, but also failed to give 
any product (Figure 4.32). 
 
 
Figure 4.32: A summary of attempts to react a vinyl alane with aldehyde 4.30 
 
The failure of the vinyl alane to react with the aldehyde 4.30 was disappointing, 
however a recent report supports these findings.148 The authors observed a complete 
failure of a vinyl alane to react with their aliphatic aldehyde (Figure 4. 33), yet 
managed to achieve a good yield of the corresponding product with benzaldehyde.  
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Figure 4. 33: A literature exampleof the failure of a vinyl alane to react with an aliphatic 
aldehyde148  
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It is tempting to speculate that this unreliability is the reason why, despite the 
drawbacks of the Baylis-Hillman reaction, the vinyl alane methodology has failed to 
achieve widespread adoption, although it has been known for almost twenty years.147  
 
In order to confirm suspicions that other metalloacrylates were unsuitable as vinyl 
anion equivalents, we prepared the vinyl bromide 4.32. Although expensive 
commercially, it can be prepared readily on a 0.25 mol scale from readily available 
precursors, by a bromine addition/dehydrobromination sequence (Figure 4.34).149  
 
 
Figure 4.34: Bromination/dehydrobromination sequence delivering bromoacrylate 4.32 
 
Attempts to produce a novel anion equivalent from vinyl bromide 4.32 by radical 
metallation150 with titanocene(III) chloride, produced by reduction of titanocene 
dichloride with elemental zinc or manganese failed. Attempts to prepare the 
corresponding unreported organozinc reagent with Reike zinc151 failed, as did the 
attempted preparation of the corresponding novel organochromium(II) reagent with 
chromium(III) chloride in the presence of manganese and catalytic nickel(II) 
chloride152 (Figure 4.35). It is probable in these reactions that Micheal addition of any 
organometallic reagent formed to the remaining vinyl bromide 4.32 was occuring, 
resulting in polymeric materials rather than stable organometallic species. 
 
 
Figure 4.35: Attempts to find a novel vinyl anion equivalent 
 
With the failure over both the Baylis-Hillman reaction and the vinyl alane addition, 
we still lacked a suitable method for creating the required allylic alcohol. In both of 
the failed approaches, the readily polymerisable acrylic alkene is conceivably to 
blame, with its nature placing a limit on the allowable reaction conditions. 
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One possible method to evade these polymerisation related problems is to form the 
C2-C3 bond with a reagent containing an alkene masked as another functional group, 
which can be converted to the alkene when desired under conditions mild enough to 
limit polymerisation. One approach that has been used is to mask the alkene as a 
tertiary amine; with subsequent quaternisation and Hoffmann elimination to return the 
alkene (Figure 4.36).153  
 
Figure 4.36: A masked alkene approach153 to acrylates , utilising a Hoffman elimination 
 
With this approach the key bond forming step then becomes an ester enolate addition 
to an aldehyde.  
 
The required masked acrylate reagent 4.33 was generated by a modified literature 
procedure; treatment of methyl acrylate with aqueous dimethylamine, followed by 
distillation from calcium hydride gave amine 4.33 cleanly (Figure 4.37). The use of 
readily available aqueous dimethylamine avoids the difficulty of handling anhydrous 
dimethylamine, required in the original preparation.154 
 
 
Figure 4.37:Synthesis of masked acrylate reagent 4.33 
 
Because of the base sensitivity of the TBS protecting group, tetrahydropyranyl ether 
(THP) protected alcohol 4.34 was prepared in excellent yield from 1,5-pentanediol 
and dihydropyran by treatment with the non-toxic mild acid catalyst bismuth(III) 
nitrate pentahydrate (Figure 4.38).155 
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Figure 4.38: Formation of THP ether 4.34 
 
Oxidation of alcohol 4.34 with IBX in refluxing THF gave only a moderate yield of 
aldehyde 4.35, presumably due to the acidic nature of IBX.145 Oxidation utilising 
buffered Dess-Martin periodinane,156 or under Swern oxidation conditions,157 
delivered the required aldehyde 4.35 in good yield (Figure 4.39).  
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Figure 4.39: Oxidation of alcohol 4.34 to aldehyde 4.35 utilising various reagents 
 
Treatment of aldehyde 4.35 with the lithium enolate of masked acrylate reagent 4.33 
gave the aminoalcohol 4.36, which was not purified but immediately treated with 
excess methyl iodide, and the quaternary amine 4.37 decomposed with sodium 
bicarbonate to give the acrylate 4.38 (Figure 4.40). Despite this procedure succeeding, 
the yields were low and erratic, ranging from 17% to 1%. Again it is likely that the 
reason for this low yield was ready polymerisation of the acrylate under the basic 
conditions of the elimination, this observation being supported by the large amounts 
of baseline material observed in TLC analysis of the elimination step, and in the final 
flash chromatography step. 
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Figure 4.40: Synthesis of acrylate 4.38 using a masked alkene approach 
 
Although the yields of acrylate 4.38 were low, they proved the validity of a masked 
alkene approach to these compounds, and signalled the need for a masked alkene that 
could be unmasked under milder conditions. 
 
Sulfoxides undergo thermal elimination to form alkenes at high temperatures, or by 
treatment with alkoxide bases at lower temperatures.158 While we felt these conditions 
would be too aggressive for our sensitive system, they alerted us to the fact that aryl 
selenoxides also undergo thermal elimination, but under much milder conditions than 
their sulfur analogues (Figure 4.41).159 This difference in reactivity has been attributed 
to the greater basic character of the selenoxide oxygen atom.159  
 
 
Figure 4.41: The difference in reactivity between sulfoxides and selenoxides, from Jones et al159 
 
A very recent report has detailed the use of selenoxides to access acrylates substituted 
at the β-position,148 and although β-substituted acrylates are less prone to 
polymerisation than unsubstituted acrylates, we felt a similar method could work for 
our system. 
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The required selenium masked acrylate 4.39 was prepared by treatment of racemic 
ethyl 2-bromopropionate with sodium phenylselenide; itself freshly prepared by 
reductive cleavage of diphenyl diselenide (Figure 4.42).160  
 
 
Figure 4.42: Preparation of the selenium masked acrylate 4.39 
 
Treatment of the lithium enolate of selenide 4.39 with aldehyde 4.30 (vide supra) 
gave a good yield of the diasteromeric selenides, as a separable mixture of syn and 
anti adducts (Figure 4.43). The assignment of relative stereochemistry of the two 
centres is based on comparison of the 13C NMR spectra of these compounds with 
reported spectra of similar compounds with known relative stereochemistry, in the 
anti adduct the shifts of the carboxyl, methyl and alcohol carbons are all shifted 
downfield relative to the syn adduct.161 
 
 
Figure 4.43: Production of the masked acrylates 4.40 and 4.41 
 
The stereochemical outcome of this reaction can be rationalised by considering the 
stereochemistry of the enolates formed. Using the Ireland model, it can be seen that 
the transition states leading to both the (E) and (Z)-enolates experience destabilising 
1,3-diaxial interactions, but the transition state leading to the (E)-enolate has a larger 
steric clash between the bulky phenylselenide group and an isopropyl group of LDA 
(Figure 4.44).162 
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Figure 4.44: Interactions in the transition states leading to the enolates of selenide 4.39 
 
This will result in a larger proportion of the (Z)-enolate being formed under the 
reaction conditions. This difference in enolate proportions is carried through the 
enolate addition, resulting in a larger proportion of the anti adduct ( 
Figure 4.45). 
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Figure 4.45: The outcome of the enolate addition for (E) and (Z) enolates of 4.39 
 
Both the syn 4.40 and anti 4.41 aldol products cleanly underwent elimination to the 
desired acrylate 4.42 upon oxidation to the corresponding selenoxide with aqueous 
hydrogen peroxide (Figure 4.46). The mild conditions of this elimination can be 
attested by the excellent yield of these sensitive compounds. The difference in yield in 
these reactions is probably attributable to differences in scale rather than differences 
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in reactivity, in each case a single product was observed after removal of the 
phenylselenoic acid by aqueous extraction. 
 
 
Figure 4.46: One-pot oxidation/elimination of selenides 4.40 and 4.41 to reveal acrylate 4.42 
 
In principle the selenoxide formed by oxidation of 4.40 and 4.41 could eliminate to 
give the desired acrylate 4.42, or alternatively across the C2-C3 bond, to give the 
enolate 4.43 (Figure 4.47). The failure to observe any products derived from 4.43 in 
this reaction can be attributed to a kinetic effect, as the rate of elimination of 
selenoxides has been shown to be strongly dependent on the pattern of substitution on 
the β-carbon (Figure 4.47).163 In our case, the undesired C2-C3 elimination would be 
slowed both by alkyl substitution and by the presence of an oxygen atom at C3. 
 
 
Figure 4.47: Possible selenoxide elimination routes, and literature rates of selenoxide elimination. 
Kinetic data from Reich et al163 
 
With the desired allylic alcohol 4.42 in hand, work could begin on the key 
addition/elimination sequence. Treatment of alcohol 4.42 with cold acetyl chloride 
and pyridine gave acetate 4.44 in excellent yield ( 
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Figure 4.48). 
 
 
Figure 4.48: Acetylation of alcohol 4.42 
 
Heating the acetate 4.44 in neat triethylphosphite in a Carius tube induced the planned 
addition/elimination/dealkylation sequence143, to give the required allylic phosphonate 
4.45 in excellent yield ( 
Figure 4.49).  
 
 
Figure 4.49: Production of allylic phosphonate 4.45 
 
The phosphonate 4.45 was obtained as a chromatographically inseparable mixture of 
(Z) and (E) isomers, in a ratio of 7:3 as determined by 1H and 31P NMR spectroscopy. 
As the optimum geometry of the final product was unknown, the mixture of 
diastereomers was carried through the remainder of the synthesis. 
 
The stereochemistries of the alkenes in 4.45 were determined by 1H NMR NOESY 
experiments. Irradiation of the alkene protons in the major and minor products (red 
and green in Figure 4.50) showed that only the minor product gave a NOE with the 
methylene phosphonate hydrogens (blue). In addition, irradiation of the methylene 
phosphonate hydrogens produced only one NOE with the alkene protons, to the 
alkenyl proton in the minor product. Based on this data, the distance between the 
methylene phosphonate protons in the minor product must be shorter than that in the 
major product, hence the assignment of the minor and major isomers of 4.45 as (E)- 
and (Z)-alkenes respectively (Figure 4.50). 
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Figure 4.50: 1D NOESY data for allylic phosphonate 4.45 
 
This moderate stereoselectivity of the reaction for the (Z)-isomer is in accordance 
with other observations reported in the literature. While an explanation of the 
stereoselectivity was not given by the original discoverers of this reaction, the 
stereoselectivity can be explained by considering the intermediates in the reaction 
(Figure 4.51).  
 
R H
OAc
R
OAc
OEt
O
(EtO)3P
R
OAc
OEt
O-
P
OR
RO
RO
R
AcO
OEt
O
P
OR
RO
RO
CO2Et
P
EtO
EtO
EtO
CO2Et
HR
P
EtO
EtO
EtO
AcO-
R OEt
O
P
O
EtO
EtO
4.44 4.46
4.47(Z)-4.45
 
Figure 4.51: Origin of the stereoselectivity in the phosphonate formation reaction 
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After addition of the phosphite to alkene 4.44 (Figure 4.51), the zwitterionic 
phosphonium enolate 4.46 is formed, which can be considered to have significant 
carbanion character at C2. This carbanion is likely to adopt an antiperiplanar 
conformation with respect to the acetate leaving group during elimination, and could 
adopt the staggered conformation 4.47. This conformation minimises the steric 
interaction between the ester group and the alkyl tail R, and subsequent E1cb anti 
elimination and Arbusov-like phosphonium dealkylation gives the major (Z)-
phosphonate. 
 
The ester carbon in 4.47 is bulkier than the carbon that bears the phosphonium ion, 
but the distant bulk of the phosphonium group is reflected in the moderate 
stereoselectivity of the reaction. This model for the observed stereoselectivity is 
supported by evidence from the original publication of this reaction (Figure 4.52).143 
Replacement of the ester group with a cyano group reverses the stereoselectivity of 
the reaction, which can be explained by the loss of the ester-R group steric interaction. 
The use of bulky aryl R groups leads to greater stereoselectivity than simple propyl or 
hexyl alkyl groups, and the stereoselectivity is only slightly effected by changing the 
distant aryl para substituent from an electron-withdrawing chloride to electron-
donating methoxy group; indicating the increased stereoselectivity observed with aryl 
R groups is primarily steric in origin. No variation in the phosphite or carboxylate 
ester groups is reported in the paper, however by the model presented here larger 
carboxylate ester groups combined with smaller phosphite ester groups would be 
likely to result in increased (Z) selectivity. 
 
 
Figure 4.52: Literature examples of the phosphonate formation reaction, showing variation in 
stereochemical outcome with variation of the R and X groups 143  
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With the key phosphonate formation complete, the distal phosphate needed to be 
introduced. Deprotection of the TBDPS group was readily achieved with 
tetrabutylammonium fluoride (TBAF), giving alcohol 4.48 in excellent yield (Figure 
4.53). 
 
 
Figure 4.53: Deprotection of silyl ether 4.45 with TBAF 
 
Phosphorylation of this alcohol with diethyl chlorophosphate in the presence of 
DMAP gave the phosphate ester 4.49 in excellent yield (Figure 4.54). 
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Figure 4.54: Phosphorylation of alcohol 4.48 
 
Treatment of the hexaester 4.48 with trimethylsilyl bromide to remove the phosphate 
and phosphonate ester groups, followed by treatment with aqueous potassium 
hydroxide to simultaneously remove the resulting silyl ester groups and the 
carboxylate ester gave a mixture of products, which after separation by anion 
exchange chromatography and counter-ion exchange with Dowex-50X8 H+-form and 
potassium hydroxide gave the desired target 4.3 in low yield ( 
Figure 4.55).  
 
 
Figure 4.55: Final deprotection to give target 4.3 
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The yield was low presumably due to poor chemoselectivity in the phosphate 
deprotection step; however the route was able to provide sufficient quantities of 
putative inhibitor 4.3 for measurement of its inhibitory properties against DAH7P 
synthase by enzyme kinetic assay. 
 
4.5 Inhibition properties of allylic phosphonate 4.3 
 
The inhibition properties of allylic phosphonate 4.3 were analysed against E. coli 
DAH7P synthase, by the method described in Chapter Six. Initial results showed that 
phosphonate 4.3 was an inhibitor of DAH7P synthase. Detailed analysis showed that 
phosphonate 4.3 is a competitive inhibitor with respect to PEP, as evidenced by a 
Lineweaver-Burk transformation of the initial rate data. Global non-linear regression 
fitting of the initial rate data to the Michaelis-Menten equation, modified to include 
the presence of a competitive inhibitor, showed that allylic phosphonate 4.3 inhibits 
DAH7P synthase with an inhibition constant Ki of 154 ± 20 µM (Figure 4.57). 
 
This inhibition constant is a considerable improvement over that known for the parent 
PEP-mimicking portion 3.10, validating and demonstrating the advantages of a 
multivalent approach to DAH7P synthase inhibition (Figure 4.56). 
 
 
Figure 4.56: A comparison of parent compound3.10 and the improved multivalent inhibitor 4.394  
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Figure 4.57: Inhibition properties of allylic phosphonate 4.3; presented as both Michaelis-Menten 
(top) and Lineweaver-Burk (bottom) plots. Solutions of PEP (10-120 µM), manganese(II) sulfate 
(100 µM), E4P (200 µM) and allylic phosphonate 4.3 (0-1180 µM) in 1 mL of BTP buffer (50 mM, 
pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), and the loss of PEP 
followed spectrophotometrically at 232 nm. Initial rates were obtained by linear least squares 
regression of the absorbance data, and converted to progress rates 
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4.6: Synthesis of vinyl phosphonate 4.4 
 
In order to access the vinyl phosphonate 4.4 a similar disconnection to that used to 
prepare the parent PEP mimicking compound 3.12 was envisaged (Figure 4.58). This 
involved accessing the key vinyl phosphonate functionality through a Horner-Wittig-
Emmons reaction of α-ketoester 4.50. 
 
This disconnection required access to α-ketoester 4.50, which we envisaged preparing 
via the simultaneous alkyne double oxidation/ esterification chemistry of Li et al.164 
This chemistry has been used in the syntheses of several carbohydrate α-ketoacids 
including D-3-deoxy-arabinoheptulosonate.165, 166 The required bromoalkyne 4.51 
could in turn be prepared by attack of an acetylene anion equivalent on a suitable 
electrophile, followed by introduction of the bromine atom. The advantage of 
introducing the alkyne unit as a two-carbon unit by a nucleophilic substitution, as 
opposed to adding one carbon with a transformation such as the Corey-Fuchs reaction, 
is that the chemistry should also be applicable to derivatives of D-arabinose, allowing 
more complex derivatives bearing chiral hydroxyl groups to be prepared at a later 
stage. 
 
 
Figure 4.58: Initial retrosynthesis of vinyl phosphonate 4.4 
 
The synthesis began with the preparation of a suitable electrophile for alkynylation; to 
this end bromide 4.52 was prepared by selective monobromination167 of 1,5-
pentanediol followed by protection of the remaining hydroxyl group as its TBDPS 
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ether (Figure 4.59). The modest yield of these steps is probably due to the facile ring 
closure of the intermediate bromoalcohol to volatile tetrahydropyran. 
 
 
Figure 4.59: Bromination and protection of pentanediol to give bromide 4.52 
 
Treatment of bromide 4.52 with lithium acetylide ethylene diamine complex by the 
method of Romeril et al168 returned a moderate yield of the desired alkyne 4.53 ( 
Figure 4.60). 
 
Figure 4.60: Nucleophilic alkynylation to give alkyne 4.53 
 
Treatment of this alkyne with N-bromosuccinimide in the dark with catalytic silver(I) 
acetate gave a high yield of the 1-bromoalkyne 4.54 (Figure 4.61). 
 
 
Figure 4.61: Bromination of 4.53 via the corresponding silver acetylide 
 
Treatment of bromoalkyne 4.54 under the double oxidation conditions of Li164, 
namely potassium permanganate in buffered aqueous methanol, did not give rise to a 
significant amount of the expected ketoester. However, a thick film of material was 
noted on the inside of the reaction flask. It was presumed that this film indicated the 
solubility of bromoalkyne 4.54 in the reaction media was low. This is consistent with 
the literature, as the reported examples of this double oxidation involve protected 
polyol fragments derived from carbohydrates (Figure 4.62). These compounds are 
likely to have a much larger solubility in the cold aqueous reaction media than a 
hydrocarbon such as 4.54. 
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Figure 4.62: Typical known substrates for the double oxidation reaction169, 170  
 
Based on these observations, co-solvents were screened to improve the solubility of 
bromoalkyne 4.54 while maintaining a homogenous reaction mixture. The addition of 
ethyl acetate to the reaction mixture was successful in producing a low yield of the 
desired ketoester 4.54 (Figure 4.63). 
 
 
Figure 4.63: Double oxidation of bromoalkyne 4.53 to α-ketoester 4.54 
 
While these conditions were successful in producing small quantities of the desired 
ester, given the number of possible side reactions (oxidative cleavage of the ketoester, 
oxidation of methanol, interception of the acyl halide intermediate by water), it was 
felt that further deviation from the presumably optimised conditions of Li would be a 
process fraught with difficulty. Given the moderate yields of the steps in this 
synthesis, other options were investigated. 
 
The selective addition of Grignard reagents to oxalate esters at low temperatures has 
been reported to give rise to α-ketoesters (Figure 4.64);171  the intermediate 
magnesium alkoxide is stabilised by intramolecular coordination at the temperature of 
the reaction, and slows the double addition typically seen with esters. A model 
Grignard reagent was prepared; and after a number of attempts to optimise the 
selective monoaddition a moderate yield of α-ketoester was obtained (Figure 4.64). 
However these results were unable to be extended to bromide 4.52, as the requisite 
Grignard reagent 4.56 was unable to be formed from bromide 4.52 by standard 
techniques. It is of note that despite the general utility of such a Grignard reagent, its 
preparation remains unreported. 
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Figure 4.64: Grignard route to α-ketoesters 
 
With the failure of this route, other approaches were investigated. The rearrangement 
of α-chloroglycidic esters to β-halo-α-ketoesters is another approach reported to 
provide the α-ketoester framework; and the corresponding β-iodo compounds can be 
readily reduced back to the α-ketoester.172 The required α-chloroglycidic esters can be 
prepared by two carbon elongation of aldehydes, in a modified Darzens 
condensation.173 
 
This approach seemed promising for a number of reasons. The required hydrocarbon 
aldehydes are not only readily prepared, but the corresponding D-arabinopolyol 
aldehyde is accessible via the chemistry developed in Chapter Two. Furthermore, α-
chloroglycidic esters are versatile synthetic intermediates, and can be converted 
directly to other functionality of interest (Figure 4.65) such as enol phosphates and α-
hydroxyesters, and many other arrangements are possible by transformation of the 
derived β-halo-α-ketoesters.174, 175 This should allow ready adaptation of the synthesis 
to the production of structurally diverse inhibitors. 
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Figure 4.65: Known conversions of α-chloroglycidic esters to enol phosphates,174 β-halo-α-
ketoesters,173 α-hydroxyesters,175 and α-ketoesters172 
 
The Darzens reaction precursor 4.57 was readily prepared by esterification of 
dichloroacetic acid, on a large scale. The isopropyl ester was selected due to its 
success in similar reported applications in the literature173. 
 
 
Figure 4. 66: Production of Darzens precursor 4.57 
 
Treatment of a mixture of aldehyde 4.30 (vide supra) and dichloroester 4.57 with 
potassium isopropoxide in ether gave the desired α-chloroglycidic ester 4.58 after 
aqueous workup. Due to concerns about the stability of α-chloroglycidic ester 4.58, it 
was not purified further but treated immediately with freshly prepared magnesium 
iodide at low temperature; a reductive workup with commercial aqueous sodium 
hydrogen sulfite afforded the desired α-ketoester 4.59 in a low yield after flash 
chromatography ( 
Figure 4.67).  
 
Figure 4.67: Synthesis of α-ketoester 4.59 via a modified Darzens condensation 
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The low yield of the Darzens sequence was disappointing. However, it should be 
noted the yield is similar or better than that obtained by our other routes, and this 
route incorporates the carbon-carbon bond formation and the α-ketoester into the 
same sequence. The entire transformation from aldehyde 4.30 to α-ketoester 4.59 
(including preparation of fresh magnesium iodide) can be carried out in one day. 
 
Interestingly, the α-ketoester 4.59 in chloroform contains ~20% of the corresponding 
enol tautomer, a comparatively large portion when compared with a typical ketone 
such as acetone.158 Similar behaviour for other α-ketoesters has been reported, but no 
evidence was presented.173 It is conceivable that in these cases the enol tautomer is 
stabilised by conjugation of the enol alkene with the ester group. 
 
In our case, the identity of this species as the enolate was initially presumed based on 
the chemical shift of the vinyl proton; and is supported by its associated 13C shift and 
phase obtained from a combined heteronuclear single quantum coherence – 
distortionless enhancement by polarisation transfer (HSQC-DEPT) experiment, as 
well as in the selective total correlation spectroscopy (selTOCSY) spectrum shown in 
Figure 4.68. 
 
In this experiment a selected resonance is irradiated, and after a mixing period the 
spectrum is measured. The resulting spectrum shows only protons which can be 
excited by magnetisation transfer from the irradiated proton, and transfer is limited to 
protons within the same spin system. In the selTOCSY spectrum in Figure 4.68, the 
enol vinyl proton (red) has been irradiated, and strong spin transfer to the 
neighbouring allylic protons (green) can be seen. In addition, a weak transfer giving a 
signal at δ 2.8 ppm can be observed. This signal is due to the α-methylene protons 
(blue) of ketone 4.59, and arises due to equilibration between the keto and enol forms 
of 4.59 on the NMR timescale, resulting in an apparent intermolecular magnetisation 
transfer. 
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ppm (t1)
2.503.003.504.004.505.005.50
 
Figure 4.68: selTOCSY (top) and standard 1H (bottom) NMR spectra for purified ketoester 4.59 
 
With the α-ketoester 4.59 in hand, work could begin on the Horner-Wittig-Emmons 
(HWE) reaction to install the vinyl phosphonate. From the work in Chapter Three, it 
was apparent that the stereochemical outcome of this reaction was sensitive to the 
counterion of the stabilised phosphonate carbanion. Investigations with α-ketoester 
4.59 showed the same phenomenon (Figure 4.69), lithium counterions tended to 
promote the formation of the desired (E)-isomer 4.60; while the larger sodium 
counterion gave mixtures enriched in the undesired (Z)-isomer 4.61. With LDA as a 
base, quenching at -78°C gave little product, long reaction times at room temperature 
gave increased amounts of undesired (Z)-isomer 4.61, but a short period at room 
temperature gave good selectivity. A caveat is an associated decrease in overall yield, 
although these reactions were conducted on a small scale so changes in yield on a 
larger scale may be much less than indicated by these results (Figure 4.69). The 
overall low yields may be due to trapping of the ketone as its enol tautomer, due to 
previously observed facile tautomerisation of α-ketoester 4.59. 
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Figure 4.69: Effect of reaction conditions on the stereochemical course of the HWE reaction 
 
The stereochemistry of the vinyl phosphonates was assigned by 1D transient nuclear 
Overhauser enhancement spectroscopy (NOESY). The 1D-NOESY spectra for the 
two seperated isomeric vinyl phosphonates are shown in Figure 4.70.  
ppm (f1)
3.04.05.06.07.0
Figure 4.70: NOESY spectra for vinyl phosphonates 4.60 and 4.61 
 
In each case, the vinyl hydrogen has been irradiated, and in the case of the undesired 
(Z)-isomer 4.61, a NOE is observed (blue) between the vinyl hydrogen and the allylic 
hydrogens, due to their presence on the same face of the double bond. In the desired 
(E)-isomer 4.60, under the same conditions no such NOE occurs, as the vinyl and 
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allylic hydrogens are fixed further apart. Of note is the shift of the vinyl hydrogen is 
strongly dependent on double bond geometry, a phenomenon that was also observed 
in the shorter analogue 3.12 (Chapter Three). 
 
The origin of the stereoselectivity of these reactions has not been studied, however 
based on the known mechanism and stereoselectivity of the HWE reaction a possible 
model is shown in Figure 4.71.96  
 
 
Figure 4.71: A model for the origin of the stereoselectivity in the HWE reaction 
 
Initial attack of the stabilised carbanion 4.62, where M is a lithium or sodium atom, 
on the α-ketoester 4.63 gives the alkoxide 4.64, which can then undergo 
intramolecular nucleophilic attack at phosphorus to give rise to two possible 
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oxaphosphatanes 4.65 and 4.66, which can interconvert (substituents on the rear 
phosphonate are omitted for clarity). The oxaphosphetanes 4.65 and 4.66 lead to the 
(E)- and (Z)-configured product respectively. The oxaphosphetane 4.66 is raised in 
energy relative to 4.65, due to a steric clash between the isopropyl ester and the ethyl 
phosphoester groups. A lesser steric clash between the isopropyl ester and first carbon 
of the hydrocarbon chain exists in 4.65. This explains the observed temperature effect, 
as more thermal energy is removed from the system, the equilibrium will increasingly 
favour the lower energy oxephosphetane 4.66; subsequent elimination of diethyl 
phosphate results in a higher proportion of the (E)-configured product. 
 
The differing stereoselectivities with different metal ions is also explained by this 
model. It is known from extensive studies of the aldol reaction, that the 
stereoselectivity of an aldol addition is dependent on enolate counterion. The aldol 
reaction proceeds through a cyclic six-membered transition state similar to that which 
has been proposed here for the HWE addition, and the origin of the counterion effect 
in the aldol reaction is attributed to the smaller metals having shorter metal-oxygen 
bond distances, which tighten the cyclic transition state.176 In this case, the small ionic 
radius of lithium may also have this effect, by holding the cyclic intermediate more 
tightly and exacerbating the difference in energy of the two oxaphosphetane 
intermediates. 
 
Treatment of the (E)-vinyl phosphonate 4.60 with TBAF in THF cleanly removed the 
TBDPS ether, giving the alcohol 4.67 in good yield (Figure 4.72). 
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Figure 4.72: Deprotection of 4.60 with TBAF 
 
Treatment of alcohol 4.67 with diethyl chlorophosphate and DMAP gave the 
phosphate ester 4.68 in excellent yield ( 
Figure 4.73). 
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Figure 4.73: Phosphorylation of 4.67 
 
Treatment of the ester 4.68 with trimethylsilyl bromide, followed by aqueous 
potassium hydroxide, anion-exchange chromatography and lyophilisation gave a 
small amount of white solid. Analysis of this solid by 1H and 31P NMR spectroscopy 
showed that it contained several vinyl phosphonate species. Resubjecting this material 
to careful anion-exchange chromatography gave the desired vinyl phosphonate 4.4, 
but as a 1:1 mixture of (E)- and (Z)-isomers (Figure 4.74). 
 
 
Figure 4.74: Deprotection of 4.68 to give vinyl phosphonate 4.4. 
 
The reason for the isomerisation side reaction is unclear. Similar isomerisation was 
not observed in the preparation of the parent compound 3.12 (Chapter Three), which 
suggests that the distal phosphate is in some way responsible for the side reaction. 
Isolation of the bromide side product 4.69 (Figure 4.75), produced by non-
chemoselective phosphate cleavage, showed that it was only in the (E)-configuration, 
which supports this hypothesis. The chemistry of similar compounds is relatively 
unexplored, and a search for related phenomena in the literature was unsuccessful. 
 
 
Figure 4.75: Bromide side product 4.69 
 
One possible mechanism for the isomerisation reaction would be a reversible addition 
of the distal phosphate to the electron-deficient alkene in 4.4, to give phospholactone 
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4.70. This lactone could then ring open by elimination of phosphate, returning the 
alkene of 4.4 but as a mixture of stereoisomers (Figure 4. 76).  
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Figure 4. 76: A possible distal phosphate dependent mechanism for the isomerisation of 4.4 
 
While the required medium-ring cyclisation might not normally be considered facile, 
it should be noted that only traces of phospholactone 4.70 need be formed in the 
reaction mixture in order for the isomerisation to proceed, as long as equilibration 
between open-chain 4.4 and phospholactone 4.70 is rapid. 
 
Despite the disappointing yield of target 4.4 and its isomerisation, sufficient material 
was obtained by this route for characterisation of its inhibition properties against 
DAH7P synthase. 
 
4.7 Inhibition properties of vinyl phosphonate 4.4 and related compounds 
 
The inhibitory properties of vinyl phosphonate 4.4 were assayed against E. coli 
DAH7P synthase. Based on a Lineweaver-Burk analysis of the initial rate data, the 
inhibitor was determined to be competitive with respect to PEP (Figure 4.77). At 
higher concentrations of 4.4 the data deviated from an idealised Lineweaver-Burk 
plot. The reason for this deviation remains unclear, but may be due to added 
complications introduced by the bisubstrate nature of vinyl phosphonate 4.4, or by the 
mixture of (E)- and (Z)-isomers present. The inhibitor 4.4 was not found to be time-
dependent in its action, with no significant difference in inhibition when the inhibitor 
was preincubated for times ranging from thirty seconds to thirty minutes. 
 
Fitting of the initial rate data to the Michaelis-Menten equation (Figure 4.77) modified 
for competitive inhibition showed that vinyl phosphonate 4.4 was a potent inhibitor of 
DAH7P synthase; with an inhibition constant Ki of 5.3 ± 0.6 µM. This result is similar 
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to the unelaborated compound 3.12, however the unelaborated compound 3.12 
consisted solely of the designed (E)-isomer, the corresponding (Z)-isomer is a much 
weaker inhibitor of DAH7P synthase. 
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Figure 4.77: Inhibition properties of bisubstrate vinyl phosphonate 4.4 against E. coli DAH7P 
synthase. Solutions of PEP (25-100 µM), manganese(II) sulfate (100 µM), E4P (200 µM) and vinyl 
phosphonate 4.4 (0-167 µM) in 1 mL of BTP buffer (50 mM, pH 6.8) were initiated by the 
addition of E. coli DAH7P synthase (2 µg), and the loss of PEP followed spectrophotometrically 
at 232 nm. Initial rates were obtained by linear least squares regression of the absorbance data, 
and converted to progress rates 
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The undesired bromide 4.69, produced by non-regioselective dealkylation during the 
deprotection step was also evaluated as an inhibitor of E. coli DAH7P synthase. It too 
proved to be a potent inhibitor of E. coli DAH7P synthase, with a Ki of 3.6 ± 0.4 µM 
(Figure 4.78). 
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Figure 4.78: Bromide 4.69 as a DAH7P synthase inhibitor. Solutions of PEP (25-100 µM), 
manganese(II) sulfate (100 µM), E4P (200 µM) and bromide 4.69 (0-248 µM) in 1 mL of BTP 
buffer (50 mM, pH 6.8) were initiated by the addition of E. coli DAH7P synthase (2 µg), and the 
loss of PEP followed spectrophotometrically at 232 nm. Initial rates were obtained by linear least 
squares regression of the absorbance data, and converted to progress rates 
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The potency of bromide 4.69 was initially surprising, since it lacks the terminal 
phosphate group designed to enhance the binding of these compounds to DAH7P 
synthase. One possible explanation is the reaction of the bromide with a nucleophilic 
active site residue could anchor the compound in the active site, in a similar manner to 
a terminal phosphate. 
 
In order to investigate this possibility, the interaction of bromide 4.69 with E. coli 
DAH7P synthase was investigated by time-course kinetic experiments. No significant 
time-dependence in the interaction of bromide 4.69 with DAH7P synthase was 
observed. 
 
Based on these results, it appears the interaction of bromide 4.69 with DAH7P 
synthase is predominantly non-covalent in nature. In addition, the presence of a distal 
bromine atom appears to have little positive or negative influence on the binding 
affinity of bromide 4.69. 
 
4.8 Summary 
 
In this chapter the extension of small PEP-like molecules to larger molecules capable 
of interacting with both the enzymes PEP site and the E4P phosphate site was 
investigated. These inhibitors were proposed to be more potent that the isolated PEP-
like portion, and indeed for allylic phosphonate 4.3 this hypothesis was found to be 
correct, with a considerable increase in potency on extension (Figure 4.79). 
 
 
Figure 4.79: A comparison of PEP-like fragment 3.10 and bisubstrate inhibitor 4.394, 95  
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The addition of a distal phosphate group was not sufficient to create strong inhibitors 
from molecules which do not strongly interact with the enzyme PEP site, as seen for 
acrylate 4.2 (Figure 4. 80).  
 
 
Figure 4. 80: Influence of the distal phosphate where the PEP end does not strongly bind to the 
PEP site 
 
This result implies that the PEP-like portion of the molecule is the major contributor 
to the overall binding affinity of the bisubstrate molecules. This is again illustrated 
with the bromide 4.69, which has a similar inhibition constant to its parent compound 
3.12 (Figure 4.81). This result also suggests that the hydrocarbon linker is not 
introducing any destabilising steric or hydrophobic effects to the enzyme-inhibitor 
interaction. 
 
 
Figure 4.81: PEP-mimicking compound 3.12 and bromide 4.69 
 
The study of the molecule bearing the most potent PEP-like portion was complicated 
by a previously unknown terminal phosphate dependent isomerisation. Despite this 
obstacle, characterisation of a 1:1 mixture of stereoisomers showed a similar 
inhibition constant to that for the unelaborated PEP-like compound 3.12 (Figure 4.82).  
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Figure 4.82: Similar inhibition constants displayed by parent (E)-phosphonate 3.12 and mixture 
4.4 
The behaviour of the isomeric mixture 4.4 indicates that the inhibition constant for the 
designed compound is likely to be in the low µM range. Assuming no contribution of 
any kind from the (Z)-isomer of 4.4 gives an inhibition constant of ~ 2.5 µM. 
Intriguingly, this improvement from 3.12 is similar to that observed upon extension of 
the allylic phosphonate 4.3, where a ~1.75-fold increase in binding is observed from 
the PEP-mimicking 3.10. 
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Chapter Five: Discussion, Modelling and Future 
Directions 
 
5.1: Inhibition Results Summary 
 
The aim of this project was to investigate the inhibition of DAH7P synthase. This aim 
has been achieved, with a number of new inhibitors of DAH7P synthase designed, 
synthesised and evaluated during the course of this project (Figure 5.1).  
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Figure 5.1: A summary of inhibitors of E. coli DAH7P synthase discovered during this project, 
compared to the structure of PEP 
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In addition to these inhibitors, a number of compounds have been shown that do not 
inhibit DAH7P synthase (Figure 5.2). These compounds also provide insights into the 
components necessary for DAH7P synthase inhibition. 
 
Figure 5.2: Compounds found to not be inhibitors of DAH7P synthase, compared with PEP. 
 
From comparisons between these molecules, new insights into the inhibition of 
DAH7P synthase can be obtained. In this chapter, interpretations of the binding of 
these molecules are presented, using in part information gleaned from molecular 
modeling studies of the putative enzyme-inhibitor complexes. Possible directions for 
future work are also presented. 
 
5.2: (R) and (S)-phospholactate, and cyclopropane 3.5 
 
As was discovered in Chapter Three, both (R)- and (S)-configured phospholactate are 
inhibitors of DAH7P synthase, however despite possessing the same functionality the 
(R)-isomer is a more potent inhibitor by more than an order of magnitude (Figure 5.3).  
 
 
Figure 5.3: (R) and (S)-phospholactate 
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The reason for this difference is not immediately obvious. PEP is trigonal planar at 
C2, so the difference in affinity is presumably not based on differences in substrate 
mimicking. However, there is a possible mechanistic explanation. 
 
The mechanism of DAH7P synthase requires attack by a water molecule at PEP C2 
during some stage of the reaction; with the water oxygen atom ultimately becoming 
the carbonyl oxygen of linear DAH7P during subsequent phosphate elimination. As 
was discussed in Chapter One, opinion differs on the exact mechanism by which this 
takes place, but the most chemically reasonable of the proposed mechanisms is shown 
in Figure 5.4. 
 
 
Figure 5.4: The Lewis-acid mechanism of DAH7P synthase activity 
 
From analysis of the structures of DAH7P synthases and KDO8P synthases 
determined by X-ray diffraction, it is clear that several water molecules are 
structurally conserved across enzyme, species and family divides. Two such waters 
fall within close proximity to PEP C2, one in a pocket on the re face of PEP and 
another coordinated to the metal (or held by hydrogen bonding in non-metallo 
KDO8P synthases) on the si face of PEP (Figure 5.5).  
 
Due to their proximity and conservation, these water molecules are candidates to be 
the nucleophilic water which intercepts the oxocarbenium ion during the enzyme 
reaction. As discussed in Chapter One, the water on the re face is a better candidate 
for the water nucleophile. The metal coordinated water on the si face is probably an 
artifact of the experimental conditions; it occupies the only accessible coordination 
site on the metal, which would be required by the E4P carbonyl oxygen atom during 
the enzyme reaction. The corresponding water in non-metallo A. aeolicus KDO8P 
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synthase mutants has been shown to be replaced by the carbonyl of A5P in high-
resolution structures of the enzyme-PEP-A5P ternary complex.42  
 
 
Figure 5.5: Conserved water molecules (green) on the si and re faces of PEP inside the S. 
ceravisae DAH7P synthase active site (PDB: 1of8)40. The view is from the E4P pocket; the surface 
indicates solvent-accessible active site surface, spheres are drawn at 30% of the relevant atoms 
Van der Waals contact radius. Hydrogen atoms are omitted. The presence of a pocket for the re-
face water is clearly visible. 
 
The oxocarbenium ion produced during the enzyme reaction is prochiral, so attack of 
water from the re and si faces will result in different diastereomeric hemiketal 
phosphates; which are epimers at C2. Attack of the re-face water would give a (S)-
configured hemiketal phosphate. 
 
 
Figure 5.6: Comparison of (R), (S)-phospholactates and the (S)-hemiketal phosphate 
 
The (S)-hemiketal phosphate shares the same configuration as the more potent (R)-
isomer of phospholactate; if the lactate methyl group is considered a mimic of the 
similarly sized hydroxyl group in the hemiketal phosphate. Thus the (R)-isomer may 
be better recognised by the transition state form of the enzyme, resulting in increased 
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affinity for the (R)-isomer. However, the opposite form of the argument can be 
composed if the lactate methyl group is considered a mimic of the PEP methylene 
group. 
 
In order to gain a better insight into the affinity difference between (R)- and (S)-
phospholactate, the possible enzyme-inhibitor complexes were investigated by 
computational chemistry. The active site architecture of the highest resolution E. coli 
DAH7P synthase structure, 1n8f27, was isolated, prepared and energy minimised, and 
both enantiomers of phospholactate docked using Glide177. 
 
Interestingly, the resulting model enzyme-inhibitor complexes showed the (R)-
enzyme complex was the slightly more stable, as indicated by a Glide score slightly 
more than 10% larger than that for the (S)-enzyme complex (Figure 5.7). The Glide 
score reflects both favourable and unfavourable interactions, such as hydrogen bonds 
and steric clashes. However, the difference in observed Glide score is not large 
considering the difference in inhibition constant. This may reflect the fact the 
molecules are being forced to fit the ground state form of the enzyme, which might 
fail to fully show any affinity increase the (R)-isomer has from mimicking the 
hemiketal phosphate intermediate. 
 
 
Figure 5.7: Comparison of experimental and theoretical binding strengths of (R) and (S) 
phospholactate 
 
A close investigation of the docking results shows that both the phosphate and 
carboxylate groups of the inhibitors occupy their respective sites in the PEP site, and 
have their methyl groups pointing on opposite sides to the plane of PEP, with the C2-
methine proton occupying the position of the PEP methylene group (Figure 5.8). This 
result is consistent with the earlier suggestion that (R)-phospholactate is more potent 
due to it mimicking the chirality of the hemiketal phosphate intermediate resulting 
from attack of the re face water. 
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Figure 5.8: Comparison of the calculated positions of (S)- (mauve) and (R)- (cyan) 
phospholactates with the crystallographically determined position of PEP (yellow) in the crystal 
structure of E. coli DAH7P synthase (1n8f)27. A: view along the PEP C2-C3 bond, in the plane of 
PEP, highlighting the similar phosphate positions and the dissimilar methyl and methylene 
positions. B: view down the PEP plane from the carboxyl side, highlighting the similar locations 
of the PEP methylene and lactate methine hydrogen atoms. 
 
In each case, the phosphate group is very similarly positioned, perhaps indicating it is 
the main interaction responsible for positioning the molecules. In the model (R)-3.3-
enzyme complex and the crystallographically determined enzyme-PEP complex, a 
carboxyl group oxygen occupies a similar position in space. In the corresponding 
model (S)-3.4 complex, both carboxyl oxygens straddle the site without either 
occupying it. This inability of the carboxyl group of (S)-3.4 to bind in the same place 
as PEP and (R)-3.3 seems to be related to the ability of the enzyme site to tolerate the 
out of plane methyl group. In the model (S)-3.4 complex the methyl group points 
toward the ring carbons of the conserved proline P98 (Chapter One); the docked 
position putting the methyl hydrogens close (2.86 Å) to the proline methylene 
hydrogens. This steric interaction prevents further twisting of (S)-3.4, in turn 
preventing optimum fit of the carboxylate to the PEP site.  
 
Based on this analysis, one might expect cyclopropane 3.5 to bind in a fashion similar 
to (R)-phospholactate 3.3, in order to minimise this proposed proline-inhibitor steric 
interaction. This conclusion could also be reached from comparision of the inhibition 
constants, rather since cyclopropane 3.5 has significantly smaller inhibition constant 
than (S)-phospholactate (Figure 5.9).  
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Figure 5.9: Comparison of phospholactates 3.3 and 3.4, cyclopropane 3.5 and PEP 
 
By the model of phospholactate binding presented earlier, this would suggest 
cyclopropane 3.5 lacks the proposed destabilising methyl-proline interaction in it 
inhibitor-enzyme complex, which is observed with (S)-phospholactate. This 
possibility was investigated by docking cyclopropane 3.5 in the same manner as (R)- 
and (S)-phospholactate. As was suggested by their corresponding inhibition constants, 
the modelled interaction of cyclopropane 3.5 with the enzyme closely resembles that 
of (R)-phospholactate. In the model, one methylene of the cyclopropane falls into the 
same position as the methylene of PEP; the remaining methylene of the cyclopropane 
group is pushed into the re-face water pocket (Figure 5.10). This allows the 
cyclopropyl group to adopt the furtherest possible position from proline P98. This 
finding reinforces the proposed role of proline P98 in the stereoselectivity of 
phospholactate binding by E. coli DAH7P synthase. 
 
 
Figure 5.10: A comparison of the crystallographically determined position of PEP in E. coli 
DAH7P synthase structure 1n8f27 (yellow carbons), and the calculated position of cyclopropane 
3.5 (lime green carbons) 
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The glide score determined for the interaction of cyclopropane 3.5 (-3.69) is larger 
than that determined for either enantiomer of phospholactate (-5.59 for (R), -5.17 for 
(S)), which would suggest that cyclopropane 3.5 interacts more weakly with the 
enzyme than either enantiomer of phospholactate. Since from kinetic studies it is clear 
this is not the case, it may simply reflect the shortcomings of current docking 
methodology. 
 
In the model (R)-phospholactate-enzyme complex, the methyl group falls into a 
pocket in the floor of the active site, which is normally occupied by the re-face water 
(see Figure 5.5 for a diagram of this pocket). The methyl group and re face water are 
closely placed (C-O distance: 2.80 Å), which would prevent simultaneous binding of 
the re-face water and this conformation of (R)-3.3. This might suggest the re-face 
water is readily displaced, which potentially highlights its role in the enzyme 
mechanism, since the water which attacks the oxocarbenium ion is consumed with 
each turnover. The presence of this pocket allows optimum overlap of the carboxylate 
of (R)-phospholactate with the PEP carboxylate site, presumably increasing its affinity 
relative to (S)-phospholactate. 
 
Displacement of this water may provide an additional increase in the affinity of the 
enzyme for (R)-3.3 in another manner. By releasing a well-ordered water molecule 
from the active site, the loss of entropy upon binding (R)-3.3 is lessened, which may 
result in an increased affinity. Such a phenomenon has been observed in the design of 
inhibitors for HIV-1 protease.178 In principle, a similar phenomenon may occur during 
the binding of cyclopropane 3.5, since it also utilises the pocket on the re face of PEP, 
which help may explain why it is a more potent inhibitor than (S)-phospholactate. 
 
However, entropic contributions to protein-ligand interactions are complex and poorly 
understood; and contradictory examples of affinity loss on water displacement are 
known.179 Water molecules are traditionally treated as displaceable in docking,180 and 
the water molecules are typically stripped during preparation of the active site 
architecture unless they mediate protein-ligand interactions. Furthermore, the force-
fields used for docking are poor at predicting water-apolar interactions. A recent 
systematic study of this problem found that water molecules in partially apolar 
environments, which make less than three hydrogen bonding contacts with 
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neighbouring residues, are typically displaceable upon inhibitor binding.180 Based on 
this criterion, the re-face water might be considered displaceable, as it is only close 
enough to make one direct hydrogen bond with the active site via glutamate E143; 
although an additional hydrogen bond mediated via a second water molecule to 
tyrosine Y94 and a hydrogen bond with the PEP phosphate group are also present 
(Figure 5.11).  
 
One method to investigate this postulated displacement of the re-face water will be to 
analyse the interaction of (R)-phospholactate with DAH7P synthase by X-ray 
crystallography. 
 
 
Figure 5.11: The hydrogen bonding partners of the re-face water molecule (green) in E. coli 
DAH7P synthase structure 1n8f40. Distances are indicated in angstroms. 
 
In conclusion, the difference in interaction between (R)-phospholactate and (S)-
phospholactate is complex, and potentially has contributions from transition state 
binding effects, as well as entropic and enthalpic effects. Based on docking of both 
enantiomers of phospholactate, the interactions seem to stem from the ability of the 
enzyme to tolerate the out of plane methyl groups in each structure. In the model, the 
clash of the (S)-isomer methyl group with the wall of the active site destabilises the 
enzyme-inhibitor complex relative to the corresponding (R)-complex. In addition to 
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lacking the destabilising steric interaction of (S)-phospholactate, the displacement of a 
structurally conserved water in the modelled interactions of (R)-phospholactate and 
cyclopropane 3.5 with DAH7P synthase may provide an additional increase in 
binding affinity for these compounds. 
 
5.3: Future directions from phospholactates 3.3, 3.4 and cyclopropane 3.5 
 
The results of our studies of phospholactates 3.3, 3.4 and cyclopropane 3.5can be used 
to design new molecules to inhibit DAH7P synthase. These molecules can be used to 
further map the interaction of DAH7P synthase with inhibitors, as well as being used 
as PEP-mimicking portions of extended molecules such as those described in Chapter 
4. 
 
An interesting comparision to both cyclopropane 3.5 and (R)-and (S)-phospholactate 
would be the geminal dimethyl compound 5.1 (Figure 5.12). It possesses the ability to 
form the destabilising steric methyl-proline interaction predicted in the modelled (S)-
phospholactate-enzyme complex; and the potentially stabilising methyl group 
displacement of water proposed in the modelled (R)-phospholactate complex. The 
binding affinity of this compound may cast light on the relative importance of each 
effect in inhibitor binding.  
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Figure 5.12: Simple analogue 5.1 
 
One way to increase the affinity of similar molecules to DAH7P synthase would be to 
not only utilise the proposed water-displacement effect of the (R)-configured 
phospholactate 3.3, but build in an additional polar interaction of the molecule with 
the re-face water pocket by functionalising the methyl group. Both 5.2 and 5.3 (Figure 
5.13) could be expected to fulfill this criterion. The compound 5.2 is (R)-2-
phosphoglycerate; its interaction with A. aeolicus KDO8P synthase has been 
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investigated crystallographically68; but no inhibition constant has been reported. 
Interestingly, in the A. aeolicus KDO8P synthase-phosphoglycerate complex the 
displacement of the re-face water from its pocket by the 3-hydroxyl group that is 
postulated here was in fact observed. The phosphate and carboxylate groups of 
phosphoglycerate 5.2 were also observed to occupy the corresponding PEP phosphate 
and carboxylate sites in the enzyme, as predicted for (R)-phospholactate 3.3. 
 
 
Figure 5.13: Possible methods of further exploiting the proposed (R)-methyl/water pocket 
interaction 
 
The information gained from studying the interaction of phospholactate could also be 
used to design higher-affinity multivalent molecules. In order for the hydrocarbon 
linker to occupy the same position as the PEP methylene group, it needs to replace the 
methine proton of (R)-phospholactate. Based on this rationale, the (S)-isomer 5.4 (n = 
1) will be of interest (Figure 5. 14). The extended compound 5.5 (n=2) may be of 
utility in the study of inhibition of KDO8P synthase, and its additional flexibility may 
allow it to also be a potent DAH7P synthase inhibitor. 
 
The molecules are potentially accessible from a Darzens-like approach as employed in 
Chapter Four; the chiral 2-hydroxyl group could be generated by catalytic asymmetric 
reduction of an α-ketoester. The efficencies of various chiral reducing agents in the 
asymmetric reduction of α-ketoesters have been recently investigated.181 
Alternatively, many other methods are also available to generate similar substructures, 
including both asymmetric transition-metal33 and organic catalysts.182  
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Figure 5. 14: A possible multivalent version of (R)-phospholactate; and suggested catalytic 
sources of chirality. While 5.4  would give the same length as DAH7P, extension to 5.5 may give 
improved binding in addition to activity against KDO8P synthase.  
 
5.4: Vinyl phosphonates 3.12 and 3.15 
 
The most potent single site molecule in this study, (E)-vinyl phosphonate 3.12, binds 
considerably more strongly than that previously determined for the isosteric 
phosphonate analogue of PEP 3.10, and only slightly less than PEP itself (Figure 
5.15).94, 95 This result is astounding, and reinforces the utility of locking the movement 
of rotatable bonds in inhibitor design, in order to obtain an entropic binding 
advantage. 
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Figure 5.15: The effect of conformational restriction on enzyme inhibition 
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The binding of vinyl phosphonate 3.12 was investigated by docking the compound to 
E. coli DAH7P synthase using Glide. As predicted, the binding of (E)-vinyl 
phosphonate 3.12 mimics that of PEP, with the phosphonate occupying the PEP 
phosphate sites. However, only one carboxylate oxygen occupies the PEP carboxylate 
pocket; and the whole molecule is twisted toward the E4P site (Figure 5.16). The 
origin of the twisting effect is unclear, but may be derived from the extended planarity 
over the vinyl phosphonate-C2-C3 system, since in the crystallographically 
determined conformations of enzyme bound PEP there is a slight (~15°) dihedral twist 
in the corresponding P-O-C2-C3 system, which allows a slight shortening of the 
carboxylate-phosphate distance. 
 
Figure 5.16:The highest-scored docked conformation of (E)-vinyl phosphonate 3.12 (blue 
carbons) and the crystallographically determined binding of PEP (yellow carbons) to E. coli 
DAH7P synthase (1n8f). Oxygen atoms are in red, phosphate in orange and hydrogen atoms in 
white. The solvent accessible surface of the active site is indicated. Methyl hydrogen atoms of 
phosphonate 3.12 removed for clarity 
 
Whether this difference exists in the actual system is unclear. The similarity in 
binding affinity between PEP and vinyl phosphonate 3.12 is suggestive of them 
sharing a very similar binding mode, perhaps even more similar than suggested by the 
docking result. There also must some flexibility in the shape of the PEP site, since 
based on the solvent accessible surface in the crystal structure it is not possible to 
remove PEP from its site without clashes with the walls of the active site. Therefore, it 
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is likely an “induced-fit” mechanism operates during PEP binding, in which the shape 
of the PEP site deforms in the presence of PEP in order to provide an optimum fit. 
This same process may operate during the binding of vinyl phosphonate 3.12, 
allowing it to bind with the observed high affinity. This possibility is another that 
could be investigated by X-ray crystallography. 
 
5.5: Future directions from vinyl phosphonates 3.12 and 3.15 
 
The strong binding of vinyl phosphonate 3.12 could allow it to be used as an inert 
substitute for PEP, and allow the structure of the enzyme-3.12-E4P ternary complex 
to determined under catalytically valid conditions. This structure could greatly 
improve our understanding of the mechanism of DAH7P synthase. 
 
The vinyl phosphonate 3.12 is already a strong inhibitor, and as we saw with 
trifluoromethyl analogue 3.15 further modification may hinder binding. One 
possibility for increased affinity would be to produce the vinyl fluoride 5.6 ( 
Figure 5.17). The fluorine atom should decrease the pKa2 of the neighbouring 
phosphonate, allowing it to better mimic PEP. Whether the fluorine atom also 
interferes with binding will be of interest. Vinyl fluoride 5.6 is presumably accessible 
by HWE reaction of fluorobisphosphonate 5.7, itself prepared by fluorination of 
bisphosphonate 5.8.  
 
 
Figure 5.17: Vinyl fluoride 5.6 and a suggested route for its synthesis 
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5.6: Comparision between phosphoenolpyruvate and sulfoenolpyruvate 
 
The failure of SEP 3.20 to inhibit or act as a substrate of DAH7P synthase was an 
unexpected finding, given the close similarity in structure between SEP 3.20 and PEP. 
 
 
Figure 5. 18: PEP and SEP 3.20 
 
In order to gain further understanding of possible reasons for the failure of SEP 3.20 
to inhibit DAH7P synthase, the interaction of SEP and E. coli DAH7P synthase was 
modelled by docking. The best model (glide score: -2.44) displayed an overall similar 
location to PEP in the active site, with the SEP sulfate group in a similar position to 
the PEP phosphate group and the SEP carboxylate group in a similar position to the 
PEP carboxylate group (Figure 5.19) 
 
 
Figure 5.19; A comparison of the modelled position of SEP 3.20 (pale blue/ red/ gold 
corresponding to carbon/ oxygen/ sulfur respectively) and the crystallographically determined 
position of PEP (yellow/ red/ orange corresponding to carbon/ oxygen/ phosphate respectively) in 
1n8f.pdb27 
 
However unlike PEP, SEP 3.20 displayed a large dihedral twist across the enol ester 
carbon oxygen bond. This twist appears to be introduced due to steric clashes between 
a sulfate oxygen atom and the SEP methylene group (Figure 5.20). 
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Figure 5.20: Left: the large dihedral angle present in the modelled conformation of SEP. Right: 
the clash between the sulfate oxygen (red) and the methylene carbon C3 (blue). Spheres are 
drawn at each atom’s van der Waals radii. 
 
The corresponding dihedral angle in the crystallographically determined PEP-enzyme 
complex 1n8f27 is 13.2°, which allows PEP to adopt a relatively planar geometry in 
the active site. The best model (glide score: -2.44) of the SEP-enzyme complex has a 
dihedral angle of 51.8°, and the only other model produced by Glide (glide score -
2.31) has dihedral angle of 32.5°. Manual manipulation of the dihedral to a more PEP-
like value results in very unfavourable levels of van der Waals overlap (greater than 
25% overlap of radii) between the sulfate oxygen and the methylene group at dihedral 
angles less than 29°.  
 
In order for SEP to gain a good fit to the same site as PEP, it must adopt a similar 
conformation to that of PEP. As the enol ester dihedral angle approaches 13° 
however, the sulfate group encounters increasing steric repulsion from its interaction 
with the methylene group, which prevents the molecule from adopting the same 
conformation as PEP. Thus the decrease overall energy available from more closely 
fitting the conformation of PEP is countered by the increasing steric repulsion as the 
enol ester dihedral is forced flat. This places a limit on allowable conformations of 
SEP in the SEP-enzyme complex, making the potentially more tightly bound PEP-like 
conformations inaccessible. This would manifest itself as a decreased ability for SEP 
to bind to DAH7P synthase relative to PEP. 
 
Another factor that was hypothesised to limit the binding of SEP was the difference in 
charge state. The sulfate group of SEP is only capable of adopting a -1 charge, while 
the phosphate group of PEP can adopt a -2 charge. Based on this difference, one 
Chapter Five: Discussion, Modelling and Future Directions 163 
would expect qualitatively a difference in binding affinity between SEP and PEP due 
to decreased charge (or Coulombic) interactions. This difference would be difficult to 
quantitate experimentally without contribution from other factors, but it can be 
measured relatively easily in the modelled interactions of PEP and SEP, where the 
individual components of the binding energy are calculated seperately. In order to 
investigate the effect of charge state on the lack of interaction between SEP and 
DAH7P synthase, the Coulombic and hydrogen bonding energies (Ecoul and Ehbond 
respectively) of calculated PEP-DAH7P synthase and SEP-DAH7P synthase 
complexes were compared (Figure 5.21). 
 
 
model SEP/ kJ mol-1 PEP/ kJ mol-1 ∆E/ kJ mol-1 
Ehbond -2.33 -2.29 -0.03 
Ecoul -91.29 -149.91 58.62 
Figure 5.21: A comparision between the hydrogen bonding and Coulombic components of the 
ligand enzyme interaction in calculated SEP and PEP DAH7P synthase complexes. 
 
As be seen in Figure 5.21, while there is little differences in the contributions of 
hydrogen bonding to the interaction of each ligand with the receptor, there is a large 
difference in the contributions of charge interactions. The differences in charge state 
lead ultimately to greater than 58 kJ mol-1 difference in Coulombic interaction energy 
between the two complexes. This large energy difference will be reflected in the 
apparent affinities of SEP and PEP to the enzyme. 
 
In conclusion, while the large difference in affinities between PEP and SEP 3.20 
remains a surprising result, the use of molecular modeling techniques has identified 
that both differences in charge state and subtle differences in geometry may be in part 
responsible for the differences in affinity between SEP and PEP in DAH7P synthase 
binding. 
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5.7: Metal interacting inhibitors 3.17 and 3.25 
 
The use of compounds that interfere with the metal coordination site is also of 
interest. As was seen in Chapter Three, the incorporation of a metal ligand at C3 of 
PEP (as in cyanoPEP 3.17) is capable of stopping the compound from being a 
substrate, presumably due to the cyano group blocking the coordination of the E4P 
carbonyl, and stopping Lewis acid catalysis. In addition, the metal chelator 
fosmidomycin was also able to inhibit DAH7P synthase relatively strongly, 
presumably also by metal coordination (Figure 5.22). 
 
 
Figure 5.22: Inhibitors potentially exploiting metal interaction 
 
The binding of cyanoPEP 3.17 to DAH7P synthase was investigated by docking 
studies. The highest scoring dock of cyanoPEP 3.17 to E. coli DAH7P synthase gave 
a model with an overall similar binding to that of PEP, with the phosphate and 
carboxylate groups occupying their respective sites Figure 5.23. However, the plane 
of the alkene has been distorted toward the metal, allowing the cyano group to 
coordinate the metal atom as designed. The cyano nitrogen atom occupies a very 
similar position to that of the metal-coordinated si-face water in the crystal structure 
(and hence the carbonyl oxygen of E4P in the active ternary complex). 
 
The calculated manganese-nitrogen distance (2.92 Å) is slightly longer than that in the 
known complex hexa(acetonitrile)mangenese(II) triflate, which has a manganese-
nitrogen distance of 2.11 Å.183  
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Figure 5.23: Comparison of the calculated binding position of cyanoPEP 3.17 (khaki carbons) 
with that of PEP (yellow carbons) in the crystallographically determined enzyme-PEP complex 
1n8f27. Note the similar positions of the cyanide nitrogen atom with the oxygen of the crystal 
structure si-face water (transparent green sphere, drawn at 30% van der Waals radius). The 
cyanide nitrogen-manganese distance is indicated in angstroms 
 
These findings can be used to inform future work on both DAH7P synthase and 
KDO8P synthase. As was discussed in Chapter One, the mechanism of DAH7P 
synthase and KDO8P synthase have been recently postulated to differ in their mode of 
aldehyde activation; while DAH7P synthases employ Lewis acid catalysis, KDO8P 
synthases are thought to employ protic acid catalysis. Based on this proposition, one 
might expect cyanoPEP 3.17 to be a substrate of KDO8P synthase, since it lacks a 
Lewis acid activation to interfere with, although there are also obvious steric and 
electronic differences between PEP and cyanoPEP 3.17. The interaction of this 
compound with metallo-KDO8P synthases will be of particular interest, since the 
metal has been postulated to perform a non-catalytic role in these enzymes. 
 
The binding of fosmidomycin 3.25 to DAH7P synthase was also investigated by 
docking studies. Solution conformers of the minimised structure of fosmidomycin (in 
its phosphonate monoanion and hydroxamate ion state) were generated, and 
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representative conformers lacking an intramolecular hydroxamate-phosphonate 
hydrogen bond were docked to E. coli DAH7P synthase. 
 
Surprisingly, the highest scoring model (glide score: -6.95) shows a non-coordinating 
role for the hydroxamate group (Figure 5.24). This group, rather than forming a 
complex with the metal ion, forms part of a bidentate interaction with arginine R234 
of the PEP phosphate binding pocket. The monoanionic phosphonate in turn binds to 
the PEP carboxylate binding pocket, with the hydrocarbon chain of fosmidomycin 
forming a hydrophobic interaction with proline P98, in the same manner as PEP’s C3 
is observed to do. 
 
 
Figure 5.24: The highest scoring model of the fosmidomycin-E. coli DAH7P synthase complex. 
Note the reversal of the usual phosphoryl binding affinty; while K97 and R92 form a carboxylate 
site for PEP, they bind the phosphonate of fosmidomycin (green carbons, orange phosphate) in 
this structure. The PEP phosphate site formed in part by R234 and R165 now binds the 
hydroxamate moiety of fosmidomycin. No interaction of fsomidomycin with the manganese atom 
(grey) is present in the model 
 
This non-metal binding role for the fosmidomycin hydroxamate group is an 
interesting proposition. It has been discovered in this work that the inhibition of 
DAH7P synthase by fosmidomycin is sensitive to the metal ions used (Chapter 
Three), with the strength of inhibition following the series Fe(II), Mn(II) > Co(II). 
While this would appear to suggest a role for the metal in the interaction of 
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fosmidomycin with DAH7P synthase, it may instead reflect the formation of enzyme 
free metal-fosmidomycin complexes in situ, which would lower the concentration of 
fosmidomycin in the cuvette. The stabilities of the relevant enzyme free metal-
fosmidomycin complexes have not been measured, however the stabilities of metal 
complexes with another hydroxamate ligand, desferrioxamine B, have been measured 
and found to correspond well to the Irving-Williams series.184 Based on this series, the 
relative stabilities of fosmidomycin-metal complexes should have the form 
Mn(II)<Fe(II)<Co(II). Thus the metal ions that are predicted to give the least stable 
complexes give the strongest inhibition of DAH7P synthase; which may indicate the 
metal dependancy of inhibition is simply due to decreases in free fosmidomycin 
concentration by complex formation. However, while the Irving-Williams series 
mainly reflects electrostatic effects, unusual geometries (such as the Jahn-Teller 
distortion present in six coordinate copper(II) complexes) are known to influence the 
relative positions of metals in the series.184 Thus the series may not be easily 
applicable to the unusual distorted trigonal bipyrimidal geometries present in DAH7P 
synthase-metal complexes. 
 
A lower scoring model fosmidomycin conformation (glide score: -5.87), has the 
phosphonate occupying the PEP phosphate pocket, and while the hydroxamate is not 
directly interacting with the metal ion, it falls close to it. Rotation of the C3-C4 bond 
would put the hydroxamate carbonyl oxygen within 2.9 Å of the manganese atom 
(Figure 5.25).  
 
This rotation in the model would move the hydroxamate away from its interaction 
with arginine R92, but toward its other interaction partners lysine K97 and K186, 
which may be able to compensate for the loss of interaction with R92. 
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Figure 5.25: A lower scoring model of the fosmidomycin-enzyme complex. Fosmidomycin (green 
carbons) is shown in the models calculated position; the transparent portion indicates the 
position of the hydroxamate portion of the molecule after manual rotation of the C3-C4 bond to 
allow close approach to the manganese atom (grey). 
 
It is of note that preliminary studies of fosmidomycin inhibition with metal 
independent and metal dependent KDO8P synthases show little to no inhibition. 
These enzymes have the same relative distance between the PEP carboxylate and 
phosphate pockets, yet an increased distance between the PEP phosphate pocket and 
the metal ion site is present in KDO8P synthase. This difference in enzyme structure 
may allow the elucidation of the mechanism of fosmidomycin inhibition of DAH7P 
synthase. The differing metal ion position would make it harder for the short 
hydrocarbon chain of fosmidomycin to span the distance between the phosphate 
pocket and metal ion, rendering the relative inhibition by fosmidomycin weakened for 
KDO8P synthase if the role of the hydroxamate group is to act as a metal coordinating 
group. Likewise, the similar positions of the carboxylate and phosphate pockets 
should lead to similar inhibition potencies in both DAH7P synthase and KDO8P 
synthase if the role of the hydroxamate group is to mimic the PEP carboxylate or 
phosphate groups.  
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In summary, there are two possible mechanisms of inhibition of DAH7P synthase by 
fosmidomycin. One mechanism involves the hydroxamate group binding to the PEP 
phosphate or carboxylate pocket by hydrogen bonding and ionic interactions. This 
mechanism is directly supported by computational models. The other mechanism 
involves interaction the fosmidomycin hydroxamate group with the DAH7P synthase 
metal ion cofactor. This mechanism is not directly supported by computational 
methods, however conformation of fosmidomycin required is similar conformations 
deemed possible by conformational methods. Indirect support from this mechanism is 
provided by the metal-binding behaviour of fosmidomycin in its natural target enzyme 
DXR, as well as inhibition metal dependency studies and preliminary studies of 
related enzymes.  
 
5.8: Future Directions for metal binding inhibitors 
 
These findings lead to a number of future directions for research into the interaction 
of fosmidomycin and DAH7P synthase. Given the known efficacy of fosmidomycin 
as an antibiotic and antimalarial drug; fosmidomycin might form a useful starting 
point for creating antibiotic and antimalarial drugs active against DAH7P synthase. 
 
A starting point for this research will be to better characterise the interaction between 
fosmidomycin and DAH7P synthase, using techniques such as X-ray crystallography 
to determine to bound conformation of fosmidomycin, and confirm or disprove the 
proposed metal-coordination mechanism of action.  
 
Improved compounds can then be designed from this information. Restricting the 
conformation of rotatable bonds to their active conformation can reduce the entropic 
cost of binding, and as shown in this work can result in large increases in binding 
affinity. Accordingly, restricting the allowable conformations of the chain of 
fosmidomycin may give more potent analogues.  
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Figure 5.26: Possible conformationally restricted forms of fosmidomycin, and suggested routes of 
preparation 
 
If it is found fosmidomycin binds to the enzyme through interaction with PEP 
phosphate site and the enzyme metal ion (Figure 5.25), then the conformation of the 
backbone will resemble the arrangement in (E)-vinyl phosphonate 5.9 (Figure 5.26), 
consequently 5.9 should display improved DAH7P synthase inhibition. 
 
Likewise, if fosmidomycin binds without interaction with the metal (Figure 5.24), 
then its backbone will resemble the trans-cyclopropane 5.10 (Figure 5.26). 
Consequently, 5.10 should be able to inhibit DAH7P synthase more strongly than 
fosmidomycin, by preorganising the phosphonate and hydroxamate in space. 
Interestingly, cyclopropane 5.10 has been prepared in both racemic and enantiopure 
trans forms as part of studies into the natural fosmidomycin target DXR, and has been 
reported to strongly interfere with the growth of malarial parasite P. falciparum.185 
 
Potent inhibitors may also be accessible by including functional groups in the chain 
that interact with the active site to allow the compound to more quickly adopt its 
active conformation. Possible ways to achieve this are by introducing a group to bind 
at the PEP carboxylate site or at the distal E4P phosphate site (or both), in a similar 
manner to the compounds designed in Chapter Four (Figure 5.27). 
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Figure 5.27: Extension of fosmidomycin to compounds making multiple enzyme contacts 
 
The addition of an E4P phosphate mimicking portion is a potentially general addition 
to any of the constrained fosmidomycin-type molecules in Figure 5.26. 
 
In addition to the future directions described above, any of the small PEP molecules in 
Chapter Three of this work could be investigated in their effects against both metallo 
and non-metallo KDO8P synthases; any differences in inhibitory potential may 
illuminate subtle mechanistic differences between the types of enzymes. 
 
5.9: Multivalent inhibitors 
 
Taken together, the results presented in Chapter Four of our attempts to increase 
potency by simply extending compounds to contact the E4P phosphate site are 
illuminating (Figure 5.28). 
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Figure 5.28: Overview of the results of Chapter Four 
 
A number of key points are illustrated by this diagram. The comparison between 
acrylic acid and acrylate 4.2 show that the introduction of a terminal phosphate group 
is not capable of rendering an otherwise uninhibitory compound capable of inhibiting 
DAH7P synthase. This finding reinforces the necessity of a group mimicking the 
phosphate group of PEP in order to produce binding. 
 
Comparing isosteric phosphonate 3.10 with its extended form 4.3 shows that the 
design rationale was correct, and that by adding a distal phosphate group a 
considerable increase in binding can be produced. 
 
The results of extending vinyl phosphonate 3.12 to 4.4 are less straightforward, due to 
the unfortunate propensity of vinyl phosphonate 4.4 to undergo isomerisation to an 
~1:1 mixture of (E) and (Z)-vinyl phosphonates on deprotection. However arguably 
an increase in potency is observed on extension; since the desired (E)-phosphonate is 
at half the concentration of the total vinyl phosphonate concentration, assuming no 
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competition between the (E) and (Z)-forms for the active site leads to an inhibition 
constant of ~2.7 µM. This analysis assumes the (Z)-isomer is comparatively inactive. 
This is likely to be a reasonable assumption based on the inactivity of both acrylate 
4.2 and the corresponding shortened (Z)-vinyl phosphonate (Figure 5.29). 
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Figure 5.29: The rationale behind the proposed relative inactivity of (Z)-4.4 
 
The origin of the increased potency in the extended compound is due to the phosphate 
group rather than the hydrocarbon linker. This is demonstrated by the bromide 4.69, 
which has a slight to no increase in inhibitory potency relative to parent compound 
3.12. While non-covalent interactions between proteins and the halogens are known 
(the so called “halogen-bond”186), these are evidently not strong enough in this case to 
significantly increase the potency of bromide 4.69 relative to the parent 3.12. 
 
5.10: Future directions for multivalent compounds 
 
There still remain areas of investigation with these compounds. Due to its potency and 
stability, the extended isosteric phosphonate 4.3 will be a good basis for further 
investigations. Now that the potency of such compounds is established, attempts could 
be made to resolve the effects alkene geometry of inhibition by 4.3. Ideally it might be 
possible separate the different alkene isomers of 4.3, by chromatographic techniques 
such as silver-ion flash chromatography or preparative HPLC. Alternatively, the 
comparative affinities of (Z) and (E)-4.4 could be inferred by changing the relative 
proportion of each in the mixture. Accordingly, the proportions of alkenes in the 
mixture may be able to be changed by photochemical isomerisation, or by the 
selective destruction of one isomer by chemical resolution. Some variation in isomer 
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ratios may be introduced by modifying the protecting groups in phosphonylation 
reaction, by our proposed model (Chapter Four) larger carboxylate ester groups 
combined with smaller phosphite ester groups should lead to greater (Z)-selectivity. 
 
The extended isosteric phosphonate 4.4 will also provide a useful scaffold to study the 
effect of other functionality on inhibition by DAH7P synthase. For example, will the 
addition of hydroxyl groups to the hydrocarbon chain in 4.4 result in increased 
potency, or will it lead to the complex slow binding behaviour observed with amine 
2.3? The necessary compound (Figure 5.30) should be able to be prepared by 
substituting a protected D-arabino aldehyde (Chapter Two) for the simpler straight 
chain aldehyde used to prepare 4.3. 
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Figure 5.30: A hydroxylated form of extended isoteric phosphonate 4.4 
 
Likewise, the influence of having metal ligands such as cyano or hydroxamate groups 
on the hydrocarbon linker could be investigated. 
 
All of the syntheses in Chapter Four suffer from poor chemoselectivity of the final 
phosphate deprotection step; all with yields <20% and requiring expensive and time-
consuming preparative anion-exchange chromatography to isolate the desired 
molecule from the reaction mixtures. It seems the unhindered nature of a primary 
phosphate group in these compounds (perhaps unsurprisingly) leads to poor 
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selectivity between removal of the ethyl protecting groups and cleavage of the desired 
C7-phosphate bond. 
A number of protecting groups have been devised for phosphate groups76. However 
phosphate protecting groups are comparatively poorly investigated when compared to 
carboxyl ester groups, and for complex syntheses there are comparatively few 
precendented options. Commonly used groups such as phenyl- and benzyl phosphates 
are cleaved by hydrogenolysis, conditions which are not compatible with alkene 
containing molecules such as those in Chapter Four. In addition, the hydrogenolysis 
reaction can be non-trivial, especially for more complex phenyl phosphates. 
 
Groups cleaved by reductive elimination, such as 2,2,2-trichloroethyl esters, were also 
excluded from use in this work; due to concerns over the susceptibility of electron 
deficient olefins (such as those in Chapter Four) to radical polymerisation. However, 
further investigation may result in suitably mild deprotection conditions allowing their 
use, although the careful removal of residual metal ions after deprotection will be 
required before assays with metal-dependent enzymes such as DAH7P synthase. 
 
A possibility is the use of groups which are cleaved by β-elimination, such as 2-
cyanoethyl and 2-(p-nitrophenyl)ethyl esters. These are traditionally cleaved 
chemoselectively by elimination with bases such as DBU76, leading to the free 
phosphate and acrylonitrile or p-nitrostyrene respectively. Occasionally trimethylsilyl 
chloride is also included, to improve the rate of the second deprotection. The 2-
cyanoethyl ester in particular has found considerable use in nucleoside chemistry, 
which shares similar problems of chemoselective deprotection. A similar group 
cleaved under even more specific conditions is the 2-(trimethylsilyl)ethyl ester76, 
which is cleaved by nucleophilic fluoride sources to trimethylsilyl fluoride, ethylene 
and the desired phosphate. This group has been rarely applied in phosphate chemistry, 
and further experimentation may be required to elucidate suitable deprotection 
conditions. In addition, this group is expensive, and careful synthetic planning may be 
required to avoid selectivity problems with the use of synthetically valuable tert-
butyldimethylsilyl and tert-butyldiphenylsilyl hydroxyl protecting groups.  
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Figure 5.31: Possible improved phosphorus protecting groups for the synthesis of complex 
phosphorylated molecules 
 
Further investigation of these and related groups in the synthesis of complex 
phosphates such as those in this work would potentially lead to greater selectivity 
during deprotection, and ultimately ease access to these and related molecules. 
 
5.11: Summary 
 
During this project, the inhibition of DAH7P synthase was investigated. A number of 
new inhibitors of DAH7P synthase have been prepared during this work and new 
strategies to achieve DAH7P synthase inhibition explored. Based on the results of this 
exploration, new directions for the inhibition of DAH7P synthase have been 
suggested, and it is hoped this work will lead to the future development of more 
potent DAH7P synthase inhibitors. 
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Chapter Six: Experimental 
 
6.1 General Experimental 
 
6.1.1 Solvents and Reagents 
 
Solvents and reagents were dried by standard methods187 where required prior to use. 
Tetrahydrofuran, 1,2-dimethoxyethane and diethyl ether were freshly distilled from 
sodium wire/ benzophenone. Dichloromethane, diisopropylamine and acetonitrile 
were freshly distilled from calcium hydride. Toluene was freshly distilled from 
sodium. Dimethylsulfoxide (DMSO) was dried azeotropically by distilling out ~25% 
of the volume of the undried DMSO, this fraction was discarded and the remaining 
DMSO distilled and stored over dried 4Å molecular sieves until further use188. Allyl 
alcohol and isopropyl alcohol were dried over 4Å molecular sieves, then distilled and 
stored over 4Å molecular sieves. Methanol was dried in analogous manner but using 
3Å molecular sieves. Hexane was distilled from calcium hydride. Triethyl phosphite 
was distilled from sodium wire. Diisopropylethylamine, pyridine, diethyl oxalate and 
2,6-lutidine were distilled from calcium hydride and stored over 4Å molecular sieves. 
Diethyl(azodicarboxylate) was cautiously vacuum distilled behind a safety shield, and 
stored at -20°C. Oxalyl chloride was stored frozen at -20°C. Acetic anhydride, acetyl 
chloride and 3-bromopyridine were distilled from calcium hydride. Benzaldehyde was 
vacuum distilled. Cyclohexylamine was distilled from potassium hydroxide. 
Cerium(III) chloride heptahydrate, diethyl chlorophosphate, magnesium powder, 
DBU, sodium borohydride and sodium cyanoborohydride were obtained from 
commercial sources, and once opened stored in a desiccator over silica. Commercial 
trimethylsilyl bromide was stored over fresh copper shavings in a desiccator once 
opened. Methyl acrylate, n-butyllithium solution, diisobutylaluminum hydride 
solution and lithium acetylide ethylenediamine complex were stored sealed at 4°C. 
Sodium bis(trimethylsilyl)amide solution, Grubbs first- and second-generation 
catalysts, Hoveyda-Grubbs first- and second-generation catalysts were stored 
individually sealed under argon, in a desiccator over silica. Grubbs phosphine-free 
catalyst was prepared as previously described139. The butyl Otera transesterification 
catalyst was prepared as previously described for the methyl analogue132. 2-
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Iodoxybenzoic acid (IBX) was prepared by oxidation of 2-iodobenzoic acid with 
Oxone® as previously described189. Dess-Martin periodinane was prepared by 
acetylation of IBX with hot acetic anhydride and toluenesulfonic acid as previously 
described190. 2-(Bromomethyl)acrylic acid was prepared as previously described191 
from 2,2-bis(hydroxylmethyl) diethyl malonate192, and dried in vacuo over 
phosphorus pentoxide prior to use in Mitsunobu reactions. Trifluoroacetic anhydride 
was prepared by distillation of trifluoroacetic acid from phosphorus pentoxide. (Z)-
1,4-Diacetoxybutene was prepared by acetylation of the corresponding diol with 
acetic anhydride, and vacuum distilled prior to use. Ethereal hydrogen chloride was 
prepared by saturation of anhydrous diethyl ether with a stream of hydrogen chloride 
gas, prepared by reaction of ammonium chloride and concentrated sulfuric acid and 
dried by bubbling through further concentrated sulfuric acid. Potassium isopropoxide 
solutions for Darzens reactions were freshly prepared from dry isopropanol and 
potassium metal. Imidazole was recrystallised from distilled hexanes, and stored in a 
dessicator over silica. N-bromosuccinimide was recrystallised from water, dried over 
phosphorus pentoxide, and stored in the dark at 4°C. N-methylmorpholine N-oxide 
was recrystallised from acetone, and dried over phosphorus pentoxide under vacuum. 
Methyl iodide was distilled, and stored in the dark at 4°C over fresh copper shavings. 
Commerical Dowex resins were washed well with 1.2 M hydrochloric acid until the 
filtrate ran colourless; then washed with water until the filtrate ran neutral to pH 
paper, then air-dried before use. Dowex resins in their potassium form were prepared 
by washing the acidic resin well with 10% w/v potassium hydroxide, then with water 
until the filtrate ran neutral to pH paper, then air-dried. All other reagents were 
obtained from commercial sources, and used as received. 
Commercial solutions of n-butyllithium were quantified as required by a modification 
of a literature procedure193; by titration against a known quantity of menthol in 
tetrahydrofuran, using catalytic 2,2’-bipyridine as an indicator under argon. 
Commercial sodium bis(trimethylsilyl)amide was quantified as required by a 
modification of a literature procedure194, by titration with a known concentration of 
menthol in tetrahydrofuran, using pre-generated 2,2’-bipyridine-butyllithium adduct 
as an indicator under argon. In each case the concentration was taken from a mean of 
three concordant results. 
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6.1.2 Chromatography 
 
TLC was carried out on Merck Silica Gel 60 F254 aluminum-backed sheets, and 
visualized under UV (254 nm), followed routinely by staining with basic aqueous 
potassium permanganate and heating in a stream of hot air. In some situations staining 
with acidified ethanolic ninhydrin (amines), acidified ethanolic vanillin (general), 
ethanolic phosphomolybdic acid (general) or ethanolic 2,4-dinitrophenylhydrazine (α-
ketoesters) was advantageous. Flash chromatography was carried out on silica gel, 
230-400 mesh. Chromatographic hexane, dichloromethane and ethyl acetate were 
distilled prior to use from calcium hydride; analytical grade diethyl ether, acetonitrile 
and methanol was used as supplied.  
 
Anion exchange chromatography was carried out on Pharmacia SourceQ® resin, 
utilising a Biorad Biologic® FPLC pump, quad-wavelength detector and automated 
fraction collection system at 4°C.  
 
Preparative HPLC was carried out with Waters 600 controller and Waters 2487 dual-
wavelength detector, on a Rainin Instruments Dynamax® Microsorb® normal phase 21 
x 250 mm column. Filtered analytical grade dichloromethane and methanol were used 
for HPLC. 
 
6.1.3 Reactions and Work-ups 
 
All reactions were carried out under an inert atmosphere of dry argon or nitrogen, 
unless otherwise stated. Microwave irradiations were performed in a domestic 1600 
W microwave oven, modified to include a reflux condenser and inert gas source. 
Crude organic extracts were dried with anhydrous magnesium sulfate followed by 
filtration, unless otherwise stated. Evaporations were carried out on a rotary 
evaporator, preferably with a bath temperature of less than 40oC.  
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6.1.4 Phosphate Assay for detection of products 
 
The Lanzetta reagent was prepared fresh, by the following preparation: 
 
 3 parts 0.045% w/v malachite green oxalate in water 
 1 part 4.2% w/v ammonium molybdate in 4M HCl 
0.1 parts 1.5% v/v Triton X-100 
 
The reagents were mixed in the dark, stirred for 30 minutes and filtered through a 0.45 
µm filter before use. For phosphate detection, two assays were carried out. The first 
determines the fractions that contain inorganic phosphate, the second fractions 
containing phosphate monoesters. In the first, 100 µL of sample is mixed with 700 µL 
of Lanzetta reagent, incubated for 20 minutes, then the absorbance determined at 630 
nm . For the second, 300 µL of the sample is mixed with 10 µL calf alkaline 
phosphatase solution (10 units /mL, in 4 mM MgCl2), and incubated for 2.5 hours. A 
100 µL digest sample is mixed with 700 µL of Lanzetta reagent, incubated for 20 
minutes, then the absorbance determined at 630 nm. 
 
6.1.5 NMR Spectroscopy 
 
NMR spectroscopy was carried out at the Institute of Fundamental Sciences, Massey 
University on a Bruker Avance® 400 MHz or Bruker Avance® 500 MHz NMR 
spectrometer, utilising a quadnuclei 1H/13C/19F/31P or 1H/13C inverse detection probe 
respectively; or at the Department of Chemistry, University of Canterbury on a Varian 
UNITY 300 MHz or Varian INOVA 500 MHz NMR spectrometer, utilising a 
standard 1H/13C probe or inverse detection 1H/13C probe respectively. 1H and 13C 
spectra are referenced to external tetramethylsilane; 31P NMR spectra are referenced 
to external 85% phosphoric acid. 
31P NMR concentration determinations are performed relative to a known 
approximately equimolar quantity of potassium dihydrogen phosphate. Effects arising 
from different relaxation times were checked for prior to determination; and 1H-
coupled spectra were collected to avoid signal artifacts arising from NOE from the 1H 
decoupling pulse. 
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6.1.6 Mass Spectrometry 
 
High-resolution mass spectroscopy was carried out either by the Department of 
Chemistry at the University of Auckland, on a VG-7070 high-resolution mass 
spectrometer (electron ionisation, chemical ionisation, fast atom bombardment 
techniques); or by the Department of Chemistry at the University of Canterbury on a 
Micromass LCT spectrometer (positive and negative ion electrospray ionisation 
techniques). Unless otherwise noted, high resolution mass spectral data (HRMS) 
reported for compounds refers to positive ion electrospray ionisation data. 
 
6.1.7 UV-Visible and IR Spectrometry 
 
UV-Visible spectrophotometry was carried out on a Varian Cary® One UV-Visible 
spectrophotometer, in stoppered quartz cells. The temperature was continously 
controlled at 298 K by the use of a jacketed multicell holder, connected to an external 
Varian Peltier temperature controller filled with either water or ethylene glycol. 
FTIR spectroscopy was conducted on a Shimadzu FTIR-8201 PC Spectrometer, either 
by diffuse reflectance in potassium bromide suspensions (solids) or as films between 
sodium chloride plates, cast from chloroform (oils). 
 
6.1.8 Enzyme Assays 
 
Enzyme activity was monitored by UV-Visible spectrophotometry, following the 
decrease in absorbance at 232 nm as the enol alkene of PEP is consumed. DAHP 
synthase inhibitor assays were conducted with recombinant E. coli DAH7P synthase 
(phenylalanine-repressed isozyme), which was prepared as previously described, 
diluted to ~2 mg mL-1 and stored at -80°C until required. Enzyme solutions were 
thawed and centrifuged (14 000 rpm/ 2 minutes) prior to use, and stored on ice during 
use. 
The BTP buffer utilised for both activity measurements and stock solution preparation 
was prepared by dissolving sufficient bis-tris-propane free base in MilliQ water to 
give a 50 mM solution, then adjusting the pH to 6.8 with hydrochloric acid. The 
resulting mixture was treated with Chelex® resin for two hours, then filtered through 
a 0.2 µm membrane and stored at 4°C until required. Stock solutions of PEP and E4P 
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were prepared from monopotassium-PEP (Sigma) and sodium-E4P (Sigma) 
respectively, in buffer. Solutions were treated with Chelex® resin for 2 hours, and 
filtered through a 0.2 µm filter and stored until further use. PEP solutions were stored 
frozen at -20°C; to avoid problems with concentration-dependent oligomerisation E4P 
solutions were stored at 4°C. Stock solutions of manganese(II) sulfate, cobalt(II) 
chloride and iron(II) sulfate were prepared in MilliQ water at 10 mM; and were 
filtered through a 0.2 µm membrane and stored at 4°C until use. Inhibitor solutions 
were prepared in BTP buffer, and treated with Chelex® resin and filtered through a 
0.2 µm filter before use.  
 
Inhibition constants were measured by enzyme assay. Cuvettes containing PEP, E4P, 
manganese(II) sulfate and inhibitor in BTP buffer at 25°C were initiated by the 
addition of ~2 µg enzyme, the initial rate of reaction was determined by linear least-
squares fitting of the change in absorbance with time. Collected initial rate data at 
given inhibitor and substrate concentrations were converted to positive values, and 
globally fitted by multivariable non-linear least squares regression using Grafit® to 
the Michaelis-Menten equation modified for competitive inhibition: 
max[ ]
[ ]1 [ ]m
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V S
v
IK S
K
=
 
+ + 
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where  v = initial rate;  
Vmax = maximum rate  
[S] = competitive substrate concentration  
Km = Michaelis constant in the absence of inhibitor 
[I] = inhibitor concentration 
Ki = inhibition constant 
 
6.1.9 Computational Methods 
 
All molecular modelling experiments were conducted with the Schrödinger Suite 
2005. Ligands were built using Maestro, and were energy-minimised with 
Macromodel 9.0 using the OPLS2005 force field. Conformational searches were used 
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to establish representative initial ligand conformations for docking. These searches 
were carried out with Macromodel 9.0, by the MCMM method using a GB/SA water 
model and the OPLS2005 force field, with 3000 steps for the search and up to 5000 
iterations for the minimisation of each structure. The minimisation was stopped with 
the default gradient confergence threshold of δ = 0.05 kJ mol-1 Å-1. The default Polak-
Ribiere conjugate gradient method was used for all minimisations. 
 
The docking grid was generated from chain A of the E. coli DAH7P synthase 
structure 1n8f.pdb, using the protein preparation function of Glide. The centre of grid 
was defined as the PEP ligand observed in the crystal structure, and was generated by 
Glide using the default settings. 
 
The docking of flexible ligands into the grid was performed with Glide utilising the 
following parameters: OPLS2005 force field, extra precision mode, 9000 poses per 
ligand for the initial docking run, scoring window for keeping initial poses:5000, 1000 
best poses per ligand kept for energy minimisation, energy minimisation with a 
distance dependent dielectric constant of 2 and a maximum of 5000 conjugate steps. 
The 10 highest scoring poses for each ligand were output for evalution. 
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6.2 Experimental Procedures 
 
6.2.1: Experimental for Chapter Two 
 
D-arabinose diethyl dithioacetal 
 
 
 
To a stirred solution of D-arabinose (10.00 g, 66.6 mmol) in aqueous 6M HCl solution 
(100 mL) was added ethanethiol (12.0 mL, 162 mmol). After three hours stirring at 
room temperature, the reaction was cooled to 4oC for two hours, and the crystalline 
product collected by filtration. The product was recrystallised from ethanol, and the 
crystals washed with a small quantity of cold hexane to give D-arabinose diethyl 
dithioacetal 2.5 (14.31g, 84%) as white plates. mp: 127-130°C; Rf (60% ethyl 
acetate/hexane): 0.14; 1H NMR (400 MHz, d4-MeOH) δ ppm. 4.08 (d, J = 9.2 Hz, 1H, 
H1), 4.00 (d, J = 8.5 Hz, 1H, H3), 3.87 (d, J = 9.4 Hz, 1H, H2), 3.82 (dd, J = 11.2 Hz, 
3.1 Hz, 1H, H5’), 3.67 (m, 1H, H4), 3.59 (dd, J = 10.9 Hz, 5.1 Hz, 1H, H5), 2.69 (4H, 
m, SCH2CH3), 1.23 (6H, m, SCH2CH3),13C NMR (101 MHz, d4-MeOH) δ ppm 72.1 
(C4), 71.7 (C3), 71.0 (C2), 64.1 (C5), 55.1 (C1), 24.3 (SCH2CH3), 13.8 (app d, 
SCH2CH3), 
 
2,3:4,5-Di-O-isopropylidene-D-arabinose diethyl dithioacetal 
 
 
 
To a stirred solution of polyol 2.5 (1.217 g, 4.77 mmol) in acetone (35 mL) was added 
concentrated hydrochloric acid (600 µL), and the mixture was stirred under a drying 
tube for 5 hours. The solution was dried, filtered through a plug of anhydrous 
potassium carbonate and evaporated. Flash chromatography (20% ether/hexane) gave 
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diisopropylidene acetal 2.6 as a colourless oil (1.363g, 85%) with data as reported in 
the literature195. Rf (40% ether/hexane) 0.76, 1H NMR (400 MHz, CDCl3) δ ppm: 4.30 
(m, 1H, H2), 4.14 (m, 1H, H5’), 4.08 (m, 2H, H3 & H4), 4.04 (d, J = 2.7 Hz, 1H, 
H1), 3.97 (dd, J = 8.4, 4.3 Hz, 1H, H5), 2.74 (m , 6H, 2x SCH2CH3), 1.45 (s, 3H, 
CMe2), 1.42 (s, 3H, CMe2), 1.38 (s, 3H, CMe2), 1.30 (s, 3H, CMe2), 1.27 (m, 6H, 2x 
SCH2CH3) 13C NMR (101 MHz, CDCl3) δ ppm 110.2 (CMe2), 109.7 (CMe2), 84.4 
(C2), 79.1 (C4), 77.1 (C3), 67.8 (C5), 52.4 (C1), 27.3 (CMe2), 27.1 (CMe2), 26.6 
(CMe2), 25.2 (app d, SCH2CH3), 24.9 (CMe2), 14.4 (app d, SCH2CH3), HRMS (EI): 
Required for C15H28O4S2: 336.14290; Found 336.14258 
 
Ethyl 2-(((4S,4'R,5R)-2,2,2',2'-tetramethyl-4,4'-bi(1,3-dioxolan)-5-yl) 
methylamino) acetate – Mercury Route 
 
 
To a vigorously solution of dithioacetal 2.6 (3.496 g, 10.4 mmol) in acetone (40.5 
mL) and water (4.5 mL) was added red mercury(II) oxide (5.643 g, 26.0 mmol) and 
mercury(II) chloride (7.074 g, 26.0 mmol). After 22 hours, the suspension was filtered 
through celite, and evaporated. The residue was suspended in chloroform (60 mL), 
filtered, and washed with 1M aqueous potassium iodide (4x 60 mL), 50% saturated 
sodium thiosulfate
 
(2x 60 mL), brine (60 mL), dried and evaporated. (NB: the celite, 
chloroform precipitate and KI washes contain mercury compounds, and should be 
disposed of accordingly).  
The resulting yellow oil (2.067 g, 8.98 mmol, assuming pure aldehyde) was dissolved 
in methanol (36 mL), and anhydrous sodium acetate (1.483 g, 18.1 mmol), ethyl 
glycinate hydrochloride (1.253 g, 8.98 mmol) and activated 4Å molecular sieves 
(9.023 g) were each added, and the mixture stirred under nitrogen for 45 minutes. 
Sodium cyanoborohydride (1.142 g, 18.2 mmol) was added, and stirred for 16 hours. 
The mixture was then filtered through celite, and the celite washed with methanol. 
The filtrate was evaporated, the residue dissolved in 60 mL chloroform, washed with 
50% saturated potassium carbonate
 
(2x 60 mL), brine (60 mL), dried and evaporated. 
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Flash chromatography (40% ethyl acetate/hexane) gave secondary amine 2.8 as a 
colourless oil (1.767 g, 54% over two steps). Rf (80% ethyl acetate/hexane) 0.56;  
1H NMR (400 MHz, CDCl3) δ ppm 4.18 (q, J =: 7.2 Hz, 2H, CO2CH2CH3), 4.11 (m, 
1H, H5’), 4.04 (m, 2H, H2 & H4), 3.93 (dd, J = 8.5 Hz, 5.1 Hz, 1H, H5), 3.67 (t, J = 
8.1 Hz, 1H, H3), 3.45 (d, J = 3.4 Hz, 2H, NCH2CO2Et), 2.97 (dd, J = 12.2 Hz, 3.4 
Hz, 1H, H1), 2.77 (dd, J = 12.3 Hz, 6.8 Hz, 1H, H1), 1.95 (br s, NH), 1.35 (s, 2x 
CMe2, 6H), 1.35 (s, 3H, CMe2), 1.33 (s, 3H, CMe2), 1.27 (app q, J = 3.4 Hz, 3H, 
CO2CH2CH3) 13C NMR (101 MHz, CDCl3) δ ppm 171.1 (CO2CH2CH3), 109.6 
(CMe2), 109.3 (CMe2), 80.2 (C2), 79.2 (C3), 77.1 (C4), 67.8 (C5), 60.3 
(CO2CH2CH3), 51.5 (C1), 51.1 (NCH2CO2Et), 27.2 (CMe2), 26.9 (CMe2), 26.6 
(CMe2), 25.2 (CMe2), 14.2 (CO2CH2CH3), HRMS (FAB, m-nitrobenzyl alcohol 
matrix): Required for C15H27NO6: 318.19166; Found 318.19139 
 
Ethyl 2-(((4S,4'R,5R)-2,2,2',2'-tetramethyl-4,4'-bi(1,3-dioxolan)-5-
yl)methylamino) acetate – Iodine Route 
 
 
 
To a vigorously solution of dithioacetal 2.6 (1.610 g, 4.79 mmol) in acetone (33 mL) 
was added water (750 µL, 41.7 mmol), sodium hydrogen carbonate (1.780 g, 21.2 
mmol) and iodine (2.658 g, 10.5 mmol) and the dark mixture stirred overnight. 
Saturated aqueous sodium thiosulfate was added until the stirred brown solution 
became colourless, and the solution volume was reduced by around a third on a rotary 
evaporator. Brine was added to give a volume of 50 mL, and the solution was 
extracted with ethyl acetate (4x 40 mL). The combined organic fractions were washed 
with brine, dried and evaporated. The resulting yellow oil (1.791 g, 7.78 mmol, 
assuming pure aldehyde) was dissolved in methanol (20 mL), and anhydrous sodium 
acetate (0.840 g, 10.2 mmol), ethyl glycinate hydrochloride (0.701 g, 5.02 mmol) and 
activated 4Å molecular sieves (5.076 g) were added, and stirred under nitrogen for 30 
minutes, then sodium cyanoborohydride (0.642 g, 10.2 mmol) was added, and stirred 
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for 17 hours. The mixture was then filtered through celite, and the celite plug washed 
with methanol. The filtrate was evaporated, dissolved in chloroform (30 mL) and 
water (10 mL), the organic layer separated, and the aqueous washed with further 
chloroform (30 mL). The combined organic layers were washed with saturated 
aqueous potassium carbonate (60 mL), brine (60 mL), dried and evaporated. Flash 
chromatography (40% ethyl acetate/hexane) gave secondary amine 2.8 as a colourless 
oil (0.654 g, 41% over two steps), with analytical data identical to that reported above. 
 
Diethyl hydroxymethylphosphonate78 
 
 
 
To stirred diethyl phosphite (6.44 mL, 50.5 mmol) in a 25 mL round bottom flask 
under nitrogen (a large flask is required to contain the foam produced in the reaction) 
was added finely ground paraformaldehyde (1.56 g, 52.0 mmol as CH2O) and dry 
triethylamine (0.70 mL, 5.02 mmol), and the flask (with condenser) was placed in a 
120oC oil bath, and stirred for 4 hours (caution: reaction can initiate violently), then 
cooled to room temperature and evaporated at 80°C (rotary evaporator) to remove 
excess formaldehyde. Dichloromethane (20 mL) was added, and the organic layer was 
washed with saturated ammonium chloride (2x 20 mL), saturated potassium carbonate 
(2x 20 mL), dried and evaporated to give phosphonate alcohol 2.9 (4.094 g, 48%) as a 
colourless oil, approximately 85% pure by 31P NMR, which was used without further 
purification. Key data: 1H NMR (400 MHz, CDCl3) δ ppm 4.71 (br, 1H, PCH2OH), 
4.03 (app p, J = 7.0 Hz, 4H, POCH2CH3), 3.79 (d, 2H, J = 6.1 Hz, PCH2OH), 1.22 (t, 
6H, J = 7.1 Hz, POCH2CH3); 13C NMR (101 MHz, CDCl3) δ ppm 62.9 (d, J = 6.7 
Hz, POCH2CH3), 57.1 (d, J = 162.8 Hz, PCH2OH), 16.8 (d, J = 5.7 Hz, POCH2CH3); 
31P NMR (162 MHz, 1H-decoupled, CDCl3) δ ppm -25.7 (PCH2OH). 
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(Diethoxyphosphonyl)methyl trifluoromethanesulfonate79 
 
 
 
To a stirred solution of alcohol 2.9 (2.01 g, 11.94 mmol) and dry 2,6-lutidine (1.70 
mL, 30.6 mmol) in dry dichloromethane (20 mL) under nitrogen at –78°C was added 
triflic anhydride (2.30 mL, 13.7 mmol), and stirring was continued for 1.5 hours, over 
which time the cold-bath was allowed to warm to –20°C. The cold bath was replaced 
with an ice-bath, and stirring continued for another 1.5 hours. The brown reaction 
mixture was poured into diethyl ether (150 mL), and cooled to –20oC for 1 hour, the 
crystallised lutidinium triflate filtered, and the filtrate was washed with water (3x 150 
mL), 1.2M HCl solution (2x 150 mL), brine (150 mL), dried and evaporated to give 
triflate 2.10 (2.141 g, 60%) as a yellow oil, which was ~80% pure by 19F NMR 
spectroscopy, and was used as such without further purification. Key data: 1H NMR 
(400 MHz, CDCl3) δ ppm 4.57 (d, 2H, J = 8.7 Hz, PCH2OTf), 4.18 (app p, J = 7.0 
Hz, 4H, POCH2CH3), 1.35 (t, J = 7.0 Hz, 6H, POCH2CH3 13C NMR (101 MHz, 
CDCl3) δ ppm 118.9 (d, J = 318.3 Hz, OS(O)2CF3), 66.7 (d, J = 169.2 Hz, 
PCH2OTf), 64.6 (d, J = 6.5 Hz, POCH2CH3), 16.6 (d, J = 5.3 Hz, POCH2CH3); ); 31P 
NMR (162 MHz, 1H-decoupled, CDCl3) δ ppm -13.5 (PCH2OTf); 19F NMR (376 
MHz, CDCl3) δ ppm -79.32 (OS(O)2CF3). 
 
Ethyl 2-(((diethoxyphosphonyl)methyl)(((4S,4'R,5R)-2,2,2',2'-tetramethyl-4,4'-
bi(1,3-dioxolan)-5-yl)methyl)amino)acetate 
 
 
 
To a stirred solution of secondary amine 2.8 (299 mg, 0.941 mmol) in dry acetonitrile 
(7 mL) under argon was added anhydrous potassium carbonate (502 mg, 3.63 mmol) 
and triflate 2.10 (271 mg, 0.722 mmol at 80%), and stirring was continued for 4 
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hours. The suspension was filtered, the filtrate evaporated and suspended in 
chloroform (25 mL) with the aid of a sonicator. The chloroform phase was washed 
with 2% w/v sodium hydroxide (25 mL), and the aqueous phase extracted with further 
chloroform (25 mL). The combined organic extracts were washed with brine (50 mL), 
dried and evaporated. Flash chromatography (step-gradient, 200 mL 40% ethyl 
acetate/hexane, then 60% ethyl acetate/hexane) gave tertiary amine 2.11 as a 
colourless syrup (258 mg, 76%). Rf (10% methanol/chloroform) 0.88. 1H NMR (400 
MHz, CDCl3) δ ppm 4.09 (m, 7H, H5’, 2x P(O)OCH2CH3 & CO2CH2CH3), 3.99 (m, 
2H, H2 & H4), 3.86 (dd, 1H, J = 8.4 Hz, 5.3 Hz, H5), 3.68 (dd, 2H, J = 24.8 Hz; 17.9 
Hz, NCH2P), 3.26 (dd, 2H, J = 9.7 Hz, 1.7 Hz, NCH2CO2Et), 3.09 (br d, 1H, J = 14.2 
Hz, H1’), 2.92 (dd, 1H, J = 14.0 Hz, 7.2 Hz, H1), 1.34 (s, 3H, CMe2), 1.31 (s, 3H, 
CMe2), 1.27 (m, 12H, 2x CMe2, 2x P(O)OCH2CH3), 1.21 (t, 3H, J = 7.2 Hz, 
CO2CH2CH3); 13C NMR (101 MHz, CDCl3) δ ppm 109.6, (CMe2), 109.4 (CMe2), 
80.5 (C2), 78.9 (C3), 77.0 (C4), 67.6 (C5), 61.9 (app dd, 2x P(O)OCH2CH3), 60.2 
(CO2CH2CH3), 58.3 (d, J = 10.3 Hz, C1), 55.8 (d, J = 3.7 Hz, NCH2CO2Et), 50.3 (d, 
J = 160.1 Hz, NCH2P), 27.1 (CMe2), 26.9 (CMe2), 26.6, (CMe2), 25.2 (CMe2), 16.5 
(d, J = 5.5 Hz,  P(O)OCH2CH3), 14.3 (CO2CH2CH3); 31P NMR (162 MHz, CDCl3, 
1H-coupled) δ ppm 25.2, (sept, J = 
 
8.8 Hz, CH2P(O)OEt) HRMS: Required 
C20H38NO9P: 467.22842 Found: 467.22834. 
 
(2S,3R,4R)-5-(Tert-butyldiphenylsilyloxy)-1,1-bis(ethylthio)pentane-2,3,4-triol 
 
OH
OH
OH
HO SEt
SEt
OH
OH
OH
TBDPSO SEt
SEtTBDPSCl
Im, CH2Cl2
(83%)
2.5 2.13
 
 
To a vigorously stirred solution of 2.5  (0.660 g, 2.59 mmol) in dry dichloromethane 
(20 mL) under nitrogen was added imidazole (0.361 g, 5.30 mmol), the solution was 
cooled to 0°C, and tert-butyl diphenylchlorosilane (0.70 mL, 2.73 mmol) was added 
dripwise. The solution was allowed to warm to room temperature; after 23 hours the 
solution was evaporated, and the residue taken up in chloroform (25 mL). The 
chloroform solution was washed with water (3x 25 mL) and dried and evaporated. 
Flash chromatography (25% ethyl acetate/ hexane) gave 2.13 as an oil, that solidifies 
to a waxy white solid on standing under high vacuum (1.07 g, 83%). Rf (25% ethyl 
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acetate/ hexane): 0.33; 1H NMR (400 MHz, CDCl3) δ ppm 7.66 (m, 4H, Ph2Si), 7.38 
(m, 6H,Ph2Si), 4.06 (m, 2H, H1 & H4), 3.84 (m, 3H, H5,H5’& H2), 3.76 (dd, J = 7.3 
Hz, 4.7 Hz, 1H, H3), 2.67 (m, 4H, SCH2CH3), 1.25 (t, J = 7.4 Hz, 6H, SCH2CH3), 
1.04 (s, 9H, Me3CSi); 13C NMR (101 MHz, CDCl3) δ ppm 136.0 (Ph2Si), 133.4 
(Ph2Si); 130.3 (Ph2Si); 128.2 (Ph2Si); 72.8 (C3), 70.8, 70.4, (C2, C4), 65.1 (C5), 56.1 
(C1), 27.3 (CMe3); 26.0 (SCH2CH3), 23.9 (SCH2CH3), 15.0 (s, SCH2CH3), 14.9 
(SCH2CH3); HRMS (EI, positive ion) calculated for C25H38O4SiS2 494.198082, found 
494.196335. 
 
(2S,3R,4R)-5-(Tert-butyldiphenylsilyloxy)-1,1-bis(ethylthio)pentane-2,3,4-triyl 
triacetate 
 
 
 
To a stirred solution of triol 2.13 (1.116 g, 2.26 mmol) in pyridine (15 mL) was added 
acetic anhydride (10 mL) and a catalytic quantity of DMAP. The mixture was heated 
to 60°C, and after 16 hours the mixture was cooled to 0°C, and methanol (20 mL) was 
added dropwise, the mixture stirred for 30 minutes then concentrated to 
approximately 20 mL. The residue was diluted with diethyl ether (40 mL), and 
extracted with 1.2M HCl solution (3x 60 mL), 10% w/v sodium hydroxide (2x 60 
mL), water (2x 60 mL), brine (60 mL), dried and evaporated. The residue was 
separated by flash chromatography (40% diethyl ether/hexane) to give triacetate 2.14 
(0.814 g, 58%) as a colourless oil. Rf (25% ethyl acetate/hexane) 0.55; 1H NMR (400 
MHz, CDCl3) δ ppm 7.61 (m, 4H, Ph2Si), 7.36 (m, 6H, Ph2Si), 5.82 (dd, J = 7.7, 2.6 
Hz, 1H, H3), 5.28 (dd, J = 7.9, 2.7 Hz, 1H, H2), 5.08 (m, 1H, H4), 3.85 (d, J = 7.9 
Hz, 1H, H1), 3.68 (m, 2H, H5H5’), 2.59 (m, 2x SCH2CH3), 2.06 (s, 3H, C(O)CH3), 
1.99 (s, 3H, C(O)CH3), 1.97 (s, 3H, C(O)CH3), 1.18 (m, 2x SCH2CH3), 1.00 (s, 9H, 
Me3CSi); 13C NMR: (101 MHz, CDCl3) δ ppm 170.4 (C(O)CH3), 170.3 (C(O)CH3), 
169.9 (C(O)CH3), 136.1 (Ph2Si), 133.4 (Ph2Si), 130.1 (Ph2Si), 128.2 ( Ph2Si), 71.7 
(C4), 71.3 (C2), 70.1 (C3), 62.7 (C5), 52.6 (C1), 27.0 (Me3CSi), 25.4 (SCH2CH3), 
25.3 (SCH2CH3), 21.3 (2x C(O)CH3), 21.4 (C(O)CH3), 19.6 (Me3CSi), 14.6 
(SCH2CH3), 14.5 (SCH2CH3). 
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2,3 -O-isopropylidene-D-arabinose diethyl dithioacetal 
 
 
To a solution of diacetonide 2.6 (1.506 g, 4.19 mmol) in methanol (10 mL) was added 
a 1M aqueous HCl solution (1 mL, 1 mmol), and the resulting solution was stirred at 
50°C. After 45 minutes the solution was neutralised by the addition of saturated 
aqueous sodium bicarbonate solution, and the solvent evaporated. The resulting 
residue was suspended in dichloromethane and water, filtered to remove precipitated 
tetraol 2.5, the organic phase separated, and the aqueous phase extracted with 
dichloromethane. The combined organic phases were dried and evaporated, and the 
resulting oil separated by flash chromatography (40% ethyl acetate/hexane) to give 
recovered starting diacetonide 2.6 (96.6 mg, 6%) and diol 2.16 (689.5 mg, 55%) with 
spectral data as reported in the literature195. Rf (40% ethyl acetate / hexane): 0.29; 1H 
NMR (400 MHz, CDCl3) δ ppm 4.32 (dd, J = 6.9 Hz, 3.7 Hz, 1H, H2), 4.08 (t,  J = 
7.2 Hz, 1H, H3), 4.02 (d, J = 3.7 Hz, 1H, H1), 3.81 (dd, J = 11.2, 3.2 Hz , 1H, H5’), 
3.74 (m, 1H, H4), 3.67 (dd, J = 11.2, 5.7 Hz 1H, H5), 3.15 (br s, 2H, C4OH & 
C5OH), 2.72 (m, 4H, 2x SCH2CH3), 1.44 (s, 3H, CMe2), 1.36 (s, 3H, CMe2), 1.26 (t J 
= 7.3 Hz, 3H, SCH2CH3), 1.25 (t, J = 7.3 Hz, 3H, SCH2CH3); 13C NMR (101 MHz, 
CDCl3) δ ppm 110.1 (CMe2), 83.3 (C2), 79.2 (C3), 73.1 (C4), 64.0 (C5), 53.2 (C1), 
27.3 (CMe2), 27.1 (CMe2), 25.4 (SCH2CH3), 25.1 (SCH2CH3), 14.4 (2x SCH2CH3); 
HRMS (EI): Required for C12H24O4S2: 296.11160; Found: 296.11143. 
 
2,3-O-isopropylidene-4-(O-acetyl) -5-(tert-butyldiphenylsilyloxy) D-arabinose 
diethyl dithioacetal 
 
 
To a solution of diol 2.16 (689.5 mg, 2.33 mmol) in acetonitrile (21 mL) at 0°C under 
argon was added imidazole (329.8 mg, 4.84 mmol) and tert-butyldiphenylsilyl 
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chloride (630 µL, 2.42 mmol). The solution was stirred overnight, and the temperature 
was slowly allowed to rise to room temperature by melting of the ice-bath. Acetic 
anhydride (1.5 mL, 15.9 mmol), dry pyridine (3 mL, 37.2 mmol) and 4-
(dimethylamino)pyridine (154 mg, 1.26 mmol) were added, and the solution brought 
to reflux under argon. After 3 hours at reflux, the solution was cooled and methanol (5 
mL) was added, after 10 minutes solution was evaporated. The residue was taken up 
in dichloromethane (25 mL), washed with saturated ammonium chloride (3x 25 mL), 
saturated sodium bicarbonate solution (1x 25 mL), saturated sod ium chloride solution 
(1x 25 mL), dried and evaporated. The residue was separated by flash 
chromatography (20% diethyl ether/ hexane) to give arabinose derivative 2.17 
(1.054g, 79%) as a colourless oil, with spectral data as reported in the literature195. Rf 
(40% ether/ hexane): 0.70; 1H NMR (400 MHz, CDCl3) δ ppm 7.65 (d, J = 7.0 Hz, 
4H, SiPh2), 7.38 (m, 6H, SiPh2), 5.11 (m, 1H, H4), 4.40 (t, J = 6.9 Hz, 1H, H3), 4.29 
(m, 1H, H2), 3.92 (dd, J = 11.3, 3.56 Hz, 1H, H5’), 3.84 (m, 2H, H1 & H5), 2.69 (m, 
4H, 2x SCH2CH3), 2.04 (s, 3H, OC(O)Me), 1.43 (s, 3H, Me2C), 1.31 (s, 3H, Me2C), 
1.24 (t, J = 7.4Hz, 6H, 2x SCH2CH3), 1.04 (s, 9H, Me3C); 13C NMR (101 MHz, 
CDCl3) δ ppm 170.0 (OC(O)Me), 135.6 (d,  J = 2.8 Hz, PhSi), 133.2 (PhSi), 129.8 (J 
= 5.1 Hz, PhSi), 127.7 (d, J = 1.5 Hz, PhSi), 110.6 (CMe2), 82.7 (C2), 77.1 (C3),  
74.7 (C4), 62.7 (C5), 53.5 (C1), 27.2 (Me2C), 27.2 (Me2C), 26.7 (Me3C), 25.3 
(SCH2CH3), 25.1 (SCH2CH3), 21.1 (OC(O)Me), 19.2 (Me3C), 14.4 (2x SCH2CH3); 
HRMS (FAB, m-nitrobenzyl alcohol matrix): Required for C30H45O5SiS2: 577.24777; 
Found: 577.24678. 
 
Ethyl 2-(((4R,5S)-5-((R)-1-acetoxy-2-(tert-butyldiphenylsilyloxy)ethyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)methylamino)acetate 
 
 
 
To a vigorously solution of dithioacetal 2.17 (238.3 mg, 0.413 mmol)  in acetone 
(1.58 mL) was added water (175 µL), red mercury(II) oxide (209.2 mg, 0.966 mmol) 
and mercury(II) chloride (288.3 mg, 1.062 mmol). After 15 hours, the suspension was 
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filtered through celite, and the filtrate evaporated. The residue was resuspended in 
chloroform (20 mL), filtered, and washed with 1M aqueous potassium iodide (2x 20 
mL), 50% saturated aqueous sodium thiosulfate
 
solution (20 mL), brine (20 mL), 
dried and evaporated. (NB: the celite, chloroform precipitate and KI washes contain 
mercury compounds, and should be disposed of accordingly).  
The resulting yellow oil (129.2 mg, 0.275 mmol assuming pure aldehyde) was 
dissolved in methanol (1.2 mL), and anhydrous sodium acetate (46.9 mg, 0.572 
mmol), ethyl glycinate hydrochloride (38.6 mg, 0.277 mmol) and activated 4A 
molecular sieves (277 mg) were added, and stirred under nitrogen for 50 minutes, then 
sodium cyanoborohydride (43.9 mg, 0.699 mmol) was added, and stirred for 15 hours. 
The mixture was then filtered through celite, and the celite plug washed with 
methanol. The filtrate was evaporated, dissolved in dichloromethane and saturated 
sodium bicarbonate solution, the organic phase was separated, and the aqueous phase 
washed with dichloromethane. The combined organic phases were washed with brine, 
dried and evaporated. Flash chromatography (50% ethyl acetate/ hexane) gave 
secondary amine 2.18 (72.1 mg, 31% over two steps) as a colourless oil. Rf (40% 
ethyl acetate/ hexane): 0.33; 1H NMR (400 MHz, CDCl3) δ ppm 7.67 (dm, J = 7.2 
Hz, 4H, SiPh2), 7.40 (m, 6H, SiPh2), 5.10 (m, 1H, H4), 4.20 (q, J = 7.2 Hz, 2H, 
CO2CH2CH3), 4.07 (dt, J = 7.5, 2.8 Hz, 1H, H2), 4.00 (m, 1H, H3), 3.87 (m, 2H, 
H5H5’), 3.43 (s, 2H, NCH2CO2Et), 2.87 (dd, J = 12.3, 3.0 Hz, 1H, H1’), 2.74 (dd, J = 
12.4, 7.3 Hz, 1H, H1), 2.06 (s, 3H, OC(O)Me), 1.86 (br s, NH), 1.40 (s, 3H, Me2C), 
1.33 (s, 3H, Me2C), 1.28 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 1.05 (s, 9H, Me3C); 13C 
NMR (101 MHz, CDCl3) δ ppm 172.2 (CO2CH2CH3), 170.1, (OC(O)Me), 135.6 (d,  J 
= 4.4 Hz, PhSi), 133.2 (p-PhSi), 129.8 (d, J = 5.9 Hz, PhSi), 127.7 (d, J = 2.5 Hz, 
PhSi), 109.6 (Me2C), 78.5 (C2), 76.5 (C3), 74.4 (C4), 62.8 (C5), 60.7 (CO2CH2CH3), 
52.0 (C1), 51.0 (NCH2CO2Et), 27.2 (Me2C), 26.8 (Me2C), 26.7 (Me3C), 21.0 
(OC(O)Me), 19.2 (Me3C), 14.2 CO2CH2CH3; HRMS (FAB+, m-nitrobenzyl alcohol 
matrix): Required for C30H44NO7Si: 558.28871; Found: 558.28856. 
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Ethyl 2-((((4R,5S)-5-((R)-1-acetoxy-2-(tert-butyldiphenylsilyloxy)ethyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)methyl)((diethoxyphosphonyl)methyl)amino)acetate 
 
 
 
To a stirred solution of secondary amine 2.18 (136 mg, 0.244 mmol) in dry 
acetonitrile (1.8 mL) under argon was added anhydrous potassium carbonate (133.2 
mg, 0.964 mmol) and fresh diethyl phosphonomethyl triflate (80.7 mg, 0.215 mmol at 
80%). After 18 hours stirring, the solution was filtered through a celite plug, and the 
filtrate evaporated. The residue was resuspended in chloroform (25 mL) and saturated 
aqueous sodium bicarbonate solution (10 mL), the organic phase separated, washed 
with brine (10 mL), dried and evaporated. The residue was separated by column 
chromatography (60% ethyl acetate/hexane) to give tertiary amine 2.19 (90.1 mg, 
65%) as a colourless oil. Rf (40% ethyl acetate/hexane): 0.17; 1H NMR (400 MHz, 
CDCl3) δ ppm 7.61 (dm, J = 7.0 Hz, 4H, SiPh2), 7.35 (m, 6H, SiPh2), 5.03 (m, 1H, 
H4), 4.08 (m, 7H, H2 & CO2CH2CH3 & 2x P(O)OCH2CH3), 3.83 (m, 3H, H3 & 
H5H5’), 3.67 (dd, 2H, J =, 36.4, 18.0 Hz, NCH2P), 3.24 (m, 2H, NCH2CO2Et), 2.96 
(m, 2H, H1H1’), 2.03 (s, 3H, OC(O)Me), 1.32 (s, 3H, Me2C), 1.27 (m, 9H, 2x 
P(O)OCH2CH3 and Me2C), 1.22 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 1.00, (s, 9H, 
Me3C); 13C NMR (101 MHz, CDCl3) δ ppm 171.1 (d, J = 1.46 Hz, CO2CH2CH3), 
170.2 (OC(O)Me), 135.6 (d,  J = 3.2 Hz, PhSi), 133.2  (PhSi), 129.7 (d, J = 5.2 Hz, 
PhSi), 127.7 (d, J = 2.7 Hz, PhSi), 109.7, Me2C, 79.0, (C2), 76.2 (C3), 74.5 (C4), 
62.9 (C5), 62.0 (dd, J = 7.0 Hz, 2x P(O)OCH2CH3), 60.2, CO2CH2CH3, 58.5 (d, J =  
11.1 Hz, C1), 55.7 (d, J =  4.9 Hz, NCH2CO2Et), 50.0 (d, J = 160.4 Hz, NCH2P), 27.1 
(Me2C), 26.8 (Me2C), 26.7 (Me3C), 21.0 (OC(O)Me), 19.2 (Me3C), 16.5 
(P(O)OCH2CH3), 16.4 (P(O)OCH2CH3), 14.2 (CO2CH2CH3); 31P NMR (162 MHz, 
CDCl3, 1H-decoupled) δ ppm: 24.6 (NCH2P); HRMS (FAB, m-nitrobenzyl alcohol 
matrix): Required for C35H55NO10PSi: 708.33329; Found: 708.33263. 
 
Chapter Six: Experimental   195 
 
Ethyl 2-((((4R,5S)-5-((R)-1-acetoxy-2-hydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)methyl)((diethoxyphosphonyl)methyl)amino)acetate 
 
 
 
To a stirred solution of TBDPS ether 2.19 (90.0 mg, 0.127 mmol) in dry THF (1.9 
mL) under argon was added a 1M THF solution of tetrabutylammonium fluoride (0.33 
mL, 0.33 mmol). The brown solution was stirred for 1.75 hours, then evaporated. The 
residue was immediately purified by flash chromatography (50% ethyl acetate/hexane 
till silyl fluoride byproduct elutes, then 100% ethyl acetate) to give alcohol 2.20 (49.2 
mg, 82%) as a colourless oil. Rf (100% ethyl acetate): 0.30, 1H NMR (400 MHz, 
CDCl3) δ ppm 4.81 (br s, 1H, C5-OH), 4.39 (dd, J = 11.5 Hz and 2.3 Hz, 1H, H5’), 
4.13 (m, 8H, 2x P(O)OCH2CH3 & CO2CH2CH3 & H2 & H5), 3.85 (t, J = 8.5 Hz, 1H, 
H3); 3.78 (m, 1H, H4), 3.66 (dd, 2H, J = 29.8 Hz, 18.0 Hz , NCH2P), 3.13 (m, 4H, 
H1H1’, NCH2CO2Et), 2.09 (s, 3H, OC(O)Me), 1.33 (m, 12H, 2x P(O)OCH2CH3 and 
2x Me2C), 1.21 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 13C NMR (101 MHz, CDCl3) δ ppm 
171.3 (OC(O)Me), 171.1 (CO2CH2CH3), 109.1 (Me2C), 80.9 (C2), 77.6 (C3), 71.9 
(C4), 66.7 (C5), 62.3 (app dd, J = 7.3 Hz, 2.8 Hz, 2x P(O)OCH2CH3), 60.6 
(CO2CH2CH3), 57.6 (d, J = 4.6 Hz, NCH2CO2Et), 57.4 (d, J = 10.2 Hz, C1), 51.3 (d, 
J = 164.0 Hz, NCH2P), 27.0 (Me2C), 26.8 (Me2C), 21.0, OC(O)Me, 16.4 (app dd,  J = 
5.3 Hz, 2x P(O)OCH2CH3), 14.2 (CO2CH2CH3); 31P NMR (162 MHz, CDCl3, 1H-
decoupled) δ ppm 24.2 (NCH2P); HRMS (FAB, m-nitrobenzyl alcohol matrix), 
Required for C19H37NO10P: 470.21551; Found: 470.21604. 
 
Ethyl 2-((((4R,5S)-5-((R)-1-acetoxy-2-(diethoxyphosphoryl)ethyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)methyl)((diethoxyphosphonyl)methyl)amino)acetate 
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To a stirred solution of triethyl phosphite (43 µL, 0.25 mmol) in dry dichloromethane 
(0.8 mL) at 0°C under argon was added iodine (56.0 mg, 0.22 mmol). Stirring was 
continued for 5 minutes, over which time the brown colour of iodine disappeared. The 
resulting solution of diethylphosphoryl iodide was added dripwise (syringe pump) 
over 15 minutes to a solution of alcohol 2.20 (50.9 mg, 0.108 mmol) and pyridine (66 
µL, 0.819 mmol) in dry dichloromethane (4.2 mL) under argon. After all the 
diethylphosphoryl iodide solution had been added, the solution was stirred for a 
further 25 minutes, then 50% saturated aqueous potassium carbonate (6 mL) and 
dichloromethane (10 mL) were added. After 5 minutes vigorous stirring the organic 
layer was separated, the aqueous phase extracted with dichloromethane (10 mL). The 
combined organic layers were washed with brine (10 mL), dried and evaporated. The 
residue was separated by flash chromatography (100% ethyl acetate) to give 
phosphate 2.21 (37.3 mg, 57%) as a colourless oil. Rf (100% ethyl acetate): 0.30, 1H 
NMR (400 MHz, CDCl3) δ ppm 4.40 (dd, J = 11.6 Hz, 2.4 Hz, 1H, H5’), 4.26 (app p, 
J = 7.3 Hz, 4H, OP(O)OCH2CH3), 4.14 (m, 8H, 2x P(O)OCH2CH3 & CO2CH2CH3 & 
H2 & H5), 3.86 (t, J  = 7.8 Hz, 1H, H3), 3.79 (m, 1H, H4), 3.67 (dd, J = 32.3, 18.0 
Hz, 2H, NCH2P), 3.18 (m, 3H, NCH2CO2Et, H1’), 3.06 (dd, 1H, J = 14.8, 4.0 Hz, 
H1), 2.10 (s, 3H, OC(O)Me), 1.36 (m, 18H, 4x P(O)OCH2CH3 and 2x Me2C), 1.36 
(m, 18H, 4x P(O)OCH2CH3 and 2x Me2C), 1.28 (t, J = 7.3 Hz, 3H, CO2CH2CH3); 13C 
NMR (101 MHz, CDCl3) δ ppm 171.3 (OC(O)Me), 171.1 (d, J = 8.1 Hz, 
NCH2CO2Et), 109.1 (Me2C), 80.9 (C2), 77.6 (C3), 71.9 (C4), 66.7 (C5), 65.2 (app t, J 
= 2.8 Hz, OP(O)OCH2CH3), 62.3 (app dd, J = 6.9 Hz, 3.0 Hz, CH2P(O)OCH2CH3), 
60.6 (CO2CH2CH3), 57.6 (d, J = 3.6 Hz, NCH2CO2Et), 57.4 (d, J = 11.0 Hz, C1), 
51.3 (d, J = 163.9 Hz, NCH2P), 27.0 (Me2C), 26.8 (Me2C), 21.0 (OC(O)Me), 16.5 (t, 
J = 5.0 Hz, 2x CH2P(O)OCH2CH3), 16.0 (t,  J = 3.6 Hz, 2x OP(O)OCH2CH3), 14.3 
(CO2CH2CH3); 31P NMR (162 MHz, CDCl3, 1H-decoupled) δ ppm -13.2,(OP(O)OEt); 
24.1, (NCH2P); HRMS (FAB, m-nitrobenzyl alcohol matrix): Required for 
C23H36NO13P2: 606.24444, Found: 606.24369. 
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Ammonium 2-((phosphonomethyl) ((2R,3S,4R)- 2,3,4-trihydroxy-5-
(phospho)pentyl)amino)acetate 
 
 
 
To a stirred solution of phosphate triester 2.21 (31.9 mg, 52.7 µmol) in dry 
acetonitrile (750 µL) under argon at 4oC was added triethylamine (73 µL, 0.53 mmol) 
and trimethylsilyl bromide (56 µL, 0.42 mmol). The resulting tan suspension was 
stirred for 19 hours, then further portions of triethylamine (35 µL, 0.25 mmol) and 
trimethylsilyl bromide (25 µL, 0.19 mmol) were added. Stirring was continued for 4 
hours, then water (1 mL) was added, and the brown suspension stirred vigorously for 
30 minutes, then extracted with chloroform (3x 2.5 mL). The aqueous solution was 
briefly placed under vacuum on a rotary evaporator at room temperature to remove 
volatiles, then stirred at 75oC for two hours. The pH of the solution was adjusted to 13 
with 10% aqueous KOH, then stirred at 75oC for one hour. The solution was cooled, 
and the volatiles again removed on a rotary evaporator. The solution was diluted to 2 
mL with water, centrifugally filtered through a 0.2 µm filter and purified by anion-
exchange chromatography (0 – 500 mM ammonium bicarbonate). The fractions 
containing product (at ~125 mM ammonium bicarbonate) were lyophilised to give the 
target molecule 2.3 (7 mg, 16%). 1H NMR (D2O, pD 13, COSY) δ ppm 4.16 (H2), 
4.11 (H5’), 4.03 (H5), 3.95 (H4 or H3), 3.71 (H3 or H4), 3.61 (NCHH’CO2H), 3.32 
(NCHH’CO2H), 3.02 (H1’), 2.80 (NCHH’P), 2.79,(H1), 2.68 (NCHH’P); 13C NMR 
(101 MHz, D2O, pD 13) δ ppm 180.5 (NCH2CO2H), 71.2 (C3), 70.8 (d, J =: 6.7 Hz, 
C5), 67.2 (C2), 65.9 (d, J = 4.4 Hz, NCH2CO2H), 60.7 (d, J = 6.5 Hz, C4), 59.1 (d, J 
= 8.4 Hz, C1), 52.6 (d, J = 140.8 Hz, NCH2P); 31P NMR: (162 MHz, D2O, pD 13, 1H-
coupled) 16.7 (t, J
  
= 10.8 Hz, CH2P(O)(O-)2), 4.9 (t, J = 6.0 Hz, CH2OP(O)( O-)2). 
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6.2.2 Experimental for Chapter Three 
 
Methyl 2-(diethoxyphosphoryloxy)propanoate 
 
 
 
A solution of triethylphosphite (0.860 mL, 5.01 mmol) in dichloromethane (12 mL) 
under nitrogen was cooled to 0°C, and iodine (1.159 g, 4.57 mmol) was added. The 
solution was stirred until the characteristic brown iodine colour had been discharged 
(~ 5 minutes). The resulting solution of diethylphosphoryl iodide was added dripwise 
over 15 minutes to (S)-methyl lactate (400.1 mg, 3.843 mmol) in pyridine (2.5 mL) 
and dichloromethane (60 mL) at 0°C under nitrogen. Once addition was complete the 
mixture was stirred for 1 hour, then quenched with saturated aqueous sodium 
bicarbonate solution (20 mL), and stirred vigorously for 5 minutes. The organic phase 
was separated, and washed with 1.2 M aqueous hydrochloric acid (2x 75 mL), 
saturated aqueous sodium bicarbonate solution (75 mL), and brine (75 mL), dried and 
evaporated. Flash chromatography (50% ethyl acetate/hexane) gave the phosphate 
ester (615.9 mg, 67%). Rf (50% ethyl acetate/hexane): 0.34; 1H NMR (400 MHz, 
CDCl3) δ ppm 4.83 (qd, J = 14.1, 7.0 Hz, 1H, H2), 4.17-3.99 (m, 4H, POCH2CH3), 
3.70 (s, 3H, CO2Me), 1.48 (d, J = 6.9 Hz, 3H, H3), 1.27 (dt, J = 7.1, 3.3 Hz, 6H, 
POCH2CH3); 13C NMR (101 MHz, CDCl3) δ ppm 171.0 (d, J = 5.2 Hz, C1), 71.6 (d, 
J = 5.2 Hz, C2), 64.2 (d, J = 6.0 Hz, POCH2CH3), 64.0 (d, J = 6.0 Hz, POCH2CH3), 
52.4 (CO2Me), 19.2 (d, J = 5.4 Hz, C3), 16.0 (app dd, J = 6.9, 1.0 Hz, 2x 
POCH2CH3); 31P NMR (162 MHz, CDCl3) δ ppm -2.0 (C2OPOEt); [α]D20 = -18.3°.  
Treatment of (R)-methyl lactate (400.6 mg, 3.85 mmol) under the same conditions 
gave the corresponding (R)-phosphoester (475.6 mg, 51%), with identical spectral 
data except [α]D20 = +18.5°. 
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Tris(cyclohexylammonium) 2-(phosphoryl)propanoate 
 
CO2Me
O
P
O
OEt
OEt
CO2
-
O
P
O
O-
O- (CyNH3
+)3
1. TMSBr, CH2Cl2
2. aq KOH; Dowex-H
3. CyNH2
(R)-3.3
(S)-3.4
 
 
To a solution of (R)-phosphoester (470.5 mg, 1.96 mmol) in dichloromethane (15 mL) 
under nitrogen was added trimethylsilyl bromide (1.55 mL, 11.7 mmol), and the 
mixture was stirred overnight then evaporated. The residue was dissolved in 10% w/v 
aqueous potassium hydroxide, stirred for five minutes then extracted with 
dichloromethane (3x 2 mL) and the organic phases discarded. The aqueous phase was 
passed through a short column of Dowex-50X8 H+-form, eluted with water (20 mL), 
neutralised with cyclohexylamine and lyophilised to give a white powder, (757.3 mg). 
Analysis of the solid (1H NMR) showed the hydrolysis of the carboxylate ester was 
incomplete, so a portion of the solid (474.2 mg) was treated with 10% w/v aqueous 
potassium hydroxide (4 mL) for two hours, the mixture was extracted with 
dichloromethane (3x 2 mL) and the organic phases discarded. After treatment with 
Dowex-50X8 H+-form and cyclohexylamine and lyophillisation, (R)-phospholactate 
tris(cyclohexylammonium salt) 3.3 was obtained as a white solid (361.7 mg, 63%), 
containing ~20% lactate due to neighbouring group assisted hydrolysis. 1H NMR (500 
MHz, D2O) δ ppm 4.3-4.2 (app p, J = 7.3 Hz, 1H, H2-OP), 3.1-2.9 (q, J = 7.0 Hz, 
0.25H, H2-OH), 1.9-1.7 (m, CyNH3+), 1.7-1.6 (m, CyNH3+), 1.6 (d, J = 6.9 Hz, 3H, 
C3), 1.5 (dm, J = 12.8 Hz, CyNH3+), 1.2-1.1 (m, CyNH3+), 1.0 (m, CyNH3+); 13C 
NMR (75 MHz, D2O) δ ppm 181.5 (d, J = 6.4 Hz, C1), 71.9 (d, J = 5.0 Hz, C2), , 
50.5 (CyNH3+), 30.5 (CyNH3+), 24.5 (CyNH3+), 24.0 (CyNH3+), 20.3 (d, J = 3.1 Hz, 
C3), lactate 182.6 (C1), 68.6 (C2), 20.2 (C3); 31P NMR (121 MHz, D2O) δ ppm 2.1 
(C2OP); 2.0 (Pi). [α]20365 nm: +2.6°; ESI-MS, (negative ion, 20% AcOH matrix): 
required for C3H6O6P-: 168.9902, found 168.9904. 
In a similar manner the (S)-isomer 3.4 was prepared, with the spectral data in 
accordance with that above, except [α]20365 nm: -2.9°; and ESI-MS, (negative ion, 20% 
AcOH matrix): required for C3H6O6P-: 168.9902, found 168.9909. 
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Methyl 1-(diethoxyphosphoryl)cyclopropanecarboxylate 
 
 
 
A solution of diazomethane (freshly prepared from Diazald® by the manufacturers 
directions) in diethyl ether was added dropwise from a flame-polished pipette behind 
a safety shield to a solution of 1-hydroxy 1-carboxylcyclopropane (206 mg, 2.018 
mmol) in ethanol (2 mL) at 0°C, until TLC (50% ethyl acetate/hexane) indicated the 
absence of free acid. Nitrogen was bubbled thorough the solution to remove excess 
diazomethane, and the solution was evaporated.  
The crude methyl ester (291.8 mg) was dissolved in dichloromethane (20 mL) under 
nitrogen, and pyridine (0.980 mL, 12.1 mmol) and DMAP (51.2 mg, 0.419 mmol) 
were added, followed by diethyl chlorophosphate (0.875 mL, 6.05 mmol). The 
mixture was stirred overnight, then quenched with saturated aqueous sodium 
bicarbonate solution (10 mL) and stirred vigorously for 15 minutes. The organic phase 
was separated, and the aqueous phase extracted with dichloromethane (20 mL). The 
combined organic phases were washed with saturated ammonium chloride solution 
(2x 30 mL) and brine (30 mL), dried and evaporated. Flash chromatography (100% 
ethyl acetate) gave phosphate ester 3.8 as a colourless oil (396.8 mg, 78%). Rf (80% 
ethyl acetate/hexane): 0.13; 1H NMR (500 MHz, CDCl3) δ ppm 4.21-4.13 (m, 4H, 
POCH2CH3), 4.07-3.99 (m, 3H, CO2Me), 1.30 (t, J = 7.2 Hz, 6H, POCH2CH3), 1.26 
(dt, J = 7.1, 0.8 Hz, 2H, H3-phosphoryl face), 1.17 (t, J = 7.1 Hz, 2H, H3-carboxyl 
face); 13C NMR (126 MHz, CDCl3) δ ppm 171.2 (C1), 65.3 (app t, J = 3.0 Hz, 2x 
POCH2CH3), 63.7 (d, J = 5.9 Hz, C2), 60.5 (CO2Me), 16.3 (d, J = 6.7 Hz, C3), 16.1 
(t, J = 3.6 Hz, 2x POCH2CH3). HRMS, required for C9H18O6P 253.0841, found 
253.0843. 
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Ammonium 1-(phosphoryl)cyclopropanecarboxylate 
 
 
 
To a solution of ester 3.8 (312.5 mg, 1.24 mmol) in dichloromethane (12 mL) under 
nitrogen was added trimethylsilyl bromide (0.980 mL, 7.42 mmol), and the mixture 
stirred overnight. The mixture was evaporated, and the residue dissolved in 10% w/v 
aqueous potassium hydroxide (5 mL) and stirred for 3 hours. The mixture was 
extracted with dichloromethane (3x 5 mL), and the organic extracts discarded. The 
aqueous phase was loaded onto a column of Dowex-50X8 H+-form (20 x 70 mm), and 
eluted with water (45 mL). The filtrate was neutralised with cyclohexylamine, and 
lyophilised. 
A portion (200 mg) of crude product was recrystallised from methanol/acetone 
(crystallised at -80°C/ 2 hours), and the collected material (61 mg) was purified by 
anion-exchange chromatography (Source Q, 0-1M ammonium bicarbonate). The 
product was located by treatment of the fractions with the Lanzetta reagent, and the 
active fractions lyophilised to give a crude preparation of cyclopropane 3.5 (5.2 mg). 
The mixture contained only one phosphorus species by 31P NMR, and appeared 
mostly desired product by 13C NMR but some impurities were observed in the 1H 
NMR spectrum. Key data91: 1H NMR (300 MHz, D2O) δ ppm 1.2 (app t, J = 10.8 Hz, 
H3); 13C NMR (75 MHz, D2O) δ ppm 164.5 (C1), 50.5 (C2), 24.0 (C3), 31P NMR 
(121 MHz, D2O) δ ppm 0.7 (C2OP). 
 
Methyl 3-(diethoxyphosphonyl)-2-methylacrylate 
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To a solution of tetraethyl methylene bisphosphonate (820 µL, 3.30 mmol) in 
tetrahydrofuran (4 mL) under nitrogen at -78°C was added a 0.846 M solution of 
sodium bis(trimethylsilyl)amide in tetrahydrofuran (3.6 mL, 3.05 mmol), and the 
mixture was stirred for 30 minutes, and allowed to come to -35°C over this time. The 
cold bath was replaced with an ice bath, and technical grade methyl pyruvate (96%, 
290 µL, 3.08 mmol) was added dropwise. The mixture was stirred for 2.5 hours, and 
quenched with saturated potassium dihydrogen phosphate (5 mL). The 
tetrahydrofuran was removed on a rotary evaporator, and the residue extracted with 
ethyl acetate (5x 10 mL).The combined organic phases were washed with brine (50 
mL), dried and evaporated. Flash chromatography (60% ethyl acetate/hexane) gave 
pure (E)-3.13 (116.3 mg, 16%) and (Z)-3.14 (137.1 mg, 24%), which contained ~10% 
(E)-isomer by NMR.  
(E)-isomer: Rf (60% ethyl acetate/hexane): 0.25; 1H NMR (500 MHz, CDCl3) δ ppm 
6.64 (dq, J = 16.0, 1.2 Hz, 1H, H3’), 4.11-4.04 (dq, J = 7.8, 7.1 Hz, 4H, 
C3’POCH2CH3), 3.76 (s, 3H, CO2Me), 2.23 (dd, J = 3.6, 1.3 Hz, 3H, H3), 1.30 (t, J = 
7.1, 6H, C3’POCH2CH3); 13C NMR (75 MHz, CDCl3) δ ppm 167.1 (d, J = 29.3 Hz, 
C1), 147.1 (d, J = 9.0 Hz, C2), 125.5 (d, J = 185.9 Hz, C3’), 62.2 (d, J = 5.6 Hz, 
C3’POCH2CH3), 52.9 (s, CO2Me), 16.6 (d, J = 6.4 Hz, C3’POCH2CH3), 16.0 (d, J = 
6.3 Hz, C3); 31P NMR (121 MHz, CDCl3) δ ppm 13.0 (C3’POCH2CH3). HRMS, 
required for C9H18O5P 237.0892, found 237.0885. 
 
(Z)-isomer: Rf (60% ethyl acetate/hexane): 0.10; 1H NMR (500 MHz, CDCl3) δ ppm 
5.72 (dq, J = 14.7, 1.4 Hz, 1H), 4.10-3.98 (m, 4H, C3’POCH2CH3), 3.76 (s, 3H, 
CO2Me), 2.04 (app t, J = 1.4 Hz, 3H, H3), 1.26 (t, J = 7.1 Hz, 6H, C3’POCH2CH3); 
13C NMR (75 MHz, CDCl3) δ ppm 168.3 (d, J = 9.4 Hz, C1), 149.6 (d, J = 3.1 Hz, 
C2), 120.7 (d, J = 188.6 Hz, C3), 62.2 (d, J = 5.6 Hz, C3’POCH2CH3), 52.6 (s, 
CO2Me), 22.7 (d, J = 20.5 Hz, C3), 16.5 (d, J = 6.5 Hz, C3’POCH2CH3); 31P NMR 
(121 MHz, CDCl3) δ ppm 13.8 (C3’POCH2CH3). 
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Tris(cyclohexylammonium) (E)-2-methyl-3-phosphonatoacrylate 
 
 
 
To a solution of ester 3.13 (116.3 mg, 0.492 mmol) in dichloromethane (3.8 mL) 
under nitrogen was added trimethylsilyl bromide (390 µL, 2.95 mmol), and the 
mixture was stirred overnight then evaporated. The residue was dissolved in 10% w/v 
aqueous potassium hydroxide (2 mL), stirred for five minutes then extracted with 
dichloromethane (3x 2 mL) and the organic phases discarded. The aqueous phase was 
passed through a short column of Dowex-50X8 H+-form (10 x 80 mm), eluted with 
water (30 mL), neutralised with cyclohexylamine and lyophilised to give a white 
powder (328.8 mg). Analysis of this powder by NMR showed only the presence of the 
desired product 3.12, and 31P NMR quantitation showed the powder was 48% pure 
(69% yield), the balance presumably being inorganic cyclohexylammonium salts 
and/or waters of hydration. 
1H NMR (500 MHz, D2O) δ ppm 6.19 (dd, J = 14.6, 1.2 Hz, 1H, H3’), 3.10-2.88 
(CyNH3+), 1.87 (dd, J = 2.9, 1.2 Hz, 3H, H3), 1.85-1.78 (m, CyNH3+), 1.67-1.59 (m, 
CyNH3+), 1.48 (dm, J = 12.8 Hz, CyNH3+), 1.24-1.09 (m, CyNH3+), 1.01 (ddm, J = 
22.2, 10.1 Hz, CyNH3+); 13C NMR (75 MHz, D2O) δ ppm 178.4 (d, J = 22.5 Hz, C1), 
144.7 (d, J = 4.2 Hz, C2), 131.2 (d, J = 165.9 Hz, C3’), 50.5 (CyNH3+), 30.5 
(CyNH3+), 24.5 (CyNH3+), 24.0 (CyNH3+), 16.4 (d, J = 6.5 Hz, C3); 31P NMR (121 
MHz, D2O, 1H-decoupled) δ ppm 9.8 (C3’P); 31P NMR (121 MHz, D2O, 1H-coupled) 
δ ppm 9.8 (d, J = 14.9 Hz, C3’PO32-). ESI-MS, (negative ion, 20% AcOH matrix). 
required for C4H6O5P-: 164.9953; found: 164.9948. 
 
(Z)-Methyl 3-(diethoxyphosphonyl)-2-(trifluoromethyl)acrylate 
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A stirred solution of diisopropylamine (340 µL, 2.41 mmol) in tetrahydrofuran (20 
mL) was cooled to -78°C under nitrogen, and a 1.6 M solution of n-butyllithium in 
hexanes (1.38 mL, 2.21 mmol) was added. After 30 minutes, tetraethyl methylene 
bisphosphonate (620 µL, 2.49 mmol) was added, the mixture was stirred for 20 
minutes before methyl 3,3,3-trifluoropyruvate (200 µL, 1.96 mmol) was added. The 
mixture was stirred for ten minutes, then brought to 0°C and stirred for 2.5 hours. The 
reaction was quenched with saturated aqueous potassium dihydrogen phosphate (5 
mL), and the tetrahydrofuran removed on a rotary evaporator. The residue was 
partitioned between dichloromethane (20 mL) and water (10 mL), the aqueous phase 
was separated and extracted with further dichloromethane (10 mL). The combined 
organic phases were washed with 10% w/v sodium hydroxide (2x 10 mL), 1.2 M 
hydrochloric acid (10 mL) and brine (10 mL). The organic phase was dried and 
evaporated. Flash chromatography (60 % ethyl acetate/hexane) gave phosphonate 
3.16 as an oil (238.3 mg, 42%). Rf (60% ethyl acetate/hexane): 0.32; 1H NMR (500 
MHz, CDCl3) δ ppm 6.47 (d, J = 9.3 Hz, 1H, H3’), 4.21-4.06 (m, 4H, POCH2CH3), 
3.82 (s, 3H, CO2Me), 1.28 (app dd, J = 14.9, 7.7 Hz, 6H, POCH2CH3); 13C NMR (75 
MHz, CDCl3) δ ppm 170.9 (C1), 128.1 (dd, J = 185.0, 5.4 Hz, C3’), 62.9 (d, J = 5.8 
Hz, POCH2CH3), 53.2 (d, J = 0.9 Hz, CO2Me), 16.1 (d, J = 6.0 Hz, POCH2CH3); 31P 
NMR (121 MHz, CDCl3) δ ppm 9.8 (C3’P).  
 
Tris(cyclohexylammonium) (Z)-3-phosphonato-2-(trifluoromethyl)acrylate 
 
 
 
Deprotection of ester 3.16 (283.3 mg, 0.821 mmol), by the method described for 3.13 
gave free phosphonate 3.15 as a white powder (583.5 mg). The powder gave only the 
expected signals for 3.15 by NMR, however the cyclohexylamine signals integrated to 
give a higher value than expected. Quantitation by 31P NMR showed the powder was 
25% product 3.15 (34% yield), the balance presumably being inorganic 
cyclohexylammonium salts and/or waters of hydration. 1H NMR (300 MHz, D2O) δ 
ppm 6.75 (d, J = 6.2 Hz, H3’), 3.21-2.89 (m, CyNH3+), 2.02-1.75 (m, CyNH3+), 1.75-
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1.59 (m, CyNH3+), 1.52 (dm, J = 12.2 Hz, CyNH3+), 1.21 (m, CyNH3+) 13C NMR (75 
MHz, D2O) δ ppm 142.2 (dd, J = 153.1, 3.1 Hz, C3’), 50.6 (CyNH3+), 30.5 (CyNH3+), 
24.5 (CyNH3+), 24.0 (CyNH3+); 31P NMR (121 MHz, D2O) δ ppm 4.6 (overlapping 
dq, J = 7.5, 2.4 Hz, F3CCC(H)P);. HRMS (ESI, negative ion, 20% AcOH matrix): 
required for C4H3O5F3P: 218.9670, found 218.9670. 
 
Potassium 1-cyano-3-ethoxy-3-oxoprop-1-en-2-olate101 
 
 
 
Finely cut potassium metal (2.495 g, 63.8 mmol) was slowly added in small portions 
to a mixture of ethanol (16 mL) and diethyl ether (11.5 mL) under argon, once the 
initially vigorous reaction slowed the mixture was sonicated until all of the metal had 
reacted. The resulting solution of potassium ethoxide was cooled to 0°C under 
nitrogen, and diethyl oxalate (4.3 mL, 31.7 mmol) was added. The heterogeneous 
mixture was stirred for 30 minutes, then acetonitrile (1.7 mL, 32.6 mmol) was added, 
the ice bath was removed and the mixture stirred at room temperature for 1 hour. 
Diethyl ether (15 mL) was added, the solid yellow residue was suspended with 
vigorous stirring and filtered, and the solid washed well with cold diethyl ether. The 
solid was dried under high vacuum overnight to give potassium enolate 3.18 as a 
lemon yellow solid (4.080 g, 72%), which was not further purified. mp: >200°C; 1H 
NMR (500 MHz, d4-methanol) δ ppm 4.34-4.06 (m, 2H, CO2CH2CH3), 3.78-3.65 
(app t, J = 4.2 Hz, 0.5H, H3-enol geometry A), 3.62-3.55 (app t, J = 4.2 Hz, 0.5H, 
H3-enol geometry B), 1.41-1.23 (m, 3H, CO2CH2CH3) 13C NMR (126 MHz, d4-
methanol) δ ppm 169.9 (C1 isomer A), 166.6 (C1 isomer B), 133.7, 122.1, 72.1, 60.7 
(CO2CH2CH3), 13.1 (CO2CH2CH3). 
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Ethyl 3-cyano-2-(diethoxyphosphoryl)acrylate – NMR optimised procedure 
 
 
 
To a stirred mixture of enolate 3.18 (540.1 mg, 3.02 mmol) and acetonitrile (15 mL) 
under argon was added diethyl chlorophosphate (460 µL, 3.17 mmol). The mixture 
was stirred for ten minutes, then poured into diethyl ether (150 mL). The diethyl ether 
solution was washed with 0.6 M aqueous hydrochloric acid (2x 30 mL), then with 1:3 
saturated aqueous sodium bicarbonate solution:water (4x 50 mL) and brine (50 mL). 
The organic phase was dried and evaporated to give crude unstable enol phosphate 
3.19 (400.8 mg, 48%) as a 60:40 (E):(Z) mixture, containing other phosphoryl species, 
which was not purified further but used in the same day for the next step. Key data: 
1H NMR (400 MHz, CDCl3) δ ppm 6.07 (d, J = 1.6 Hz, 0.6H, E-H3), 6.00 (d, J = 2.0 
Hz, 0.4H, Z-H3), 4.02 (app p, J = 7.2 Hz, 4H, OPOCH2CH3), 13C NMR (101 MHz, 
CDCl3) δ ppm 159.7 (C1), 152.4 (C1), 113.2 (Z-C3CN), 112.7 (d, J = 2.6 Hz,  E-
C3CN), 95.6 (d, J = 7.0 Hz, C3), 94.5 (d, J = 4.4 Hz, C3), 16.0 (app t, J = 6.8 Hz, 
POCH2CH3), 13.9 (CO2CH2CH3), 13.9 (CO2CH2CH3); 31P NMR (162 MHz, CDCl3) δ 
ppm -7.9 (Z-C2OP), -8.3 (E-C2OP). 
 
Cyclohexylammonium (E)-3-(cyano)phosphoenolpyruvate 
 
 
 
To a solution of ester 3.19 (400.8 mg, 1.45 mmol) in dichloromethane (14 mL) under 
nitrogen was added trimethylsilyl bromide (1.4 mL, 10.6 mmol), and the mixture was 
stirred overnight. The mixture was evaporated, and 10% w/v potassium hydroxide (6 
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mL) was added, and the mixture was sat for 5 minutes. The mixture was extracted 
with dichloromethane (3 x 10 mL), and the organic phases discarded. The aqueous 
phase was passed through a short column of Dowex-50X8 H+-form (10 x 60 mm), and 
eluted with water (20 mL). The filtrate was neutralised with cyclohexylamine, and 
lyophilised. Recrystallisation of the tan powder from methanol/diethyl ether gave a 
white solid identified as cyanophosphoenolpyruvate cyclohexylammonium salt 3.17 
(84.8 mg, 6%), by comparison with known spectral data101. 1H NMR (400 MHz, D2O) 
δ ppm 5.52 (d, J = 1.8 Hz, E-H3), 3.05-2.91 (m, CyNH3+), 1.93-1.72 (m, CyNH3+), 
1.74-1.54 (m, CyNH3+), 1.48 (dm, J = 12.7 Hz, CyNH3+), 1.28-1.07 (m, CyNH3+), 
1.08-0.93 (m, CyNH3+).  
 
Ethyl 3-bromo-2-hydroxypropanoate104 
 
 
 
A solution of technical grade ethyl bromopyruvate (≥70%, 3.25 mL, 18.1 mmol) in 
methanol (12 mL) was slowly transferred by cannula into a solution of sodium 
cyanoborohydride (1.779 g, 28.3 mmol) in methanol (16 mL) under argon at 0°C, the 
bromopyruvate flask was washed with further methanol (4 mL), and the washings 
transferred by cannula into the cyanoborohydride flask. A catalytic quantity of 
bromocresol green was added, and the blue solution was treated with an ethereal 
solution of hydrogen chloride dropwise until solution was yellow. The mixture was 
stirred for 3 hours, then evaporated. The residue was partitioned between saturated 
ammonium chloride solution (25 mL) and diethyl ether (25 mL), the aqueous phase 
was separated and extracted with diethyl ether (5x 30 mL). The combined organic 
extracts were washed with brine (20 mL), dried and evaporated. The yellow oily 
residue was mixed with diethyl ether (20 mL), and cooled to -78°C under nitrogen for 
2.5 hours. The resulting white crystalline bromolactate 3.21 (1.1468 g) was collected 
by filtration. The mother liquor was evaporated, the semi-solid residue dissolved in a 
minimum quantity of diethyl ether, and allowed to crystallise at -80°C overnight to 
give a second crop of bromolactate 3.21 (1.187 g), giving a total yield of bromolactate 
3.21 of 2.338 g (46%). mp: 39-44°C; Rf (80% ethyl acetate/hexane): 0.12; 1H NMR 
Chapter Six: Experimental   208 
 
(500 MHz, CDCl3) δ ppm 4.50 (t, J = 3.4 Hz, 1H), 4.38-4.23 (m, 2H, CO2CH2CH3), 
3.70 (dq, J = 10.7, 3.5 Hz, 2H, CHCH2Br), 2.96 (br s, 1H, C3OH), 1.33 (t, J = 7.1 
Hz, 3H, CO2CH2CH3), 13C NMR (75 MHz, CDCl3) δ ppm 171.8 (C1), 70.0 (C2), 62.8 
(CO2CH2CH3), 35.4 (C3), 14.5 (CO2CH2CH3); HRMS, Required for C5H10O3Br: 
196.9813, Found: 196.9805. 
 
Pyridinium ethyl 3-bromo-2-(sulfo)propanoate104 
 
 
 
To a solution of technical grade pyridine-sulfur trioxide complex (49-50% as SO3, 
297 mg, 1.84 mmol as SO3) in tetrahydrofuran (3 mL) under argon was added 
bromolactate 3.21 (336.6 mg, 1.71 mmol) in tetrahydrofuran (2 mL). The mixture was 
stirred overnight, and then the tetrahydrofuran carefully evaporated on a rotary 
evaporator (bath ≤30°C) until the first signs evaporation had ceased. The semi-solid 
residue was diluted with chloroform, and sat at -20°C for 2 hours. The resulting 
precipitate of excess pyridine-sulfur trioxide complex was separated by 
centrifugation, and the supernatant carefully evaporated to give unstable pyridinium 
sulfate 3.22 (489 mg, 80%), as a pale yellow syrup, containing <15% unsulfated 
starting material by NMR. 1H NMR (500 MHz, CDCl3) δ ppm 10.80 (br s, PyH+), 
9.06 (br s, 2H, Py-H2), 8.58-8.44 (m, 1H, Py-H4), 8.07 (m, 2H, Py-H3), 5.24 (t, J = 
4.0 Hz, 1H, H2), 4.37-4.10 (m, 2H, CO2CH2CH3), 3.89 (dd, J = 10.8, 4.3 Hz, 1H, 
H3a), 3.79 (dd, J = 10.8, 3.7 Hz, 1H, H3b), 1.28 (t, J = 7.1 Hz, 3H, CO2CH2CH3). 13C 
NMR (75 MHz, CDCl3) δ ppm 169.0 (C1), 146.5 (br, Py-C4), 142.7 (br, 2xPy-C2), 
127.7 (br, 2xPy-C3), , 74.5 (C2), 62.3 (CO2CH2CH3), 32.5 (C3), 14.4 (CO2CH2CH3); 
HRMS (electrospray, negative ion) required for C5H8O6SBr-: 274.9225, found 
274.9232. 
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Potassium sulfoenolpyruvate104 
 
 
 
A mixture of pyridinium sulfate 3.22 (461.3 mg, 1.30 mmol) and water (420 µL) was 
stirred vigorously while 1M aqueous potassium hydroxide was added in portions (10 
portions, 420 µL per portion, added at accurately timed 2 minute intervals). Once all 
of the potassium hydroxide had been added, the yellow solution was stirred for 1 
hour. The reaction was worked up at 4°C due to the poor stability of SEP 3.20 to 
acidic conditions. The yellow solution was loaded onto a short column (10 x 80 mm) 
of Dowex-50X4 H+-form, and the column was quickly eluted with water into an ice-
cooled flask until an elutate pH of ~6 (approximately 25-30 mL). The combined 
elutate was neutralised with saturated aqueous barium hydroxide, lyophilised, and the 
pale yellow solid collected. The crude solid was mixed with water (25 mL), and 
filtered through a 0.2 µm membrane filter and the filtrate diluted with absolute ethanol 
(220 mL) and sat at 4°C overnight. The majority of the mother liquor was discarded, 
and the precipitated solid was suspended in ~60 mL of mother liquor and the solid 
collected by centrifugation (8000x g, 3 minutes, 4°C). The supernatant was discarded, 
and the solid resuspended in absolute ethanol (10 mL) and again the solid was 
collected by centrifugation and the supernatant discarded. The ethanol 
suspension/centrifugation process was repeated twice more, and the collected fine 
solid was dried under high vacuum for one hour. Analysis of the solid by FTIR 
(diffuse reflectance, KBr solid suspension) indicated it was the barium salt of SEP 
(1377, 1288, 1263 cm-1 sulfate S=O asymmetric, symmetric and symmetric stretches; 
1585, 1421 cm-1 carboxylate symmetric and asymmetric stretches; 1211, 1640(d) cm-1 
enol C-O and C=C stretches). The barium salt of SEP was dissolved in the minimum 
volume of water (~12 mL), and loaded onto a column  of Dowex-50X4 K+-form (14 x 
90 mm), and the column eluted with water (35 mL). The combined elutates were 
lyophilised to give potassium sulfoenolpyruvate 3.20 as a fine white powder (126.5 
mg, 40%). 1H NMR (300 MHz, D2O) δ ppm 5.65 (d, J = 2.0 Hz, 1H, H3Z), 5.40 (d, J 
= 2.0 Hz, 1H, H3E); 13C NMR (75 MHz, D2O) δ ppm 169.3 (C1), 149.3 (C2), 107.6 
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(C3); HRMS (electrospray, negative ion): required for C3H3O6S-: 166.9650; found 
166.9649. 
 
2-Aminothiazole-4-carboxylic acid 
 
CO2H
Br
O
N
S
H2N
CO2H
H2N NH2
S
EtOH, NaOAc
(72%)
3.24
 
 
To a stirred solution of bromopyruvic acid (503.6 mg, 3.02 mmol) in absolute ethanol 
(20 mL) was added thiourea (233.2 mg, 3.06 mmol), and the solution was stirred 
vigorously for 30 minutes. The ethanol was evaporated, and the residue suspended in 
water (10 mL). Solid sodium acetate was added until a pH of 5 was reached, and the 
suspension was cooled to 4°C for twenty minutes. The precipitated solid was 
collected and dried to give thiazole 3.24 as a white solid (316 mg, 72%). 1H NMR 
(300 MHz, d6-DMSO) δ ppm 7.48 (s, 1H, H3), 7.28 (br s, 2H, CNH2); 13C NMR (75 
MHz, d6-DMSO) δ ppm 168.9 (C1), 163.2 (C4), 143.7 (C2), 117.4 (C3), FTIR 
(diffuse reflectance, KBr solid suspension) cm-1: 3530, 3279, 2800, 1844, 1652, 1599, 
1570. 
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6.4 Experimental for Chapter Four 
 
Diethyl hex-5-enyl phosphate 
 
 
 
To a stirred solution of hex-5-en-1-ol (0.36 mL, 3.02 mmol) in dichloromethane (15 
mL) under nitrogen was added DMAP (73.1 mg, 0.598 mmol) and 
diisopropylethylamine (1.04 mL, 5.97 mmol); followed by diethyl chlorophosphate 
(0.65 mL, 4.50 mmol). After stirring overnight, additional dichloromethane (15 mL) 
and saturated aqueous sodium bicarbonate solution (15 mL) were added, and the 
mixture stirred vigorously for twenty minutes. The organic phase was separated, and 
washed sequentially with equal volumes of 1.2M HCl solution and brine, dried and 
evaporated. Flash chromatography (40% ethyl acetate/hexane) afforded 4.5 as a 
colourless oil (619.4 mg, 87%). Rf (40% ethyl acetate/hexane): 0.25; 1H NMR (500 
MHz, CDCl3) δ ppm; 5.76 (tdd, J = 16.9, 10.2, 6.7, Hz, 1H, H2), 4.98 (ddd, J = 17.1, 
3.1, 1.6 Hz, 1H, H1E), 4.93 (tdd, J = 10.2, 2.1, 1.1 Hz, 1H, H1Z), 4.08 (app qd, J = 
9.0, 7.4 Hz, 6H, H6 & POCH2CH3), 2.06 (ddt, J = 14.3, 7.3, 1.2 Hz, 2H, H3), 1.67 
(app td, J = 14.9, 6.7 Hz, 2H, H5), 1.46 (app p, J = 7.7 Hz, 2H, H4), 1.31 (dt, J = 7.1, 
0.9 Hz, 6H, POCH2CH3), 13C NMR (75 MHz, CDCl3) δ ppm 138.2 (C2), 114.8 (C1), 
67.3 (d, J = 6.0 Hz, POC6), 63.6 (d, J = 5.7 Hz, POCH2CH3), 33.1 (C3), 29.6 (d, J = 
6.9 Hz, POC6C5), 24.6 (C4), 16.1 (d, J = 6.7 Hz, POCH2CH3); 31P NMR (121 MHz, 
CDCl3, 1H decoupled) δ ppm -0.3 (OPOCH2CH3); HRMS, required for C10H22O4P 
237.1256, found 237.1245. 
 
Methyl 7-(diethoxyphosphoryloxy)hept-2-enoate 
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To a solution of alkene 4.5 (235.6 mg, 0.997 mmol) and methyl acrylate (180 µL, 2.00 
mmol) in dichloromethane (5 mL) was added Grubbs second generation catalyst (42.3 
mg, 50 µmol, 5 mol%). The mixture was deoxygenated by purging three cycles of 
vacuum/argon, then refluxed overnight under argon. After 20 hours, the reaction was 
cooled, DMSO (180 µL, ~50 catalyst equivalents) was added and stirring continued at 
room temperature overnight. Evaporation and flash chromatography (60% ethyl 
acetate/hexane), followed by the addition of further dichloromethane (5 mL) and 
DMSO (180 µL), stirring overnight and a second round of flash chromatography 
(50% ethyl acetate/hexane) gave acrylate 4.6 as a pale yellow oil (268 mg, 91%). Rf 
(60% ethyl acetate/hexane): 0.26; 1H NMR (500 MHz, CDCl3) δ ppm 6.91-6.85 (m, 
1H, H3), 5.77 (app ddd, J = 15.7, 2.5, 1.3 Hz, 1H, H2), 4.08-4.00 (m, 4H, 
POCH2CH3), 3.98 (dt, J = 10.5, 6.5 Hz, 2H, H7), 3.66 (app dd, J = 3.2, 1.1 Hz, 3H, 
CO2Me), 2.23-2.14 (m, 2H, H4), 1.68-1.61 (m, 2H, H6), 1.56-1.46 (m, 2H, H5), 1.27 
(td, J = 7.0, 4.0 Hz, 6H, POCH2CH3); 13C NMR (126 MHz, CDCl3) δ ppm 167.1 
(C1), 148.9 (C3), 121.5 (C2), 67.3 (d, J = 5.9 Hz, C7), 64.0 (d, J = 5.9 Hz, 
POCH2CH3), 51.6 (CO2Me), 31.7 (C4), 29.8 (d, J = 7.0 Hz, C6), 24.1 (C5), 16.3 (d, J 
= 6.6 Hz, POCH2CH3); 31P NMR (121 MHz, CDCl3, 1H-coupled) δ ppm -0.4 (sept, J 
= 7.6 Hz, C7OP); HRMS, Required for C12H24O6P: 295.1311, Found: 295.1297. 
 
7-(Phospho)hept-2-enoate, potassium salt 
 
 
 
To a solution of ester 4.6 (134 mg, 0.455 mmol) in dichloromethane (3.5 mL) under 
nitrogen was added trimethylsilyl bromide (360 µL, 2.73 mmol) dropwise, the 
mixture was then stirred overnight. The reaction was quenched with methanol (1 mL) 
and evaporated. The residue was dissolved in 10% w/v aqueous potassium hydroxide 
(4 mL), and stirred vigorously for three hours. After three hours the aqueous phase 
was extracted with dichloromethane (3x 3 mL), and the organic phases discarded. The 
aqueous phase was passed through a short column of Dowex-50X8 (H+-form, 10 x 50 
mm), the filtrate was collected and the column washed with water (15 mL). The 
combined aqueous extracts were lyophilised, and separated by preparative anion-
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exchange chromatography, (SourceQ® resin, 4°C, 0 to 1M ammonium bicarbonate 
gradient elution, product elutes at 180 mM ammonium bicarbonate). The product 
fractions were lyophilised, redissolved in water (1 mL), passed through a short 
column of Dowex-50X8 (H+-form, to quench any residual ammonium bicarbonate) 
then thorough a column of Dowex-50X8 (K+-form). The filtrate was lyophilised to 
give phosphate 4.2 as an off-white powder (14.4 mg, 9%), containing <20% residual 
ethyl groups (NMR). 1H NMR (500 MHz, D2O, presat) δ ppm 6.49 (td, J = 14.2, 6.9 
Hz, 1H, H3), 5.68 (d, J = 15.7 Hz, 1H, H2), 3.60 (app dd, J = 12.5, 6.6 Hz, 2H, H7), 
2.05 (dd, J = 13.7, 7.0 Hz, H4), 1.46 (app sext, J = 7.1 Hz 2H, H6), 1.35 (app p, J = 
7.4 Hz , 2H, H5); 13C NMR (126 MHz, D2O, HSQC-DEPT135) δ ppm 145.7 (C2), 
126.1 (C3), 64.3 (C7), 31.2 (C4) , 29.9 (C6), 24.3 (C5), 31P NMR (121 MHz, D2O, 
1H-decoupled): 4.2 (br s, C7OP). 
 
Hex-5-enyl 2-(bromomethyl)acrylate 
 
 
 
To a stirred solution of acid (1.6484 g, 9.99 mmol) in diethyl ether (15 mL) at 0°C 
under nitrogen was added distilled diethylazodicarboxylate (1.58 mL, 10.0 mmol). In 
another flask, a solution of hex-5-enyl alcohol (1.08 mL, 8.99 mmol) and 
triphenylphosphine (2.624 g, 10.0 mmol) in diethyl ether (10 mL) was prepared, the 
solution was transferred to a dropping funnel and added dropwise to the vigorously 
stirred acid/DEAD solution. The funnel was washed with further diethyl ether (5 mL), 
the washings were also added dropwise to the acid flask. The resulting mixture was 
stirred vigorously overnight; the ice bath was allowed to melt during this time. The 
suspension was filtered through a short plug of silica (1 x 5 cm), the precipitate 
washed well with diethyl ether (2x 20 mL), and the combined filtrates evaporated. 
Pentane (50 mL) was added to the residue, the precipitated triphenylphosphine oxide 
was removed by filtration, and the filtrate evaporated and purified by flash 
chromatography (5% diethyl ether/hexane) to afford ester 4.9 as a colourless oil 
(1.3345 g, 60%). Rf (5% diethyl ether/hexane): 0.36; 1H NMR (500 MHz, CDCl3) δ 
ppm 6.32 (d, J = 0.7 Hz, 1H, H3’E), 5.94 (d, J = 0.8 Hz, 1H, H3’Z), 5.80 (tdd, J = 
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16.9, 10.2, 6.7, Hz, 1H, H5), 5.02 (ddd, J = 17.1, 3.4, 1.6 Hz, 1H, H6Z), 4.97 (tdd, J 
= 10.2, 2.0, 1.1, Hz, 1H, H6E), 4.22 (t, J = 6.6 Hz, 2H, H1), 4.18 (d, J = 0.8 Hz, 2H, 
CH2Br), 2.10 (dd, J = 14.3, 7.2 Hz, 1H, H4), 1.72 (td, J = 14.8, 6.7 Hz, 2H, H2), 1.50 
(m, 2H, H3); 13C NMR (126 MHz, CDCl3) δ ppm 165.1 (C1’), 138.5 (C2’), 137.8 
(C5), 129.3 (C3’), 115.2 (C6), 65.5 (C1), 33.5 (C4), 29.6 (CH2Br), 28.2 (C2), 25.4, 
(C3). 
 
Allyl 2-(bromomethyl)acrylate 
 
 
 
By a similar method as used for 4.9 but using allyl alcohol (190 µL, 2.79 mmol) gave 
ester 4.20 (332.6 mg, 58%) after flash chromatography (10% diethyl ether/hexane). Rf 
(10% diethyl ether/hexane): 0.39; 1H NMR (500 MHz, CDCl3) δ ppm 6.36 (dd, J = 
1.2, 0.8 Hz, 1H, H3’E), 6.01-5.91 (m, 2H, H3’Z, H2), 5.37 (dm, J = 17.2 Hz, 1H, 
H3E), 5.27 (dtd, J = 10.4, 2.3, 1.2 Hz, 1H, H3Z), 4.71 (dm, J = 5.6 Hz, 2H, H1), 4.19 
(dd, J = 1.7, 0.8 Hz, 2H, H3’’); 13C NMR (75 MHz, CDCl3) δ ppm 164.7 (C1), 137.6 
(C2’), 132.0 (C2), 129.6 (C3’), 118.7 (C3), 66.1 (C1), 29.5 (C3’’). 
 
Acetoxyhept-5-enyl 2-(bromomethyl)acrylate 
 
 
 
To a solution of diene 4.9 (123.5 mg, 0.500 mmol) in dichloromethane (1 mL) was 
added diacetoxy-(Z)-butene (115 µL, 0.721 mmol). The resulting olefin solution was 
added via syringe to a solution of Grubbs second generation catalyst (11.7 mg, 13.8 
µmol, 2.8 mol %) in dichloromethane (1 mL) under argon, and the syringe washed 
with further dichloromethane (0.5 mL). The combined solutions were degassed (3x 
cycles of vacuum/ argon), and refluxed overnight under argon. After 23 hours heating 
Chapter Six: Experimental   215 
 
ceased, the reaction was quenched with DMSO (100 µL) and stirred overnight. Flash 
chromatography (10% diethyl ether/hexane) gave hindered diene 4.19 (99.4 mg, 
66%), as an unseparated 93:7 E:Z mixture of isomers.. Rf (10% diethyl ether/hexane): 
0.49; 1H NMR (500 MHz, CDCl3) δ ppm 6.30 (s, 1H, H3’E), 5.92 (s, 1H, H3’Z), 5.73 
(tdd, J = 15.4, 7.4, 0.7 Hz, 1H, H5), 5.56 (tdd, 15.4, 6.5, 0.9 Hz, 1H, H6), 4.48 (d, J = 
6.4 Hz, 2H, H7), 4.19 (t, J = 6.5 Hz, 2H, H1), 4.15 (s, 2H, CH2Br), 2.09 (app q, J = 
7.2, 7.1 Hz, 2H, H4), 2.03 (s, 3H, C(O)CH3), 1.68 (dq, J = 10.3 Hz, 6.73 Hz, 2H, H2), 
1.49 (app quintet, J = 7.6 Hz, 2H, H3), distinct Z isomer signals: 6.35 (s, 0.08H, Z- 
H3’Z), 5.95 (s, 0.08H, Z- H3’E), 4.59 (d, J = 6.7 Hz, 0.16H, Z-H7), 4.26 (s, 0.16H, Z-
CH2Br); 13C NMR (126 MHz, CDCl3) δ ppm 171.1 (OC(O)CH3), 165.1 (C1’), 137.8 
(C2’), 135.8 (C5), 129.3 (C3’), 124.7, (C6) 65.4 (C7 and C1), 32.0 (C4), 29.6 
(CH2Br), 28.3 (C3), 25.5 (C2), 21.3 (C(O)CH3). HRMS; required for C13H20O4Br 
319.0545, found 319.0537. 
 
Summary of unsuccessful RCM reactions* 
 
Diene [diene] Catalyst Notes 
4.20 20 mM GII  
4.19 0.67 mM GII  
4.19 0.67 mM GII + 10 mol% Ti(OiPr)4  
4.20 5 mM GII + 10 mol% Ti(OiPr)4 
4.20 6 mM GPF  
4.19 3 mM GII + 10 mol% Ti(OiPr)4, diene slow addition (10 hrs) 
4.20 2 mM GI Diene, catalyst slow addition (8 hrs)  
4.9 7 mM GII Toluene, 80°C 
4.9 46 mM HGI  
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4.9 111 µM GII Toluene, reflux 
4.9 2 mM GII Diene, catalyst slow addition 
4.9 20 mM GII + 25 mol% Ti(OiPr)4 
4.9 5 mM GII  
4.9 23 mM GII  
4.9 19 mM GII 2x 10 min microwave heating, 2x 2 mol% catalyst  
4.9 2 mM GI + 15 mol% Ti(OiPr)4, diene slow addition 
4.9 2.6 mM HGII  
* Standard parameters: refluxed all reactants with conventional heating, overnight in 
dichloromethane under argon. Deviations from these parameters are noted. 
 
Key data for Metathesis Byproducts 
 
 
 
oil; Rf (20% diethyl ether/hexane): 0.40; 1H NMR (500 MHz, CDCl3) δ ppm major E 
isomer: 6.31 (s, 0.9H, H3’E), 5.92 (s, 0.9H, H3’Z), 5.39 (ddd, J = 5.2, 3.7, 1.4 Hz, 
0.9H, E-H5), 4.19 (m, 2H, both isomers H1), 4.16 (s, H3’’), 2.01 (m, 2H, both 
isomers H4), 1.68 (app td, J = 14.7, 6.7 Hz, 2H, both isomers H2); 1.48-1.40 (m, 2H, 
H3) distinct (Z)-isomer signals: 6.36 (s, 0.1H, H3’E), 5.95 (s, 0.1H, H3’Z), 5.36 (t, J 
= 4.6 Hz, 0.1H, Z-H5), 4.27 (s, 0.2H, H3’’); 13C NMR (126 MHz, CDCl3): 130.4 
(C5), 129.2 (C3’), 65.6 (C1), 32.0 (C4), 29.8 (C3’’), 28.1 (C4), 25.9 (C3); HRMS, 
required for C18H27O4Br2 465.0276, found 465.0254. 
 
 
 
white solid, mp: 60-62°C; Rf (20% diethyl ether/hexane): 0.24; 1H NMR (500 MHz, 
CDCl3) δ ppm major E isomer: 6.35 (s, 1H, H3’E), 5.98 (s, 1H, H3’Z), 5.97-5.93 (m, 
1H, H2), 4.74 (dd, J = 2.8, 1.3 Hz, 1H, H3’’), 4.19 (d, J = 0.4 Hz, 1H, H1); distinct 
(Z)-isomer signals: 6.42 (s, 0.1H), 6.01 (s, 0.1H), 5.89-5.83 (m, 0.1H), 4.85 (dd, J = 
4.0, 1.0 Hz, 0.2H), 4.29 (d, J = 0.7 Hz, 0.2H); 13C NMR (75 MHz, CDCl3) δ ppm 
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164.7 (C1’), 137.5 (C2’), 129.8 (C3’), 128.1 (C2), 64.8 (C1), 29.5 (C3’’). HRMS 
(electrospray, Cs+ matrix) required for C12H14O4CsBr2: 512.8313, found 512.8326 
(M-Cs+). 
 
5-(Tert-butyldimethylsilyloxy)pentan-1-ol 
 
 
 
To a solution of imidazole (2.862g, 42.0 mmol) in dichloromethane (200 mL) was 
added pentane-1,5-diol (6.3 mL, 60.0 mmol); The suspension was stirred vigorously 
at 0°C under nitrogen as a solution of tert-butyldimethylsilyl chloride (3.018 g, 20.0 
mmol) in dichloromethane (50 mL) was added dripwise over approximately one hour. 
The resulting solution was stirred vigorously overnight, the ice bath being allowed to 
thaw over this time. Water (150 mL) was added, and the organic phase was separated 
and washed with further water (2x 150 mL), saturated ammonium chloride solution 
(150 mL), and brine (150 mL); the solution was dried and evaporated. Flash 
chromatography (40% ethyl acetate/hexane) gave monoprotected diol 4.23 as a 
colourless oil (3.4345g, 79%) with spectral data in accordance with the literature196. Rf 
(20% ethyl acetate/hexane): 0.29; 1H NMR (500 MHz, CDCl3) δ ppm 3.57 (app t, 4H, 
J = 6.6 Hz, H1&H5), 1.51 (m, H2&H4), 1.36 (m, 2H, H3), 0.84 (d, 9H, J = 1.3 Hz, 
Me3CSi), 0.00 (d, 6H, J = 1.3 Hz, Me2Si),; 13C NMR (75 MHz, CDCl3) δ ppm 63.1 
(C1), 62.5 (C5), 32.4 (C2), 32.3 (C4), 25.9 (Me3CSi), 21.9 (C3), 18.3 (Me3CSi). 
 
5-(Tert-butyldimethylsilyloxy)pentanal via IBX oxidation 
 
 
 
To a vigorously stirred solution of alcohol 4.23 (3.4345 g, 15.73 mmol) in 
tetrahydrofuran (66 mL) and dimethylsulfoxide (10 mL, 140. 7 mmol) was added 2-
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iodoxybenzoic acid (6.627 g, 23.6 mmol), and the mixture was stirred overnight. The 
mixture was filtered through celite, evaporated and the residue diluted with diethyl 
ether (250 mL). The liquid was decanted from the precipitate, and washed with water 
(2x 200 mL) and brine (200 mL), dried and evaporated. The residue was loaded onto a 
short plug of silica and eluted with 10% ethyl acetate/hexane. Evaporation of product 
fractions gave aldehyde 4.24 as a pale yellow oil (2.554g, 75%) with spectral data in 
accordance with the literature197. Rf (20% ethyl acetate/hexane): 0.71; 1H NMR (500 
MHz, CDCl3) δ ppm 9.74 (t, J = 1.76 Hz, 1H, H1), 3.60 (t, J = 6.21 Hz, 2H, H5), 
2.43 (dt, J = 7.35, 1.76 Hz, 2H, H2), 1.72-1.63 (m, 2H, H3), 1.57-1.49 (m, 2H, H4), 
0.86 (s, 9H, Me3CSi), 0.02 (s, 6H, Me2Si); 13C NMR (75 MHz, CDCl3): 202.5 (C1), 
62.5 (C5), 43.6 (C2), 32.0 (C4), 25.9 (Me3CSi), 18.6 (C3), 18.3 (Me3CSi). 
 
Ethyl 2-(hydroxy(phenyl)methyl)acrylate146 
 
 
 
A vigorously stirred suspension of N-methylmorpholine N-oxide (234.7 mg, 2.00 
mmol) in tetrahydrofuran (3.8 mL) under nitrogen was cooled to 0°C, and 
diisobutylaluminium hydride (20 wt% in toluene, 1.25 mL, 1.5 mmol) was added 
dropwise. The suspension became a solution on DIBAL addition, and a small amount 
of effervescence was observed. After 45 minutes, ethyl propiolate 4.28 (102 µL, 1.01 
mmol) was added, and stirring continued for one hour. To the resulting solution of 
vinyl alane was added benzaldehyde (120 µL, 1.18 mmol), the ice bath was removed 
and the mixture stirred for five hours at room temperature. The mixture was cooled to 
0°C, and saturated aqueous citric acid (5 mL) was added dropwise with vigorous 
stirring, after five minutes ethyl acetate (10 mL) was added. The organic phase was 
separated, and the aqueous phase was extracted with further ethyl acetate (2x 10 mL). 
The combined organic phases were washed with saturated aqueous sodium 
bicarbonate solution (10 mL) and brine (10 mL), dried and evaporated. Flash 
chromatography (10% ethyl acetate/hexane) gave recovered benzaldehyde (39 mg) 
and the desired acrylate (52.8 mg, 25%); with spectral data in accordance with that 
published. 
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5-(Tert-butyldiphenylsilyloxy)pentan-1-ol 
 
 
 
By the same method as for 4.23; using tert-butyldiphenylsilyl chloride (2.60 mL, 10.1 
mmol) gave the corresponding mono-TBDPS protected alcohol 4.29 (3.126 g, 90%) 
after flash chromatography (20% ethyl acetate/hexane) with spectral data in 
accordance with the literature198. Rf (20% ethyl acetate/hexane): 0.36; 1H NMR (500 
MHz, CDCl3) δ ppm 7.68 (m, 4H, o-SiArH), 7.46-7.34 (m, m,p-SiArH), 3.69 (dt, J = 
6.29, 0.82 Hz, 2H, H5), 3.62 (dt, J = 6.52, 1.40 Hz, 2H, H1), 1.66-1.51 (m, 6H, H2, 
H3, H4), 1.07 (t, J = 1.12 Hz, 9H, Me3CSi); 13C NMR (126 MHz, CDCl3) δ ppm 
135.8 (ArSi), 134.3 (ArSi), 129.8 (ArSi), 127.9 (ArSi), 64.1 (C5), 63.2(C1), 32.7 
(C4), 32.5 (C2), 27.1 (Me3CSi), 22.3 (C3), 19.5 (Me3CSi); HRMS: Required for 
C21H31O2Si: 343.2093, Found: 343.2080. 
 
5-(Tert-butyldiphenylsilyloxy)pentanal 
 
 
 
By the same method as for 4.24; using TBDPS-alcohol 4.29 (1.3721 g, 4.01 mmol) 
after flash chromatography (10% ethyl acetate/hexane) gave aldehyde 4.30 (850.7 mg, 
62%) with spectral data in accordance with the literature199. Rf (20% ethyl 
acetate/hexane): 0.73; 1H NMR (500 MHz, CDCl3) δ ppm 9.76 (t, J = 1.76 Hz, 1H, 
H1), 7.71-7.65 (m, 4H, o-SiArH), 7.46-7.37 (m, 6H, m,p-SiArH), 3.69 (t, J = 6.17 Hz, 
2H, H5), 2.42 (dt, J = 7.36, 1.76 Hz, 2H, H2), 1.80-1.70 (m, 2H, H3), 1.65-1.57 (m, 
2H, H4), 1.07 (s, 9H, Me3CSi); 13C NMR (126 MHz, CDCl3) δ ppm 202.9 (C1), 135.8 
(ArSi), 134.1 (ArSi), 129.8 (ArSi), 127.9 (ArSi), 63.5 (C5), 43.8 (C2), 32.1 (C4), 
27.1(Me3CSi), 19.4 (Me3CSi), 18.8 (C3); HRMS: Required for C21H29O2Si: 341.1937, 
Found: 341.1936. 
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Ethyl 7-(tert-butyldiphenylsilyloxy)-3-hydroxy-2-methyleneheptanoate 
 
(iBu)2Al CO2Et
TBDPSOTBDPSO O
OH
CO2Et
NMO, BF3•OEt2, THF, RT
(12%)4.30 4.31
 
 
A solution of vinyl alane was prepared from ethyl propiolate 4.28 as described above 
for ethyl 2-(hydroxy(phenyl)methyl)acrylate. Aldehyde 4.30 (416.2 mg, 1.22 mmol) 
followed by boron trifluoride - diethyl ether complex  (150 µL, 1.22 mmol) were 
added dropwise at 0ºC, then the pale yellow mixture was stirred at room temperature 
for four hours, before quenching and workup as above for ethyl 2-
(hydroxy(phenyl)methyl)acrylate. Flash chromatography (15% ethyl acetate/hexane) 
gave aliphatic acrylate 4.31 (52.9 mg, 12%), contaminated with a small amount of 
aldehyde 4.30. Rf (20% ethyl acetate/hexane): 0.36; 1H NMR (500 MHz, CDCl3) δ 
ppm 7.75-7.64 (m, 4H, SiArH), 7.46-7.36 (m, 6H, SiArH), 6.24 (d, J = 1.07 Hz, 1H, 
H3’E), 5.79 (t, J = 1.07, Hz, 1H, H3’Z), 4.41 (dd, J = 7.14, 5.66 Hz, 1H, H3), 4.25 (q, 
J = 7.14 Hz, 2H, CO2CH2CH3), 3.70 (t, J = 6.35 Hz, 2H, H7 ), 2.96 (br s, 1H, 
C3OH), 1.73-1.59 (m, H4, H6), 1.49-1.42 (m, H5), 1.08 (s, 9H, Me3CSi), 1.32 (t, J = 
7.12, 3H, CO2CH2CH3); 13C NMR (126 MHz, CDCl3) δ ppm 166.9 (C1), 142.9 (C2), 
135.9 (ArSi), 134.3 (ArSi), 129.8 (ArSi) , 127.9 (ArSi), 125.0 (C3’), 72.0 (C3), 64.1 
(C5), 61.1 (CO2CH2CH3), 36.2 (C2), 32.6 (C4) , 27.2 (Me3CSi), 22.4 (C5), 19.5, 
(Me3CSi),  14.4 (CO2CH2CH3). 
 
Methyl 2-bromoacrylate149 
 
 
 
To a stirred solution of methyl acrylate (22.0 mL, 0.244 mol) in chloroform (100 mL) 
was added bromine (12.5 mL, 0.243 mol) dropwise over twenty minutes. After 
stirring for 3 hours the mixture was evaporated, and the residue diluted with diethyl 
ether (150 mL) and pentane (150 mL). The mixture was stirred vigorously as 
triethylamine (35 mL, 0.251 mol) was added dropwise, and after three hours the 
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suspension was filtered, and the precipitate washed with pentane (200 mL). The 
combined filtrates were washed with water (150 mL), dried and evaporated. The 
residue was vacuum distilled (65-75°C/ 48 mmHg) to give methyl 2-bromoacrylate 
(27.301 g, 68%) as a colourless oil. 1H NMR (500 MHz, CDCl3) δ ppm 6.95 (app t, J 
= 1.5 Hz, 1H), 6.26 (app t, J = 1.5 Hz, 1H), 3.82 (d, 3H, J = 1.5 Hz), 13C NMR (126 
MHz, CDCl3) δ ppm 162.7 (CO2Me), 131.1 (C=CH2), 121.2 (CBr), 53.7 (CO2Me). 
 
Methyl 3-(dimethylamino)propanoate 
 
 
 
To a vigorously stirred mixture of 40% aqueous methylamine (7 mL, 55.3 mmol as 
Me2NH) and diethyl ether (20 mL) was added methyl acrylate (4.5 mL, 50.0 mmol) 
dropwise. Once the initial exothermic reaction subsided the mixture was brought to 
reflux. After 3 hours the mixture was cooled, diluted with further diethyl ether (50 
mL) and dried with sodium sulfate. The sodium sulfate was washed with further 
diethyl ether (100 mL), and the combined extracts were evaporated. Kugelrohr 
distillation (70°C/high vacuum) gave methyl 3-(dimethylamino)propanoate 4.33 
(2.258g, 34%). The compound was stored over 4Å molecular sieves at 4°C. 1H NMR 
(500 MHz, d4-MeOH) δ ppm 5.05 (s, 3H, CO2Me), 4.02 (t, J = 7.2 Hz, 2H, 
CH2NMe2), 3.89 (t, J = 7.2 Hz, 2H, CH2CO2Me), 3.62 (s, 6H, Me2N); 13C NMR (126 
MHz, CDCl3) δ ppm 32.9 (CH2CO2Me), 45.4 (Me2N), 51.8 (CO2Me), 54.9 
(CH2NMe2), 173.0 (CO2Me). 
 
5-(Tetrahydro-2H-pyran-2-yloxy)pentan-1-ol 
 
 
 
To a vigorously stirred suspension of 1,5-pentanediol (6.2728 g, 60.2 mmol) in 
dichloromethane (40 mL) was added dihydropyran (1.80 mL, 19.7 mmol) and finely 
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ground bismuth(III) nitrate pentahydrate (484.3 mg, 0.998 mmol, 5 mol%). After 2.5 
hours the mixture was filtered through a plug of 1:1 chromatographic silica:celite, and 
the plug eluted with dichloromethane (50 mL fractions). The fractions containing 
product were combined and evaporated to give THP diethyl ether 4.34 (3.5061 g, 
94%) with spectral data in accordance with the literature200. Rf (40% ethyl 
acetate/hexane): 0.25; 1H NMR (500 MHz, CDCl3) δ ppm 4.54 (dd, J = 4.28, 2.84 Hz, 
1H, H1’), 3.83 (ddd, J = 11.06, 7.67, 3.34 Hz, 1H, H5’a), 3.72 (td, J = 9.65, 6.72, Hz, 
1H, H5a), 3.60 (t, J = 6.58 Hz, 2H, H1), 3.50-3.43 (m, 1H, H5’b), 3.37 (td, J = 9.65, 
6.5 Hz, 1H, H5b), 2.12 (br s, 1H, C1OH), 1.84-1.75 (m, 1H, H3’a), 1.72-1.64 (m, 1H, 
H2’a), 1.64-1.45 (m, 8H, H2, H4, H2’b, H3’b, H4’), 1.45-1.37 (m, 2H, H3); 13C NMR 
(126 MHz, CDCl3) δ ppm 98.8 (C1’), 67.4 (C5), 62.6 (C1), 62.3 (C5’), 32.4 (C2) , 
30.6 (C2’), 29.3 (C4), 25.4 (C4’), 22.4 (C3), 19.6 (C3’a). 
 
5-(Tetrahydro-2H-pyran-2-yloxy)pentanal via buffered Dess-Martin periodinane 
 
NaHCO3, CH2Cl2
(75%)
THPO OTHPO OH
O
I
O
AcO OAc
OAc
4.34 4.35
 
 
To Dess-Martin periodinane (2.757g, 6.5 mmol) in dichloromethane (30 mL) was 
added in small portions sodium bicarbonate solution (845.3 mg, 10.06 mmol) 
followed by alcohol 4.34 (205 mg, 1.09 mmol) in dichloromethane (1 mL). After 4.5 
hours the mixture was poured into diethyl ether (100 mL), filtered through celite, 
washed with saturated aqueous sodium bicarbonate solution (50 mL) and brine (50 
mL), dried and evaporated. Flash chromatography (20% ethyl acetate/hexane) 
afforded aldehyde 4.35 (152.8 mg, 75%) with spectral data in accordance with the 
literature201; Rf (40% ethyl acetate/hexane): 0.67; 1H NMR (500 MHz, CDCl3) δ ppm 
9.75 (t, J = 1.7 Hz, 1H, H1), 4.54 (dd, J = 4.2, 2.7 Hz, 1H, H1’), 3.90-3.78 (m, 1H, 
H5’a), 3.73 (td, J = 9.7, 6.4 Hz, 1H, H5a), 3.51-3.42 (m, 1H, H5’b), 3.37 (td, J = 9.7, 
6.2 Hz, 1H, H5b), 2.46 (dt, J = 7.3, 1.6 Hz, 1H, H2), 1.80-1.43 (m, 10H, H3, H4, H2’, 
H3’ H4’); 13C NMR (126 MHz, CDCl3); 99.1 (C1’), 67.2 (C5), 62.6 (C5’), 43.7 (C2), 
30.9 (C2’), 29.1 (C4), 25.5 (C4’), 19.9 (C3’), 19.3 (C3). 
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5-(Tetrahydro-2H-pyran-2-yloxy)pentanal via Swern oxidation 
 
 
 
A solution of oxalyl chloride (1.95 mL, 22.7 mmol) in dichloromethane (50 mL) was 
cooled to -60°C (dry ice/ chloroform, monitored with a thermocouple) under nitrogen, 
and DMSO (3.2 mL, 45. 1 mmol) in dichloromethane (10 mL) was added dropwise 
from a pressure equalised dropping funnel. Once all of the DMSO solution had been 
added, stirring was continued at -60°C for five minutes, the funnel was charged with 
alcohol 4.34 (3.5061 g, 18.62 mmol) in dichloromethane (19 mL) and the alcohol 
solution was added dropwise to the oxidant solution. Once all of the alcohol had been 
added, the solution was stirred for 30 minutes, then brought to -20°C. Neat 
triethylamine (12.5 mL, 89.7 mmol), was then added dropwise; once addition was 
complete the mixture was stirred for 20 minutes then brought to room temperature. 
Diethyl ether (100 mL) was added, and the solution washed with saturated ammonium 
chloride solution (50 mL), saturated sodium bicarbonate solution (100 mL), and brine 
(100 mL). The solution was dried and evaporated, and flash chromatography (20% 
ethyl acetate/hexane) gave aldehyde 4.35 as a colourless oil (2.334 g, 67%), with 
spectral data as reported above. 
 
Methyl-3-hydroxy-2-methylene-7-(tetrahydro-2H-pyran-2-yloxy)heptanoate  
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A solution of diisopropylamine (980 µL, 7.04 mmol) in tetrahydrofuran (20 mL) was 
cooled to -78°C under nitrogen, and a 1.6M solution of n-butyllithium in hexanes (4.0 
mL, 6.4 mmol) was added dropwise. The mixture was stirred at -78°C for ten minutes, 
then brought to 0°C for thirty minutes, then cooled back to -78°C. A solution of 
aminoester 4.33 (707 mg, 5.39 mmol) in tetrahydrofuran (2 mL) was slowly added, 
and the solution stirred for 15 minutes. To the resulting enolate solution was added a 
solution of aldehyde 4.35 (999.5 mg, 5.37 mmol) in tetrahydrofuran (2 mL), the 
solution was stirred for twenty minutes then quenched with saturated sodium 
carbonate (10 mL) and allowed to come to room temperature. The mixture was 
diluted with water (10 mL), the organic phase separated and the aqueous phase 
extracted with chloroform (2x 25 mL). The organic extracts were dried separately 
over sodium sulfate, and evaporated to give a pale yellow oil (1.165 g). This oil was 
immediately dissolved in diethyl ether (10 mL) and excess methyl iodide (5 mL) was 
added. The mixture was stirred in the dark for 2 hours, and diluted with pentane (30 
mL). The solution was carefully decanted from the resulting sticky residue, and the 
residue was washed in the same flask with further pentane (30 mL). Ethyl acetate (10 
mL) and saturated aqueous sodium bicarbonate solution (10 mL) were added, and the 
heterogeneous mixture stirred vigorously for five hours. The mixture was diluted with 
dichloromethane (50 mL), the aqueous phase was separated and washed with further 
dichloromethane (2x 30 mL). The combined dichloromethane phases were washed 
with brine (30 mL – an emulsion initially formed, which slowly separates over 15-20 
minutes), dried and evaporated. Flash chromatography (30% ethyl acetate/hexane) 
gave acrylate 4.38 (144.7 mg, 10% over three steps). In similar experiments the yields 
were erratic, ranging from 17% on a 0.82 mmol scale to 1.1% on 12.5 mmol scale. Rf 
(33% ethyl acetate/hexane): 0.38; 1H NMR (500 MHz, CDCl3) δ ppm 6.20 (d, J = 
0.88 Hz, 1H, alkene H-E), 5.79 (s, 1H, alkene H-Z), 4.55 (s, 1H, H1’), 4.39 (dd, J = 
7.04, 5.61 Hz, 1H, H3), 4.12-4.06 (m, 2H, CO2CH2CH3), 3.83 (t, J =  9.94 Hz, 1H, 
H5’a), 3.72 (dd, J = 6.79, 2.64 Hz, 1H, H7a), 3.47 (dd, J = 5.82, 5.39 Hz, 1H, H5’b), 
3.37 (td, J = 10.91, 7.32 Hz, 1H, H7b), 2.77 (br s, 1H, C3OH), 1.80 (dd, J = 17.93, 
9.47 Hz, 1H, H3’a), 1.73-1.35 (m, 11H, H4, H5, H6, H2’, H3b’ H4’), 1.23 (m, 3H, 
CO2CH2CH3); 13C NMR (126 MHz, CDCl3) δ ppm 171.4 (C1), 142.8 (C2), 125.189 
(term. alkene C), 99.2 (C1’), 71.7 (C3), 67.7 (C7), 62.6 (C5’), 60.6 (CO2CH2CH3), 
36.3 (C4), 31.0 (C4’), 29.7 (C6), 25.7 (C2’), 21.3 (C5), 19.9 (C3’), 14.4 
(CO2CH2CH3); HRMS; required for C14H25O5 273.1702, found 273.1699. 
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(±)-Ethyl 2-(phenylselanyl)propanoate 
 
 
 
To a solution of diphenyl diselenide (3.747 g, 12.0 mmol) in absolute ethanol (90 mL) 
at 0°C, under a  calcium chloride drying tube as a gas outlet, was added in small 
portions sodium borohydride (1.364 g, 36.1 mmol) over 45 minutes. Once all of the 
borohydride had been added, stirring was continued for a further 30 minutes. To the 
resulting colourless solution of phenylselenylsodium was added a solution of (±)-ethyl 
2-bromopropionate (3.9 mL, 30.0 mmol) in absolute ethanol (20 mL) dropwise over 
15 minutes and the mixture stirred for 1 hour. Water (50 mL) was added, and the 
mixture was concentrated to remove ethanol on a rotary evaporator in a fumehood. To 
the residue was added further water (25 mL) and diethyl ether (100 mL), and the 
mixture was stirred vigorously and filtered through a plug of celite. The organic phase 
was separated, and washed with brine (50 mL), dried over sodium sulfate for one 
hour, filtered and evaporated. The residue was filtered through a silica plug (55 x 55 
mm), and eluted with 100 mL portions of 10% diethyl ether/hexane. Evaporation of 
the fractions containing product gave masked acrylate reagent 4.39 (4.877 g, 79%) as 
a near colourless oil, with spectral data in accordance with the literature.160 Rf (10% 
diethyl ether/hexane): 0.5; 1H NMR (500 MHz, CDCl3) δ ppm 7.61 (m, 2H, m-ArH), 
7.36-7.25 (m, 3H, o, p-ArH), 4.09 (dq, J = 7.12, 1.67 Hz, 2H, CO2CH2CH3), 3.77 (dq, 
J = 7.14, 1.61 Hz, 1H, H2), 1.55 (dd, J = 7.14, 1.68 Hz, 3H, H3), 1.17 (dd, J = 7.12, 
1.61 Hz, 3H, CO2CH2CH3); 13C NMR (126 MHz, CDCl3) δ ppm 173.4 (C1), 135.6 
(m-ArSe C), 128.9 (o-ArSe C), 128.4 (p-ArSe C), 127.8 (i-ArSe C), 60.9 
(CO2CH2CH3), 37.3 (C2), 17.6 (CO2CH2CH3), 13.9 (C3); HRMS, required for 
C11H15O280Se 259.0237, found 259.0247. 
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Ethyl 7-(tert-butyldiphenylsilyloxy)-3-hydroxy-2-methyl- 2- 
(phenylselanyl)heptanoate 
 
 
 
To a stirred solution of diisopropylamine (1.14 mL, 8.42 mmol) in tetrahydrofuran (65 
mL) at -78°C under nitrogen was added dropwise a 1.42M solution of n-butyllithium 
in hexanes (5.5 mL, 7.81 mmol). After 45 minutes, selenyl ester 4.39 (2.337 g, 9.09 
mmol) in tetrahydrofuran (5 mL) was added, and the mixture was stirred for one hour. 
To the resulting enolate solution was added aldehyde 4.30 (2.203 g, 6.47 mmol) in 
tetrahydrofuran (5 mL) dropwise. After 1.5 hours the solution was quenched with 
saturated ammonium chloride solution (50 mL) and the mixture allowed to come to 
room temperature. Enough water was added to dissolve the precipitate, and the 
organic phase was separated. The aqueous phase was extracted with diethyl ether (2x 
50 mL), and the combined organic phases were washed with brine (50 mL) dried and 
evaporated. Flash chromatography (5% ethyl acetate/hexane until excess selenide 4.39 
elutes, then 10% ethyl acetate/hexane) afforded the product as cleanly separated syn-
4.40 (1.098 g, 28%) and anti-4.41(1.690 g, 44%) adducts.  
syn adduct 4.40: Rf (10% ethyl acetate/hexane): 0.46; 1H NMR (500 MHz, CDCl3) δ 
ppm 7.67 (dm, J= 7.0 Hz, 4H, m-HArSi), 7.62 (dm, J = 6.9 Hz, 2H, m-HArSe), 7.46-
7.35 (m, 7H, o,p-HArSi, p-HArSe), 7.35-7.30 (t, J = 7.3 Hz, 2H o-HArSe), 4.15-4.03 
(m, 2H, CO2CH2CH3), 3.91 (dd, J = 9.7, 1.3 Hz, 1H, H3), 3.66 (dt, J = 6.2, 1.2 Hz, 
2H, H7), 2.92 (br s, 1H, C3OH), 1.72-1.52 (m, 4H, H4, H6), 1.44, (m, 2H, H5), 1.41 
(d, J= 1.1 Hz, 3H, H3’), 1.38-1.26 (m, 2H, H3), 1.12 (dt, J = 7.1, 2.0 Hz, 3H, 
CO2CH2CH3), 1.05 (d, J = 1.3 Hz, 9H); 13C NMR (75 MHz, CDCl3): 173.4 (C1), 
138.3 (ArSi), 135.8 (ArSi), 134.3 (ArSe), 129.8 (ArSe), 129.7 (ArSi), 129.2 (ArSe), 
129.1 (ArSe), 127.9 (ArSi), 73.2 (C3), 64.1 (C7), 61.3 (CO2CH2CH3), 57.9 (C2), 32.7 
(C6), 32.0 (C5), 27.2 (Me3CSi), 23.4 (C4), 19.5 (Me3CSi), 17.3 (CO2CH2CH3), 14.1 
(C3’); HRMS required for C32H43O480SeSi: 599.2096, found 599.2121.  
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anti adduct 4.41: Rf (10% ethyl acetate/hexane): 0.26; 1H NMR (500 MHz, CDCl3) δ 
ppm 7.70 (dm, J = 6.4 Hz, 4H m-HArSi), 7.58 (dm, J = 7.6 Hz, 2H, m-HArSe), 7.46-
7.36 (m, 7H, o,p-HArSi, p-HArSe), 7.31 (t, J = 7.6 Hz, 2H, o-HArSe), 4.12 (qt, J = 
7.1, 1.5 Hz, 2H, CO2CH2CH3), 3.87 (dd, J = 10.1 Hz, 1.1 Hz, 1H, H3), 3.70 (dt, J = 
6.0, 1.5 Hz, 2H, H7), 2.79 (br s, 1H, C3OH), 1.89 (m, 1H, H4a), 1.79-1.56 (m, 3H, 
H4b), 1.44, (m, 2H, H5), 1.42 (s, 3H, H3’), 1.22 (dt, J = 7.1, 1.0 Hz, 3H, 
CO2CH2CH3), 1.07 (s, 9H, Me3CSi); 13C NMR (75 MHz, CDCl3): 174.3 (C1), 138.4 
(ArSi), 135.9 (ArSi), 134.3 (ArSe), 129.8 (ArSe), 129.6 (ArSi), 129.0 (ArSe), 127.9 
(ArSi), 127.0 (ArSe), 75.7 (C3), 64.1 (C7), 61.5 (CO2CH2CH3), 55.1 (C2), 32.7 (C6), 
31.6 (C5), 27.2 (Me3CSi), 23.5 (C4), 19.5 (Me3CSi), 18.5 (CO2CH2CH3), 14.3 (C3’); 
HRMS required for C32H43O480SeSi: 599.2096, found 599.2087. 
 
Ethyl 7-(tert-butyldiphenylsilyloxy)-3-hydroxy-2-methyleneheptanoate 
 
 
 
To a solution of anti-selenide 4.41 (1.690 g, 2.83 mmol) in diethyl ether (60 mL) and 
water (15 mL) was added an excess of 50% w/w aqueous hydrogen peroxide (1.5 
mL). The biphasic mixture was stirred vigorously for 2.5 hours, then water (20 mL) 
was added, the organic phase was separated and the aqueous phase was extracted with 
diethyl ether (40 mL). The combined organic phases were washed with brine (50 mL), 
dried and evaporated to give acrylate 4.42 as a pale yellow oil (1.175 g, 94%). Rf 
(20% ethyl acetate/hexane): 0.38; 1H NMR (500 MHz, CDCl3) δ ppm: 7.69 (d, J = 
7.8 Hz, 4H, m-HArSi), 7.45-7.39 (m, 1H, o,p-HArSi), 6.24 (d, J = 0.8 Hz, 1H, H3’E), 
5.78 (app t, J =  0.9 Hz, 1H, H3’Z), 4.40 (t, J = 6.4 Hz, 1H, H3), 4.25 (q, J = 7.1 Hz, 
2H, CO2CH2CH3), 3.69 (t, J = 6.4 Hz, 2H, H7), 2.65 (br s, 1H, C3OH), 1.73-1.50 (m, 
5H, H5, H6, H4a), 1.50-1.38 (m, 1H, H4b), 1.33 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 
1.07 (s, 9H, Me3CSi); 13C NMR (75 MHz, CDCl3): 166.9 (C1), 142.9 (C2), 135.9 
(ArSi), 134.3 (ArSi), 129.8 (ArSi), 128.6 (ArSi), 125.0 (C3’), 72.1 (C3), 64.1 (C7), 
61.1 (CO2CH2CH3), 36.2 (C5), 32.6 (C6), 27.2 (Me3CSi), 22.4 (C4), 19.5 (Me3CSi), 
14.4 (CO2CH2CH3). HRMS, required for C26H37O4Si: 441.2461, found 441.2477. 
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Ethyl 3-acetoxy-7-(tert-butyldiphenylsilyloxy)-2-methyleneheptanoate 
 
 
 
A solution of alcohol 4.42 (1.175 g, 2.67 mmol) in dichloromethane (25 mL) was 
cooled to 0°C under nitrogen, and pyridine (430 µL, 5.34 mmol) and acetyl chloride 
(380 µL, 5.37 mmol) were added. The mixture was stirred for three hours, then 
evaporated. Immediate purification of the residue by flash chromatography gave 
acetate 4.44 as a colourless oil (1.197 g, 93%). Rf (20% ethyl acetate/hexane): 0.45; 
1H NMR (500 MHz, CDCl3) δ ppm 7.66 (dm, J = 6.5 Hz, 4H, ArSi), 7.46-7.35 (m, 
6H, ArSi), 6.28 (d, J = 1.6 Hz, 1H, H3’E), 5.74 (app t, J = 1.1 Hz, 1H, H3’Z), 5.67-
5.60 (app t, J = 3.7 Hz, 1H, H3), 4.23 (qtd, J = 10.7, 7.0, 3.6 Hz, 2H, CO2CH2CH3), 
3.66 (dt, J = 6.2, 2.4 Hz, 2H, H7), 2.07 (d, J = 2.8 Hz, 3H, OAc), 1.82-1.73 (m, 1H, 
H4a) 1.73-1.34 (m, 5H, H4b, H5, H6), 1.30 (dt, J = 7.2, 2.7 Hz, 3H, CO2CH2CH3), 
1.05 (d, J = 2.6 Hz, 9H); 13C NMR (75 MHz, CDCl3) δ ppm 170.2 (OC(O)Me), 165.5 
(C1), 140.7 (C2), 135.8 (ArSi), 134.3 (d, J = 1.2 Hz, iArSi), 129.8 (ArSi), 127.9 
(ArSi), 125.0 (C3’), 72.0 (C3), 63.8 (C7), 61.1 (CO2CH2CH3), 34.3 (C4), 32.4 (C6), 
27.1 (Me3CSi), 21.9 (C5), 21.3 (OC(O)Me), 19.5 (Me3CSi), 14.4 (CO2CH2CH3); 
HRMS, required for C28H39O5Si: 483.2567, found 483.2568. 
 
Ethyl 2-((diethoxyphosphonyl)methylene)-7-(tert-butyldiphenylsilyl)hept-2-
enoate 
 
 
 
A stirred mixture of acetate 4.44 (1.047 g, 2.17 mmol) and excess triethylphosphite (1 
mL, 5.83 mmol) was sealed in a resealable Carius tube, and heated behind a safety 
shield to 80°C. After 3.5 hours, the tube was cooled to room temperature, and 
vigorously stirred under high vacuum overnight. The viscous residue was dissolved in 
a small quantity of ethyl acetate, transferred to a round bottom flask and evaporated. 
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Flash chromatography (60% ethyl acetate/hexane) gave phosphonate 4.45 as a 
colourless oil (1.002 g, 82%), as an unseparated mixture of (Z)- and (E)-isomers (7:3 
by 1H and 31P NMR spectroscopy). Rf (60% ethyl acetate/hexane): 0.31; 1H NMR 
(500 MHz, CDCl3) δ ppm 7.66 (app dd, J = 6.8, 1.1 Hz, 4H, Z&E-ArSi), 7.45-7.34 
(m, 6H, Z&E-ArSi), 6.91 (app q, J = 6.9 Hz, 0.7H, Z-H3), 6.12 (app dd, J = 13.0, 7.0 
Hz, 0.3H, E-H3), 4.22 (m, 2H, Z&E-CO2CH2CH3), 4.07 (app p, J = 7.1 Hz, 4H, 
P(O)OCH2CH3), 3.70-3.62 (m, 2H, Z&E-H7), 2.96 (d, J = 22.1 Hz, 1.5H, Z-CH2P), 
2.88 (d, J = 21.2 Hz, 0.6H, E-CH2P), 2.56-2.47 (app p, J= 6.4. Hz, 0.6H, E-H4), 2.32-
2.21 (dt, J = 12.0, 6.9 Hz, 1.5H, Z-H4), 1.65-1.48 (m, 4H, Z&E-H5, H6), 1.35-1.22 
(m, 9H, P(O)OCH2CH3 & CO2CH2CH3), 1.04 (app dd, J = 2.8, 0.7 Hz, 9H, Me3CSi). 
13C NMR (75 MHz, CDCl3) δ ppm 167.0 (d, J = 2.7 Hz, Z-C1), 166.9 (d, J = 2.5 Hz, 
E-C1), 147.1 (d, J = 10.6 Hz, E-C3), 146.1 (d, J = 10.3 Hz, Z-C3), 135.8 (Z,E ArSi), 
134.2 (Z,E ArSi), 129.8 (Z,E ArSi) 127.9 (Z-ArSi), 127.8 (E-ArSi), 123.4 (d, J = 11.6 
Hz, Z-C2), 122.9 (d, J = 10.7 Hz, E-C2), 63.9 (E-C7), 63.8 (Z-C7), 62.2 (d, J = 6.7 
Hz, P(O)OCH2CH3), 61.2 (Z- CO2CH2CH3), 60.8 (E- CO2CH2CH3), 32.6 (E -C6), 
32.5 (Z-C6), 31.4 (d, J = 139.9 Hz, E-CH2P), 29.9 (d, J = 2.7 Hz, E-C4), 29.3 (d, J = 
2.8 Hz, Z-C4), 27.1 (Me3CSi), 25.8 (d, J = 3.1 Hz, E-C5), 25.2 (d, J = 140.4 Hz, Z-
CH2P), 25.1 (d, J = 2.7 Hz, Z-C5), 19.5 (Me3CSi), 16.6 (d, J = 6.3 Hz, 
P(O)OCH2CH3), 14.5 (CO2CH2CH3); 31P NMR (121 MHz, CDCl3) δ ppm 27.2 (Z-
CH2P), 27.0 (E-CH2P); HRMS; required for C30H46O6PSi 561.2801, found 561.2787. 
 
Ethyl 2-((diethoxyphosphonyl)methylene)-7-hydroxyhept-2-enoate 
 
 
 
To a stirred solution of phosphonate 4.45 (993.6 mg, 1.77 mmol) in tetrahydrofuran 
(20 mL) was added a 1M solution of tetrabutylammonium fluoride in tetrahydrofuran 
(3.60 mL, 3.6 mmol). After two hours the reaction seemed to have stopped before 
completion (TLC), a further portion of TBAF (0.6 mL, 0.6 mmol) was added. After 
one hour the mixture was evaporated, and immediately purified by flash 
chromatography (100% acetonitrile). Evaporation of the solvent gave alcohol 4.48 as 
a colourless oil (515.7 mg, 90%). Rf (100% acetonitrile): 0.20; 1H NMR (500 MHz, 
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CDCl3) δ ppm 6.90 (dd, J = 13.8, 7.3 Hz, 0.7H, Z-H3), 6.12 (dd, J = 13.0, 7.4 Hz, 
0.3H, E-H3), 4.22-4.11 (m, 2H, Z&E-CO2CH2CH3), 4.02 (app p, J = 7.2 Hz, 4H, 
P(O)OCH2CH3), 3.64-3.55 (m, 2H, Z&E-H7), 2.94 (d, J = 22.1 Hz, 1.8H, Z-CH2P), 
2.82 (d, J = 21.2 Hz, 0.7H, E-CH2P), 2.55-2.45 (m, 0.9H, E-H4), 2.32-2.22 (m, 1.8H, 
Z-H4), 1.60-1.46 (m, 4H, Z&E-H5&H6), 1.32-1.19 (m, 9H, P(O)OCH2CH3 & 
CO2CH2CH3). 13C NMR (75 MHz, CDCl3) δ ppm 166.9 (Z-C1), 147.4 (d, J = 10.6 
Hz, E-C3), 146.2 (d, J = 10.2 Hz, Z-C3), 123.1 (d, J = 11.2 Hz, Z-C2), 122.7 (d, J = 
10.6 Hz, E-C2), 62.1 (d, J = 18.8 Hz, P(O)OCH2CH3), 62.3 (Z-C7), 62.2 (E-C7), 61.2 
(Z-CO2CH2CH3), 60.9 (E-CO2CH2CH3), 32.3 (E,Z-C6), 31.2 (d, J = 140.0 Hz, E-
CH2P), 29.7 (d, J = 2.9 Hz, E-C4), 29.1 (d, J = 2.9 Hz, Z-C4), 25.5 (d, J = 3.3 Hz, E-
C5), 24.9 (d, J = 140.8 Hz, Z-CH2P), 24.8 (d, J = 3.2 Hz, Z-C5), 16.6 (d, J = 6.2 Hz, 
E-P(O)OCH2CH3), 16.6 (d, J = 6.2 Hz , Z-P(O)OCH2CH3), 14.5 (s, Z- CO2CH2CH3), 
14.5 (s, E- CO2CH2CH3); HRMS, required for C14H28O6P: 323.1624, found 323.1630. 
 
Ethyl 2-((diethoxyphosphonyl)methyl)-7-(diethoxyphosphoryl)hept-2-enoate 
 
HO
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To a solution of alcohol 4.48 (184 mg, 0.571 mmol) in dichloromethane (3 mL) under 
nitrogen was added diisopropylethylamine (200 µL, 1.15 mmol) and DMAP (14.1 mg, 
115 µmol). To this mixture was added diethyl chlorophosphate (130 µL, 0.900 mmol), 
and the mixture stirred overnight. The mixture was added to dichloromethane (5 mL) 
and saturated aqueous sodium bicarbonate solution (5 mL), and stirred vigorously for 
twenty minutes. The organic phase was separated, and the aqueous phase extracted 
with dichloromethane (5 mL). The combined organic phases were extracted with 
saturated ammonium chloride solution (5 mL), and the aqueous phase was back-
extracted with further dichloromethane (5 mL). The combined dichloromethane 
phases were dried and evaporated. Flash chromatography (5% methanol/ 
dichloromethane) afforded phosphate 4.49 (218.5 mg, 83%) as a pale yellow oil. Rf 
(5% methanol/ dichloromethane): 0.58; 1H NMR (500 MHz, CDCl3) δ ppm 6.86 (dd, 
J = 13.5, 7.3 Hz, 0.7H, Z-H3), 6.08 (dd, J = 12.9, 7.4 Hz, 0.3H, E-H3), 4.30-4.13 (m, 
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2H, Z&E-CO2CH2CH3), 4.12-3.95 (m, 10H, CH2P(O)OCH2CH3, OP(O)OCH2CH3, 
H7), 2.94 (d, J = 22.1 Hz, 1.8H, Z-CH2P), 2.84 (d, J = 21.3 Hz, 0.7H, E-CH2P), 2.52 
(dq, J = 7.4, 5.2 Hz, 0.7H, E-H4), 2.29 (dq, J = 7.4, 5.0 Hz, 2H, Z-H4), 1.78-1.62 (m, 
2H, H6), 1.59-1.48 (m, 2H, H5), 1.37-1.21 (m, 15H, CH2P(O)OCH2CH3, 
OP(O)OCH2CH3, CO2CH2CH3); 13C NMR (75 MHz, CDCl3) δ ppm 166.9 (d, J = 2.8 
Hz, C1), 146.3 (d, J = 10.4 Hz, E-C3), 145.2 (d, J = 10.4 Hz, Z-C3), 123.8 (d, J = 
11.5 Hz, z-C2), 123.3 (d, J = 10.6 Hz, E-C2), 67.5 (d, J = 6.2 Hz, E-C7OP), 67.4 (d, J 
= 5.9 Hz, Z-C7OP), 63.9 (d, J = 5.8 Hz), 63.9-63.7 (m, E&Z-CH2P(O)OCH2CH3), 
62.2 (d, J = 6.7 Hz, E&Z-OP(O)OCH2CH3), 61.2 (Z-CO2CH2CH3), 60.9 (E-
CO2CH2CH3), 31.3 (d, J = 140.0 Hz, E-CH2P), 30.2 (d, J = 7.0 Hz, Z-C6), 30.1 (d, J 
= 6.9 Hz, E-C6), 29.5 (d, J = 2.2 Hz, E-C4), 29.0 (d, J = 2.7 Hz, Z-C4), 25.4 (d, J = 
3.2 Hz, E-C5), 25.1 (d, J = 140.4 Hz, Z-CH2P), 24.7 (d, J = 2.8 Hz, Z-C5), 16.6 (d, J 
= 6.4 Hz, CH2P(O)OCH2CH3), 16.4 (d, J = 6.7 Hz, OP(O)OCH2CH3), 14.5 
(CO2CH2CH3), 31P NMR (121 MHz, CDCl3) δ ppm 27.0 (E-CH2P), 26.8 (Z-CH2P),-
0.3 (E&Z-C7OP); HRMS, required for C18H37O9P2: 459.1913, found 459.1913. 
 
Potassium 2-phosphonylmethyl-7-phosphorylhept-2-enoate 
 
 
 
Ester 4.49 (100.7 mg, 0.220 mmol) was stirred in dichloromethane (1.2 mL) under 
nitrogen, and trimethylsilyl bromide (120 µL, 0.909 mmol) was added. The mixture 
was stirred overnight, then quenched with methanol (1 mL).The mixture was 
evaporated, and the residue dissolved in 10% w/v potassium hydroxide (1 mL), and 
the mixture stirred vigorously for 3 hours. The mixture was extracted with 
dichloromethane (3x 2mL), and the organic extracts discarded. The mixture was 
passed through a short column of Dowex-50X8 H+-form (10 x 50 mm), and eluted 
with water (20 mL). The solution was neutralised with 10% w/v sodium hydroxide, 
and lyophilised. The residue was separated by preparative anion exchange 
chromatography (SourceQ® resin, 4°C, 0 to 1M ammonium bicarbonate gradient 
elution, product elutes at 220 mM ammonium bicarbonate). The product fractions 
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were lyophilised, redissolved in water (1 mL), passed through a short column of 
Dowex-50X8 (H+-form, to quench any residual ammonium bicarbonate) then 
thorough a column of Dowex-50X8 (K+-form). The filtrate was lyophilised to give 
inhibitor 4.3 (12 mg, 11%) as a mixture of (Z) and (E) isomers (65:35), with <4% 
residual ethylation. 1H NMR (500 MHz, D2O) δ ppm 5.89 (app p, J = 7.3 Hz, 0.7H, 
Z-H3), 5.11 (dd, J = 11.4, 7.2 Hz, 0.4H, Z-H3), 3.33 (dd, J = 12.5, 6.6 Hz, 1.4H, Z-
H7OP), 3.12 (app t, J = 6.7 Hz, 0.7H, E-H7OP), 2.24 (dd, J = 20.6, 3.0 Hz, 1.5H, Z-
CH2P), 2.03 (d, J = 19.4 Hz, 0.5H, E-CH2P), 1.82 (app dq, J = 7.5, 4.1 Hz, 1.5H, Z-
H4), 1.74 (app dq, J = 7.3, 4.0 Hz, 0.5H, E-H4), 1.51-1.43 (m, 0.7H, E-H6), 1.25-0.96 
(m, 3.7H, Z-H6, Z-H5, E-H5); 13C NMR (126 MHz, D2O, HSQC-DEPT135) δ ppm 
137.4 (Z-C3), 130.3 (E-C3), 64.3 (Z-C7OP), 60.4, 35.4 (E-C7OP), 34.9 (d, J = 134 
Hz, E-CH2P), 31.8 (E-C6), 29.9 (Z-C6), 29.2 (d, J = 152 Hz, Z-CH2P), 28.6 (E-C4), 
27.7 (Z-C4), 26.7 (E-C5), 24.7 (Z-C6 and/or Z-C5); 31P NMR (121 MHz, D2O) δ ppm 
19.7 (Z-C3’P), 18.3 (E-C3’-P), 3.9 (E&Z-C7OP); HRMS (electrospray, negative ion): 
required for C8H15O9P2-: 317.0191; found 317.0203. 
 
(5-Bromopentyloxy)(tert-butyl)diphenylsilane 
 
 
 
To a mixture of 1,5-pentanediol (1.044 g, 10.0 mmol) and toluene (30 mL) was added 
48% aqueous HBr (1.33 mL, 12 mmol), and the biphasic mixture was refluxed under 
nitrogen for 9 hours. The cooled mixture was diluted with diethyl ether (75 mL), and 
washed with 10% w/v aqueous sodium hydroxide (75 mL), brine (75 mL) and 3M pH 
7 potassium phosphate buffer (75 mL), dried and evaporated. The residue (1.107 g, 
6.2 mmol assuming pure alcohol) was diluted with dichloromethane (32 mL) and 
cooled to 0°C under nitrogen. DMAP (76.8 mg, 0.629 mmol), TBDPSCl (1.91 mL, 
7.45 mmol) and triethylamine (2.60 mL, 18.7 mmol) were added, and the mixture was 
stirred overnight, the ice bath being allowed to melt over this time. The mixture was 
then quenched with ammonium chloride solution (20 mL), the organic phase was 
separated and washed with further saturated ammonium chloride solution (20 mL), 
saturated aqueous sodium bicarbonate solution (20 mL), brine (20 mL). The solution 
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was dried and evaporated, and the residue purified by filtration through a short silica 
plug, eluting with 33% chloroform/hexane to give bromide 4.52 (1.572 g, 39%) with 
spectral data in accordance with the literature.202 Rf (10% chloroform/hexane): 0.26; 
1H NMR (400 MHz, CDCl3) δ ppm 7.64 (dm, J = 6.3 Hz, 4H, ArSi), 7.44-7.32 (m, 
6H, ArSi), 3.64 (t, J = 6.1 Hz, 2H, H5), 3.36 (t, J = 6.9 Hz, 2H, H1), 1.92-1.76 (m, 
2H, H2), 1.63-1.42 (m, 4H, H3, H4), 1.03 (s, 9H, Me3CSi); 13C NMR (101 MHz, 
CDCl3) δ ppm 135.6 (ArSi), 134.0 (ArSi), 129.6 (ArSi), 127.6 (ArSi), 63.6 (C5), 33.9 
(C1), 32.5 (C2), 31.6 (C4), 26.9 (Me3CSi), 24.6 (C3), 19.2 (Me3CSi). 
 
Tert-butyl(hept-6-ynyloxy)diphenylsilane 
 
 
 
To a mixture of lithium acetylide-ethylenediamine complex (379.1 mg, 4.12 mmol), 
DMSO (2.4 mL) and tetrahydrofuran (0.5 mL) at -5°C was added bromide 4.52 
(813.3 mg, 2.01 mmol) in tetrahydrofuran (0.5 mL) dropwise over thirty minutes. 
After 1.5 hours the reaction was quenched with saturated ammonium chloride solution 
(15 mL) and water (3 mL). The mixture was extracted with 50% diethyl ether/hexane 
(3x 20 mL), the combined organic phases were well washed with brine (2x 50 mL), 
dried and evaporated. Flash chromatography (15% chloroform/hexane) gave alkyne 
4.53 (370.1 mg, 53%), with spectral data in accordance with the literature.202 Rf (10% 
chloroform/hexane): 0.26; 1H NMR (400 MHz, CDCl3) δ ppm 7.64 (dm, J = 7.9 Hz, 
4H, ArSi), 7.44-7.31 (m, 6H, ArSi), 3.64 (t, J = 6.3 Hz, 2H, H7), 2.15 (dt, J = 6.7, 
6.7, 2.5 Hz, 2H, H3), 1.90 (t, J = 2.6 Hz, 1H, H1), 1.61-1.38 (m, 6H, H4, H5, H6), 
1.03 (s, 9H, Me3CSi); 13C NMR (101 MHz, CDCl3) δ ppm 135.6 (ArSi), 134.1 (ArSi), 
129.5 (ArSi), 127.6 (ArSi), 84.6 (C2), 68.168 (C1), 63.7 (C7), 32.0 (C6), 28.2 (C4), 
26.9 (Me3CSi), 25.0 (C5), 19.2 (Me3CSi), 18.4 (C3). 
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(7-Bromohept-6-ynyloxy)(tert-butyl)diphenylsilane 
 
 
 
To a solution of alkyne 4.53 (192.7 mg, 0.545 mmol) in acetone (3.1 mL) in the dark 
was added recrystallised N-bromosuccinimide (138.2 mg, 0.776 mmol) and silver(I) 
acetate (37.2 mg, 0.223 mmol). The mixture was stirred in the dark for 1.5 hours, then 
filtered through a celite plug, and the plug washed with diethyl ether (20 mL). The 
filtrate was washed with water (2x 20 mL), brine (20 mL), dried, filtered through a 
silica plug, and eluted with further diethyl ether (20 mL). The filtrate was evaporated 
to give alkynyl bromide 4.54 as a colourless oil (195 mg, 83%). Rf (10% 
chloroform/hexane): 0.49; 1H NMR (400 MHz, CDCl3) δ ppm 7.65 (dm, J = 7.7 Hz, 
4H, ArSi), 7.42-7.33 (m, 6H, ArSi), 3.65 (t, J = 6.2 Hz, 2H, H7), 2.17 (t, J = 6.6 Hz, 
2H, H3), 1.62-1.40 (m, 6H, H4, H5, H6), 1.04 (s, 9H, Me3CSi); 13C NMR (101 MHz, 
CDCl3) δ ppm 135.6 (ArSi), 134.1 (ArSi), 129.5 (ArSi), 127.6 (ArSi), 80.3 (C2), 65.8 
(C1), 63.6 (C7), 32.0 (C6), 28.0 (C4), 26.9 (Me3CSi), 25.0 (C5), 19.7 (Me3CSi), 19.2 
(C3). 
 
Methyl 7-(tert-butyldiphenylsilyloxy)-2-oxoheptanoate 
 
 
 
To a solution of alkynyl bromide 4.54 (367.2 mg, 0.855 mmol) in methanol (13 mL) 
and ethyl acetate (13 mL) at 0°C was added a solution of magnesium sulfate (258.4 
mg, 2.15 mmol) and sodium bicarbonate solution (60.8 mg, 0.724 mmol) in water (13 
mL). Further ethyl acetate (13 mL) was added, the mixture was stirred for 10 minutes 
then potassium permanganate (541.0 mg, 3.42 mmol) was added in small portions 
over 5 minutes. The resulting dark purple solution was stirred for 6 hours, filtered 
through celite, and the celite washed with ethyl acetate (30 mL). The filtrate organic 
phase was separated, and the aqueous phase extracted with ethyl acetate (30 mL). The 
combined organic phases were washed with brine until no more purple colouration 
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was extractable from the organic phase into the brine (5 x 30 mL). The organic phase 
was then dried and evaporated. Flash chromatography gave α-ketoester 4.55 as a 
colourless oil (102 mg, 29%). Rf (20% diethyl diethyl ether/hexane): 0.34; 1H NMR 
(400 MHz, CDCl3) δ ppm 7.64 (app dd, J = 7.8, 1.5 Hz, 4H, ArSi), 7.44-7.32 (m, 6H, 
ArSi), 3.84 (s, 3H, CO2Me), 3.64 (t, J = 6.3 Hz, 2H, H7), 2.80 (t, J = 7.3 Hz, 2H, 
H3), 1.68-1.49 (m, 4H, H4, H6), 1.44-1.34 (m, 2H, H5), 1.02 (s, 9H, Me3CSi); 13C 
NMR (101 MHz, CDCl3) δ ppm 194.2 (C2), 161.6 (C1), 135.6 (ArSi), 134.0 (ArSi), 
129.6 (ArSi), 127.6 (ArSi), 63.6 (C7), 52.9 (CO2Me), 39.3 (C3), 32.2 (C6), 26.9 
(Me3CSi), 25.3 (C5), 22.7 (C4), 19.2 (Me3CSi). 
 
Ethyl 2-oxohept-6-enoate 
 
 
 
A vigorously stirred portion of magnesium turnings (0.7859 g, 32.3 mmol) was 
strongly heated (heat gun) under high vacuum, and allowed to cool under nitrogen. 
Tetrahydrofuran (2.5 mL) and a small crystal of iodine was added. The mixture was 
heated to reflux for thirty seconds, and the pale grey-green mixture allowed to cool to 
room temperature. A solution of 5-pentenyl 1- bromide (2.228 g, 15.0 mmol) in 
tetrahydrofuran (2.5 mL) was prepared in a separate dry flask, and approximately half 
of this mixture was added to the magnesium turnings suspension. The mixture was 
brought to reflux for 2 minutes, and the remaining bromide solution added dropwise 
over 5 minutes. The reaction was stirred without external heating for 1.5 hours, over 
which time a dark grey suspension forms. The suspension was diluted with 
tetrahydrofuran (10 mL), and added slowly to a solution of diethyl oxalate (2.467 g, 
16.7 mmol) in THF (25 mL) under nitrogen at -78°C. A further portion of dry THF (5 
mL) was used to rinse the magnesium turnings; this solution was also slowly added to 
the diethyl oxalate solution. The solution was stirred for 30 minutes at -78°C,  and 
then the heterogeneous suspension was warmed to -10°C, where it was stirred for a 
further 30 minutes. The now homogenous solution was quenched with saturated 
aqueous ammonium chloride solution (10 mL), and concentrated on a rotary 
evaporator. The residue was diluted with water (50 mL) and chloroform (50 mL), and 
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the organic phase separated. The aqueous phase was extracted with a further 50 mL of 
chloroform, and the combined chloroform fractions washed with brine (100 mL), 
dried and evaporated. Purification of the residue by flash chromatography (10% ether/ 
hexane) gave ethyl 2-oxohept-6-enoate as a colourless oil (1.424 g, 56%). Rf (20% 
diethyl ether/hexane): 0.55; 1H NMR (500 MHz, CDCl3) δ ppm 5.77 (tdd, J = 16.9, 
10.2, 6.8, Hz, 1H, H6), 5.10-4.93 (m, 2H, H7E, H7Z), 4.33 (q, J = 7.1 Hz, 2H, 
CO2CH2CH3), 2.85 (t, J = 7.3 Hz, 2H, H3), 2.12 (app q, J = 7.1 Hz, 2H, H5), 1.76 ( 
app p, J = 7.3 Hz, 2H, H4), 1.38 (t, J = 7.2 Hz, 3H, CO2CH2CH3) 13C NMR (126 
MHz, CDCl3) δ ppm 194.5 (C2), 161.2 (C1), 137.5 (C6), 115.7 (C7), 62.4 
(CO2CH2CH3), 38.4 (C3), 32.8 (C5), 22.1(C4), 14.0 (CO2CH2CH3). 
 
Isopropyl dichloroacetate 
 
 
 
A mixture of dichloroacetic acid (80 mL, 0.970 mol) and isopropanol (25 mL, 327 
mmol) was stirred vigorously as concentrated sulfuric acid (550 µL) was added, then 
the mixture was heated to 120°C overnight under a condenser and drying tube. The 
mixture was cooled to room temperature, and diluted with dichloromethane (100 mL). 
The mixture was vigorously stirred as calcium carbonate was added in portions, until 
the mixture became too thick to stir. The mixture was filtered and the calcium salts 
washed well with chloroform, the filtrate was still acidic (pH paper) so saturated 
aqueous sodium bicarbonate solution was added cautiously until pH~6. The organic 
phase was separated and the aqueous phase diluted with an equal volume of brine and 
washed with chloroform (25 mL). The combined organic phases were dried over 
sodium sulfate and evaporated, the residue was purified by vacuum distillation (112-
118°C/160 mmHg) to give isopropyl dichloroacetate 4.57 as a colourless oil (47.866 
g, 86%). 1H NMR (500 MHz, CDCl3) δ ppm 5.89 (s, 1H, CHCl2), 5.10 (sept, 1H, J = 
6.3 Hz, OCHMe2), 1.32 (d, 6H, J = 6.3 Hz, OCHMe2); 13C NMR (126 MHz, CDCl3) 
δ ppm 164.2 (CO2iPr), 72.1 (CHCl2), 64.8 (OCHMe2), 21.6 (OCHMe2). 
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Isopropyl 7-(tert-butyldiphenylsilyloxy)-2-oxoheptanoate 
 
 
 
A solution of isopropyl dichloroacetate (2.349 g, 13.7 mmol) in isopropanol (13.5 
mL) was stirred under nitrogen at 0°C as a 1M isopropanol solution of potassium 
isopropoxide (freshly prepared from potassium metal, 13.5 mL, 13.5 mmol) was 
added dropwise. A solution of aldehyde 4.30 (2.330g, 6.84 mmol) in diethyl ether (5 
mL) was added slowly from a syringe, and the flask and syringe were washed with 
further diethyl ether (8 mL). After 1.5 hours the mixture was poured into diethyl ether 
(120 mL), and water (50 mL). The organic phase was separated and the aqueous 
phase was extracted with additional diethyl ether (100 mL). The combined organic 
phases were washed with water (50 mL) and brine (50 mL), dried and evaporated. 
The resulting crude chloroepoxide (2.873 g) was stored at -20°C before being used 
(on the same day) for the next step. 
Concurrently, powdered (-50 mesh) magnesium metal (301 mg, 12.4 mmol) was 
suspended in diethyl ether (40 mL), iodine (1.531 g, 6.05 mmol) was added, the 
mixture was refluxed under argon in the dark for three hours, and the resulting 
solution of anhydrous magnesium iodide (over excess magnesium) allowed to cool to 
room temperature in the dark.  
Crude chloroepoxide 4.58 (2.873 g) was dissolved in toluene (24 mL) and diethyl 
ether (96 mL) and the mixture was stirred and cooled to -60°C under argon. The 
magnesium iodide solution was carefully added by cannula dropwise to the 
chloroepoxide solution, care must be taken to avoid clogging the cannula with the 
excess magnesium powder. After 3.5 hours the bath had warmed to -20°C, the dark 
solution was quenched with water (50 mL) and filtered. The organic phase was 
separated, and the aqueous phase extracted with diethyl ether (2x 50 mL). The 
combined organic phases were washed with brine (50 mL), dried and evaporated. The 
crude iodoketone (2.794 g) can be stored in the dark at -20°C at this point if required.  
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The crude iodoketone was dissolved in diethyl ether (100 mL), and treated with 
commerical 40% sodium hydrogen sulfite solution (50 mL) The solution rapidly 
becomes dark, then colourless with a crystalline precipitate. After 5 minutes, a 
minimum volume of 1:1 water : saturated aqueous sodium bicarbonate solution was 
added to dissolve the precipitate, the organic phase separated and the aqueous phase 
extracted with diethyl ether (2x 50 mL). The combined organic phases were washed 
with brine (50 mL), dried and evaporated. Two rounds of flash chromatography (10% 
ethyl acetate/hexane, then 5% ethyl acetate/hexane) afforded α-ketoester 4.59 as a 
colourless oil (770.9 mg, 26%). Rf (20% ethyl acetate/hexane): 0.55; 1H NMR (500 
MHz, CDCl3) δ ppm 7.70 (dm, J = 6.5 Hz, 4H, ArSi), 7.48-7.37 (m, 6H, ArSi), 5.16 
(app oct, J = 6.3 Hz, 1.0 Hz, 1H, Me2CHOR), 3.70 (t, J = 6.3 Hz, 2H, H7), 2.83 (t, J 
= 7.4 Hz, 2H,  H3), 1.69-1.56 (m, 4H, H4, H6), 1.49-1.41 (m, 2H, H5), 1.37 (dd, J = 
6.3, 0.8 Hz, 1H, Me2CHOR), , 1.10-1.08 (app d, J = 2.4 Hz, 9H, Me3CSi);  HRMS, 
required for C26H37O4Si: 441.2461, found 441.2480. 
Distinct enolate signals, 5.69 (t, J = 7.69 Hz, enol H3), 2.26 (app q, J = 7.4 Hz, 7.2 
Hz, enol H4) 1.34 (dd, J = 6.2 Hz, iPr ester); 13C NMR (126 MHz, CDCl3) δ ppm 
195.2 (C1), 161.2 (C1), 135.8 (ArSi), 134.2 (ArSi), 129.8 (ArSi), , 127.9 (ArSi), , 70.7 
(Me2CHOR), 63.8 (C7), 39.5 (C3), 32.5 (C6), 27.1 (Me3CSi), 25.5 (C5), 23.0 (C4), 
21.9 (Me2CHOR), 19.5 (Me3CSi), distinct enol signals 165.2 (C1), 140.3 (C2), 114.0 
(C3), 70.1 (Me2CHOR), 34.9 (H6), 31.9 (C4), 22.0 (Me2CHOR). 
 
Isopropyl 7-(tert-butyldiphenylsilyloxy)-2-(diethoxyphosphonomethenyl) 
heptanoate  
 
 
 
Diisopropylamine (43 µL, 0.31 mmol) in tetrahydrofuran (2.5 mL) under nitrogen was 
stirred and cooled to -78°C, and a 1.42 M solution of n-butyllithium in hexanes (195 
µL, 0.277 mmol) was added, the resulting mixture was warmed to room temperature 
for 20 minutes, then returned to -78°C. Tetraethyl methylene bisphosphonate (75 µL, 
0.30 mmol) was added, and the mixture stirred for 30 minutes, then α-ketoester 4.59 
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(110.7 mg, 0.251 mmol) in tetrahydrofuran (1 mL) was added, and the mixture was 
stirred for 45 minutes at -78°C, then for 2 hours at room temperature. The reaction 
was quenched with saturated potassium dihydrogen phosphate (3 mL), and the 
tetrahydrofuran removed under vacuum. The precipitated salts were dissolved in the 
minimum volume of water, dichloromethane (5 mL) was added, and the aqueous 
phase was separated and washed with dichloromethane (3x 5 mL). The combined 
organic extracts were dried and evaporated. Flash chromatography (40% ethyl 
acetate/hexane) gave the desired (E)-vinylphosphonate 4.60 (41.1 mg, 28%) and the 
undesired (Z)-vinylphosphonate 4.61 (5 mg, 3%).  
(E)-isomer: Rf (40% ethyl acetate/hexane): 0.48; 1H NMR (500 MHz, CDCl3) δ ppm 
7.67 (app dd, J = 7.8, 1.5 Hz, 4H), 7.45-7.34 (m, 6H, ArSi), 6.59 (d, J = 16.7 Hz, 1H, 
H3’), 5.08 (sept., J = 6.2 Hz, 1H, Me2CHOR), 4.12 (app p, J = 7.4 Hz, 4H, 
CP(O)OCH2CH3), 3.66 (t, J = 6.5 Hz, 2H, H7), 2.72 (dt, J = 6.2, 2.0 Hz, 2H, H3), 
1.69-1.53 (m, 2H, H6), 1.53-1.38 (m, 4H, H4, H5), 1.33 (t, J = 7.1 Hz, 6H, 
CP(O)OCH2CH3), 1.28 (d, J = 6.3 Hz, 6H, Me2CHOR), 1.05 (s, 9H, Me3CSi); 13C 
NMR (126 MHz, CDCl3) δ ppm 166.0 (d, J = 29.1 Hz, C1), 152.8 (d, J = 9.4 Hz, 
C2), 135.8 (ArSi), 134.3 (ArSi), 129.7 (ArSi), 127.8 (ArSi), 124.1 (d, J = 187.1 Hz, 
C3’), 69.5 (Me2CHOR), 64.1 (C7), 62.2 (d, J = 5.8 Hz, CP(O)OCH2CH3), 34.2 
(s,1C), 32.7 (C6), 30.0 (d, J = 5.9 Hz, C3), 29.4 (d, J = 2.4 Hz, C4), 27.1 (Me3CSi), 
26.2 (C5), 21.9 (Me2CHOR), 19.4 (Me3CSi), 16.6 (d, J = 6.4 Hz, CP(O)OCH2CH3), 
31P NMR (121 MHz, CDCl3, 1H-decoupled) δ ppm 16.1 (CP(O)OEt); 31P NMR (121 
MHz, CDCl3, 1H-coupled) δ ppm 16.1 (sept, J = 7.7 Hz, HCP(O)OEt); HRMS, 
required for C31H48O6SiP 575.2958, found 575.2929. 
(Z)-isomer: Rf (40% ethyl acetate/hexane): 0.24; 1H NMR (500 MHz, CDCl3) δ ppm 
7.65 (dd, J = 7.9, 1.5 Hz, 4H, ArSi), 7.44-7.34 (m, 6H, ArSi), 5.62 (td, J = 14.9, 1.3 
Hz, 1H, H3’), 5.14 (sept., J = 6.3, Hz, 1H, Me2CHOR), 4.14-4.04 (m, 4H, 
CP(O)OCH2CH3), 3.65 (t, J = 6.4 Hz, H7), 2.36 (dt, J = 7.4, 1.1 Hz 2H, H3), 1.61-
1.50 (m, 2H, H6), 1.50-1.37 (m, 4H, H4, H5), 1.31 (t, J = 7.0 Hz, 6H, 
CP(O)OCH2CH3), 1.31 (d, J = 6.1 Hz, 6H, Me2CHOR), 1.04 (s, 9H, Me3CSi); 13C 
NMR (126 MHz, CDCl3) δ ppm 167.7 (d, J = 9.7 Hz, C1), 155.1 (d, J = 3.1 Hz, C2), 
135.8 (ArSi), 134.2 (ArSi), 129.8 (ArSi), 127.8 (ArSi), 117.3 (d, J = 187.9 Hz, C3’), 
69.5 (Me2CHOR), 63.9 (s, C7), 62.1 (d, J = 5.6 Hz, CP(O)OCH2CH3), 36.4 (d, J = 
19.0 Hz, C3), 32.4 (C5), 27.1 (Me3CSi), 27.1 (C4), 25.5 (C6), 21.9 (Me2CHOR), 19.4 
(Me3CSi), 16.5 (d, J = 6.4 Hz, CP(O)OCH2CH3); 31P NMR (121 MHz, CDCl3, 1H-
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decoupled) δ ppm 14.7 (CP(O)OEt); 31P NMR (121 MHz, CDCl3, 1H-coupled) δ ppm 
14.7 (sept, J = 7.8 Hz, HCP(O)OEt); HRMS, required for C31H48O6SiP 575.2958, 
found 575.2933. 
 
(E)-Isopropyl 7-hydroxy-2-(diethoxyphosphonomethenyl)heptanoate 
 
TBDPSO
CO2iPr
P
O
EtO
EtO
TBAF, THF
(75%)
HO
CO2iPr
P
O
EtO
EtO4.60 4.67
 
 
To a stirred solution of silyl compound 4.60 (114.2 mg, 0.200 mmol) in 
tetrahydrofuran (2 mL) was added a 1M solution of TBAF in tetrahydrofuran (400 
µL, 0.40 mmol). After 3.5 hours, the solution was evaporated, and flash 
chromatography of the residue (100% acetonitrile) afforded alcohol 4.67 as a pale 
yellow oil (49.8 mg, 75%). Rf (100% acetonitrile): 0.46; 1H NMR (500 MHz, CDCl3) 
δ ppm 6.52 (dd, J = 16.3, 3.3 Hz, 1H, H3’), 5.04 (app sext, J = 5.8 Hz, 1H), 4.12-4.02 
(m, 4H), 3.57 (dd, J = 10.9, 6.0 Hz, 2H, H7), 2.69 (br s, 2H, H3), 2.53 (br s, 1H, 
C7OH), 1.60-1.51 (m, 2H, H6), 1.51-1.35 (m, 4H, H4, H5), 1.30 (m, 6H, 
CP(O)OCH2CH3), 1.25 (m, 6H, Me2CHOR); 13C NMR (75 MHz, CDCl3) δ ppm 
165.6 (d, J = 29.5 Hz, C1), 152.4 (d, J = 9.9 Hz, C2), 123.8 (d, J = 186.8 Hz, C3’), 
69.2 (Me2CHOR), 62.3 (C7), 61.9 (d, J = 5.9 Hz, CP(O)OCH2CH3), 32.1 (C6), 29.4 
(d, J = 6.0 Hz, C3), 28.8 (d, J = 2.3 Hz, C4), 25.6 (C5), 21.6 (Me2CHOR), 16.2 (d, J 
= 6.5 Hz, CP(O)OCH2CH3); 31P NMR (121 MHz, CDCl3, 1H-decoupled) δ ppm 15.9 
(CP(O)OEt); 31P NMR (121 MHz, CDCl3, 1H-coupled) δ ppm 15.9 (sept, J = 8.0 Hz, 
HCP(O)OEt); HRMS; required for C15H30O6P: 337.1780; found: 337.1783. 
 
(E)-Isopropyl 7-(diethoxyphosphoryl)-2-(diethoxyphosphonomethenyl) 
heptanoate 
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To a stirred solution of alcohol 4.67 (49.8 mg, 0.148 mmol) in dichloromethane (1 
mL) was added diisopropylethylamine (52 µL, 0.30 mmol) and DMAP (2.6 mg, 21 
µmol). Diethyl chlorophosphate (33 µL, 0.23 mmol) was added, and the mixture was 
stirred overnight under nitrogen. The reaction was quenched with saturated aqueous 
sodium bicarbonate solution (1 mL), and stirred vigorously for 30 minutes. The 
mixture was diluted with dichloromethane (3 mL), the aqueous phase was separated 
and extracted with further dichloromethane (3x 3 mL). The combined organic extracts 
were washed with saturated ammonium chloride solution, and the aqueous phase 
back-extracted with dichloromethane (3 mL). The combined organic phases were 
dried and evaporated. The residue was purified by flash chromatography (5% 
methanol/ dichloromethane) to give phosphate ester 4.68 (65.5 mg, 94%). Rf (5% 
methanol/ dichloromethane): 0.41; 1H NMR (500 MHz, CDCl3) δ ppm 6.5 (d, J = 
16.3 Hz, 1H, H3’), 5.0 (sept, J = 6.1 Hz, 1H, Me2CHOR), 4.1-4.0 (app sext, 8H, 
CP(O)OCH2CH3, OP(O)OCH2CH3), 3.9 (app q, J = 6.7 Hz, 2H, H7), 2.66 (t, J = 6.5 
Hz, 2H, H3), 1.63 (app p, J = 7.0 Hz, 2H, H6), 1.5-1.3 (m, 4H, H4, H5), 1.3 (app q, J 
= 6.9 Hz, 12H, CP(O)OCH2CH3, OP(O)OCH2CH3), 1.2 (d, J = 6.3 Hz, 6H, 
Me2CHOR); 13C NMR (75 MHz, CDCl3) δ ppm 165.5 (d, J = 29.1 Hz, C1), 152.0 (d, 
J = 9.8 Hz, C2), 124.1 (d, J = 186.3 Hz, C3’), 69.2 (Me2CHOR), 67.3 (d, J = 6.0 Hz, 
C7), 63.5 (d, J = 5.9 Hz, OP(O)OCH2CH3), 61.8 (d, J = 5.8 Hz, CP(O)OCH2CH3), 
29.9 (d, J = 7.0 Hz, C6), 29.3 (d, J = 5.9 Hz, C3), 28.7 (d, J = 2.3 Hz, C4), 25.4 (C5), 
21.6 (Me2CHOR), 16.3 (d, J = 6.4 Hz, XP(O)OCH2CH3), 16.0 (d, J = 6.5 Hz, 
XP(O)OCH2CH3); 31P NMR (121 MHz, CDCl3, 1H-decoupled) δ ppm 15.9 
(CP(O)OCH2CH3), -0.4 (OP(O)OCH2CH3), 31P NMR (121 MHz, CDCl3, 1H-coupled) 
δ ppm 15.9 (app sept, J = 8.1 Hz, CP(O)OCH2CH3); -0.4 (app sept, J = 7.5 Hz, 
OP(O)OCH2CH3). HRMS; required for C19H39O9P2 473.2069, found 473.2047. 
 
(E,Z)-Potassium 7-(phosphoryl)-2-(phosphonomethenyl)heptanoate 
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To a solution of ester 4.68 (47.8 mg, 101 µmol) in dichloromethane (1.4 mL) was 
added trimethylsilyl bromide (135 µL, 1.02 mmol), and the mixture was stirred 
overnight under nitrogen. The reaction was quenched with methanol (1 mL) and 
evaporated. The residue was dissolved in 10% w/v potassium hydroxide (2 mL), and 
stirred vigorously for two hours. The mixture was extracted with dichloromethane (3x 
2 mL), and the organic extracts discarded. The solution was passed through a column 
of Dowex-50X8 H+-form (10 x 90 mm), and eluted with water (30 mL). The solution 
was neutralised with 10% w/v sodium hydroxide, and lyophilised. The residue was 
separated by preparative anion exchange chromatography (two rounds, SourceQ® 
resin, 4°C, 0 to 1M ammonium bicarbonate gradient elution, product elutes at 250 
mM ammonium bicarbonate). The product fractions were lyophilised, redissolved in 
water (1 mL), passed through a short column of Dowex-50X8 (H+-form, to quench 
any residual ammonium bicarbonate) then thorough a column of Dowex-50X8 (K+-
form). The filtrate was lyophilised to give inhibitor 4.4 (1.7 mg, 3%) as a 1:1 mixture 
of (E) and (Z) isomers. The bromide side product 4.69 was also isolated from the 
chromatography step (eluting at 140 mM ammonium bicarbonate) as its 
tris(ammonium) salt (16.4 mg, 47%).  
Inhibitor 4.4: 1H NMR (500 MHz, D2O, presat) δ ppm 6.58 (d, J = 11.9 Hz, 1H, Z-
H3’), 5.91 (d, J = 14.7 Hz, 1H, E-H3’), 4.02 (t, J = 6.9 Hz, 2H, Z-H7’), 3.35 (t, J = 
6.8 Hz, 2H, E-H7’), 2.49 (t, J = 6.7 Hz, 2H, H3), 2.43 (t, J = 6.1, 2H, H3), 1.75-1.66 
(app p, J = 6.7 Hz, 2H, Z-H6), 1.60-1.51 (app p, J = 6.6 Hz, 2H, E-H6), 1.32-1.21 (m, 
8H, E,Z-H4, E,Z-H5); 13C NMR (126 MHz, D2O, HSQC-DEPT135) δ ppm 137.8 (d, 
J = 142.7 Hz, Z-C3’), 127.1 (d, J = 160.5 Hz, E-C3’), 66.2 (Z-C7), 35.3 (E-C7), 31.9 
(Z-C6), 29.8 (C3), 28.4 (C3), 27.9 (E-C6), 27.7 (C4s), 25.4 (C5s); 31P NMR (121 
MHz, D2O) δ ppm 9.9 (Z- C3’PO3), 7.3 (Z- C3’PO3), -3.7 (C7OPO3), -4.4 (C7OPO3).  
 
Br
CO2
-NH4
+
P
O
+H4N
-O
+H4N
-O
4.69
 
 
Bromide 4.69: 1H NMR (500 MHz, D2O) δ ppm 6.55 (d, J = 14.7 Hz, 1H, Z-H3’), 
3.40 (t, J = 6.8 Hz, 2H, H7), 2.51 (t, J = 5.8 Hz, 2H, H3), 1.83-1.71 (app p, J = 6.5 
Hz, 2H, H6), 1.39-1.34 (m, 4H, H4, H5); 13C NMR (126 MHz, D2O) δ ppm 172.2 (d, 
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J = 25.6 Hz, C1), 146.8 (d, J = 6.5 Hz, C2), 131.5 (d, J = 172.6 Hz, C3’), 35.2 (C7), 
32.0 (C6), 29.1 (d, J = 6.2 Hz, C3), 27.6 (d, J = 2.1 Hz, C4), 27.5 (C5); 31P NMR 
(121 MHz, D2O) δ ppm 9.5 (Z- C3’PO3);. HRMS (ESI, negative ion, 20% AcOH 
matrix) required for C8H13O5BrP- 298.9684, found 298.9687. 
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